| |
Title of each class
|
| |
Name of each exchange on which registered
|
|
| |
None
|
| |
Not applicable
|
|
| | Large accelerated filer ☐ | | | Accelerated filer ☐ | | | Non-accelerated filer ☒ | |
| | | | | | | | Emerging growth company ☐ | |
| | U.S. GAAP ☐ | | | International Financial Reporting Standards as issued by the International Accounting Standards Board ☒ | | | Other ☐ | |
| | |
Name
|
| | |
Position
|
| |
| | | Stephen O’Connor | | | | Chairman | | |
| | | Colin Bell | | | | Executive Director and Chief Executive Officer | | |
| | | David Watts | | | | Executive Director and Chief Financial Officer | | |
| | | Norma Dove-Edwin | | | | Independent Non-Executive Director | | |
| | | Yukiko Omura | | | | Independent Non-Executive Director | | |
| | | Juliet Ellis | | | | Independent Non-Executive Director | | |
| | | Dr Eric Strutz | | | | Independent Non-Executive Director | | |
| | | John Trueman | | | | Deputy Chairman and Non-Executive Director | | |
| | | Andrew Wright | | | | Independent Non-Executive Director | | |
| | |
Name
|
| | |
Position
|
| | |
Other principal activities outside the company
|
| |
| | | Colin Bell | | | |
Chairman
Chief Executive Officer, HSBC Bank plc and Europe |
| | | Member of the Supervisory Board, HSBC Trinkaus & Burkhardt GmbH (previously HSBC Trinkaus & Burkhardt AG) | | |
| | | Heidi Ashley | | | | Head of Communications, Europe | | | | | | |
| | | Andrew Beane | | | | Head of Commercial Banking, Europe | | | | | | |
| | | Richard Blackburn | | | | Chief Risk Officer, Europe | | | | | | |
| | | Alison Campbell | | | | Company Secretary, HSBC Bank plc and Europe | | | | | | |
| | | Mark Charles | | | | General Counsel, Europe | | | | | | |
| | | Patrick George | | | | Head of Global Markets | | | | | | |
| | | Lisa McGeough | | | | Head of Global Banking | | | | | | |
| | | Terecina Kwong | | | | Chief Operating Officer, Europe | | | | Director, HSBC Bank Armenia cjsc, HSBC Bank Malta p.l.c1 and Vizolution Limited | | |
| | |
Rachel Montgomerie
|
| | | Head of Human Resources, Europe | | | | | | |
| | | Nicolo Salsano | | | | Chief Executive, HSBC Germany | | | | | | |
| | | Andrew Sowter | | | | Head of Regulatory Compliance | | | | | | |
| | | David Watts | | | | Chief Financial Officer, Europe | | | | | | |
| | | Andrew Wild | | | | Chief Executive, HSBC Continental Europe | | | | Director, HSBC Continental Europe | | |
| | | | |
As of 31 December 2021 in £m
|
| |||
| |
Share capital of HSBC Bank plc
|
| | | | | | |
| | Ordinary shares (of nominal value £1 each) | | | |
|
797
|
| |
| | Preference shares ($0.01 non-cumulative third dollar preference shares) | | | |
|
0.172
|
| |
| | Equity | | | | | | | |
| | Called up share capital | | | |
|
797
|
| |
| | Other equity instruments1 | | | |
|
3,722
|
| |
| | Other reserves | | | |
|
(5,670)
|
| |
| | Retained earnings | | | |
|
24,735
|
| |
| | Total shareholders’ equity | | | | | 23,584 | | |
| | Non-controlling interests | | | |
|
131
|
| |
| | Total equity | | | | | 23,715 | | |
| | Group indebtedness2 | | | | | | | |
| | Debt securities in issue | | | |
|
9,428
|
| |
| | Trading liabilities – Debt securities in issue | | | |
|
1,324
|
| |
| | Debt securities in issue designated at fair value | | | |
|
26,049
|
| |
| | Subordinated liabilities | | | |
|
14,713
|
| |
| | Total indebtedness | | | | | 51,514 | | |
| | Total capitalisation and indebtedness | | | | | 75,229 | | |
| | |
Net operating income
|
| | |
2021
£m |
| | |
2020
£m |
| | |
2019
£m |
| | |||||||||
| | | | | | | |
|
6,120
|
| | | | | | 5,900 | | | | | | | 6,044 | | | |
| | |
– UK
|
| | | |
|
2,937
|
| | | | | | 2,914 | | | | | | | 2,987 | | | |
| | |
– France
|
| | | |
|
1,677
|
| | | | | | 1,528 | | | | | | | 1,653 | | | |
| | |
– Germany
|
| | | |
|
887
|
| | | | | | 814 | | | | | | | 710 | | | |
| | |
– Other countries
|
| | | |
|
619
|
| | | | | | 644 | | | | | | | 694 | | | |
| | | | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
| | For the year (£m) | | | | | | | | | | | | | | | | | | | |
| | Profit/(loss) before tax (reported basis) | | | |
|
1,023
|
| | | | | (1,614) | | | | | | (872) | | |
| | Profit/(loss) before tax (adjusted basis)1 | | | |
|
1,577
|
| | | | | (184) | | | | | | 603 | | |
| | Net operating income before change in expected credit losses and other credit impairment charges (reported basis)2 | | | |
|
6,120
|
| | | | | 5,900 | | | | | | 6,044 | | |
| | Profit/(loss) attributable to the parent company | | | |
|
1,041
|
| | | | | (1,488) | | | | | | (1,013) | | |
| | At year-end (£m) | | | | | | | | | | | | | | | | | | | |
| | Total equity attributable to shareholders of the parent company | | | |
|
23,584
|
| | | | | 23,666 | | | | | | 23,503 | | |
| | Total assets | | | |
|
596,611
|
| | | | | 681,150 | | | | | | 636,491 | | |
| | Risk-weighted assets3 | | | |
|
104,314
|
| | | | | 122,392 | | | | | | 125,413 | | |
| | Loans and advances to customers (net of impairment allowances) | | | |
|
91,177
|
| | | | | 101,491 | | | | | | 108,391 | | |
| | Customer accounts | | | |
|
205,241
|
| | | | | 195,184 | | | | | | 177,236 | | |
| | Capital ratios (%)3 | | | | | | | | | | | | | | | | | | | |
| | Common equity tier 1 | | | |
|
17.3
|
| | | | | 14.7 | | | | | | 14.2 | | |
| | Tier 1 | | | |
|
21.0
|
| | | | | 18.1 | | | | | | 17.6 | | |
| |
Total capital
|
| | |
|
31.7
|
| | | | | 27.3 | | | | | | 27.9 | | |
| | Performance, efficiency and other ratios (annualised %) | | | | | | | | | | | | | | | | | | | |
| | Return on average ordinary shareholders’ equity4 | | | |
|
4.3
|
| | | | | (7.9) | | | | | | (4.6) | | |
| | Return on tangible equity (%)5 | | | |
|
6.1
|
| | | | | (2.7) | | | | | | 0.6 | | |
| | Cost efficiency ratio (reported basis)6 | | | |
|
89.2
|
| | | | | 113.6 | | | | | | 112.2 | | |
| | Cost efficiency ratio (adjusted basis)6 | | | |
|
80.9
|
| | | | | 89.6 | | | | | | 87.9 | | |
| | Ratio of customer advances to customer accounts | | | |
|
44.4
|
| | | | | 52.0 | | | | | | 61.2 | | |
| | | | | | | | | | | | | | |
|
Markets and Securities
Services (‘MSS’) |
| |
Global Banking (‘GB’)
|
| |
GBM Other
|
| |
Commercial Banking
(‘CMB’) |
| |
Wealth and Personal Banking
(‘WPB’) |
|
|
Markets and Securities Services is a products group that services all of the company’s clients, from those in Global Banking to Commercial Banking and Wealth and Personal Banking. We offer clients a range of services and capabilities including trading, financing and securities services across asset classes and geographies, supported by dedicated sales and research teams.
Our European teams play a key role in providing cross-asset services, bridging emerging and developed markets, and collaborating with other global businesses to provide clients across the Group with bespoke products and solutions that support their growth ambitions.
We continue to invest in technology and digital transformation to enhance client experience, for example we have enhanced and automated elements of our product offering such as foreign exchange payments. We have taken actions to streamline our cost base, optimise the usage of financial resources and enhance returns. Across Europe (including the UK) we have delivered a transformation programme, pursuant to which we have streamlined our cost base through the simplification of management hierarchy, the reduction in duplicative roles and the re-location of roles from London to a lower cost location in the UK. This has improved operational efficiencies. In parallel, the group has launched a global RWA optimisation programme which, since 2019, has delivered significant gross RWA savings through initiatives such as reducing the legacy rates derivatives exposures. Conduct is at the heart of everything we do and we are determined to have the highest conduct standards in the industry.
|
| |
Global Banking delivers tailored financial solutions to corporate and institutional clients worldwide opening up opportunities through the strength of our global network and capabilities. We provide a comprehensive suite of services including corporate banking, capital markets, advisory, trade services and global liquidity and cash management.
Our European teams take a client-centric approach bringing together relationship and product expertise to deliver financial solutions customised to suit our clients’ growth ambitions and financial objectives. We work closely with our business partners including MSS, WPB and CMB, to provide a range of tailored products and services that meet the needs of clients across the company. Global Banking Europe operates as an integral part of the global business and contributes significant revenues to other regions through our European client base, supporting the Europe ambition to be the leading international wholesale bank.
|
| |
GBM Other primarily comprises Principal Investments and GBM’s share of the company’s Markets Treasury function.
The Principal Investments portfolio is focused on delivering investments that align to the group’s strategy and seeks to deliver strong returns across a diversified portfolio. Our commitment to sustainable private equity funds contributes directly to the Group’s aim to provide and facilitate $750bn and $1tn of sustainable finance and investment by 2030.
|
| | We have a clear strategy to be the leading international corporate bank in Europe. We help to connect our European customers to our international network of relationship managers and product specialists; supporting their growth ambitions and targets. Our products, which are designed to help our customers seize growth opportunities, range from term loans to region-wide treasury and trade solutions. Commercial Banking is at the centre of creating revenue synergies within the Group: we collaborate closely with our Global Banking and Markets colleagues to provide expertise in capital finance and advisory solutions to support our Commercial Banking clients. Our trade teams within Commercial Banking also provide import and export finance solutions to Global Banking and Markets clients. We also enable customers to gain visibility over their liquidity positions through our main hubs in France and Germany, which in turn helps clients to unlock efficiencies in their Treasury structures. As the European economy pivots to a net zero carbon economy, we are expanding our services and products to provide customers with innovative sustainable finance solutions and ensuring our relationship managers are informed to match these to our clients’ net zero ambitions. | | |
In Europe, Wealth and Personal Banking serves customers with their financial needs through Private Banking, Retail Banking, Wealth Management, Insurance and Asset Management.
Our core retail proposition offers a full suite of products including personal banking, mortgages, loans, credit cards, savings, investments and insurance. Alongside this, WPB offers various propositions in certain markets, including Jade, Premier, and Advance; as well as wealth solutions, financial planning and international services. In the Channel Islands and the Isle of Man, we serve local Islanders as well as international customers through our HSBC Expat proposition.
Our Private Banking proposition serves high net worth and ultra-high net worth clients with investable assets greater than $5m in Channel Islands and Isle of Man, France and Germany. The range of services available to private banking clients includes investment management, Private Wealth Solutions and bespoke lending such as lending against financial assets and residential mortgage financing for high-end properties.
Private Banking hosts a ‘Next Generation’ programme of events to support our client’s next generation in building and retaining the wealth within the family. The private bank offers this through its philanthropy advisory to our clients, which looks at business succession planning. We continue to focus on meeting the needs of our customers, the communities we serve, and our people, whilst working to build the bank of the future.
|
|
| | £(8)m | | | £589m | | | £99m | | | £490m | | | £323m | |
| | (2020: £20m) | | | (2020: £55m) | | | (2020: £(52)m) | | | (2020: £152m) | | | (2020: £(132)m) | |
| | (2019: £(305)m) | | | (2019: £617m) | | | (2019: £(111)m) | | | (2019: £457m) | | | (2019: £277m) | |
| | | | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
| | Profit/(loss) before tax (reported basis) (£m) | | | |
|
1,023
|
| | | | | (1,614) | | | | | | (872) | | |
| | Profit/(loss) before tax (adjusted basis) (£m) | | | |
|
1,577
|
| | | | | (184) | | | | | | 603 | | |
| | Cost efficiency ratio (reported) (%) | | | |
|
89.2
|
| | | | | 113.6 | | | | | | 112.2 | | |
| | Cost efficiency ratio (adjusted) (%) | | | |
|
80.9
|
| | | | | 89.6 | | | | | | 87.9 | | |
| | Return on tangible equity (%) | | | |
|
6.1
|
| | | | | (2.7) | | | | | | 0.6 | | |
| | Common equity tier 1 capital ratio (%) | | | |
|
17.3
|
| | | | | 14.7 | | | | | | 14.2 | | |
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |||||||||
| | Net interest income | | | |
|
1,754
|
| | | | | 1,898 | | | | | | 1,483 | | |
| | Net fee income | | | |
|
1,413
|
| | | | | 1,400 | | | | | | 1,344 | | |
| | Net income from financial instruments measured at fair value | | | |
|
3,432
|
| | | | | 2,314 | | | | | | 3,882 | | |
| | Gains less losses from financial investments | | | |
|
60
|
| | | | | 95 | | | | | | 38 | | |
| | Net insurance premium income | | | |
|
1,906
|
| | | | | 1,559 | | | | | | 2,147 | | |
| | Other operating income | | | |
|
594
|
| | | | | 417 | | | | | | 516 | | |
| |
Total operating income
|
| | |
|
9,159
|
| | | | | 7,683 | | | | | | 9,410 | | |
| | Net insurance claims, benefits paid and movement in liabilities to policyholders | | | |
|
(3,039)
|
| | | | | (1,783) | | | | | | (3,366) | | |
| |
Net operating income before change in expected credit losses and other credit impairment charges1
|
| | |
|
6,120
|
| | | | | 5,900 | | | | | | 6,044 | | |
| | Change in expected credit losses and other credit impairment charges | | | |
|
174
|
| | | | | (808) | | | | | | (124) | | |
| |
Net operating income
|
| | |
|
6,294
|
| | | | | 5,092 | | | | | | 5,920 | | |
| |
Total operating expenses excluding impairment of goodwill and other intangible assets2
|
| | |
|
(5,416)
|
| | | | | (5,903) | | | | | | (5,615) | | |
| | Impairment of goodwill and other intangible assets | | | |
|
(46)
|
| | | | | (802) | | | | | | (1,167) | | |
| |
Operating profit/(loss)
|
| | |
|
832
|
| | | | | (1,613) | | | | | | (862) | | |
| | Share of profit/(loss) in associates and joint ventures | | | |
|
191
|
| | | | | (1) | | | | | | (10) | | |
| |
Profit/(loss) before tax
|
| | |
|
1,023
|
| | | | | (1,614) | | | | | | (872) | | |
| | Tax credit/(expense) | | | |
|
23
|
| | | | | 136 | | | | | | (119) | | |
| |
Profit/(loss) for the year
|
| | |
|
1,046
|
| | | | | (1,478) | | | | | | (991) | | |
| | Profit/(loss) attributable to the parent company | | | |
|
1,041
|
| | | | | (1,488) | | | | | | (1,013) | | |
| | Profit attributable to non-controlling interests | | | |
|
5
|
| | | |
|
10
|
| | | |
|
22
|
| |
| | | | | |
MSS
£m |
| | |
GB
£m |
| | |
GBM
Other £m |
| | |
CMB
£m |
| | |
WPB
£m |
| | |
Corporate
Centre £m |
| | |
Total
£m |
| |||||||||||||||||||||
| | 31 Dec 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported revenue | | | | | | 2,043 | | | | | | | 1,367 | | | | | | | 310 | | | | | | | 1,096 | | | | | | | 1,276 | | | | | | | 28 | | | | | | | 6,120 | | |
| | Significant revenue items | | | | |
|
12
|
| | | | |
|
—
|
| | | | |
|
269
|
| | | | |
|
(1)
|
| | | | |
|
(1)
|
| | | | |
|
(69)
|
| | | | |
|
210
|
| |
| | – fair value movements on financial instruments1 | | | | |
|
12
|
| | | | |
|
—
|
| | | | |
|
(5)
|
| | | | |
|
(1)
|
| | | | |
|
(1)
|
| | | | |
|
—
|
| | | | |
|
5
|
| |
| | – restructuring and other related costs2 | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
274
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(69)
|
| | | | |
|
205
|
| |
| | Adjusted revenue | | | | | | 2,055 | | | | | | | 1,367 | | | | | | | 579 | | | | | | | 1,095 | | | | | | | 1,275 | | | | | | | (41) | | | | | | | 6,330 | | |
| | 31 Dec 20203 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported revenue | | | | | | 1,966 | | | | | | | 1,381 | | | | | | | 437 | | | | | | | 1,132 | | | | | | | 1,035 | | | | | | | (51) | | | | | | | 5,900 | | |
| | Significant revenue items | | | | | | 2 | | | | | | | — | | | | | | | 187 | | | | | | | 1 | | | | | | | — | | | | | | | (93) | | | | | | | 97 | | |
| | – fair value movements on financial instruments1 | | | | | | 2 | | | | | | | — | | | | | | | 2 | | | | | | | 1 | | | | | | | — | | | | | | | (2) | | | | | | | 3 | | |
| | – restructuring and other related costs2 | | | | |
|
—
|
| | | | | | — | | | | | | | 185 | | | | | | | — | | | | | | | — | | | | | | | (91) | | | | | | | 94 | | |
| | Adjusted revenue | | | | | | 1,968 | | | | | | | 1,381 | | | | | | | 624 | | | | | | | 1,133 | | | | | | | 1,035 | | | | | | | (144) | | | | | | | 5,997 | | |
| | | | | |
MSS
£m |
| | |
GB
£m |
| | |
GBM
Other £m |
| | |
CMB
£m |
| | |
WPB
£m |
| | |
Corporate
Centre £m |
| | |
Total
£m |
| |||||||||||||||||||||
| | 31 Dec 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported operating expenses | | | | | | (2,064) | | | | | | | (918) | | | | | | | (588) | | | | | | | (611) | | | | | | | (981) | | | | | | | (300) | | | | | | | (5,462) | | |
| |
Significant cost items
|
| | | | | — | | | | | | | — | | | | | | | 103 | | | | | | | (1) | | | | | | | 6 | | | | | | | 236 | | | | | | | 344 | | |
| |
– restructuring and other related costs
|
| | | | | — | | | | | | | — | | | | | | | 103 | | | | | | | (1) | | | | | | | 6 | | | | | | | 236 | | | | | | | 344 | | |
| | – settlements and provisions in connection with legal and regulatory matters | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – impairment of other intangible assets | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Adjusted operating expenses | | | | | | (2,064) | | | | | | | (918) | | | | | | | (485) | | | | | | | (612) | | | | | | | (975) | | | | | | | (64) | | | | | | | (5,118) | | |
| | 31 Dec 20202 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported operating expenses | | | | | | (1,950) | | | | | | | (878) | | | | | | | (1,351) | | | | | | | (773) | | | | | | | (1,169) | | | | | | | (584) | | | | | | | (6,705) | | |
| | Significant cost items | | | | | | 1 | | | | | | | — | | | | | | | 679 | | | | | | | 114 | | | | | | | 41 | | | | | | | 498 | | | | | | | 1,333 | | |
| | – restructuring and other related costs1 | | | | |
|
—
|
| | | | | | — | | | | | | | 218 | | | | | | | 79 | | | | | | | 5 | | | | | | | 377 | | | | | | | 679 | | |
| | – settlements and provisions in connection with legal and regulatory matters | | | | | | 1 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 8 | | | | | | | 9 | | |
| | – impairment of other intangible assets | | | | |
|
—
|
| | | | | | — | | | | | | | 461 | | | | | | | 35 | | | | | | | 36 | | | | | | | 113 | | | | | | | 645 | | |
| | Adjusted operating expenses | | | | | | (1,949) | | | | | | | (878) | | | | | | | (672) | | | | | | | (659) | | | | | | | (1,128) | | | | | | | (86) | | | | | | | (5,372) | | |
| | | | | |
MSS
£m |
| | |
GB
£m |
| | |
GBM
Other £m |
| | |
CMB
£m |
| | |
WPB
£m |
| | |
Corporate
Centre £m |
| | |
Total
£m |
| |||||||||||||||||||||
| | 31 Dec 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported profit/(loss) before tax | | | | | | (20) | | | | | | | 589 | | | | | | | (273) | | | | | | | 492 | | | | | | | 318 | | | | | | | (83) | | | | | | | 1,023 | | |
| | Net impact on reported profit and loss | | | | |
|
12
|
| | | | |
|
—
|
| | | | |
|
372
|
| | | | |
|
(2)
|
| | | | |
|
5
|
| | | | |
|
167
|
| | | | |
|
554
|
| |
| | – Significant revenue items | | | | |
|
12
|
| | | | |
|
—
|
| | | | |
|
269
|
| | | | |
|
(1)
|
| | | | |
|
(1)
|
| | | | |
|
(69)
|
| | | | |
|
210
|
| |
| | – Significant cost items | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
103
|
| | | | |
|
(1)
|
| | | | |
|
6
|
| | | | |
|
236
|
| | | | |
|
344
|
| |
| | Adjusted profit/(loss) before tax | | | | | | (8) | | | | | | | 589 | | | | | | | 99 | | | | | | | 490 | | | | | | | 323 | | | | | | | 84 | | | | | | | 1,577 | | |
| | 31 Dec 20201 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported profit/(loss) before tax | | | | | | 17 | | | | | | | 55 | | | | | | | (918) | | | | | | | 37 | | | | | | | (173) | | | | | | | (632) | | | | | | | (1,614) | | |
| | Net impact on reported profit and loss | | | | | | 3 | | | | | | | — | | | | | | | 866 | | | | | | | 115 | | | | | | | 41 | | | | | | | 405 | | | | | | | 1,430 | | |
| | – Significant revenue items | | | | | | 2 | | | | | | | — | | | | | | | 187 | | | | | | | 1 | | | | | | | — | | | | | | | (93) | | | | | | | 97 | | |
| | – Significant cost items | | | | | | 1 | | | | | | | — | | | | | | | 679 | | | | | | | 114 | | | | | | | 41 | | | | | | | 498 | | | | | | | 1,333 | | |
| | Adjusted profit/(loss) before tax | | | | | | 20 | | | | | | | 55 | | | | | | | (52) | | | | | | | 152 | | | | | | | (132) | | | | | | | (227) | | | | | | | (184) | | |
| | | | | |
MSS
£m |
| | |
GB
£m |
| | |
GBM
Other £m |
| | |
CMB
£m |
| | |
WPB
£m |
| | |
Corporate
Centre £m |
| | |
Total
£m |
| |||||||||||||||||||||
| | 31 Dec 20203 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported revenue | | | | | | 1,966 | | | | | | | 1,381 | | | | | | | 437 | | | | | | | 1,132 | | | | | | | 1,035 | | | | | | | (51) | | | | | | | 5,900 | | |
| | Significant revenue items | | | | |
|
2
|
| | | | |
|
—
|
| | | | |
|
187
|
| | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
(93)
|
| | | | |
|
97
|
| |
| | – fair value movements on financial instruments1 | | | | |
|
2
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
(2)
|
| | | | |
|
3
|
| |
| | – restructuring and other related costs2 | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
185
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(91)
|
| | | | |
|
94
|
| |
| | Adjusted revenue | | | | | | 1,968 | | | | | | | 1,381 | | | | | | | 624 | | | | | | | 1,133 | | | | | | | 1,035 | | | | | | | (144) | | | | | | | 5,997 | | |
| | 31 Dec 2019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported revenue | | | | | | 1,623 | | | | | | | 1,546 | | | | | | | 574 | | | | | | | 1,211 | | | | | | | 1,356 | | | | | | | (266) | | | | | | | 6,044 | | |
| | Significant revenue items | | | | | | 27 | | | | | | | — | | | | | | | 3 | | | | | | | 1 | | | | | | | 1 | | | | | | | (7) | | | | | | | 25 | | |
| | – UK customer redress programmes | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 1 | | | | | | | — | | | | | | | 1 | | |
| | – fair value movements on financial instruments1 | | | | | | 27 | | | | | | | — | | | | | | | 3 | | | | | | | 1 | | | | | | | — | | | | | | | (7) | | | | | | | 24 | | |
| | – restructuring and other related costs2 | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | Adjusted revenue | | | | | | 1,650 | | | | | | | 1,546 | | | | | | | 577 | | | | | | | 1,212 | | | | | | | 1,357 | | | | | | | (273) | | | | | | | 6069 | | |
| | | | | |
MSS
£m |
| | |
GB
£m |
| | |
GBM
Other £m |
| | |
CMB
£m |
| | |
WPB
£m |
| | |
Corporate
Centre £m |
| | |
Total
£m |
| |||||||||||||||||||||
| | 31 Dec 20203 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported operating expenses | | | | | | (1,950) | | | | | | | (878) | | | | | | | (1,351) | | | | | | | (773) | | | | | | | (1,169) | | | | | | | (584) | | | | | | | (6,705) | | |
| | Significant cost items | | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
679
|
| | | | |
|
114
|
| | | | |
|
41
|
| | | | |
|
498
|
| | | | |
|
1,333
|
| |
| | – restructuring and other related costs2 | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
218
|
| | | | |
|
79
|
| | | | |
|
5
|
| | | | |
|
377
|
| | | | |
|
679
|
| |
| |
– settlements and provisions in connection with legal and
regulatory matters |
| | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
8
|
| | | | |
|
9
|
| |
| | – impairment of other intangible assets | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
461
|
| | | | |
|
35
|
| | | | |
|
36
|
| | | | |
|
113
|
| | | | |
|
645
|
| |
| | Adjusted operating expenses | | | | | | (1,949) | | | | | | | (878) | | | | | | | (672) | | | | | | | (659) | | | | | | | (1,128) | | | | | | | (86) | | | | | | | (5,372) | | |
| | 31 Dec 2019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported operating expenses | | | | | | (1,950) | | | | | | | (898) | | | | | | | (830) | | | | | | | (1,175) | | | | | | | (1,729) | | | | | | | (200) | | | | | | | (6,782) | | |
| | Significant cost items | | | | | | 1 | | | | | | | — | | | | | | | 146 | | | | | | | 529 | | | | | | | 652 | | | | | | | 122 | | | | | | | 1,450 | | |
| | – costs of structural reform1 | | | | | | — | | | | | | | — | | | | | | | 29 | | | | | | | 3 | | | | | | | — | | | | | | | 55 | | | | | | | 87 | | |
| | – restructuring and other related costs | | | | | | — | | | | | | | — | | | | | | | 117 | | | | | | | 6 | | | | | | | 20 | | | | | | | 61 | | | | | | | 204 | | |
| |
– settlements and provisions in connection with legal and
regulatory matters |
| | | | | 1 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 6 | | | | | | | 7 | | |
| | – impairment of other intangible assets | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 520 | | | | | | | 632 | | | | | | | — | | | | | | | 1,152 | | |
| | Adjusted operating expenses | | | | | | (1,949) | | | | | | | (898) | | | | | | | (684) | | | | | | | (646) | | | | | | | (1,077) | | | | | | | (78) | | | | | | | (5,332) | | |
| | | | | |
MSS
£m |
| | |
GB
£m |
| | |
GBM
Other £m |
| | |
CMB
£m |
| | |
WPB
£m |
| | |
Corporate
Centre £m |
| | |
Total
£m |
| |||||||||||||||||||||
| | 31 Dec 20201 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported profit/(loss) before tax | | | | | | 17 | | | | | | | 55 | | | | | | | (918) | | | | | | | 37 | | | | | | | (173) | | | | | | | (632) | | | | | | | (1,614) | | |
| | Net impact on reported profit and loss | | | | |
|
3
|
| | | | |
|
—
|
| | | | |
|
866
|
| | | | |
|
115
|
| | | | |
|
41
|
| | | | |
|
405
|
| | | | |
|
1,430
|
| |
| | – Significant revenue items | | | | |
|
2
|
| | | | |
|
—
|
| | | | |
|
187
|
| | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
(93)
|
| | | | |
|
97
|
| |
| | – Significant cost items | | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
679
|
| | | | |
|
114
|
| | | | |
|
41
|
| | | | |
|
498
|
| | | | |
|
1,333
|
| |
| | Adjusted profit/(loss) before tax | | | | | | 20 | | | | | | | 55 | | | | | | | (52) | | | | | | | 152 | | | | | | | (132) | | | | | | | (227) | | | | | | | (184) | | |
| | 31 Dec 2019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Reported profit/(loss) before tax | | | | | | (333) | | | | | | | 617 | | | | | | | (260) | | | | | | | (73) | | | | | | | (376) | | | | | | | (447) | | | | | | | (872) | | |
| | Net impact on reported profit and loss | | | | | | 28 | | | | | | | — | | | | | | | 149 | | | | | | | 530 | | | | | | | 653 | | | | | | | 115 | | | | | | | 1,475 | | |
| | – Significant revenue items | | | | | | 27 | | | | | | | — | | | | | | | 3 | | | | | | | 1 | | | | | | | 1 | | | | | | | (7) | | | | | | | 25 | | |
| | – Significant cost items | | | | | | 1 | | | | | | | — | | | | | | | 146 | | | | | | | 529 | | | | | | | 652 | | | | | | | 122 | | | | | | | 1,450 | | |
| | Adjusted profit/(loss) before tax | | | | | | (305) | | | | | | | 617 | | | | | | | (111) | | | | | | | 457 | | | | | | | 277 | | | | | | | (332) | | | | | | | 603 | | |
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |||||||||
| | Interest income | | | |
|
3,149
|
| | | | | 4,086 | | | | | | 5,504 | | |
| | Interest expense | | | |
|
(1,395)
|
| | | | | (2,188) | | | | | | (4,021) | | |
| |
Net interest income
|
| | |
|
1,754
|
| | | | | 1,898 | | | | | | 1,483 | | |
| | Average interest-earning assets | | | |
|
354,324
|
| | | | | 369,617 | | | | | | 343,944 | | |
| | | | |
%
|
| |
%
|
| |
%
|
| |||||||||
| | Gross interest yield1 | | | |
|
0.51
|
| | | | | 0.74 | | | | | | 1.25 | | |
| | Less: gross interest payable1 | | | |
|
(0.01)
|
| | | | | (0.27) | | | | | | (0.93) | | |
| | Net interest spread2 | | | |
|
0.50
|
| | | | | 0.47 | | | | | | 0.32 | | |
| | Net interest margin3 | | | |
|
0.50
|
| | | | | 0.51 | | | | | | 0.43 | | |
| | | | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | | | |
Average
balance £m |
| |
Interest
income £m |
| |
Yield1
% |
| |
Average
balance £m |
| |
Interest
income £m |
| |
Yield1
% |
| |
Average
balance £m |
| |
Interest
income £m |
| |
Yield1
% |
| |||||||||||||||||||||||||||
| | Short term funds and loans and advances to banks | | | |
|
119,025
|
| | | |
|
(221)
|
| | | |
|
(0.19)
|
| | | | | 90,841 | | | | | | (113) | | | | | | (0.12) | | | | | | 66,056 | | | | | | 108 | | | | | | 0.16 | | |
| | Loans and advances to customers | | | |
|
99,151
|
| | | |
|
1,585
|
| | | |
|
1.60
|
| | | | | 116,518 | | | | | | 2,058 | | | | | | 1.77 | | | | | | 117,665 | | | | | | 2,492 | | | | | | 2.12 | | |
| | Reverse repurchase agreements – non-trading | | | |
|
57,630
|
| | | |
|
(132)
|
| | | |
|
(0.23)
|
| | | | | 68,573 | | | | | | 22 | | | | | | 0.03 | | | | | | 77,140 | | | | | | 478 | | | | | | 0.62 | | |
| | Financial investments | | | |
|
45,142
|
| | | |
|
497
|
| | | |
|
1.10
|
| | | | | 51,335 | | | | | | 652 | | | | | | 1.27 | | | | | | 50,194 | | | | | | 935 | | | | | | 1.86 | | |
| | Other interest-earning assets | | | |
|
33,376
|
| | | |
|
67
|
| | | |
|
0.20
|
| | | | | 42,350 | | | | | | 118 | | | | | | 0.28 | | | | | | 32,889 | | | | | | 287 | | | | | | 0.87 | | |
| |
Total interest-earning assets
|
| | |
|
354,324
|
| | | |
|
1,796
|
| | | |
|
0.51
|
| | | | | 369,617 | | | | | | 2,737 | | | | | | 0.74 | | | | | | 343,944 | | | | | | 4,300 | | | | | | 1.25 | | |
| | Trading assets and financial assets designated or mandatorily measured at fair value | | | |
|
55,806
|
| | | |
|
1,119
|
| | | |
|
2.01
|
| | | | | 66,061 | | | | | | 1,000 | | | | | | 1.51 | | | | | | 73,862 | | | | | | 1,974 | | | | | | 2.67 | | |
| | Expected credit losses provision | | | |
|
(1,326)
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | (1,347) | | | | | | — | | | | | | — | | | | | | (1,192) | | | | | | — | | | | | | — | | |
| | Non-interest-earning assets | | | |
|
239,582
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 306,223 | | | | | | — | | | | | | — | | | | | | 266,527 | | | | | | — | | | | | | — | | |
| |
Total assets
|
| | |
|
648,386
|
| | | |
|
2,915
|
| | | |
|
0.45
|
| | | | | 740,554 | | | | | | 3,737 | | | | | | 0.50 | | | | | | 683,141 | | | | | | 6,274 | | | | | | 0.92 | | |
| | | | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | | | |
Average
balance £m |
| |
Interest
income £m |
| |
Yield1
% |
| |
Average
balance £m |
| |
Interest
income £m |
| |
Yield1
% |
| |
Average
balance £m |
| |
Interest
income £m |
| |
Yield1
% |
| |||||||||||||||||||||||||||
| | UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Short term funds and loans and advances to banks | | | |
|
67,123
|
| | | |
|
228
|
| | | |
|
0.34
|
| | | | | 53,688 | | | | | | 336 | | | | | | 0.63 | | | | | | 44,068 | | | | | | 512 | | | | | | 1.16 | | |
| | Loans and advances to customers | | | |
|
39,826
|
| | | |
|
630
|
| | | |
|
1.58
|
| | | | | 50,442 | | | | | | 972 | | | | | | 1.93 | | | | | | 54,041 | | | | | | 1,353 | | | | | | 2.50 | | |
| | Reverse repurchase agreements – non-trading | | | |
|
39,012
|
| | | |
|
79
|
| | | |
|
0.20
|
| | | | | 47,508 | | | | | | 341 | | | | | | 0.72 | | | | | | 54,443 | | | | | | 759 | | | | | | 1.39 | | |
| | Financial investments | | | |
|
25,800
|
| | | |
|
209
|
| | | |
|
0.81
|
| | | | | 28,575 | | | | | | 297 | | | | | | 1.04 | | | | | | 30,230 | | | | | | 526 | | | | | | 1.74 | | |
| | Other interest-earning assets | | | |
|
25,154
|
| | | |
|
81
|
| | | |
|
0.32
|
| | | | | 34,474 | | | | | | 136 | | | | | | 0.39 | | | | | | 23,787 | | | | | | 334 | | | | | | 1.40 | | |
| |
Total interest-earning assets
|
| | |
|
196,915
|
| | | |
|
1,227
|
| | | |
|
0.62
|
| | | | | 214,687 | | | | | | 2,082 | | | | | | 0.97 | | | | | | 206,569 | | | | | | 3,484 | | | | | | 1.69 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Non UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Short term funds and loans and advances to banks | | | |
|
77,530
|
| | | |
|
(186)
|
| | | |
|
(0.24)
|
| | | | | 60,597 | | | | | | (54) | | | | | | (0.09) | | | | | | 45,808 | | | | | | 109 | | | | | | 0.24 | | |
| | Loans and advances to customers | | | |
|
59,324
|
| | | |
|
984
|
| | | |
|
1.66
|
| | | | | 66,077 | | | | | | 1,166 | | | | | | 1.76 | | | | | | 63,626 | | | | | | 1,283 | | | | | | 2.02 | | |
| | Reverse repurchase agreements – non-trading | | | |
|
21,424
|
| | | |
|
(197)
|
| | | |
|
(0.92)
|
| | | | | 25,547 | | | | | | (305) | | | | | | (1.19) | | | | | | 30,920 | | | | | | (278) | | | | | | (0.90) | | |
| | Financial investments | | | |
|
19,342
|
| | | |
|
298
|
| | | |
|
1.54
|
| | | | | 22,760 | | | | | | 359 | | | | | | 1.58 | | | | | | 19,964 | | | | | | 412 | | | | | | 2.06 | | |
| | Other interest-earning assets | | | |
|
11,726
|
| | | |
|
138
|
| | | |
|
1.18
|
| | | | | 10,968 | | | | | | 124 | | | | | | 1.13 | | | | | | 9,840 | | | | | | 223 | | | | | | 2.27 | | |
| |
Total interest-earning assets
|
| | |
|
189,346
|
| | | |
|
1,037
|
| | | |
|
0.55
|
| | | | | 185,949 | | | | | | 1,290 | | | | | | 0.69 | | | | | | 170,158 | | | | | | 1,749 | | | | | | 1.03 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Inter region elimination | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Total interest-earning assets | | | |
|
(31,937)
|
| | | |
|
(468)
|
| | | |
|
1.47
|
| | | | | (31,019) | | | | | | (635) | | | | | | 2.05 | | | | | | (32,783) | | | | | | (933) | | | | | | 2.85 | | |
| | | | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | | | |
Average
balance £m |
| |
Interest
expense £m |
| |
Cost1
% |
| |
Average
balance £m |
| |
Interest
expense £m |
| |
Cost1
% |
| |
Average
balance £m |
| |
Interest
expense £m |
| |
Cost1
% |
| |||||||||||||||||||||||||||
| | Deposits by banks | | | |
|
32,891
|
| | | |
|
(186)
|
| | | |
|
(0.57)
|
| | | | | 28,812 | | | | | | (60) | | | | | | (0.21) | | | | | | 23,298 | | | | | | 146 | | | | | | 0.63 | | |
| | Customer accounts | | | |
|
150,048
|
| | | |
|
95
|
| | | |
|
0.06
|
| | | | | 143,807 | | | | | | 321 | | | | | | 0.22 | | | | | | 136,544 | | | | | | 1,028 | | | | | | 0.75 | | |
| | Repurchase agreements – non-trading | | | |
|
32,916
|
| | | |
|
(192)
|
| | | |
|
(0.58)
|
| | | | | 38,829 | | | | | | (129) | | | | | | (0.33) | | | | | | 49,801 | | | | | | 337 | | | | | | 0.68 | | |
| | Debt securities in issue – non-trading | | | |
|
38,727
|
| | | |
|
258
|
| | | |
|
0.67
|
| | | | | 52,781 | | | | | | 546 | | | | | | 1.03 | | | | | | 54,353 | | | | | | 884 | | | | | | 1.63 | | |
| | Other interest-bearing liabilities | | | |
|
36,811
|
| | | |
|
68
|
| | | |
|
0.18
|
| | | | | 47,384 | | | | | | 160 | | | | | | 0.34 | | | | | | 38,559 | | | | | | 422 | | | | | | 1.09 | | |
| |
Total equity and interest-bearing liabilities
|
| | |
|
291,393
|
| | | |
|
43
|
| | | |
|
0.01
|
| | | | | 311,613 | | | | | | 838 | | | | | | 0.27 | | | | | | 302,555 | | | | | | 2,817 | | | | | | 0.93 | | |
| | Trading liabilities and Financial liabilities designated at fair value (excl own debt held) | | | |
|
63,925
|
| | | |
|
1,445
|
| | | |
|
2.26
|
| | | | | 65,356 | | | | | | 1,252 | | | | | | 1.92 | | | | | | 71,549 | | | | | | 1,705 | | | | | | 2.38 | | |
| | Non-interest-bearing current accounts | | | |
|
57,821
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 55,990 | | | | | | — | | | | | | — | | | | | | 50,208 | | | | | | — | | | | | | — | | |
| | Total equity and other non-interest bearing liabilities | | | |
|
235,247
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 307,595 | | | | | | — | | | | | | — | | | | | | 258,829 | | | | | | — | | | | | | — | | |
| |
Total equity and liabilities
|
| | |
|
648,386
|
| | | |
|
1,488
|
| | | |
|
0.23
|
| | | | | 740,554 | | | | | | 2,090 | | | | | | 0.28 | | | | | | 683,141 | | | | | | 4,522 | | | | | | 0.66 | | |
| | | | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | | | |
Average
balance £m |
| |
Interest
income £m |
| |
Yield1
% |
| |
Average
balance £m |
| |
Interest
income £m |
| |
Yield1
% |
| |
Average
balance £m |
| |
Interest
income £m |
| |
Yield1
% |
| |||||||||||||||||||||||||||
| | UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Deposits by banks | | | |
|
14,292
|
| | | |
|
76
|
| | | |
|
0.53
|
| | | | | 15,496 | | | | | | 256 | | | | | | 1.65 | | | | | | 15,203 | | | | | | 585 | | | | | | 3.85 | | |
| | Customer accounts | | | |
|
103,555
|
| | | |
|
100
|
| | | |
|
0.10
|
| | | | | 98,089 | | | | | | 274 | | | | | | 0.28 | | | | | | 96,364 | | | | | | 784 | | | | | | 0.81 | | |
| | Repurchase agreements – non-trading | | | |
|
25,447
|
| | | |
|
5
|
| | | |
|
0.02
|
| | | | | 31,432 | | | | | | 148 | | | | | | 0.47 | | | | | | 39,919 | | | | | | 604 | | | | | | 1.51 | | |
| | Debt securities in issue – non-trading | | | |
|
26,274
|
| | | |
|
270
|
| | | |
|
1.03
|
| | | | | 36,825 | | | | | | 576 | | | | | | 1.56 | | | | | | 40,069 | | | | | | 894 | | | | | | 2.23 | | |
| | Other interest-bearing liabilities | | | |
|
25,889
|
| | | |
|
181
|
| | | |
|
0.70
|
| | | | | 38,072 | | | | | | 261 | | | | | | 0.69 | | | | | | 31,479 | | | | | | 514 | | | | | | 1.63 | | |
| |
Total interest-bearing liabilities
|
| | |
|
195,457
|
| | | |
|
632
|
| | | |
|
0.32
|
| | | | | 219,914 | | | | | | 1,515 | | | | | | 0.69 | | | | | | 223,034 | | | | | | 3,381 | | | | | | 1.52 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Non UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Deposits by banks | | | |
|
43,076
|
| | | |
|
(30)
|
| | | |
|
(0.07)
|
| | | | | 36,090 | | | | | | 77 | | | | | | 0.21 | | | | | | 32,243 | | | | | | 184 | | | | | | 0.57 | | |
| | Customer accounts | | | |
|
46,562
|
| | | |
|
(1)
|
| | | |
|
0.00
|
| | | | | 45,832 | | | | | | 74 | | | | | | 0.16 | | | | | | 40,317 | | | | | | 267 | | | | | | 0.66 | | |
| | Repurchase agreements – non-trading | | | |
|
10,030
|
| | | |
|
(194)
|
| | | |
|
(1.93)
|
| | | | | 11,265 | | | | | | (277) | | | | | | (2.46) | | | | | | 15,960 | | | | | | (259) | | | | | | (1.62) | | |
| | Debt securities in issue – non-trading | | | |
|
14,183
|
| | | |
|
15
|
| | | |
|
0.11
|
| | | | | 17,573 | | | | | | 5 | | | | | | 0.03 | | | | | | 15,542 | | | | | | 22 | | | | | | 0.14 | | |
| | Other interest-bearing liabilities | | | |
|
13,965
|
| | | |
|
39
|
| | | |
|
0.28
|
| | | | | 12,027 | | | | | | 55 | | | | | | 0.46 | | | | | | 9,222 | | | | | | 124 | | | | | | 1.34 | | |
| |
Total interest-bearing liabilities
|
| | |
|
127,816
|
| | | |
|
(171)
|
| | | |
|
(0.13)
|
| | | | | 122,787 | | | | | | (66) | | | | | | (0.05) | | | | | | 113,284 | | | | | | 338 | | | | | | 0.30 | | |
| | Inter region elimination | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Total interest-bearing liabilities | | | |
|
(31,880)
|
| | | |
|
(418)
|
| | | |
|
1.31
|
| | | | | (31,088) | | | | | | (611) | | | | | | 1.97 | | | | | | (33,763) | | | | | | (902) | | | | | | 2.67 | | |
| | | | |
2021
% |
| |
2020
% |
| |
2019
% |
| |||||||||
| | UK | | | |
|
0.28
|
| | | | | 0.25 | | | | | | 0.03 | | |
| | Non UK | | | |
|
0.64
|
| | | | | 0.74 | | | | | | 0.83 | | |
| |
As at 31 Dec
|
| | |
|
0.50
|
| | | | | 0.51 | | | | | | 0.43 | | |
| | | | |
2021
% |
| |
2020
% |
| |
2019
% |
| |||||||||
| |
UK
|
| |
67.1
|
| |
71.0
|
| |
71.9
|
| |||||||||
| | Non UK | | | |
|
42.3
|
| | | | | 38.6 | | | | | | 39.1 | | |
| | Inter region elimination | | | |
|
(9.4)
|
| | | | | (9.6) | | | | | | (11.0) | | |
| |
As at 31 Dec
|
| | |
|
100.0
|
| | | | | 100.0 | | | | | | 100.0 | | |
| | | | | | | | | | | | | | | | | | | | | |
| |
Total Average Assets
|
| | |
|
648,386
|
| | | | | 740,554 | | | | | | 683,141 | | |
| | | | | | | | | | |
Increase/(decrease)
in 2021 compared with 2020 |
| | | | | | | |
Increase/(decrease)
in 2020 compared with 2019 |
| | | | | | | ||||||||||||||||||
| | | | |
2021
£m |
| |
Volume
£m |
| |
Rate
£m |
| |
2020
£m |
| |
Volume
£m |
| |
Rate
£m |
| |
2019
£m |
| |||||||||||||||||||||
| | Short term funds and loans and advances to banks | | | |
|
(221)
|
| | | |
|
(34)
|
| | | |
|
(74)
|
| | | | | (113) | | | | | | 40 | | | | | | (261) | | | | | | 108 | | |
| | Loans and advances to customers | | | |
|
1,585
|
| | | |
|
(308)
|
| | | |
|
(165)
|
| | | | | 2,058 | | | | | | (24) | | | | | | (410) | | | | | | 2,492 | | |
| | Reverse repurchase agreements – non trading | | | |
|
(132)
|
| | | |
|
(3)
|
| | | |
|
(151)
|
| | | | | 22 | | | | | | (53) | | | | | | (403) | | | | | | 478 | | |
| | Financial investments | | | |
|
497
|
| | | |
|
(79)
|
| | | |
|
(76)
|
| | | | | 652 | | | | | | 21 | | | | | | (304) | | | | | | 935 | | |
| | Other interest-earning assets | | | |
|
67
|
| | | |
|
(25)
|
| | | |
|
(26)
|
| | | | | 118 | | | | | | 83 | | | | | | (252) | | | | | | 287 | | |
| |
Total Interest Income
|
| | |
|
1,796
|
| | | |
|
(115)
|
| | | |
|
(826)
|
| | | | | 2,737 | | | | | | 321 | | | | | | (1,884) | | | | | | 4,300 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Short term funds and loans and advances to banks | | | |
|
228
|
| | | |
|
85
|
| | | |
|
(193)
|
| | | | | 336 | | | | | | 112 | | | | | | (288) | | | | | | 512 | | |
| | Loans and advances to customers | | | |
|
630
|
| | | |
|
(205)
|
| | | |
|
(137)
|
| | | | | 972 | | | | | | (90) | | | | | | (291) | | | | | | 1,353 | | |
| | Reverse repurchase agreements – non trading | | | |
|
79
|
| | | |
|
(61)
|
| | | |
|
(201)
|
| | | | | 341 | | | | | | (96) | | | | | | (322) | | | | | | 759 | | |
| | Financial investments | | | |
|
209
|
| | | |
|
(29)
|
| | | |
|
(59)
|
| | | | | 297 | | | | | | (29) | | | | | | (200) | | | | | | 526 | | |
| | Other interest-earning assets | | | |
|
81
|
| | | |
|
(36)
|
| | | |
|
(19)
|
| | | | | 136 | | | | | | 150 | | | | | | (348) | | | | | | 334 | | |
| |
Total Interest Income
|
| | |
|
1,227
|
| | | |
|
(172)
|
| | | |
|
(683)
|
| | | | | 2,082 | | | | | | 137 | | | | | | (1,539) | | | | | | 3,484 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Non UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Short term funds and loans and advances to banks | | | |
|
(186)
|
| | | |
|
(15)
|
| | | |
|
(117)
|
| | | | | (54) | | | | | | 35 | | | | | | (198) | | | | | | 109 | | |
| | Loans and advances to customers | | | |
|
984
|
| | | |
|
(119)
|
| | | |
|
(63)
|
| | | | | 1,166 | | | | | | 50 | | | | | | (167) | | | | | | 1,283 | | |
| | Reverse repurchase agreements – non trading | | | |
|
(197)
|
| | | |
|
49
|
| | | |
|
59
|
| | | | | (305) | | | | | | 48 | | | | | | (75) | | | | | | (278) | | |
| | Financial investments | | | |
|
298
|
| | | |
|
(54)
|
| | | |
|
(7)
|
| | | | | 359 | | | | | | 58 | | | | | | (111) | | | | | | 412 | | |
| | Other interest-earning assets | | | |
|
138
|
| | | |
|
9
|
| | | |
|
5
|
| | | | | 124 | | | | | | 26 | | | | | | (125) | | | | | | 223 | | |
| |
Total Interest Income
|
| | |
|
1,037
|
| | | |
|
24
|
| | | |
|
(277)
|
| | | | | 1,290 | | | | | | 162 | | | | | | (621) | | | | | | 1,749 | | |
| | Inter region elimination | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Total Interest Income | | | |
|
(468)
|
| | | |
|
(19)
|
| | | |
|
186
|
| | | | | (635) | | | | | | 50 | | | | | | 248 | | | | | | (933) | | |
| | | | | | | | | | |
Increase/(decrease)
in 2021 compared with 2020 |
| | | | | | | |
Increase/(decrease)
in 2020 compared with 2019 |
| | | | | | | ||||||||||||||||||
| | | | |
2021
£m |
| |
Volume
£m |
| |
Rate
£m |
| |
2020
£m |
| |
Volume
£m |
| |
Rate
£m |
| |
2019
£m |
| |||||||||||||||||||||
| | Deposits by banks | | | |
|
(186)
|
| | | |
|
(9)
|
| | | |
|
(118)
|
| | | | | (60) | | | | | | 35 | | | | | | (241) | | | | | | 146 | | |
| | Customer accounts | | | |
|
95
|
| | | |
|
14
|
| | | |
|
(240)
|
| | | | | 321 | | | | | | 55 | | | | | | (762) | | | | | | 1,028 | | |
| | Repurchase agreements – non-trading | | | |
|
(192)
|
| | | |
|
20
|
| | | |
|
(83)
|
| | | | | (129) | | | | | | (74) | | | | | | (392) | | | | | | 337 | | |
| | Debt Securities in issue – non- trading | | | |
|
258
|
| | | |
|
(145)
|
| | | |
|
(143)
|
| | | | | 546 | | | | | | (26) | | | | | | (312) | | | | | | 884 | | |
| | Other interest-bearing liabilities | | | |
|
68
|
| | | |
|
(36)
|
| | | |
|
(56)
|
| | | | | 160 | | | | | | 97 | | | | | | (359) | | | | | | 422 | | |
| |
Total Interest Expense
|
| | |
|
43
|
| | | |
|
(55)
|
| | | |
|
(741)
|
| | | | | 838 | | | | | | 84 | | | | | | (2,063) | | | | | | 2,817 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Deposits by banks | | | |
|
76
|
| | | |
|
(20)
|
| | | |
|
(160)
|
| | | | | 256 | | | | | | 11 | | | | | | (340) | | | | | | 585 | | |
| | Customer accounts | | | |
|
100
|
| | | |
|
15
|
| | | |
|
(189)
|
| | | | | 274 | | | | | | 14 | | | | | | (524) | | | | | | 784 | | |
| | Repurchase agreements – non-trading | | | |
|
5
|
| | | |
|
(28)
|
| | | |
|
(115)
|
| | | | | 148 | | | | | | (128) | | | | | | (328) | | | | | | 604 | | |
| | Debt Securities in issue – non- trading | | | |
|
270
|
| | | |
|
(165)
|
| | | |
|
(141)
|
| | | | | 576 | | | | | | (72) | | | | | | (246) | | | | | | 894 | | |
| | Other interest-bearing liabilities | | | |
|
181
|
| | | |
|
(84)
|
| | | |
|
4
|
| | | | | 261 | | | | | | 108 | | | | | | (361) | | | | | | 514 | | |
| |
Total Interest Expense
|
| | |
|
632
|
| | | |
|
(169)
|
| | | |
|
(714)
|
| | | | | 1,515 | | | | | | (47) | | | | | | (1,819) | | | | | | 3,381 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Non UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Deposits by banks | | | |
|
(30)
|
| | | |
|
15
|
| | | |
|
(122)
|
| | | | | 77 | | | | | | 22 | | | | | | (129) | | | | | | 184 | | |
| | Customer accounts | | | |
|
(1)
|
| | | |
|
1
|
| | | |
|
(76)
|
| | | | | 74 | | | | | | 37 | | | | | | (230) | | | | | | 267 | | |
| | Repurchase agreements – non-trading | | | |
|
(194)
|
| | | |
|
30
|
| | | |
|
53
|
| | | | | (277) | | | | | | 76 | | | | | | (94) | | | | | | (259) | | |
| | Debt Securities in issue – non- trading | | | |
|
15
|
| | | |
|
(1)
|
| | | |
|
11
|
| | | | | 5 | | | | | | 3 | | | | | | (20) | | | | | | 22 | | |
| | Other interest-bearing liabilities | | | |
|
39
|
| | | |
|
9
|
| | | |
|
(25)
|
| | | | | 55 | | | | | | 38 | | | | | | (107) | | | | | | 124 | | |
| |
Total Interest Expense
|
| | |
|
(171)
|
| | | |
|
(3)
|
| | | |
|
(102)
|
| | | | | (66) | | | | | | 28 | | | | | | (432) | | | | | | 338 | | |
| | Inter region elimination | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Total Interest Expense | | | |
|
(418)
|
| | | |
|
(16)
|
| | | |
|
208
|
| | | | | (611) | | | | | | 71 | | | | | | 220 | | | | | | (902) | | |
| | | | |
2021
£m |
| |||
| | Maturity of 1 year or less | | | | | | | |
| | Loans and advances to banks | | | | | 8,844 | | |
| | Loans and advances to customers | | | | | 41,439 | | |
| | | | | | | 50,283 | | |
| | Maturity after 1 year but within 5 years | | | | | | | |
| | Loans and advances to banks | | | | | 1,875 | | |
| | Loans and advances to customers | | | | | 30,879 | | |
| | | | | | | 32,754 | | |
| | Interest rate sensitivity of loans and advances to banks | | | | | | | |
| | Fixed interest rate | | | | | 1,666 | | |
| | Variable interest rate | | | | | 209 | | |
| | | | | | | 1,875 | | |
| | Interest rate sensitivity of loans and advances to customers | | | | | | | |
| | Fixed interest rate | | | | | 15,775 | | |
| | Variable interest rate | | | | | 15,104 | | |
| | | | | | | 30,879 | | |
| | Maturity after 5 years but within 15 years | | | | | | | |
| | Loans and advances to banks | | | | | 70 | | |
| | Loans and advances to customers | | | | | 11,325 | | |
| | | | | | | 11,395 | | |
| | Interest rate sensitivity of loans and advances to banks | | | | | | | |
| | Fixed interest rate | | | | | 70 | | |
| | Variable interest rate | | | | | — | | |
| | | | | | | 70 | | |
| | Interest rate sensitivity of loans and advances to customers | | | | | | | |
| | Fixed interest rate | | | | | 8,739 | | |
| | Variable interest rate | | | | | 2,586 | | |
| | | | | | | 11,325 | | |
| | Maturity after 15 years | | | | | | | |
| | Loans and advances to banks | | | |
|
—
|
| |
| | Loans and advances to customers | | | | | 8,688 | | |
| | | | | | | 8,688 | | |
| | Interest rate sensitivity of loans and advances to banks | | | | | | | |
| | Fixed interest rate | | | |
|
—
|
| |
| | Variable interest rate | | | |
|
—
|
| |
| | | | | | | | | |
| | Interest rate sensitivity of loans and advances to customers | | | | | | | |
| | Fixed interest rate | | | | | 6,572 | | |
| | Variable interest rate | | | | | 2,116 | | |
| | | | | | | 8,688 | | |
| | | | | |
2021
|
| | |
2020
|
| ||||||||||||||||||||
| | | | | |
Average
Balance £m |
| | |
Average
Rate % |
| | |
Average
Balance £m |
| | |
Average
Rate % |
| ||||||||||||
| | – demand and other – non-interest bearing | | | | |
|
3,630
|
| | | | | | | | | | | | | 3,355 | | | | | | | | | |
| | – demand – interest bearing | | | | |
|
12,990
|
| | | | |
|
(0.5)
|
| | | | | | 11,258 | | | | | | | (0.3) | | |
| | – time | | | | |
|
16,334
|
| | | | |
|
(0.7)
|
| | | | | | 14,525 | | | | | | | (0.2) | | |
| | – other | | | | |
|
4
|
| | | | |
|
30.5
|
| | | | | | 5 | | | | | | | 12.1 | | |
| |
Total
|
| | | |
|
32,958
|
| | | | | | | | | | | | | 29,143 | | | | | | | | | |
| | UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – demand and other – non-interest bearing | | | | |
|
3,590
|
| | | | | | | | | | | | | 3,308 | | | | | | | | | |
| | – demand – interest bearing | | | | |
|
8,380
|
| | | | |
|
(0.4)
|
| | | | | | 7,661 | | | | | | | (0.3) | | |
| | – time | | | | |
|
3,059
|
| | | | |
|
(0.1)
|
| | | | | | 5,145 | | | | | | | 0.7 | | |
| | – other | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | — | | | | | | | — | | |
| |
Total
|
| | | |
|
15,029
|
| | | | | | | | | | | | | 16,114 | | | | | | | | | |
| | Non-UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – demand and other – non-interest bearing | | | | |
|
40
|
| | | | | | | | | | | | | 47 | | | | | | | | | |
| | – demand – interest bearing | | | | |
|
4,610
|
| | | | |
|
(0.8)
|
| | | | | | 3,596 | | | | | | | (0.6) | | |
| | – time | | | | |
|
13,275
|
| | | | |
|
(0.9)
|
| | | | | | 9,381 | | | | | | | (0.6) | | |
| | – other | | | | |
|
4
|
| | | | |
|
30.5
|
| | | | | | 5 | | | | | | | 12.1 | | |
| |
Total
|
| | | |
|
17,929
|
| | | | | | | | | | | | | 13,029 | | | | | | | | | |
| | | | | | | | ||||||||||||||||||||||||
| | | | | |
2021
|
| | |
2020
|
| ||||||||||||||||||||
| | | | | |
Average
Balance £m |
| | |
Average
Rate % |
| | |
Average
Balance £m |
| | |
Average
Rate % |
| ||||||||||||
| | – demand and other – non-interest bearing | | | | |
|
58,437
|
| | | | | | | | | | | | | 56,874 | | | | | | | | | |
| | – demand – interest bearing | | | | |
|
113,648
|
| | | | |
|
0.0
|
| | | | | | 106,384 | | | | | | | 0.1 | | |
| | – savings | | | | |
|
18,379
|
| | | | |
|
0.2
|
| | | | | | 18,730 | | | | | | | 0.5 | | |
| | – time | | | | |
|
13,213
|
| | | | |
|
0.3
|
| | | | | | 14,066 | | | | | | | 0.6 | | |
| | – other | | | | |
|
470
|
| | | | |
|
(0.3)
|
| | | | | | 677 | | | | | | | (0.1) | | |
| | Total | | | | | | 204,147 | | | | | | | | | | | | |
|
196,731
|
| | | | | | | | |
| | UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – demand and other – non-interest bearing | | | | |
|
19,013
|
| | | | | | | | | | | | | 18,344 | | | | | | | | | |
| | – demand – interest bearing | | | | |
|
75,746
|
| | | | |
|
0.1
|
| | | | | | 71,307 | | | | | | | 0.2 | | |
| | – savings | | | | |
|
12,005
|
| | | | |
|
0.2
|
| | | | | | 10,861 | | | | | | | 0.5 | | |
| | – time | | | | |
|
11,460
|
| | | | |
|
0.1
|
| | | | | | 11,922 | | | | | | | 0.5 | | |
| | – other | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | — | | | | | | | — | | |
| | Total | | | | | | 118,224 | | | | | | | | | | | | |
|
112,433
|
| | | | | | | | |
| | Non-UK | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – demand and other – non-interest bearing | | | | |
|
39,424
|
| | | | | | | | | | | | | 38,530 | | | | | | | | | |
| | – demand – interest bearing | | | | |
|
37,902
|
| | | | |
|
0.0
|
| | | | | | 35,077 | | | | | | | 0.0 | | |
| | – savings | | | | |
|
6,374
|
| | | | |
|
0.2
|
| | | | | | 7,870 | | | | | | | 0.4 | | |
| | – time | | | | |
|
1,753
|
| | | | |
|
1.1
|
| | | | | | 2,144 | | | | | | | 1.4 | | |
| | – other | | | | |
|
470
|
| | | | |
|
(0.3)
|
| | | | | | 677 | | | | | | | (0.1) | | |
| | Total | | | | | | 85,923 | | | | | | | | | | | | |
|
84,298
|
| | | | | | | | |
| | | | |
2021
% |
| |
2020
% |
| ||||||
| |
Loans and advances to banks
|
| |
0.00
|
| |
0.00
|
| ||||||
| | Loans and advances to customers | | | |
|
0.16
|
| | | | | 0.23 | | |
| | | | |
At 31 Dec 2021
|
| |||||||||||||||||||||||||||
| | | | |
3 months
or less £m |
| |
After 3 months
but within 6 months £m |
| |
After 6 months
but within 12 months £m |
| |
After
12 months £m |
| |
Total
£m |
| |||||||||||||||
| | Uninsured time deposits | | | |
|
27,951
|
| | | |
|
1,554
|
| | | |
|
1,946
|
| | | |
|
21,292
|
| | | |
|
52,743
|
| |
| | | | |
Up to 1 year
|
| |
1 to 5 years
|
| |
5 to 10 years
|
| |
Over 10 years
|
| ||||||||||||
| | | | |
Yield %
|
| |
Yield %
|
| |
Yield %
|
| |
Yield %
|
| ||||||||||||
| | Debt securities measured at fair value through other comprehensive income | | | | | | | | | | | | | | | | | | | | | | | | | |
| | US Treasury | | | |
|
1.9
|
| | | |
|
2.1
|
| | | |
|
1.4
|
| | | |
|
3.2
|
| |
| | US Government agencies | | | |
|
0.0
|
| | | |
|
0.0
|
| | | |
|
0.0
|
| | | |
|
0.0
|
| |
| | US Government-sponsored agencies | | | |
|
0.0
|
| | | |
|
0.0
|
| | | |
|
0.0
|
| | | |
|
0.0
|
| |
| | UK Government | | | |
|
2.5
|
| | | |
|
0.5
|
| | | |
|
0.4
|
| | | |
|
2.9
|
| |
| | Hong Kong Government | | | |
|
0.0
|
| | | |
|
3.1
|
| | | |
|
0.0
|
| | | |
|
0.0
|
| |
| | Other governments | | | |
|
1.3
|
| | | |
|
1.0
|
| | | |
|
1.1
|
| | | |
|
2.7
|
| |
| | Asset-backed securities | | | |
|
9.3
|
| | | |
|
9.1
|
| | | |
|
0.5
|
| | | |
|
0.5
|
| |
| | Corporate debt and other securities | | | |
|
1.9
|
| | | |
|
1.3
|
| | | |
|
2.1
|
| | | |
|
3.0
|
| |
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |||||||||
| |
Profit/(loss)
|
| | | | | | | | | | | | | | | | | | |
| | Profit/(loss) attributable to the ordinary shareholders of the parent company | | | | | 847 | | | | | | (1,643) | | | | | | (1,120) | | |
| | Decrease/(increase) in PVIF (net of tax) | | | | | (149) | | | | | | 59 | | | | | | (56) | | |
| | Significant items (net of tax) and other adjustments1 | | | | | 468 | | | | | | 1,050 | | | | | | 1,317 | | |
| | Adjusted profit/(loss) attributable to the ordinary shareholders of the parent company | | | | | 1,166 | | | | | | (534) | | | | | | 141 | | |
| | | | | | | | | | | | | | | | | | | | | |
| | Equity | | | | | | | | | | | | | | | | | | | |
| | Average total shareholders’ equity | | | | | 23,629 | | | | | | 24,457 | | | | | | 27,028 | | |
| | Additional Tier 1 | | | | | 3,722 | | | | | | 3,722 | | | | | | 2,864 | | |
| | Average ordinary shareholders’ equity | | | | | 19,907 | | | | | | 20,735 | | | | | | 24,164 | | |
| | Effect of goodwill, PVIF and other adjustments (net of tax) | | | | | (644) | | | | | | (1,197) | | | | | | (2,170) | | |
| | Average tangible ordinary shareholders’ equity | | | | | 19,262 | | | | | | 19,538 | | | | | | 21,995 | | |
| | | | | | | | | | | | | | | | | | | | | |
| | Ratio | | | | | | | | | | | | | | | | | | | |
| | Return on average ordinary shareholders’ equity2 | | | | | 4.3% | | | | | | (7.9)% | | | | | | (4.6)% | | |
| | Return on tangible equity3 | | | | | 6.1% | | | | | | (2.7)% | | | | | | 0.6% | | |
| | | | |
At
|
| |||||||||||||||
| | | | |
31 Dec
2021 % |
| |
31 Dec
2020 % |
| |
31 Dec
2019 % |
| |||||||||
| | HSBC Bank plc | | | |
|
150
|
| | | | | 136 | | | | | | 142 | | |
| | HSBC Continental Europe | | | |
|
145
|
| | | | | 143 | | | | | | 152 | | |
| | HSBC Germany | | | |
|
170
|
| | | | | 144 | | | | | | 125 | | |
| | | | |
At
|
| |||||||||||||||
| | | | |
31 Dec
2021 % |
| |
31 Dec
2020 % |
| |
31 Dec
2019 % |
| |||||||||
| | HSBC Bank plc1 | | | | | 124 | | | | | | 133 | | | | | | 122 | | |
| | HSBC Continental Europe2 | | | |
|
130
|
| | | | | 130 | | | | | | 117 | | |
| | HSBC Germany | | | |
|
163
|
| | | | | 138 | | | | | | 121 | | |
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |||||||||
| | Currency of structural exposure | | | | | | | | | | | | | | | | | | | |
| | Euro | | | |
|
8,068
|
| | | | | 8,511 | | | | | | 8,446 | | |
| | US dollars | | | |
|
1,470
|
| | | | | 1,081 | | | | | | 1,005 | | |
| | South African rand | | | |
|
285
|
| | | | | 277 | | | | | | 324 | | |
| | Israeli new shekel | | | |
|
169
|
| | | | | 159 | | | | | | 139 | | |
| | Others, each less than £150m | | | |
|
319
|
| | | | | 446 | | | | | | 456 | | |
| |
At 31 Dec
|
| | |
|
10,311
|
| | | | | 10,474 | | | | | | 10,370 | | |
| | | | |
At estimated
liquidity value 31 Dec 2021 £m |
| |
At estimated
liquidity value 31 Dec 2020 £m |
| |
At estimated
liquidity value 31 Dec 2019 £m |
| |||||||||
| |
HSBC Bank plc
|
| | | | | | | | | | | | | | | | | | |
| | Level 1 | | | |
|
89,805
|
| | | | | 88,942 | | | | | | 68,467 | | |
| | Level 2a | | | |
|
6,320
|
| | | | | 8,260 | | | | | | 5,883 | | |
| | Level 2b | | | |
|
3,550
|
| | | | | 3,888 | | | | | | 3,289 | | |
| | HSBC Continental Europe | | | | | | | | | | | | | | | | | | | |
| | Level 1 | | | |
|
39,159
|
| | | | | 34,981 | | | | | | 32,410 | | |
| | Level 2a | | | |
|
450
|
| | | | | 267 | | | | | | 747 | | |
| | Level 2b | | | |
|
142
|
| | | | | — | | | | | | — | | |
| | HSBC Germany | | | | | | | | | | | | | | | | | | | |
| | Level 1 | | | |
|
13,072
|
| | | | | 11,044 | | | | | | 7,573 | | |
| | Level 2a | | | |
|
33
|
| | | | | 8 | | | | | | 27 | | |
| | Level 2b | | | |
|
327
|
| | | | | 315 | | | | | | 294 | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| | |
2019
£m |
| |||||||||
| | Sources | | | | | | | | | | | | | | | | | | | | | | |
| | Customer accounts | | | | |
|
205,241
|
| | | | | | 195,184 | | | | | | | 177,236 | | |
| | Deposits by banks | | | | |
|
32,188
|
| | | | | | 34,305 | | | | | | | 23,991 | | |
| | Repurchase agreements – non-trading | | | | |
|
27,259
|
| | | | | | 34,903 | | | | | | | 49,385 | | |
| | Debt securities in issue | | | | |
|
9,428
|
| | | | | | 17,371 | | | | | | | 25,039 | | |
| | Cash collateral, margin and settlement accounts | | | | |
|
37,076
|
| | | | | | 47,173 | | | | | | | 43,556 | | |
| | Subordinated liabilities | | | | |
|
12,488
|
| | | | | | 13,764 | | | | | | | 13,182 | | |
| | Financial liabilities designated at fair value | | | | |
|
33,608
|
| | | | | | 40,792 | | | | | | | 41,642 | | |
| | Liabilities under insurance contracts | | | | |
|
22,264
|
| | | | | | 22,816 | | | | | | | 24,509 | | |
| | Trading liabilities | | | | |
|
46,433
|
| | | | | | 44,229 | | | | | | | 48,026 | | |
| | – repos | | | | |
|
7,663
|
| | | | | | 8,441 | | | | | | | 349 | | |
| | – stock lending | | | | |
|
1,637
|
| | | | | | 3,356 | | | | | | | 7,498 | | |
| | – other trading liabilities | | | | |
|
37,133
|
| | | | | | 32,432 | | | | | | | 40,179 | | |
| | Total equity | | | | |
|
23,715
|
| | | | | | 23,849 | | | | | | | 24,012 | | |
| |
Other balance sheet liabilities
|
| | | |
|
146,911
|
| | | | | | 206,764 | | | | | | | 168,913 | | |
| |
At 31 Dec
|
| | | |
|
596,611
|
| | | | | | 681,150 | | | | | | | 636,491 | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| | |
2019
£m |
| |||||||||
| | Uses | | | | | | | | | | | | | | | | | | | | | | |
| | Loans and advances to customers | | | | |
|
91,177
|
| | | | | | 101,491 | | | | | | | 108,391 | | |
| | Loans and advances to banks | | | | |
|
10,784
|
| | | | | | 12,646 | | | | | | | 11,467 | | |
| | Reverse repurchase agreements – non-trading | | | | |
|
54,448
|
| | | | | | 67,577 | | | | | | | 85,756 | | |
| | Cash collateral, margin and settlement accounts | | | | |
|
34,907
|
| | | | | | 46,840 | | | | | | | 40,254 | | |
| | Assets held for sale | | | | |
|
9
|
| | | | | | 90 | | | | | | | 13 | | |
| | Trading assets | | | | |
|
83,706
|
| | | | | | 86,976 | | | | | | | 98,249 | | |
| | – reverse repos | | | | |
|
8,626
|
| | | | | | 8,182 | | | | | | | 8,358 | | |
| | – stock borrowing | | | | |
|
3,218
|
| | | | | | 4,137 | | | | | | | 5,094 | | |
| | – other trading assets | | | | |
|
71,862
|
| | | | | | 74,657 | | | | | | | 84,797 | | |
| | Financial investments | | | | |
|
41,300
|
| | | | | | 51,826 | | | | | | | 46,464 | | |
| | Cash and balances with central banks | | | | |
|
108,482
|
| | | | | | 85,092 | | | | | | | 51,816 | | |
| | Other balance sheet assets | | | | |
|
171,798
|
| | | | | | 228,612 | | | | | | | 194,081 | | |
| |
At 31 Dec
|
| | | |
|
596,611
|
| | | | | | 681,150 | | | | | | | 636,491 | | |
| | | | |
2021
£bn |
| |
2020
£bn |
| |
2019
£bn |
| |||||||||
| | Commitments to conduits | | | | | | | | | | | | | | | | | | | |
| | Multi-seller conduits1 | | | | | | | | | | | | | | | | | | | |
| | – total lines | | | |
|
4.2
|
| | | | | 5.8 | | | | | | 4.4 | | |
| | – largest individual lines | | | |
|
0.2
|
| | | | | 0.4 | | | | | | 0.2 | | |
| | Securities investment conduits – total lines | | | |
|
1.3
|
| | | | | 1.6 | | | | | | 2.4 | | |
| | Commitments to customers | | | | | | | | | | | | | | | | | | | |
| | – five largest2 | | | |
|
10.4
|
| | | | | 6.6 | | | | | | 4.4 | | |
| | – largest market sector3 | | | |
|
7.7
|
| | | | | 8.0 | | | | | | 8.7 | | |
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |||||||||
| |
Total on-balance sheet assets at 31 Dec
|
| |
596,611
|
| |
681,150
|
| |
636,491
|
| |||||||||
| | Less: | | | | | | | | | | | | | | | | | | | |
| | – reverse repo/stock borrowing receivables and derivative assets | | | |
|
(207,513)
|
| | | | | (281,125) | | | | | | (263,762) | | |
| | – other assets that cannot be pledged as collateral | | | |
|
(48,350)
|
| | | | | (51,068) | | | | | | (52,292) | | |
| |
Total on-balance sheet assets that can support funding and collateral needs at 31 Dec
|
| | |
|
340,748
|
| | | | | 348,957 | | | | | | 320,437 | | |
| | Add: off-balance sheet assets | | | | | | | | | | | | | | | | | | | |
| |
– fair value of collateral received in relation to reverse repo/stock borrowing/derivatives that is
available to sell or repledge |
| | |
|
202,794
|
| | | | | 213,690 | | | | | | 239,032 | | |
| |
Total assets that can support future funding and collateral needs
|
| | |
|
543,542
|
| | | | | 562,647 | | | | | | 559,469 | | |
| | Less: | | | | | | | | | | | | | | | | | | | |
| | – on-balance sheet assets pledged | | | |
|
(93,513)
|
| | | | | (107,671) | | | | | | (94,860) | | |
| |
– re-pledging of off-balance sheet collateral received in relation to reverse repo/stock borrowing/ derivatives |
| | |
|
(151,378)
|
| | | | | (154,486) | | | | | | (179,442) | | |
| |
Assets available to support funding and collateral needs at 31 Dec
|
| | |
|
298,651
|
| | | | | 300,490 | | | | | | 285,167 | | |
| | | | | | |
2021
£000 |
| | |
2020
£000 |
| | |
2019
£000 |
| | |||||||||
| | | Fees paid to non-executive Directors | | | | |
|
1,525
|
| | | | | | 1,256 | | | | | | | 1,136 | | | |
| | | Salaries and other emoluments1,4 | | | | |
|
3,569
|
| | | | | | 2,321 | | | | | | | 1,958 | | | |
| | | Annual incentives2 | | | | |
|
694
|
| | | | | | 576 | | | | | | | 472 | | | |
| | | Long term incentives3 | | | | |
|
511
|
| | | | | | 727 | | | | | | | 160 | | | |
| | |
Year ended 31 Dec
|
| | | |
|
6,299
|
| | | | | | 4,880 | | | | | | | 3,726 | | | |
| | | | | | |
2021
£000 |
| | |
2020
£000 |
| | |
2019
£000 |
| | |||||||||
| | | Salaries and other emoluments | | | | |
|
1,399
|
| | | | | | 1,392 | | | | | | | 1,190 | | | |
| | | Annual incentives1 | | | | |
|
558
|
| | | | | | 417 | | | | | | | 260 | | | |
| | | Long term incentives2 | | | | |
|
390
|
| | | | | | 677 | | | | | | | 105 | | | |
| | |
Year ended 31 Dec
|
| | | |
|
2,347
|
| | | | | | 2,486 | | | | | | | 1,555 | | | |
| | |
Award
|
| | |
Policy
|
| |
| | | Deferred share awards (including annual incentive awards, LTI awards delivered shares) and Group Performance Share Plan (‘GPSP’) | | | |
An assessment of performance over the relevant period ending on 31 December is used to determine the amount of the award to be granted.
•
Deferred awards generally require employees to remain in employment over the vesting period and are generally not subject to performance conditions after the grant date. An exception to these are the long-term incentive (‘LTI’) awards, which are subject to performance conditions.
Deferred share awards generally vest over a period of three, five or seven years.
Vested shares may be subject to a retention requirement post-vesting.
Awards are subject to malus and clawback.
|
| |
| | |
International Employee Share Purchase Plan
(‘ShareMatch’) |
| | |
The plan was first introduced in Hong Kong in 2013 and now includes employees based in 28 jurisdictions.
Shares are purchased in the market each quarter up to a maximum value of £750, or the equivalent in local currency.
Matching awards are added at a ratio of one free share for every three purchased.
Matching awards vest subject to continued employment and the retention of the purchased shares for a maximum period of two years and nine months.
|
| |
| | |
Main plans
|
| | |
Policy
|
| |
| | | Savings-related share option plans (‘Sharesave’) | | | |
From 2014, eligible employees for the UK plan can save up to £500 per month with the option to use the savings to acquire shares.
These are generally exercisable within six months following either the third or fifth anniversary of the commencement of a three-year or five-year contract, respectively.
The exercise price is set at a 20% (2020: 20%) discount to the market value immediately preceding the date of invitation.
|
| |
| | |
Non-executive Director
|
| | |
Appointment Date
|
| | |
Expiration of current term
|
| |
| | | Stephen O’Connor | | | | May 17, 2018 | | | | 2025 AGM | | |
| | | Norma Dove-Edwin | | | | October 28, 2021 | | | | 2025 AGM | | |
| | | Yukiko Omura | | | | May 17, 2018 | | | | 2025 AGM | | |
| | | Juliet Ellis | | | | February 1, 2021 | | | | 2024 AGM | | |
| | | Dr Eric Strutz | | | | October 28, 2016 | | | | 2023 AGM | | |
| | | John Trueman | | | | September 29, 2004 | | | | 2023 AGM | | |
| | | Andrew Wright | | | | May 17, 2018 | | | | 2025 AGM | | |
| | | | | | |
Contract date (rolling)
|
| | |
Notice period (Director and HSBC employee)
|
| |
| | | Colin Bell | | | | 22 February 2021 | | | | 6 months | | |
| | | David Watts | | | | 15 December 2021 | | | | 6 months | | |
| | | | | | |
2021
|
| | |
2020
|
| | |
2019
|
| | |||||||||
| | | Markets & Securities Services (‘MSS’) | | | | |
|
4,322
|
| | | | | | 4,590 | | | | | | | 4,508 | | | |
| | | Global Banking (‘GB’) | | | | |
|
2,458
|
| | | | | | 2,857 | | | | | | | 2,366 | | | |
| | | GBM Other | | | | |
|
140
|
| | | | | | 158 | | | | | | | 595 | | | |
| | | Commercial Banking (‘CMB’) | | | | |
|
3,023
|
| | | | | | 3,396 | | | | | | | 3,241 | | | |
| | | Wealth and Personal Banking (‘WPB’) | | | | |
|
6,709
|
| | | | | | 6,807 | | | | | | | 6,956 | | | |
| | | Corporate Centre | | | | |
|
171
|
| | | | | | 58 | | | | | | | 89 | | | |
| | | Year ended 31 Dec1,2 | | | | |
|
16,823
|
| | | | | | 17,866 | | | | | | | 17,754 | | | |
| | | | | | |
2021
|
| | |
2020
|
| | |
2019
|
| | |||||||||
| | | UK | | | | |
|
3,145
|
| | | | |
|
3,061
|
| | | | |
|
3,155
|
| | |
| | | France | | | | |
|
7,713
|
| | | | |
|
8,249
|
| | | | |
|
7,598
|
| | |
| | | Germany | | | | |
|
2,732
|
| | | | |
|
2,995
|
| | | | |
|
3,096
|
| | |
| | | Others | | | | |
|
3,233
|
| | | | |
|
3,561
|
| | | | |
|
3,905
|
| | |
| | | Total | | | | | | 16,823 | | | | | | | 17,866 | | | | | | | 17,754 | | | |
| | |
Investor Name
|
| | |
Number of shares Held
|
| | |
% of shares Held
|
| | |
Change in past three years
|
| |
| | | HSBC Holdings plc | | | | 796,969,111 | | | | 100 | | | |
Sole shareholder changed from
HSBC UK Holdings Limited to HSBC Holdings plc on 21 June 2021 |
| |
| | |
Transaction
|
| | |
For the year ended 31 December
|
| | |||||||||||||||||
| | | | | | |
2021
£000 |
| | |
20201
£000 |
| | |
20191
£000 |
| | |||||||||
| | | Short-term employee benefits2,3 | | | | |
|
13,678
|
| | | | | | 3,865 | | | | | | | 3,330 | | | |
| | | Post-employment benefits4 | | | | |
|
46
|
| | | | | | 19 | | | | | |
|
—
|
| | |
| | | Other long-term employee benefits | | | | |
|
1,378
|
| | | | | | 429 | | | | | | | 48 | | | |
| | | Share-based payments | | | | |
|
4,331
|
| | | | | | 586 | | | | | | | 348 | | | |
| | |
Total
|
| | | |
|
19,433
|
| | | | | | 4,899 | | | | | | | 3,726 | | | |
| | | | | | |
2021
|
| | |
20203
|
| | |
2019
|
| | ||||||||||||||||||||||||||||||
| | | | | | |
Balance as at
31 Dec £m |
| | |
Highest
amounts outstanding during year2 £m |
| | |
Balance as at
31 Dec £m |
| | |
Highest
amounts outstanding during year £m |
| | |
Balance as at
31 Dec £m |
| | |
Highest
amounts outstanding during year £m |
| | ||||||||||||||||||
| | | Advances and credits | | | | |
|
0.03
|
| | | | |
|
0.08
|
| | | | | | 0.03 | | | | | | | 1.5 | | | | | | | 0.2 | | | | | | | 0.4 | | | |
| | | Deposits | | | | |
|
11
|
| | | | |
|
18
|
| | | | | | 13 | | | | | | | 39 | | | | | | | 8 | | | | | | | 21 | | | |
| | | | | | |
2021
|
| | |
2020
|
| | ||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | | |
Due to/from
HSBC Holdings plc |
| | |
Due to/from subsidiaries of
HSBC Holdings plc |
| | |
Due to/ from HSBC
Holdings plc |
| | |
Due to/from subsidiaries of
HSBC Holdings plc |
| | ||||||||||||||||||||||||||||||||||||||||
| | | | | | |
Highest
balance during the year £m |
| | |
Balance
at 31 Dec £m |
| | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | ||||||||||||||||||||||||
| | | Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Trading assets | | | | |
|
108
|
| | | | |
|
19
|
| | | | |
|
4,702
|
| | | | |
|
1,360
|
| | | | | | 170 | | | | | | | 108 | | | | | | | 1,664 | | | | | | | 1,154 | | | |
| | | Derivatives | | | | |
|
2,002
|
| | | | |
|
787
|
| | | | |
|
25,566
|
| | | | |
|
21,862
|
| | | | | | 2,261 | | | | | | | 2,002 | | | | | | | 33,785 | | | | | | | 20,980 | | | |
| | |
Financial assets designated
and otherwise mandatorily measured at fair value through profit or loss |
| | | |
|
7
|
| | | | |
|
6
|
| | | | |
|
29
|
| | | | |
|
27
|
| | | | | | 7 | | | | | | | 7 | | | | | | | 29 | | | | | | | 28 | | | |
| | |
Loans and advances to banks
|
| | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
4,890
|
| | | | |
|
3,173
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 6,222 | | | | | | | 4,048 | | | |
| | | Loans and advances to customers | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
490
|
| | | | |
|
329
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 505 | | | | | | | 435 | | | |
| | | Financial investments | | | | |
|
172
|
| | | | |
|
154
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 172 | | | | | | | 172 | | | | | |
|
—
|
| | | | |
|
—
|
| | |
| | | Reverse repurchase agreements – non-trading | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2,332
|
| | | | |
|
1,690
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 4,638 | | | | | | | 1,137 | | | |
| | | Prepayments, accrued income, and other assets | | | | |
|
1,540
|
| | | | |
|
1,262
|
| | | | |
|
9,853
|
| | | | |
|
4,784
|
| | | | | | 2,228 | | | | | | | 1,431 | | | | | | | 10,821 | | | | | | | 4,250 | | | |
| | |
Total related party assets at 31 Dec
|
| | | |
|
3,829
|
| | | | |
|
2,228
|
| | | | |
|
47,862
|
| | | | |
|
33,225
|
| | | | | | 4,838 | | | | | | | 3,720 | | | | | | | 57,664 | | | | | | | 32,032 | | | |
| | | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Trading liabilities | | | | |
|
158
|
| | | | |
|
23
|
| | | | |
|
116
|
| | | | |
|
82
|
| | | | | | 406 | | | | | | | 151 | | | | | | | 742 | | | | | | | 51 | | | |
| | | Financial liabilities designated at fair value | | | | |
|
1,181
|
| | | | |
|
1,162
|
| | | | |
|
1,201
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 1,307 | | | | | | | 1,201 | | | |
| | | Deposits by banks | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
6,659
|
| | | | |
|
2,261
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 4,961 | | | | | | | 2,534 | | | |
| | | Customer accounts | | | | |
|
2,364
|
| | | | |
|
1,875
|
| | | | |
|
3,428
|
| | | | |
|
3,149
|
| | | | | | 4,200 | | | | | | | 2,080 | | | | | | | 2,565 | | | | | | | 2,234 | | | |
| | | Derivatives | | | | |
|
3,443
|
| | | | |
|
2,074
|
| | | | |
|
26,152
|
| | | | |
|
22,133
|
| | | | | | 4,649 | | | | | | | 3,443 | | | | | | | 30,283 | | | | | | | 20,878 | | | |
| | | Subordinated liabilities | | | | |
|
9,485
|
| | | | |
|
9,251
|
| | | | |
|
10,421
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 10,756 | | | | | | | 10,421 | | | |
| | | Repurchase agreements – non-trading | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
6,162
|
| | | | |
|
1,841
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 8,738 | | | | | | | 1,028 | | | |
| | |
Provisions, accruals, deferred
income, and other liabilities |
| | | |
|
189
|
| | | | |
|
179
|
| | | | |
|
8,057
|
| | | | |
|
3,826
|
| | | | | | 103 | | | | | | | 74 | | | | | | | 10,719 | | | | | | | 3,097 | | | |
| | |
Total related party liabilities at 31 Dec
|
| | | |
|
16,820
|
| | | | |
|
14,564
|
| | | | |
|
62,196
|
| | | | |
|
33,292
|
| | | | | | 9,358 | | | | | | | 5,748 | | | | | | | 70,071 | | | | | | | 41,444 | | | |
| | |
Guarantees and commitments
|
| | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2,622
|
| | | | |
|
2,061
|
| | | | | | — | | | | | | | — | | | | | | | 2,438 | | | | | | | 1,762 | | | |
| | | | | | |
Due to/from HSBC
Holdings plc |
| | |
Due to/from subsidiaries of
HSBC Holdings plc |
| | ||||||||||||||||||||
| | | | | | |
2021
£m |
| | |
2020
£m |
| | |
2021
£m |
| | |
2020
£m |
| | ||||||||||||
| | | Income statement | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Interest income | | | | |
|
4
|
| | | | | | 5 | | | | | |
|
32
|
| | | | | | 55 | | | |
| | | Interest expense1 | | | | |
|
50
|
| | | | | | (55) | | | | | |
|
58
|
| | | | | | 256 | | | |
| | | Fee income | | | | |
|
8
|
| | | | | | 13 | | | | | |
|
61
|
| | | | | | 55 | | | |
| | | Fee expense | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
357
|
| | | | | | 389 | | | |
| | | Trading income | | | | |
|
—
|
| | | | | | — | | | | | |
|
2
|
| | | | | | 2 | | | |
| | | Trading expense | | | | |
|
—
|
| | | | | | — | | | | | |
|
—
|
| | | | | | 2 | | | |
| | | Other operating income | | | | |
|
7
|
| | | | | | 30 | | | | | |
|
236
|
| | | | | | 365 | | | |
| | | General and administrative expenses | | | | |
|
143
|
| | | | | | 126 | | | | | |
|
2,110
|
| | | | | | 2,077 | | | |
| | | | | | |
2019
|
| | ||||||||||||||||||||||||
| | | | | | |
Due to/ from HSBC
Holdings plc |
| | |
Due to/from subsidiaries of
HSBC Holdings plc |
| | ||||||||||||||||||||
| | | | | | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | ||||||||||||
| | | Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Trading assets | | | | | | 98 | | | | | | | 75 | | | | | | | 676 | | | | | | | 302 | | | |
| | | Derivatives | | | | | | 1,685 | | | | | | | 1,447 | | | | | | | 24,696 | | | | | | | 18,130 | | | |
| | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | 8 | | | | | | | 7 | | | | | | | 198 | | | | | | | 27 | | | |
| | | Loans and advances to banks | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 5,341 | | | | | | | 1,957 | | | |
| | | Loans and advances to customers | | | | | | 406 | | | | | |
|
—
|
| | | | | | 612 | | | | | | | 400 | | | |
| | | Financial investments | | | | | | 229 | | | | | | | 160 | | | | | |
|
—
|
| | | | |
|
—
|
| | |
| | | Reverse repurchase agreements – non-trading | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 6,303 | | | | | | | 4,638 | | | |
| | | Prepayments, accrued income, and other assets | | | | | | 1,810 | | | | | | | 23 | | | | | | | 10,914 | | | | | | | 5,402 | | | |
| | |
Total related party assets at 31 Dec
|
| | | | | 4,236 | | | | | | | 1,712 | | | | | | | 48,740 | | | | | | | 30,856 | | | |
| | | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Trading liabilities | | | | | | 348 | | | | | | | 326 | | | | | | | 1,591 | | | | | | | 293 | | | |
| | | Financial liabilities designated at fair value | | | | | | 1,241 | | | | | |
|
—
|
| | | | | | 1,310 | | | | | | | 1,191 | | | |
| | | Deposits by banks | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 7,373 | | | | | | | 2,928 | | | |
| | | Customer accounts | | | | | | 3,855 | | | | | | | 1,762 | | | | | | | 3,119 | | | | | | | 1,992 | | | |
| | | Derivatives | | | | | | 3,163 | | | | | | | 1,501 | | | | | | | 22,940 | | | | | | | 18,055 | | | |
| | | Subordinated liabilities | | | | | | 6,060 | | | | | |
|
—
|
| | | | | | 10,509 | | | | | | | 9,787 | | | |
| | | Repurchase agreements – non-trading | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 4,279 | | | | | | | 4,279 | | | |
| | | Provisions, accruals, deferred income, and other liabilities | | | | | | 1,766 | | | | | | | 73 | | | | | | | 9,968 | | | | | | | 4,342 | | | |
| | |
Total related party liabilities at 31 Dec
|
| | | | | 16,433 | | | | | | | 3,662 | | | | | | | 61,089 | | | | | | | 42,867 | | | |
| | |
Guarantees and commitments
|
| | | | | — | | | | | | | — | | | | | | | 7,774 | | | | | | | 1,802 | | | |
| | | | | | |
Due to/from
HSBC Holdings plc |
| | |
Due
to/from subsidiaries of HSBC Holdings plc |
| | ||||||
| | | | | | |
2019
£m |
| | |
2019
£m |
| | ||||||
| | | Income statement | | | | | | | | | | | | | | | | |
| | | Interest income | | | | | | 9 | | | | | | | 142 | | | |
| | | Interest expense1 | | | | | | 84 | | | | | | | 329 | | | |
| | | Fee income | | | | | | 10 | | | | | | | 47 | | | |
| | | Fee expense | | | | | | 2 | | | | | | | 356 | | | |
| | | Trading income | | | | | | — | | | | | | | 8 | | | |
| | | Trading expense | | | | | | — | | | | | | | 15 | | | |
| | | Other operating income | | | | | | 69 | | | | | | | 322 | | | |
| | | General and administrative expenses | | | | | | 38 | | | | | | | 2,207 | | | |
| | | | | | |
2021
|
| | ||||||||||||||||||||||||||||||||||||||
| | | | | | |
Due to/from subsidiaries of
HSBC Bank plc subsidiaries |
| | |
Due to/from
HSBC Holdings plc |
| | |
Due to/from subsidiaries of
HSBC Holdings plc |
| | ||||||||||||||||||||||||||||||
| | | | | | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | ||||||||||||||||||
| | | Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Trading assets | | | | |
|
603
|
| | | | |
|
264
|
| | | | |
|
108
|
| | | | |
|
19
|
| | | | |
|
4,695
|
| | | | |
|
1,360
|
| | |
| | | Derivatives | | | | |
|
15,309
|
| | | | |
|
9,025
|
| | | | |
|
2,002
|
| | | | |
|
787
|
| | | | |
|
22,953
|
| | | | |
|
19,755
|
| | |
| | |
Financial assets designated and
otherwise mandatorily measured at fair value through profit or loss |
| | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | |
| | | Loans and advances to banks | | | | |
|
3,172
|
| | | | |
|
2,259
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
3,561
|
| | | | |
|
2,100
|
| | |
| | | Loans and advances to customers | | | | |
|
6,446
|
| | | | |
|
3,850
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
416
|
| | | | |
|
242
|
| | |
| | | Financial investments | | | | |
|
3,337
|
| | | | |
|
3,337
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | |
| | |
Reverse repurchase agreements –
non-trading |
| | | |
|
2,313
|
| | | | |
|
2,313
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2,058
|
| | | | |
|
1,428
|
| | |
| | |
Prepayments, accrued income
and other assets |
| | | |
|
5,921
|
| | | | |
|
1,685
|
| | | | |
|
1,537
|
| | | | |
|
1,261
|
| | | | |
|
9,327
|
| | | | |
|
4,557
|
| | |
| | |
Investments in subsidiary
undertakings |
| | | |
|
6,479
|
| | | | |
|
6,479
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | |
| | |
Total related party assets at
31 Dec |
| | | | | 43,580 | | | | | | | 29,212 | | | | | | | 3,647 | | | | | | | 2,067 | | | | | | | 43,010 | | | | | | | 29,442 | | | |
| | | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Trading liabilities | | | | |
|
112
|
| | | | |
|
49
|
| | | | |
|
158
|
| | | | |
|
21
|
| | | | |
|
116
|
| | | | |
|
82
|
| | |
| | |
Financial liabilities designated at
fair value |
| | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
1,181
|
| | | | |
|
1,162
|
| | | | |
|
1,201
|
| | | | |
|
—
|
| | |
| | | Deposits by banks | | | | |
|
1,808
|
| | | | |
|
1,229
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
3,245
|
| | | | |
|
965
|
| | |
| | | Customer accounts | | | | |
|
1,287
|
| | | | |
|
696
|
| | | | |
|
2,364
|
| | | | |
|
1,875
|
| | | | |
|
3,321
|
| | | | |
|
3,013
|
| | |
| | | Derivatives | | | | |
|
17,378
|
| | | | |
|
10,190
|
| | | | |
|
3,443
|
| | | | |
|
2,074
|
| | | | |
|
23,787
|
| | | | |
|
20,182
|
| | |
| | | Subordinated liabilities | | | | |
|
700
|
| | | | |
|
700
|
| | | | |
|
9,262
|
| | | | |
|
9,033
|
| | | | |
|
10,187
|
| | | | |
|
—
|
| | |
| | |
Repurchase agreements – non-
trading |
| | | |
|
988
|
| | | | |
|
431
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
5,670
|
| | | | |
|
1,645
|
| | |
| | |
Provisions, accruals, deferred
income and other liabilities |
| | | |
|
6,166
|
| | | | |
|
1,127
|
| | | | |
|
174
|
| | | | |
|
166
|
| | | | |
|
6,423
|
| | | | |
|
3,302
|
| | |
| | |
Total related party liabilities
at 31 Dec |
| | | | | 28,439 | | | | | | | 14,422 | | | | | | | 16,582 | | | | | | | 14,331 | | | | | | | 53,950 | | | | | | | 29,189 | | | |
| | | Guarantees and commitments | | | | |
|
5,338
|
| | | | |
|
2,676
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
1,686
|
| | | | |
|
1,130
|
| | |
| | | | | | |
2020
|
| | ||||||||||||||||||||||||||||||||||||||
| | | | | | |
Due to/from subsidiaries of
HSBC Bank plc subsidiaries |
| | |
Due to/from
HSBC Holdings plc |
| | |
Due to/from subsidiaries of
HSBC Holdings plc |
| | ||||||||||||||||||||||||||||||
| | | | | | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | ||||||||||||||||||
| | | Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Trading assets | | | | | | 907 | | | | | | | 234 | | | | | | | 169 | | | | | | | 108 | | | | | | | 1,664 | | | | | | | 1,154 | | | |
| | | Derivatives | | | | | | 19,139 | | | | | | | 15,309 | | | | | | | 2,261 | | | | | | | 2,002 | | | | | | | 31,986 | | | | | | | 19,829 | | | |
| | |
Financial assets designated and
otherwise mandatorily measured at fair value through profit or loss |
| | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | |
| | | Loans and advances to banks | | | | | | 5,263 | | | | | | | 2,123 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 4,794 | | | | | | | 3,083 | | | |
| | | Loans and advances to customers | | | | | | 8,198 | | | | | | | 6,446 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 395 | | | | | | | 322 | | | |
| | | Financial investments | | | | | | 2,214 | | | | | | | 2,214 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | |
| | |
Reverse repurchase agreements – non-trading
|
| | | | | 3,070 | | | | | | | 965 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 1,942 | | | | | | | 775 | | | |
| | |
Prepayments, accrued income and other assets
|
| | | | | 4,769 | | | | | | | 2,986 | | | | | | | 2,228 | | | | | | | 1,430 | | | | | | | 10,063 | | | | | | | 4,136 | | | |
| | | Investments in subsidiary undertakings | | | | | | 6,458 | | | | | | | 6,458 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | |
| | |
Total related party assets at
31 Dec |
| | | | | 50,018 | | | | | | | 36,735 | | | | | | | 4,658 | | | | | | | 3,540 | | | | | | | 50,844 | | | | | | | 29,299 | | | |
| | | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Trading liabilities | | | | | | 10 | | | | | | | 1 | | | | | | | 406 | | | | | | | 151 | | | | | | | 742 | | | | | | | 51 | | | |
| | |
Financial liabilities designated at
fair value |
| | | | | 318 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 1,307 | | | | | | | 1,201 | | | |
| | | Deposits by banks | | | | | | 1,956 | | | | | | | 1,096 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 3,089 | | | | | | | 1,471 | | | |
| | | Customer accounts | | | | | | 1,287 | | | | | | | 1,287 | | | | | | | 4,200 | | | | | | | 2,080 | | | | | | | 2,509 | | | | | | | 2,178 | | | |
| | | Derivatives | | | | | | 18,174 | | | | | | | 17,378 | | | | | | | 4,649 | | | | | | | 3,443 | | | | | | | 29,159 | | | | | | | 20,161 | | | |
| | | Subordinated liabilities | | | | | | 700 | | | | | | | 700 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 10,519 | | | | | | | 10,187 | | | |
| | |
Repurchase agreements – non-
trading |
| | | | | 2,349 | | | | | | | 988 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 8,468 | | | | | | | 1,028 | | | |
| | |
Provisions, accruals, deferred
income and other liabilities |
| | | | | 7,716 | | | | | | | 1,563 | | | | | | | 63 | | | | | | | 45 | | | | | | | 9,578 | | | | | | | 2,510 | | | |
| | |
Total related party liabilities
at 31 Dec |
| | | | | 32,510 | | | | | | | 23,013 | | | | | | | 9,318 | | | | | | | 5,719 | | | | | | | 65,371 | | | | | | | 38,787 | | | |
| | | Guarantees and commitments | | | | | | 11,011 | | | | | | | 4,974 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 1,427 | | | | | | | 893 | | | |
| | | | | | |
2019
|
| | ||||||||||||||||||||||||||||||||||||||
| | | | | | |
Due to/from subsidiaries of
HSBC Bank plc subsidiaries |
| | |
Due to/from
HSBC Holdings plc |
| | |
Due to/from subsidiaries of
HSBC Holdings plc |
| | ||||||||||||||||||||||||||||||
| | | | | | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | |
Highest
balance during the year £m |
| | |
Balance at
31 Dec £m |
| | ||||||||||||||||||
| | | Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Trading assets | | | | | | 1,363 | | | | | | | 907 | | | | | | | 98 | | | | | | | 75 | | | | | | | 676 | | | | | | | 302 | | | |
| | | Derivatives | | | | | | 30,022 | | | | | | | 13,839 | | | | | | | 1,685 | | | | | | | 1,447 | | | | | | | 23,229 | | | | | | | 17,134 | | | |
| | | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | 197 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | |
| | | Loans and advances to banks | | | | | | 6,290 | | | | | | | 4,029 | | | | | | | — | | | | | | | — | | | | | | | 4,871 | | | | | | | 1,404 | | | |
| | | Loans and advances to customers | | | | | | 7,771 | | | | | | | 6,969 | | | | | | | 406 | | | | | | | — | | | | | | | 586 | | | | | | | 353 | | | |
| | | Financial investments | | | | | | 185 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | |
| | |
Reverse repurchase agreements – non-trading
|
| | | | | 7,095 | | | | | | | 3,070 | | | | | | | — | | | | | | | — | | | | | | | 4,080 | | | | | | | 1,782 | | | |
| | |
Prepayments, accrued income and other assets
|
| | | | | 5,217 | | | | | | | 2,405 | | | | | | | 1,807 | | | | | | | 21 | | | | | | | 9,828 | | | | | | | 5,301 | | | |
| | | Investments in subsidiary undertakings | | | | | | 8,930 | | | | | | | 6,025 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | |
| | |
Total related party assets at 31 Dec
|
| | | | | 67,070 | | | | | | | 37,244 | | | | | | | 3,996 | | | | | | | 1,543 | | | | | | | 43,270 | | | | | | | 26,276 | | | |
| | | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Trading liabilities | | | | | | 3 | | | | | | | — | | | | | | | 348 | | | | | | | 326 | | | | | | | 1,591 | | | | | | | 293 | | | |
| | | Financial liabilities designated at fair value | | | | | | 318 | | | | | | | 318 | | | | | | | 1,241 | | | | | | | — | | | | | | | 1,310 | | | | | | | 1,191 | | | |
| | | Deposits by banks | | | | | | 3,905 | | | | | | | 1,428 | | | | | | | — | | | | | | | — | | | | | | | 5,003 | | | | | | | 1,416 | | | |
| | | Customer accounts | | | | | | 924 | | | | | | | 534 | | | | | | | 3,855 | | | | | | | 1,762 | | | | | | | 3,063 | | | | | | | 1,890 | | | |
| | | Derivatives | | | | | | 26,270 | | | | | | | 13,702 | | | | | | | 3,163 | | | | | | | 1,501 | | | | | | | 21,730 | | | | | | | 17,243 | | | |
| | | Subordinated liabilities | | | | | | 701 | | | | | | | 700 | | | | | | | 5,827 | | | | | | | — | | | | | | | 10,272 | | | | | | | 9,566 | | | |
| | | Repurchase agreements – non-trading | | | | | | 2,996 | | | | | | | 1,058 | | | | | | | — | | | | | | | — | | | | | | | 4,279 | | | | | | | 4,279 | | | |
| | | Provisions, accruals, deferred income and other liabilities | | | | | | 8,954 | | | | | | | 3,877 | | | | | | | 1,747 | | | | | | | 49 | | | | | | | 9,107 | | | | | | | 3,959 | | | |
| | |
Total related party liabilities at 31 Dec
|
| | | | | 44,071 | | | | | | | 21,617 | | | | | | | 16,181 | | | | | | | 3,638 | | | | | | | 56,355 | | | | | | | 39,837 | | | |
| | | Guarantees and commitments | | | | | | 17,029 | | | | | | | 8,749 | | | | | | | — | | | | | | | — | | | | | | | 6,604 | | | | | | | 923 | | | |
| | | | | | |
2021
|
| | | | | | | | | |
2020
|
| | | | | | | | | ||||||
| | | | | | |
Number
|
| | |
£m
|
| | |
Number
|
| | |
£m
|
| | ||||||||||||
| | | At 1 Jan | | | | | | 796,969,111 | | | | | | | 797 | | | | | | | 796,969,111 | | | | | | | 797 | | | |
| | | At 31 Dec | | | | | | 796,969,111 | | | | | | | 797 | | | | | | | 796,969,111 | | | | | | | 797 | | | |
| | | | | | |
2021
|
| | | | | | | | | |
2020
|
| | | | | | | | | ||||||
| | | | | | |
Number
|
| | |
£000
|
| | |
Number
|
| | |
£000
|
| | ||||||||||||
| | | At 1 Jan and 31 Dec | | | | | | 35,000,000 | | | | | | | 172 | | | | | | | 35,000,000 | | | | | | | 172 | | | |
| | |
Exhibit
Number |
| | |
Description
|
| |
| | | 1 | | | | | | |
| | | 8.1 | | | | | | |
| | | 15.1 | | | | | |
| | | | | HSBC Bank plc | | |||
| | | | | By: | | |
/s/ David Watts
|
|
| | | | | | | | Name: David Watts | |
| | | | | | | | Title: Director | |
| | | Index to Financial Statements and Notes on the Financial Statements | | | | | | F-1 | | | |
| | | Report of PricewaterhouseCoopers, LLP, Independent Registered Public Accounting Firm | | | | | | F-3 | | | |
| | | Consolidated Income Statements for the Years Ended 31 December, 2021, 2020 and 2019 | | | | | | F-5 | | | |
| | | Consolidated Statements of Comprehensive Income/(Loss) for the Years Ended 31 December 2021, 2020 and 2019 | | | | | | F-6 | | | |
| | | Consolidated Balance Sheet as of 31 December 2021 and 2020 | | | | | | F-7 | | | |
| | | Consolidated Statements of Cash Flows for the Years Ended 31 December 2021, 2020 and 2019 | | | | | | F-8 | | | |
| | | Consolidated Statements of Changes in Equity for the Years Ended 31 December 2021, 2020 and 2019 | | | | | | F-9 | | | |
| | | Notes to the Consolidated Financial Statements | | | | | | F-12 | | | |
| | | | | | | Page | | |
| | Consolidated income statement | | | | | F-5 | | |
| | Consolidated statement of comprehensive income | | | | | F-6 | | |
| | Consolidated balance sheet | | | | | F-7 | | |
| | Consolidated statement of cash flows | | | | | F-8 | | |
| | Consolidated statement of changes in equity | | | | | F-9 | | |
| | | | | | | | | |
| | | | | | F-12 | | | |
| | | | | | F-23 | | | |
| | | | | | F-24 | | | |
| | | | | | F-25 | | | |
| | | | | | F-26 | | | |
| | | | | | F-33 | | | |
| | | | | | F-34 | | | |
| | | | | | F-37 | | | |
| | | | | | F-37 | | | |
| | | | | | F-41 | | | |
| | | | | | F-41 | | | |
| | | | | | F-49 | | | |
| | | | | | F-50 | | | |
| | | | | | F-50 | | | |
| | | | | | F-55 | | | |
| | | | | | F-56 | | | |
| | | | | | F-56 | | | |
| | | | | | F-57 | | | |
| | | | | | F-57 | | | |
| | | | | | F-58 | | | |
| | | | | | F-60 | | | |
| | | | | | F-62 | | | |
| | | | | | F-62 | | | |
| | | | | | F-63 | | | |
| | | | | | F-63 | | | |
| | | | | | F-64 | | | |
| | | | | | F-65 | | | |
| | | | | | F-66 | | | |
| | | | | | F-68 | | | |
| | | | | | F-70 | | | |
| | | | | | F-71 | | | |
| | | | | | F-72 | | | |
| | | | | | F-72 | | | |
| | | | | | F-75 | | | |
| | | | | | F-78 | | | |
| | | | | | F-79 | | |
| | | | | | F-109 | | | |
| | | | | | F-110 | | |
| | | | | |
Notes*
|
| | |
2021
£m |
| | |
2020
£m |
| | |
2019
£m |
| ||||||||||||
| | Net interest income | | | | | | | | | | | |
|
1,754
|
| | | | | | 1,898 | | | | | | | 1,483 | | |
| | – interest income1,2 | | | | | | | | | | | |
|
3,149
|
| | | | | | 4,086 | | | | | | | 5,504 | | |
| | – interest expense3 | | | | | | | | | | | |
|
(1,395)
|
| | | | | | (2,188) | | | | | | | (4,021) | | |
| | Net fee income | | | | |
|
2
|
| | | | |
|
1,413
|
| | | | | | 1,400 | | | | | | | 1,344 | | |
| | – fee income | | | | | | | | | | | |
|
2,706
|
| | | | | | 2,674 | | | | | | | 2,590 | | |
| | – fee expense | | | | | | | | | | | |
|
(1,293)
|
| | | | | | (1,274) | | | | | | | (1,246) | | |
| |
Net income from financial instruments held for trading or managed
on a fair value basis |
| | | |
|
3
|
| | | | |
|
1,733
|
| | | | | | 1,758 | | | | | | | 2,055 | | |
| |
Net income from assets and liabilities of insurance businesses,
including related derivatives, measured at fair value through profit or loss |
| | | |
|
3
|
| | | | |
|
1,214
|
| | | | | | 254 | | | | | | | 1,288 | | |
| | Changes in fair value of long-term debt and related derivatives | | | | |
|
3
|
| | | | |
|
(8)
|
| | | | | | 17 | | | | | | | (8) | | |
| | Changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss | | | | |
|
3
|
| | | | |
|
493
|
| | | | | | 285 | | | | | | | 547 | | |
| | Gains less losses from financial investments | | | | | | | | | | | |
|
60
|
| | | | | | 95 | | | | | | | 38 | | |
| | Net insurance premium income | | | | |
|
4
|
| | | | |
|
1,906
|
| | | | | | 1,559 | | | | | | | 2,147 | | |
| | Other operating income4 | | | | | | | | | | | |
|
594
|
| | | | | | 417 | | | | | | | 516 | | |
| |
Total operating income
|
| | | | | | | | | | |
|
9,159
|
| | | | | | 7,683 | | | | | | | 9,410 | | |
| | Net insurance claims, benefits paid and movement in liabilities to policyholders | | | | |
|
4
|
| | | | |
|
(3,039)
|
| | | | | | (1,783) | | | | | | | (3,366) | | |
| |
Net operating income before change in expected credit losses and other
credit impairment charges5 |
| | | | | | | | | | | | 6,120 | | | | | |
|
5,900
|
| | | | |
|
6,044
|
| |
| | Change in expected credit losses and other credit impairment charges | | | | | | | | | | | |
|
174
|
| | | | | | (808) | | | | | | | (124) | | |
| |
Net operating income
|
| | | | | | | | | | |
|
6,294
|
| | | | | | 5,092 | | | | | | | 5,920 | | |
| |
Total operating expenses
|
| | | | | | | | | | |
|
(5,462)
|
| | | | | | (6,705) | | | | | | | (6,782) | | |
| | – employee compensation and benefits | | | | |
|
5
|
| | | | |
|
(2,023)
|
| | | | | | (2,340) | | | | | | | (2,225) | | |
| | – general and administrative expenses | | | | | | | | | | | |
|
(3,265)
|
| | | | | | (3,092) | | | | | | | (3,034) | | |
| |
– depreciation and impairment of property, plant and equipment and right of use assets
|
| | | | | | | | | | |
|
(110)
|
| | | | | | (372) | | | | | | | (210) | | |
| | – amortisation and impairment of intangible assets | | | | |
|
21
|
| | | | |
|
(64)
|
| | | | | | (901) | | | | | | | (161) | | |
| | – goodwill impairment | | | | |
|
21
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | (1,152) | | |
| |
Operating profit/(loss)
|
| | | | | | | | | | |
|
832
|
| | | | | | (1,613) | | | | | | | (862) | | |
| | Share of profit/(loss) in associates and joint ventures | | | | |
|
18
|
| | | | |
|
191
|
| | | | | | (1) | | | | | | | (10) | | |
| |
Profit/(loss) before tax
|
| | | | | | | | | | |
|
1,023
|
| | | | | | (1,614) | | | | | | | (872) | | |
| | Tax credit /(expense) | | | | |
|
7
|
| | | | |
|
23
|
| | | | | | 136 | | | | | | | (119) | | |
| |
Profit/(loss) for the period
|
| | | | | | | | | | |
|
1,046
|
| | | | | | (1,478) | | | | | | | (991) | | |
| | Profit/(loss) attributable to the parent company | | | | | | | | | | | |
|
1,041
|
| | | | | | (1,488) | | | | | | | (1,013) | | |
| | Profit attributable to non-controlling interests | | | | | | | | | | | |
|
5
|
| | | | | | 10 | | | | | | | 22 | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| | |
2019
£m |
| |||||||||
| | Profit/(loss) for the year | | | | |
|
1,046
|
| | | | | | (1,478) | | | | | | | (991) | | |
| | Other comprehensive (expense)/income | | | | | | | | | | | | | | | | | | | | | | |
| | Items that will be reclassified subsequently to profit or loss when specific conditions are met: | | | | | | | | | | | | | | | | | | | | | | |
| | Debt instruments at fair value through other comprehensive income | | | | |
|
(237)
|
| | | | | | 213 | | | | | | | 121 | | |
| | – fair value (losses)/gains | | | | |
|
(247)
|
| | | | | | 366 | | | | | | | 238 | | |
| | – fair value gains transferred to the income statement on disposal | | | | |
|
(63)
|
| | | | | | (90) | | | | | | | (39) | | |
| | – expected credit (recoveries)/losses recognised in the income statement | | | | |
|
(5)
|
| | | | | | 8 | | | | | | | (27) | | |
| | – income taxes | | | | |
|
78
|
| | | | | | (71) | | | | | | | (51) | | |
| | Cash flow hedges | | | | |
|
(165)
|
| | | | | | 118 | | | | | | | 65 | | |
| | – fair value (losses)/gains | | | | |
|
(40)
|
| | | | | | 86 | | | | | | | 214 | | |
| | – fair value (gains)/losses reclassified to the income statement | | | | |
|
(202)
|
| | | | | | 72 | | | | | | | (127) | | |
| | – income taxes | | | | |
|
77
|
| | | | | | (40) | | | | | | | (22) | | |
| | Exchange differences | | | | |
|
(603)
|
| | | | | | 467 | | | | | | | (707) | | |
| | Items that will not be reclassified subsequently to profit or loss: | | | | | | | | | | | | | | | | | | | | | | |
| | Remeasurement of defined benefit asset/liability | | | | |
|
44
|
| | | | | | (8) | | | | | | | 12 | | |
| | – before income taxes | | | | |
|
61
|
| | | | | | (18) | | | | | | | (14) | | |
| | – income taxes | | | | |
|
(17)
|
| | | | | | 10 | | | | | | | 26 | | |
| |
Equity instruments designated at fair value through other comprehensive
income |
| | | |
|
2
|
| | | | | | 2 | | | | | | | 2 | | |
| | – fair value gains | | | | |
|
2
|
| | | | | | 2 | | | | | | | 2 | | |
| | – income taxes | | | | |
|
—
|
| | | | | | — | | | | | | | — | | |
| |
Changes in fair value of financial liabilities designated at fair value upon
initial recognition arising from changes in own credit risk |
| | | |
|
2
|
| | | | | | 67 | | | | | | | (251) | | |
| | – fair value gains | | | | |
|
3
|
| | | | | | 93 | | | | | | | (386) | | |
| | – income taxes | | | | |
|
(1)
|
| | | | | | (26) | | | | | | | 135 | | |
| |
Other comprehensive (expense)/income for the year, net of tax
|
| | | |
|
(957)
|
| | | | | | 859 | | | | | | | (758) | | |
| |
Total comprehensive income/(expense) for the year
|
| | | |
|
89
|
| | | | | | (619) | | | | | | | (1,749) | | |
| | Attributable to: | | | | | | | | | | | | | | | | | | | | | | |
| | – shareholders of the parent company | | | | |
|
93
|
| | | | | | (653) | | | | | | | (1,745) | | |
| | – non-controlling interests | | | | |
|
(4)
|
| | | | | | 34 | | | | | | | (4) | | |
| |
Total comprehensive income/(expense) for the year
|
| | | |
|
89
|
| | | | | | (619) | | | | | | | (1,749) | | |
| | | | | |
Notes*
|
| | |
2021
£m |
| | |
2020
£m |
| |||||||||
| | Assets | | | | | | | | | | | | | | | | | | | | | | |
| | Cash and balances at central banks | | | | | | | | | | | |
|
108,482
|
| | | | | | 85,092 | | |
| | Items in the course of collection from other banks | | | | | | | | | | | |
|
346
|
| | | | | | 243 | | |
| | Trading assets | | | | |
|
10
|
| | | | |
|
83,706
|
| | | | | | 86,976 | | |
| | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | |
|
13
|
| | | | |
|
18,649
|
| | | | | | 16,220 | | |
| | Derivatives | | | | |
|
14
|
| | | | |
|
141,221
|
| | | | | | 201,210 | | |
| | Loans and advances to banks | | | | | | | | | | | |
|
10,784
|
| | | | | | 12,646 | | |
| | Loans and advances to customers | | | | | | | | | | | |
|
91,177
|
| | | | | | 101,491 | | |
| | Reverse repurchase agreements – non-trading | | | | | | | | | | | |
|
54,448
|
| | | | | | 67,577 | | |
| | Financial investments | | | | |
|
16
|
| | | | |
|
41,300
|
| | | | | | 51,826 | | |
| | Prepayments, accrued income and other assets | | | | |
|
22
|
| | | | |
|
43,127
|
| | | | | | 55,565 | | |
| | Current tax assets | | | | | | | | | | | |
|
1,135
|
| | | | | | 444 | | |
| | Interests in associates and joint ventures | | | | |
|
18
|
| | | | |
|
743
|
| | | | | | 497 | | |
| | Goodwill and intangible assets | | | | |
|
21
|
| | | | |
|
894
|
| | | | | | 766 | | |
| | Deferred tax assets | | | | |
|
7
|
| | | | |
|
599
|
| | | | | | 597 | | |
| | Total assets | | | | | | | | | | | | | 596,611 | | | | | |
|
681,150
|
| |
| | Liabilities and equity | | | | | | | | | | | | | | | | | | | | | | |
| | Liabilities | | | | | | | | | | | | | | | | | | | | | | |
| | Deposits by banks | | | | | | | | | | | |
|
32,188
|
| | | | | | 34,305 | | |
| | Customer accounts | | | | | | | | | | | |
|
205,241
|
| | | | | | 195,184 | | |
| | Repurchase agreements – non-trading | | | | | | | | | | | |
|
27,259
|
| | | | | | 34,903 | | |
| | Items in the course of transmission to other banks | | | | | | | | | | | |
|
489
|
| | | | | | 290 | | |
| | Trading liabilities | | | | |
|
23
|
| | | | |
|
46,433
|
| | | | | | 44,229 | | |
| | Financial liabilities designated at fair value | | | | |
|
24
|
| | | | |
|
33,608
|
| | | | | | 40,792 | | |
| | Derivatives | | | | |
|
14
|
| | | | |
|
139,368
|
| | | | | | 199,232 | | |
| | Debt securities in issue | | | | | | | | | | | |
|
9,428
|
| | | | | | 17,371 | | |
| | Accruals, deferred income and other liabilities | | | | |
|
25
|
| | | | |
|
43,456
|
| | | | | | 53,395 | | |
| | Current tax liabilities | | | | | | | | | | | |
|
97
|
| | | | | | 139 | | |
| | Liabilities under insurance contracts | | | | |
|
4
|
| | | | |
|
22,264
|
| | | | | | 22,816 | | |
| | Provisions | | | | |
|
26
|
| | | | |
|
562
|
| | | | | | 861 | | |
| | Deferred tax liabilities | | | | |
|
7
|
| | | | |
|
15
|
| | | | | | 20 | | |
| | Subordinated liabilities | | | | |
|
27
|
| | | | |
|
12,488
|
| | | | | | 13,764 | | |
| | Total liabilities | | | | | | | | | | | | | 572,896 | | | | | |
|
657,301
|
| |
| | Equity | | | | | | | | | | | | | | | | | | | | | | |
| | Total shareholders’ equity | | | | | | | | | | | |
|
23,584
|
| | | | | | 23,666 | | |
| | – called up share capital | | | | |
|
30
|
| | | | |
|
797
|
| | | | | | 797 | | |
| | – other equity instruments | | | | |
|
30
|
| | | | |
|
3,722
|
| | | | | | 3,722 | | |
| | – other reserves | | | | | | | | | | | |
|
(5,670)
|
| | | | | | (4,682) | | |
| | – retained earnings | | | | | | | | | | | |
|
24,735
|
| | | | | | 23,829 | | |
| | Non-controlling interests | | | | | | | | | | | |
|
131
|
| | | | | | 183 | | |
| | Total equity | | | | | | | | | | | | | 23,715 | | | | | |
|
23,849
|
| |
| | Total liabilities and equity | | | | | | | | | | | | | 596,611 | | | | | |
|
681,150
|
| |
| | | | | |
2021
£m |
| | |
2020
£m |
| | |
2019
£m |
| |||||||||
| |
Profit/(loss) before tax
|
| | | |
|
1,023
|
| | | | | | (1,614) | | | | | | | (872) | | |
| | Adjustments for non-cash items | | | | | | | | | | | | | | | | | | | | | | |
| | Depreciation, amortisation and impairment1 | | | | |
|
174
|
| | | | | | 1,273 | | | | | | | 1,523 | | |
| | Net gain from investing activities | | | | |
|
(62)
|
| | | | | | (99) | | | | | | | (59) | | |
| | Share of (profit)/losses in associates and joint ventures | | | | |
|
(191)
|
| | | | | | 1 | | | | | | | 10 | | |
| | Change in expected credit losses gross of recoveries and other credit impairment charges | | | | |
|
(171)
|
| | | | | | 810 | | | | | | | 130 | | |
| | Provisions including pensions | | | | |
|
104
|
| | | | | | 424 | | | | | | | 231 | | |
| | Share-based payment expense | | | | |
|
96
|
| | | | | | 78 | | | | | | | 88 | | |
| | Other non-cash items included in profit/loss before tax | | | | |
|
(198)
|
| | | | | | 135 | | | | | | | (19) | | |
| | Elimination of exchange differences2 | | | | |
|
4,926
|
| | | | | | (2,527) | | | | | | | 4,001 | | |
| |
Changes in operating assets and liabilities
|
| | | |
|
9,602
|
| | | | | | 35,418 | | | | | | | (1,840) | | |
| | – change in net trading securities and derivatives | | | | |
|
8,157
|
| | | | | | 8,070 | | | | | | | (1,310) | | |
| | – change in loans and advances to banks and customers | | | | |
|
11,149
|
| | | | | | 6,780 | | | | | | | 3,441 | | |
| | – change in reverse repurchase agreements – non-trading | | | | |
|
9,538
|
| | | | | | 16,084 | | | | | | | (7,293) | | |
| | – change in financial assets designated and otherwise mandatorily measured at fair value | | | | |
|
(2,429)
|
| | | | | | 735 | | | | | | | 787 | | |
| | – change in other assets | | | | |
|
10,924
|
| | | | | | (7,513) | | | | | | | (12,074) | | |
| | – change in deposits by banks and customer accounts | | | | |
|
7,940
|
| | | | | | 28,262 | | | | | | | (4,141) | | |
| | – change in repurchase agreements – non-trading | | | | |
|
(7,643)
|
| | | | | | (14,482) | | | | | | | 2,803 | | |
| | – change in debt securities in issue | | | | |
|
(7,943)
|
| | | | | | (7,668) | | | | | | | 2,318 | | |
| | – change in financial liabilities designated at fair value | | | | |
|
(7,191)
|
| | | | | | (402) | | | | | | | 4,390 | | |
| | – change in other liabilities | | | | |
|
(12,295)
|
| | | | | | 5,432 | | | | | | | 9,539 | | |
| | – contributions paid to defined benefit plans | | | | |
|
(24)
|
| | | | | | (22) | | | | | | | (13) | | |
| | – tax paid | | | | |
|
(581)
|
| | | | | | 142 | | | | | | | (287) | | |
| |
Net cash from operating activities
|
| | | |
|
15,303
|
| | | | | | 33,899 | | | | | | | 3,193 | | |
| | – purchase of financial investments | | | | |
|
(18,890)
|
| | | | | | (21,037) | | | | | | | (26,200) | | |
| | – proceeds from the sale and maturity of financial investments | | | | |
|
25,027
|
| | | | | | 17,417 | | | | | | | 24,304 | | |
| | – net cash flows from the purchase and sale of property, plant and equipment | | | | |
|
52
|
| | | | | | (70) | | | | | | | (58) | | |
| | – net investment in intangible assets | | | | |
|
(45)
|
| | | | | | (150) | | | | | | | (385) | | |
| |
– net cash outflow from investment in associates and acquisition of businesses and subsidiaries
|
| | | |
|
(85)
|
| | | | | | (371) | | | | | | | (49) | | |
| |
– net cash flow on disposal of subsidiaries, businesses, associates and joint ventures
|
| | | |
|
—
|
| | | | | | 57 | | | | | | | — | | |
| |
Net cash from investing activities
|
| | | |
|
6,059
|
| | | | | | (4,154) | | | | | | | (2,388) | | |
| | – issue of ordinary share capital and other equity instruments | | | | |
|
—
|
| | | | | | — | | | | | | | 1,319 | | |
| | – redemption of preference shares and other equity instruments | | | | |
|
—
|
| | | | | | (318) | | | | | | | — | | |
| | – subordinated loan capital issued | | | | |
|
10,466
|
| | | | | | — | | | | | | | 6,736 | | |
| | – subordinated loan capital repaid3 | | | | |
|
(10,902)
|
| | | | | | (18) | | | | | | | (7,100) | | |
| | – dividends to the parent company | | | | |
|
(194)
|
| | | | | | (263) | | | | | | | (2,985) | | |
| | – funds received from the parent company | | | | |
|
—
|
| | | | | | 1,000 | | | | | | | — | | |
| | – dividends paid to non-controlling interests | | | | |
|
(1)
|
| | | | | | — | | | | | | | (17) | | |
| |
Net cash from financing activities
|
| | | |
|
(631)
|
| | | | | | 401 | | | | | | | (2,047) | | |
| |
Net increase/(decrease) in cash and cash equivalents
|
| | | |
|
20,731
|
| | | | | | 30,146 | | | | | | | (1,242) | | |
| | Cash and cash equivalents at 1 Jan | | | | |
|
125,304
|
| | | | | | 92,338 | | | | | | | 97,058 | | |
| | Exchange difference in respect of cash and cash equivalents | | | | |
|
(5,112)
|
| | | | | | 2,820 | | | | | | | (3,478) | | |
| |
Cash and cash equivalents at 31 Dec4
|
| | | |
|
140,923
|
| | | | | | 125,304 | | | | | | | 92,338 | | |
| | Cash and cash equivalents comprise of | | | | | | | | | | | | | | | | | | | | | | |
| | – cash and balances at central banks | | | | |
|
108,482
|
| | | | | | 85,092 | | | | | | | 51,816 | | |
| | – items in the course of collection from other banks | | | | |
|
346
|
| | | | | | 243 | | | | | | | 707 | | |
| | – loans and advances to banks of one month or less | | | | |
|
7,516
|
| | | | | | 8,676 | | | | | | | 6,889 | | |
| | – reverse repurchase agreement with banks of one month or less | | | | |
|
17,430
|
| | | | | | 21,020 | | | | | | | 23,116 | | |
| | – treasury bills, other bills and certificates of deposit less than three months | | | | |
|
235
|
| | | | | | 685 | | | | | | | 728 | | |
| | – cash collateral and net settlement accounts | | | | |
|
7,403
|
| | | | | | 9,878 | | | | | | | 9,485 | | |
| | – less: items in the course of transmission to other banks | | | | |
|
(489)
|
| | | | | | (290) | | | | | | | (403) | | |
| |
Cash and cash equivalents at 31 Dec4
|
| | | |
|
140,923
|
| | | | | | 125,304 | | | | | | | 92,338 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Other reserves
|
| | | | | | | | | | | | | | | | | | | | | | ||||||||||||||||||||||||
| | | | | |
Called up
share capital £m |
| | |
Other
equity instruments £m |
| | |
Retained
earnings £m |
| | |
Financial
assets at FVOCI reserve £m |
| | |
Cash flow
hedging reserve £m |
| | |
Foreign
exchange reserve £m |
| | |
Group
reorganisation reserve £m |
| | |
Total
share- holders’ equity £m |
| | |
Non-
controlling interests £m |
| | |
Total
equity £m |
| ||||||||||||||||||||||||||||||
| | At 1 Jan 2021 | | | | | | 797 | | | | | | | 3,722 | | | | | | | 23,829 | | | | | | | 1,309 | | | | | | | 158 | | | | | | | 1,543 | | | | | | | (7,692) | | | | | | | 23,666 | | | | | | | 183 | | | | | | | 23,849 | | |
| |
Profit for the year
|
| | | | | — | | | | | | | — | | | | | | | 1,041 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 1,041 | | | | | | | 5 | | | | | | | 1,046 | | |
| |
Other comprehensive
(expense)/income (net of tax) |
| | | | | — | | | | | | | — | | | | | | | 46 | | | | | | | (234) | | | | | | | (165) | | | | | | | (595) | | | | | | | — | | | | | | | (948) | | | | | | | (9) | | | | | | | (957) | | |
| |
– debt instruments at fair value through other comprehensive income
|
| | | | | — | | | | | | | — | | | | | | | — | | | | | | | (236) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (236) | | | | | | | (1) | | | | | | | (237) | | |
| |
– equity instruments designated at fair value through other comprehensive income
|
| | | | | — | | | | | | | — | | | | | | | — | | | | | | | 2 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 2 | | | | | | | — | | | | | | | 2 | | |
| |
– cash flow hedges
|
| | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (165) | | | | | | | — | | | | | | | — | | | | | | | (165) | | | | | | | — | | | | | | | (165) | | |
| |
– changes in fair value of financial liabilities designated at fair value due to movement in own credit risk1
|
| | | | | — | | | | | | | — | | | | | | | 2 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 2 | | | | | | | — | | | | | | | 2 | | |
| |
– remeasurement of defined
benefit asset/liability |
| | | | | — | | | | | | | — | | | | | | | 44 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 44 | | | | | | | — | | | | | | | 44 | | |
| |
– exchange differences
|
| | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (595) | | | | | | | — | | | | | | | (595) | | | | | | | (8) | | | | | | | (603) | | |
| |
Total comprehensive income/ (expense) for the year |
| | | | | — | | | | | | | — | | | | | | | 1,087 | | | | | | | (234) | | | | | | | (165) | | | | | | | (595) | | | | | | | — | | | | | | | 93 | | | | | | | (4) | | | | | | | 89 | | |
| |
Dividends to the parent company2
|
| | | | | — | | | | | | | — | | | | | | | (194) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (194) | | | | | | | (1) | | | | | | | (195) | | |
| |
Net impact of equity-settled
share-based payments |
| | | | | — | | | | | | | — | | | | | | | (10) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (10) | | | | | | | — | | | | | | | (10) | | |
| |
Change in business combinations and other movements3
|
| | | | | — | | | | | | | — | | | | | | | 23 | | | | | | | 6 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 29 | | | | | | | (47) | | | | | | | (18) | | |
| | At 31 Dec 2021 | | | | | | 797 | | | | | | | 3,722 | | | | | | | 24,735 | | | | | | | 1,081 | | | | | | | (7) | | | | | | | 948 | | | | | | | (7,692) | | | | | | | 23,584 | | | | | | | 131 | | | | | | | 23,715 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Other reserves
|
| | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||
| | | | | |
Called up
share capital £m |
| | |
Other equity
instruments £m |
| | |
Retained
earnings £m |
| | |
Financial
assets at FVOCI reserve £m |
| | |
Cash flow
hedging reserve £m |
| | |
Foreign
exchange reserve £m |
| | |
Group
reorganisation reserve £m |
| | |
Total share-
holders’ equity £m |
| | |
Non-
controlling interests £m |
| | |
Total equity
£m |
| ||||||||||||||||||||||||||||||
| | At 1 Jan 2020 | | | | | | 797 | | | | | | | 3,722 | | | | | | | 24,449 | | | | | | | 1,089 | | | | | | | 40 | | | | | | | 1,098 | | | | | | | (7,692) | | | | | | | 23,503 | | | | | | | 509 | | | | | | | 24,012 | | |
| | Loss for the year | | | | | | — | | | | | | | — | | | | | | | (1,488) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (1,488) | | | | | | | 10 | | | | | | | (1,478) | | |
| |
Other comprehensive income
(net of tax) |
| | | | | — | | | | | | | — | | | | | | | 56 | | | | | | | 216 | | | | | | | 118 | | | | | | | 445 | | | | | | | — | | | | | | | 835 | | | | | | | 24 | | | | | | | 859 | | |
| | – debt instruments at fair value through other comprehensive income | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 214 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 214 | | | | | | | (1) | | | | | | | 213 | | |
| | – equity instruments designated at fair value through other comprehensive income | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 2 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 2 | | | | | | | — | | | | | | | 2 | | |
| | – cash flow hedges | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 118 | | | | | | | — | | | | | | | — | | | | | | | 118 | | | | | | | — | | | | | | | 118 | | |
| | – changes in fair value of financial liabilities designated at fair value due to movement in own credit risk1 | | | | | | — | | | | | | | — | | | | | | | 67 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 67 | | | | | | | — | | | | | | | 67 | | |
| |
– remeasurement of defined
benefit asset/liability |
| | | | | — | | | | | | | — | | | | | | | (11) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (11) | | | | | | | 3 | | | | | | | (8) | | |
| | – exchange differences | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 445 | | | | | | | — | | | | | | | 445 | | | | | | | 22 | | | | | | | 467 | | |
| | Total comprehensive (expense)/income for the year | | | | | | — | | | | | | | — | | | | | | | (1,432) | | | | | | | 216 | | | | | | | 118 | | | | | | | 445 | | | | | | | — | | | | | | | (653) | | | | | | | 34 | | | | | | | (619) | | |
| | Capital securities issued during the period | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | Dividends to the parent company2 | | | | | | — | | | | | | | — | | | | | | | (263) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (263) | | | | | | | — | | | | | | | (263) | | |
| |
Net impact of equity-settled
share-based payments |
| | | | | — | | | | | | | — | | | | | | | 11 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 11 | | | | | | | — | | | | | | | 11 | | |
| | Capital contribution3 | | | | | | — | | | | | | | — | | | | | | | 1,000 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 1,000 | | | | | | | — | | | | | | | 1,000 | | |
| | Change in business combinations and other movements4 | | | | | | — | | | | | | | — | | | | | | | 64 | | | | | | | 4 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 68 | | | | | | | (360) | | | | | | | (292) | | |
| | At 31 Dec 2020 | | | | | | 797 | | | | | | | 3,722 | | | | | | | 23,829 | | | | | | | 1,309 | | | | | | | 158 | | | | | | | 1,543 | | | | | | | (7,692) | | | | | | | 23,666 | | | | | | | 183 | | | | | | | 23,849 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Other reserves
|
| | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||
| | | | | |
Called up
share capital £m |
| | |
Other equity
instruments £m |
| | |
Retained
earnings £m |
| | |
Financial
assets at FVOCI reserve £m |
| | |
Cash flow
hedging reserve £m |
| | |
Foreign
exchange reserve £m |
| | |
Group
reorganisation reserve £m |
| | |
Total share-
holders’ equity £m |
| | |
Non-
controlling interests £m |
| | |
Total equity
£m |
| ||||||||||||||||||||||||||||||
| | At 1 Jan 2019 | | | | | | 797 | | | | | | | 2,403 | | | | | | | 28,649 | | | | | | | 969 | | | | | | | (25) | | | | | | | 1,777 | | | | | | | (7,692) | | | | | | | 26,878 | | | | | | | 531 | | | | | | | 27,409 | | |
| | Loss for the year | | | | | | — | | | | | | | — | | | | | | | (1,013) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (1,013) | | | | | | | 22 | | | | | | | (991) | | |
| |
Other comprehensive
income/(expense) (net of tax) |
| | | | | — | | | | | | | — | | | | | | | (238) | | | | | | | 120 | | | | | | | 65 | | | | | | | (679) | | | | | | | — | | | | | | | (732) | | | | | | | (26) | | | | | | | (758) | | |
| | – debt instruments at fair value through other comprehensive income | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 118 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 118 | | | | | | | 3 | | | | | | | 121 | | |
| | – equity instruments designated at fair value through other comprehensive income | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 2 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 2 | | | | | | | — | | | | | | | 2 | | |
| | – cash flow hedges | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 65 | | | | | | | — | | | | | | | — | | | | | | | 65 | | | | | | | — | | | | | | | 65 | | |
| | – changes in fair value of financial liabilities designated at fair value due to movement in own credit risk1 | | | | | | — | | | | | | | — | | | | | | | (251) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (251) | | | | | | | — | | | | | | | (251) | | |
| |
– remeasurement of defined
benefit asset/liability |
| | | | | — | | | | | | | — | | | | | | | 13 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 13 | | | | | | | (1) | | | | | | | 12 | | |
| | – exchange differences | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (679) | | | | | | | — | | | | | | | (679) | | | | | | | (28) | | | | | | | (707) | | |
| | Total comprehensive income/(loss) for the year | | | | | | — | | | | | | | — | | | | | | | (1,251) | | | | | | | 120 | | | | | | | 65 | | | | | | | (679) | | | | | | | — | | | | | | | (1,745) | | | | | | | (4) | | | | | | | (1,749) | | |
| | Capital securities issued during the period2 | | | | | | — | | | | | | | 1,319 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 1,319 | | | | | | | — | | | | | | | 1,319 | | |
| | Dividends to the parent company3 | | | | | | — | | | | | | | — | | | | | | | (2,985) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (2,985) | | | | | | | (17) | | | | | | | (3,002) | | |
| |
Net impact of equity-settled
share-based payments |
| | | | | — | | | | | | | — | | | | | | | 16 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 16 | | | | | | | — | | | | | | | 16 | | |
| | Capital contribution | | | | | | — | | | | | | | — | | | | | | | | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | Change in business combinations and other movements | | | | | | — | | | | | | | | | | | | | | 20 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 20 | | | | | | | (1) | | | | | | | 19 | | |
| | At 31 Dec 2019 | | | | | | 797 | | | | | | | 3,722 | | | | | | | 24,449 | | | | | | | 1,089 | | | | | | | 40 | | | | | | | 1,098 | | | | | | | (7,692) | | | | | | | 23,503 | | | | | | | 509 | | | | | | | 24,012 | | |
| |
|
| |||
| |
The majority of valuation techniques employ only observable market data. However, certain financial instruments are classified on the basis of valuation techniques that feature one or more significant market inputs that are unobservable, and for them, the measurement of fair value is more judgemental:
|
| |||
| |
Judgements
|
| |
Estimates
|
|
| |
An instrument in its entirety is classified as valued using significant unobservable inputs if, in the opinion of management, a significant proportion of the instrument’s inception profit or greater than 5% of the instrument’s valuation is driven by unobservable inputs
‘Unobservable’ in this context means that there is little or no current market data available from which to determine the price at which an arm’s length transaction would be likely to occur. It generally does not mean that there is no data available at all upon which to base a determination of fair value (consensus pricing data may, for example, be used)
|
| |
Details on the group’s level 3 financial instruments and the sensitivity of their valuation to the effect of applying reasonable possible alternative assumptions in determining their fair value are set out in Note 11
|
|
| |
|
| |||
| |
Origination CRR
|
| |
Significance trigger – PD to increase by
|
|
| |
0.1-1.2
|
| |
15bps
|
|
| |
2.1-3.3
|
| |
30bps
|
|
| |
Origination CRR
|
| |
Additional significance criteria – Number of CRR grade notches
deterioration required to identify as significant credit deterioration (stage 2) (> or equal to) |
|
| |
0.1
|
| |
5 notches
|
|
| |
1.1–4.2
|
| |
4 notches
|
|
| |
4.3–5.1
|
| |
3 notches
|
|
| |
5.2–7.1
|
| |
2 notches
|
|
| |
7.2–8.2
|
| |
1 notch
|
|
| |
8.3
|
| |
0 notch
|
|
| |
Model
|
| |
Regulatory capital
|
| |
IFRS 9
|
|
| |
PD
|
| |
Through the cycle (represents long-run average PD throughout a full economic cycle)
The definition of default includes a backstop of 90+ days past due, although this has been modified to 180+ days past due for some portfolios, particularly UK and US mortgages
|
| |
Point in time (based on current conditions, adjusted to take into account estimates of future conditions that will impact PD)
Default backstop of 90+ days past due for all portfolios
|
|
| |
EAD
|
| |
Cannot be lower than current balance
|
| |
Amortisation captured for term products
|
|
| |
LGD
|
| |
Downturn LGD (consistent losses expected to be suffered during a severe but plausible economic downturn)
Regulatory floors may apply to mitigate risk of underestimating downturn LGD due to lack of historical data
Discounted using cost of capital
All collection costs included
|
| |
Expected LGD (based on estimate of loss given default including the expected impact of future economic conditions such as changes in value of collateral)
No floors
Discounted using the original effective interest rate of the loan
Only costs associated with obtaining/selling collateral included
|
|
| |
Other
|
| | | | |
Discounted back from point of default to balance sheet date
|
|
| |
|
| |||
| |
The calculation of the group’s ECL under IFRS 9 requires the group to make a number of judgements, assumptions and estimates. The most significant are set out below:
|
| |||
| |
Judgements
|
| |
Estimates
|
|
| |
Defining what is considered to be a significant increase in credit risk
Selecting and calibrating the PD, LGD and EAD models, which support the calculations, including making reasonable and supportable judgements about how models react to current and future economic conditions
Selecting model inputs and economic forecasts, including determining whether sufficient and appropriately weighted economic forecasts are incorporated to calculate unbiased expected loss
Making management judgemental adjustments to account for late breaking events, model and data limitations and deficiencies, and expert credit judgements
|
| |
The section ‘Measurement uncertainty and sensitivity analysis of ECL estimates’ from page F-83 sets out the assumptions used in determining ECL, and provides an indication of the sensitivity of the result to the application of different weightings being applied to different economic assumptions
|
|
| |
|
| |||
| |
|
|
| |
The recognition of deferred tax assets depends on judgements
|
|
| |
Judgements
|
|
| |
In assessing the probability and sufficiency of future taxable profit, we consider the availability of evidence to support the recognition of deferred tax assets. taking into account the inherent risk in long term forecasting and drivers of recent history of tax losses where applicable, taking into account the future reversal of existing taxable temporary differences and tax planning strategies including corporate reorganisations. Specific judgements supporting deferred tax assets are described in Note 7.
|
|
| |
|
|
| |
|
| |||
| |
The recognition and measurement of provisions requires the group to make a number of judgements, assumptions and estimates. The most significant are set out below:
|
| |||
| |
Judgements
|
| |
Estimates
|
|
| |
Determining whether a present obligation exists. Professional advice is taken on the assessment of litigation and similar obligations
Provisions for legal proceedings and regulatory matters typically require a higher degree of judgement than other types of provisions. When matters are at an early stage, accounting judgements can be difficult because of the high degree of uncertainty associated with determining whether a present obligation exists, and estimating the probability and amount of any outflows that may arise. As matters progress, management and legal advisers evaluate on an ongoing basis whether provisions should be recognised, revising previous estimates as appropriate. At more advanced stages, it is typically easier to make estimates around a better defined set of possible outcomes
|
| |
Provisions for legal proceedings and regulatory matters remain very sensitive to the assumptions used in the estimate. There could be a wider range of possible outcomes for any pending legal proceedings, investigations or inquiries. As a result, it is often not practicable to quantify a range of possible outcomes for individual matters. It is also not practicable to meaningfully quantify ranges of potential outcomes in aggregate for these types of provisions because of the diverse nature and circumstances of such matters and the wide range of uncertainties involved
|
|
| |
|
| |||
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |||||||||
| | Account services | | | |
|
271
|
| | | | | 239 | | | | | | 334 | | |
| | Funds under management | | | |
|
465
|
| | | | | 424 | | | | | | 427 | | |
| | Cards | | | |
|
44
|
| | | | | 44 | | | | | | 47 | | |
| | Credit facilities | | | |
|
246
|
| | | | | 250 | | | | | | 301 | | |
| | Broking income | | | |
|
368
|
| | | | | 369 | | | | | | 289 | | |
| | Unit trusts | | | |
|
5
|
| | | | | 3 | | | | | | 6 | | |
| | Imports/exports | | | |
|
40
|
| | | | | 41 | | | | | | 51 | | |
| | Remittances | | | |
|
84
|
| | | | | 62 | | | | | | 74 | | |
| | Underwriting | | | |
|
286
|
| | | | | 360 | | | | | | 287 | | |
| | Global custody | | | |
|
200
|
| | | | | 220 | | | | | | 118 | | |
| | Insurance agency commission | | | |
|
17
|
| | | | | 19 | | | | | | 20 | | |
| | Other | | | |
|
680
|
| | | | | 643 | | | | | | 636 | | |
| |
Fee income
|
| | |
|
2,706
|
| | | | | 2,674 | | | | | | 2,590 | | |
| | Less: fee expense | | | |
|
(1,293)
|
| | | | | (1,274) | | | | | | (1,246) | | |
| |
Net fee income
|
| | |
|
1,413
|
| | | | | 1,400 | | | | | | 1,344 | | |
| | | | | |
MSS
£m |
| | |
GB
£m |
| | |
GBM
Other £m |
| | |
CMB
£m |
| | |
WPB
£m |
| | |
Corporate
Centre £m |
| | |
Total
£m |
| |||||||||||||||||||||
| | Year ended 31 Dec 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fee income | | | | | | 1,251 | | | | | | | 861 | | | | | | | 89 | | | | | | | 415 | | | | | | | 633 | | | | | | | (543) | | | | | | | 2,706 | | |
| | Less: fee expense | | | | |
|
(1,245)
|
| | | | |
|
(188)
|
| | | | |
|
(83)
|
| | | | |
|
(54)
|
| | | | |
|
(255)
|
| | | | |
|
532
|
| | | | |
|
(1,293)
|
| |
| | Net fee income | | | | | | 6 | | | | | | | 673 | | | | | | | 6 | | | | | | | 361 | | | | | | | 378 | | | | | | | (11) | | | | | | | 1,413 | | |
| | Year ended 31 Dec 20201 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fee income | | | | | | 1,243 | | | | | | | 857 | | | | | | | 94 | | | | | | | 407 | | | | | | | 603 | | | | | | | (530) | | | | | | | 2,674 | | |
| | Less: fee expense | | | | | | (1,209) | | | | | | | (172) | | | | | | | (123) | | | | | | | (51) | | | | | | | (245) | | | | | | | 526 | | | | | | | (1,274) | | |
| | Net fee income | | | | | | 34 | | | | | | | 685 | | | | | | | (29) | | | | | | | 356 | | | | | | | 358 | | | | | | | (4) | | | | | | | 1,400 | | |
| | Year ended 31 Dec 20191 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fee income | | | | | | 1,266 | | | | | | | 787 | | | | | | | 80 | | | | | | | 391 | | | | | | | 625 | | | | | | | (559) | | | | | | | 2,590 | | |
| | Less: fee expense | | | | | | (1,265) | | | | | | | (116) | | | | | | | (126) | | | | | | | (41) | | | | | | | (243) | | | | | | | 545 | | | | | | | (1,246) | | |
| | Net fee income | | | | | | 1 | | | | | | | 671 | | | | | | | (46) | | | | | | | 350 | | | | | | | 382 | | | | | | | (14) | | | | | | | 1,344 | | |
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |||||||||
| | Net income/(expenses) arising on: | | | | | | | | | | | | | | | | | | | |
| | Net trading activities | | | |
|
3
|
| | | | | 1,948 | | | | | | 4,054 | | |
| | Other instruments managed on a fair value basis | | | |
|
1,730
|
| | | | | (190) | | | | | | (1,999) | | |
| |
Net income from financial instruments held for trading or managed on a fair value basis
|
| | |
|
1,733
|
| | | | | 1,758 | | | | | | 2,055 | | |
| |
Financial assets held to meet liabilities under insurance and investment contracts
|
| | |
|
1,305
|
| | | | | 290 | | | | | | 1,364 | | |
| | Liabilities to customers under investment contracts | | | |
|
(91)
|
| | | | | (36) | | | | | | (76) | | |
| |
Net income from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss
|
| | |
|
1,214
|
| | | | | 254 | | | | | | 1,288 | | |
| | Derivatives managed in conjunction with the group’s issued debt securities | | | |
|
(337)
|
| | | | | 112 | | | | | | 124 | | |
| | Other changes in fair value | | | |
|
329
|
| | | | | (95) | | | | | | (132) | | |
| |
Changes in fair value of designated debt and related derivatives
|
| | |
|
(8)
|
| | | | | 17 | | | | | | (8) | | |
| |
Changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss
|
| | |
|
493
|
| | | | | 285 | | | | | | 547 | | |
| |
Year ended 31 Dec
|
| | |
|
3,432
|
| | | | | 2,314 | | | | | | 3,882 | | |
| | | | |
Non-linked
insurance £m |
| |
Linked life
insurance £m |
| |
Investment contracts
with DPF1 £m |
| |
Total
£m |
| ||||||||||||
| | Gross insurance premium income | | | |
|
218
|
| | | |
|
429
|
| | | |
|
1,360
|
| | | |
|
2,007
|
| |
| | Reinsurers’ share of gross insurance premium income | | | |
|
(100)
|
| | | |
|
(1)
|
| | | |
|
—
|
| | | |
|
(101)
|
| |
| | Year ended 31 Dec 2021 | | | | | 118 | | | | | | 428 | | | | | | 1,360 | | | | | | 1,906 | | |
| | Gross insurance premium income | | | | | 205 | | | | | | 274 | | | | | | 1,185 | | | | | | 1,664 | | |
| | Reinsurers’ share of gross insurance premium income | | | | | (100) | | | | | | (5) | | | | | | — | | | | | | (105) | | |
| | Year ended 31 Dec 2020 | | | | | 105 | | | | | | 269 | | | | | | 1,185 | | | | | | 1,559 | | |
| | Gross insurance premium income | | | | | 231 | | | | | | 245 | | | | | | 1,772 | | | | | | 2,248 | | |
| | Reinsurers’ share of gross insurance premium income | | | | | (98) | | | | | | (3) | | | | | | — | | | | | | (101) | | |
| | Year ended 31 Dec 2019 | | | | | 133 | | | | | | 242 | | | | | | 1,772 | | | | | | 2,147 | | |
| | | | | |
Non-linked
insurance £m |
| | |
Linked life
insurance £m |
| | |
Investment contracts
with DPF1 £m |
| | |
Total
£m |
| ||||||||||||
| |
Gross claims and benefits paid and movement in
liabilities |
| | | |
|
120
|
| | | | |
|
550
|
| | | | |
|
2,420
|
| | | | |
|
3,090
|
| |
| | – claims, benefits and surrenders paid | | | | |
|
126
|
| | | | |
|
106
|
| | | | |
|
1,554
|
| | | | |
|
1,786
|
| |
| | – movement in liabilities | | | | |
|
(6)
|
| | | | |
|
444
|
| | | | |
|
866
|
| | | | |
|
1,304
|
| |
| | Reinsurers’ share of claims and benefits paid and movement in liabilities | | | | |
|
(45)
|
| | | | |
|
(6)
|
| | | | |
|
—
|
| | | | |
|
(51)
|
| |
| | – claims, benefits and surrenders paid | | | | |
|
(68)
|
| | | | |
|
(1)
|
| | | | |
|
—
|
| | | | |
|
(69)
|
| |
| | – movement in liabilities | | | | |
|
23
|
| | | | |
|
(5)
|
| | | | |
|
—
|
| | | | |
|
18
|
| |
| | Year ended 31 Dec 2021 | | | | | | 75 | | | | | | | 544 | | | | | | | 2,420 | | | | | | | 3,039 | | |
| |
Gross claims and benefits paid and movement in
liabilities |
| | | | | 143 | | | | | | | 300 | | | | | | | 1,404 | | | | | | | 1,847 | | |
| | – claims, benefits and surrenders paid | | | | | | 102 | | | | | | | 93 | | | | | | | 1,578 | | | | | | | 1,773 | | |
| | – movement in liabilities | | | | | | 41 | | | | | | | 207 | | | | | | | (174) | | | | | | | 74 | | |
| | Reinsurers’ share of claims and benefits paid and movement in liabilities | | | | | | (64) | | | | | | | — | | | | | | | — | | | | | | | (64) | | |
| | – claims, benefits and surrenders paid | | | | | | (62) | | | | | | | (3) | | | | | | | — | | | | | | | (65) | | |
| | – movement in liabilities | | | | | | (2) | | | | | | | 3 | | | | | | | — | | | | | | | 1 | | |
| | Year ended 31 Dec 2020 | | | | | | 79 | | | | | | | 300 | | | | | | | 1,404 | | | | | | | 1,783 | | |
| |
Gross claims and benefits paid and movement in
liabilities |
| | | | | 105 | | | | | | | 363 | | | | | | | 2,957 | | | | | | | 3,425 | | |
| | – claims, benefits and surrenders paid | | | | | | 136 | | | | | | | 96 | | | | | | | 1,490 | | | | | | | 1,722 | | |
| | – movement in liabilities | | | | | | (31) | | | | | | | 267 | | | | | | | 1,467 | | | | | | | 1,703 | | |
| | Reinsurers’ share of claims and benefits paid and movement in liabilities | | | | | | (56) | | | | | | | (3) | | | | | | | — | | | | | | | (59) | | |
| | – claims, benefits and surrenders paid | | | | | | (61) | | | | | | | (3) | | | | | | | — | | | | | | | (64) | | |
| | – movement in liabilities | | | | | | 5 | | | | | | | — | | | | | | | — | | | | | | | 5 | | |
| | Year ended 31 Dec 2019 | | | | | | 49 | | | | | | | 360 | | | | | | | 2,957 | | | | | | | 3,366 | | |
| | | | |
Non-linked
insurance £m |
| |
Linked life
insurance £m |
| |
Investment contracts
with DPF1 £m |
| |
Total
£m |
| ||||||||||||
| | Gross liabilities under insurance contracts at 1 Jan 2021 | | | |
|
594
|
| | | |
|
1,512
|
| | | |
|
20,710
|
| | | |
|
22,816
|
| |
| | Claims and benefits paid | | | |
|
(126)
|
| | | |
|
(106)
|
| | | |
|
(1,554)
|
| | | |
|
(1,786)
|
| |
| | Increase in liabilities to policyholders | | | |
|
120
|
| | | |
|
550
|
| | | |
|
2,420
|
| | | |
|
3,090
|
| |
| | Exchange differences and other movements2 | | | |
|
(32)
|
| | | |
|
(18)
|
| | | |
|
(1,806)
|
| | | |
|
(1,856)
|
| |
| | Gross liabilities under insurance contracts at 31 Dec 2021 | | | | | 556 | | | | | | 1,938 | | | | | | 19,770 | | | | | | 22,264 | | |
| | Reinsurers’ share of liabilities under insurance contracts | | | |
|
(93)
|
| | | |
|
(53)
|
| | | |
|
—
|
| | | |
|
(146)
|
| |
| | Net liabilities under insurance contracts at 31 Dec 2021 | | | | | 463 | | | | | | 1,885 | | | | | | 19,770 | | | | | | 22,118 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Gross liabilities under insurance contracts at 1 Jan 2020 | | | | | 576 | | | | | | 1,295 | | | | | | 19,638 | | | | | | 21,509 | | |
| | Claims and benefits paid | | | | | (102) | | | | | | (93) | | | | | | (1,578) | | | | | | (1,773) | | |
| | Increase in liabilities to policyholders | | | | | 143 | | | | | | 300 | | | | | | 1,404 | | | | | | 1,847 | | |
| | Exchange differences and other movements2 | | | | | (23) | | | | | | 10 | | | | | | 1,246 | | | | | | 1,233 | | |
| | Gross liabilities under insurance contracts at 31 Dec 2020 | | | | | 594 | | | | | | 1,512 | | | | | | 20,710 | | | | | | 22,816 | | |
| | Reinsurers’ share of liabilities under insurance contracts | | | | | (118) | | | | | | (47) | | | | | | — | | | | | | (165) | | |
| | Net liabilities under insurance contracts at 31 Dec 2020 | | | | | 476 | | | | | | 1,465 | | | | | | 20,710 | | | | | | 22,651 | | |
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |||||||||
| | Wages and salaries | | | |
|
1,609
|
| | | | | 1,917 | | | | | | 1,752 | | |
| | Social security costs | | | |
|
341
|
| | | | | 367 | | | | | | 383 | | |
| | Post-employment benefits1 | | | |
|
73
|
| | | | | 56 | | | | | | 90 | | |
| |
Year ended 31 Dec
|
| | |
|
2,023
|
| | | | | 2,340 | | | | | | 2,225 | | |
| | | | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||
| | Markets and Securities Services | | | |
|
4,322
|
| | | | | 4,590 | | | | | | 4,508 | | |
| | Global Banking | | | |
|
2,458
|
| | | | | 2,857 | | | | | | 2,366 | | |
| | Global Banking and Markets Other | | | |
|
140
|
| | | | | 158 | | | | | | 595 | | |
| | Commercial Banking | | | |
|
3,023
|
| | | | | 3,396 | | | | | | 3,241 | | |
| | Wealth and Personal Banking | | | |
|
6,709
|
| | | | | 6,807 | | | | | | 6,955 | | |
| | Corporate Centre | | | |
|
171
|
| | | | | 58 | | | | | | 89 | | |
| |
Year ended 31 Dec1,2
|
| | |
|
16,823
|
| | | | | 17,866 | | | | | | 17,754 | | |
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |||||||||
| | Restricted share awards | | | |
|
96
|
| | | | | 77 | | | | | | 86 | | |
| | Savings-related and other share award option plans | | | |
|
1
|
| | | | | 2 | | | | | | 2 | | |
| |
Year ended 31 Dec
|
| | |
|
97
|
| | | | | 79 | | | | | | 88 | | |
| |
Award
|
| |
Policy
|
|
| |
Deferred share awards (including annual incentive awards, LTI awards delivered shares) and Group Performance Share Plan (‘GPSP’)
|
| |
An assessment of performance over the relevant period ending on 31 December is used to determine the amount of the award to be granted.
Deferred awards generally require employees to remain in employment over the vesting period and are generally not subject to performance conditions after the grant date. An exception to these are the LTI awards, which are subject to performance conditions. Deferred share awards generally vest over a period of three, five or seven years. Vested shares may be subject to a retention requirement post-vesting. Awards are subject to malus and clawback. |
|
| |
International Employee Share Purchase Plan (‘ShareMatch’)
|
| |
The plan was first introduced in Hong Kong in 2013 and now includes employees based in 28 jurisdictions.
Shares are purchased in the market each quarter up to a maximum value of £750, or the equivalent in local currency. Matching awards are added at a ratio of one free share for every three purchased. Matching awards vest subject to continued employment and the retention of the purchased shares for a maximum period of two years and nine months. |
|
| | | | |
2021
Number (000s) |
| |
2020
Number (000s) |
| |
2019
Number (000s) |
| |||||||||
| |
Restricted share awards outstanding at 1 Jan
|
| | |
|
24,367
|
| | | | | 24,578 | | | | | | 23,395 | | |
| | Additions during the year1 | | | |
|
15,479
|
| | | | | 16,823 | | | | | | 19,358 | | |
| | Released in the year1 | | | |
|
(16,690)
|
| | | | | (16,024) | | | | | | (17,742) | | |
| | Forfeited in the year | | | |
|
(1,328)
|
| | | | | (1,010) | | | | | | (433) | | |
| |
Restricted share awards outstanding at 31 Dec
|
| | |
|
21,828
|
| | | | | 24,367 | | | | | | 24,578 | | |
| | Weighted average fair value of awards granted (£) | | | |
|
4.49
|
| | | | | 5.58 | | | | | | 5.99 | | |
| |
Main plans
|
| |
Policy
|
|
| |
Savings-related share option plans (‘Sharesave’)
|
| |
From 2014, eligible employees for the UK plan can save up to £500 per month with the option to use the savings to acquire shares.
These are generally exercisable within six months following either the third or fifth anniversary of the commencement of a three-year or five-year contract, respectively.
The exercise price is set at a 20% (2020: 20%; 2019: 20%) discount to the market value immediately preceding the date of invitation.
|
|
| | | | |
Savings-related
share option plans |
| |||||||||
| | | | |
Number
(000s) |
| |
WAEP1
£ |
| ||||||
| | Outstanding at 1 Jan 2021 | | | | | 7,206 | | | | | | 2.96 | | |
| | Granted during the year2 | | | |
|
984
|
| | | |
|
3.25
|
| |
| | Exercised during the year | | | |
|
(227)
|
| | | |
|
3.97
|
| |
| | Expired during the year | | | |
|
(99)
|
| | | |
|
4.70
|
| |
| | Forfeited during the year | | | |
|
(928)
|
| | | |
|
3.68
|
| |
| | Outstanding at 31 Dec 2021 | | | | | 6,936 | | | | | | 2.87 | | |
| | Weighted average remaining contractual life (years) | | | | | 2.98 | | | | | | | | |
| | Outstanding at 1 Jan 2020 | | | | | 4,245 | | | | | | 4.78 | | |
| | Granted during the year2 | | | | | 5,909 | | | | | | 2.56 | | |
| | Exercised during the year | | | | | (107) | | | | | | 4.43 | | |
| | Expired during the year | | | | | (78) | | | | | | 4.64 | | |
| | Forfeited during the year | | | | | (2,763) | | | | | | 4.79 | | |
| | Outstanding at 31 Dec 2020 | | | | | 7,206 | | | | | | 2.96 | | |
| | Weighted average remaining contractual life (years) | | | | | 3.64 | | | | | | | | |
| | Outstanding at 1 Jan 2019 | | | | | 4,008 | | | | | | 4.88 | | |
| | Granted during the year2 | | | | | 2,078 | | | | | | 4.68 | | |
| | Exercised during the year | | | | | (801) | | | | | | 4.32 | | |
| | Expired during the year | | | | | (35) | | | | | | 4.17 | | |
| | Forfeited during the year | | | | | (1,005) | | | | | | 5.43 | | |
| | Outstanding at 31 Dec 2019 | | | | | 4,245 | | | | | | 4.78 | | |
| | Weighted average remaining contractual life (years) | | | | | 2.76 | | | | | | | | |
| | | | |
Fair value of
plan assets £m |
| |
Present value of
defined benefit obligations £m |
| |
Total
£m |
| |||||||||
| | Defined benefit pension plans | | | |
|
668
|
| | | |
|
(742)
|
| | | |
|
(74)
|
| |
| | Defined benefit healthcare plans | | | |
|
—
|
| | | |
|
(68)
|
| | | |
|
(68)
|
| |
| | At 31 Dec 2021 | | | | | 668 | | | | | | (810) | | | | | | (142) | | |
| | Total employee benefit liabilities (within ‘Accruals, deferred income and other liabilities’) | | | | | | | | | | | | | | | |
|
(196)
|
| |
| | Total employee benefit assets (within ‘Prepayments, accrued income and other assets’) | | | | | | | | | | | | | | | | | 54 | | |
| | Defined benefit pension plans | | | | | 693 | | | | | | (876) | | | | | | (183) | | |
| | Defined benefit healthcare plans | | | | | — | | | | | | (75) | | | | | | (75) | | |
| | At 31 Dec 2020 | | | | | 693 | | | | | | (951) | | | | | | (258) | | |
| | Total employee benefit liabilities (within ‘Accruals, deferred income and other liabilities’) | | | | | | | | | | | | | | | | | (288) | | |
| | Total employee benefit assets (within ‘Prepayments, accrued income and other assets’) | | | | | | | | | | | | | | | | | 30 | | |
| | | | | |
Fair value of plan assets
|
| | |
Present value of
defined benefit obligations |
| | |
Net defined benefit asset/(liability)
|
| ||||||||||||||||||||||||||||||
| | | | | |
HSBC Trinkaus &
Burkhardt Pension Plan2 £m |
| | |
Other
plans £m |
| | |
HSBC Trinkaus &
Burkhardt Pension Plan2 £m |
| | |
Other
plans £m |
| | |
HSBC Trinkaus &
Burkhardt Pension Plan2 £m |
| | |
Other
plans £m |
| ||||||||||||||||||
| | At 1 Jan 2021 | | | | | | 435 | | | | | | | 258 | | | | | | | (489) | | | | | | | (387) | | | | | | | (54) | | | | | | | (129) | | |
| | Service cost | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(7)
|
| | | | |
|
(27)
|
| | | | |
|
(7)
|
| | | | |
|
(27)
|
| |
| | – current service cost | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(8)
|
| | | | |
|
(11)
|
| | | | |
|
(8)
|
| | | | |
|
(11)
|
| |
| | – past service cost and gains from settlements | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
1
|
| | | | |
|
(16)
|
| | | | |
|
1
|
| | | | |
|
(16)
|
| |
| | Net interest income/(cost) on the net defined benefit asset/(liability) | | | | |
|
3
|
| | | | |
|
4
|
| | | | |
|
(3)
|
| | | | |
|
(3)
|
| | | | |
|
—
|
| | | | |
|
1
|
| |
| | Remeasurement effects recognised in other comprehensive income | | | | |
|
17
|
| | | | |
|
(2)
|
| | | | |
|
26
|
| | | | |
|
16
|
| | | | |
|
43
|
| | | | |
|
14
|
| |
| | – return on plan assets (excluding interest income) | | | | |
|
17
|
| | | | |
|
(2)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
17
|
| | | | |
|
(2)
|
| |
| | – actuarial gains/(losses) | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
26
|
| | | | |
|
16
|
| | | | |
|
26
|
| | | | |
|
16
|
| |
| | – other changes | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Exchange differences | | | | |
|
(28)
|
| | | | |
|
(1)
|
| | | | |
|
29
|
| | | | |
|
9
|
| | | | |
|
1
|
| | | | |
|
8
|
| |
| | Benefits paid | | | | |
|
—
|
| | | | |
|
(15)
|
| | | | |
|
10
|
| | | | |
|
19
|
| | | | |
|
10
|
| | | | |
|
4
|
| |
| | Other movements1 | | | | |
|
7
|
| | | | |
|
(10)
|
| | | | |
|
(4)
|
| | | | |
|
69
|
| | | | |
|
3
|
| | | | |
|
59
|
| |
| | At 31 Dec 2021 | | | | | | 434 | | | | | | | 234 | | | | | | | (438) | | | | | | | (304) | | | | | | | (4) | | | | | | | (70) | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | A1 Jan 2020 | | | | | | 405 | | | | | | | 175 | | | | | | | (434) | | | | | | | (325) | | | | | | | (29) | | | | | | | (150) | | |
| | Service cost | | | | |
|
—
|
| | | | | | — | | | | | | | (12) | | | | | | | (1) | | | | | | | (12) | | | | | | | (1) | | |
| | – current service cost | | | | |
|
—
|
| | | | | | — | | | | | | | (14) | | | | | | | (10) | | | | | | | (14) | | | | | | | (10) | | |
| | – past service cost and gains from settlements | | | | |
|
—
|
| | | | | | — | | | | | | | 2 | | | | | | | 9 | | | | | | | 2 | | | | | | | 9 | | |
| | Net interest income/(cost) on the net defined benefit asset/(liability) | | | | | | 3 | | | | | | | 16 | | | | | | | (4) | | | | | | | (16) | | | | | | | (1) | | | | | | | — | | |
| |
Remeasurement effects recognised in other comprehensive income
|
| | | | | (3) | | | | | | | 84 | | | | | | | (20) | | | | | | | (79) | | | | | | | (23) | | | | | | | 5 | | |
| | – return on plan assets (excluding interest income) | | | | | | (3) | | | | | | | 26 | | | | | | | — | | | | | | | — | | | | | | | (3) | | | | | | | 26 | | |
| | – actuarial gains/(losses) | | | | |
|
—
|
| | | | | | — | | | | | | | (21) | | | | | | | (27) | | | | | | | (21) | | | | | | | (27) | | |
| | – other changes | | | | |
|
—
|
| | | | | | 58 | | | | | | | 1 | | | | | | | (52) | | | | | | | 1 | | | | | | | 6 | | |
| | Exchange differences | | | | | | 23 | | | | | | | — | | | | | | | (24) | | | | | | | (9) | | | | | | | (1) | | | | | | | (9) | | |
| | Benefits paid | | | | |
|
—
|
| | | | | | (39) | | | | | | | 10 | | | | | | | 46 | | | | | | | 10 | | | | | | | 7 | | |
| | Other movements1 | | | | | | 7 | | | | | | | 22 | | | | | | | (5) | | | | | | | (3) | | | | | | | 2 | | | | | | | 19 | | |
| | At 31 Dec 2020 | | | | | | 435 | | | | | | | 258 | | | | | | | (489) | | | | | | | (387) | | | | | | | (54) | | | | | | | (129) | | |
| | | | |
2022
£m |
| |
2023
£m |
| |
2024
£m |
| |
2025
£m |
| |
2026
£m |
| |
2027-2031
£m |
| ||||||||||||||||||
| |
HSBC Trinkaus & Burkhardt Pension Plan1
|
| | |
|
10
|
| | | | | 9 | | | | | | 9 | | | | | | 11 | | | | | | 10 | | | | | | 59 | | |
| | | | | |
31 Dec 2021
|
| | |
31 Dec 2020
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | |
Value
£m |
| | |
Quoted
market price in active market £m |
| | |
No quoted
market price in active market £m |
| | |
Thereof HSBC
£m |
| | |
Value
£m |
| | |
Quoted
market price in active market £m |
| | |
No quoted
market price in active market £m |
| | |
Thereof HSBC
£m |
| ||||||||||||||||||||||||
| |
HSBC Trinkaus & Burkhardt Pension
Plan |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fair value of plan assets | | | | |
|
434
|
| | | | |
|
377
|
| | | | |
|
57
|
| | | | |
|
—
|
| | | | | | 435 | | | | | | | 418 | | | | | | | 17 | | | | | | | — | | |
| | – equities | | | | |
|
11
|
| | | | |
|
11
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 19 | | | | | | | 19 | | | | | | | — | | | | | | | — | | |
| | – bonds | | | | |
|
112
|
| | | | |
|
112
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 109 | | | | | | | 109 | | | | | | | — | | | | | | | — | | |
| | – other | | | | |
|
311
|
| | | | |
|
254
|
| | | | |
|
57
|
| | | | |
|
—
|
| | | | | | 307 | | | | | | | 290 | | | | | | | 17 | | | | | | | — | | |
| | | | |
Discount rate
% |
| |
Inflation rate
% |
| |
Rate of
increase for pensions % |
| |
Rate of pay
increase % |
| ||||||||||||
| | HSBC Trinkaus & Burkhardt Pension Plan | | | | | | | | | | | | | | | | | | | | | | | | | |
| | At 31 Dec 2021 | | | | | 1.14 | | | | | | 1.75 | | | | | | 1.75 | | | | | | 1.75 | | |
| | At 31 Dec 2020 | | | | | 0.70 | | | | | | 1.75 | | | | | | 1.50 | | | | | | 2.50 | | |
| | | | |
Mortality
table |
| |
Life expectancy at age 65 for a male
member currently: |
| |
Life expectancy at age 65 for a
female member currently: |
| ||||||||||||||||||
| | | | |
|
| |
Aged 65
|
| |
Aged 45
|
| |
Aged 65
|
| |
Aged 45
|
| ||||||||||||
| | HSBC Trinkaus & Burkhardt Pension Plan | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | At 31 Dec 2021 | | |
RT 2018G1
|
| | | | 20.6 | | | | | | 23.4 | | | | | | 24.0 | | | | | | 26.3 | | |
| | At 31 Dec 2020 | | |
RT 2018G
|
| | | | 20.3 | | | | | | 23.1 | | | | | | 23.8 | | | | | | 26.0 | | |
| | | | |
HSBC Trinkaus & Burkhardt Pension Plan Obligation
|
| |||||||||||||||||||||||||||||||||
| | | | |
Financial impact of increase
|
| |
Financial impact of decrease
|
| ||||||||||||||||||||||||||||||
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| ||||||||||||||||||
| | Discount rate – increase/decrease of 0.25% | | | |
|
(13)
|
| | | | | (15) | | | | | | (13) | | | | |
|
13
|
| | | | | 16 | | | | | | 14 | | |
| | Inflation rate – increase/decrease of 0.25% | | | |
|
11
|
| | | | | 16 | | | | | | 9 | | | | |
|
(9)
|
| | | | | (12) | | | | | | (9) | | |
| | Pension payments and deferred pensions – increase/decrease of 0.25% | | | |
|
9
|
| | | | | 10 | | | | | | 9 | | | | |
|
(8)
|
| | | | | (10) | | | | | | (9) | | |
| | Pay – increase/decrease of 0.25% | | | |
|
2
|
| | | | | 4 | | | | | | 4 | | | | |
|
(2)
|
| | | | | (4) | | | | | | (3) | | |
| | Change in mortality – increase of 1 year | | | |
|
16
|
| | | | | 19 | | | | | | 14 | | | | |
|
N/A
|
| | | | | N/A | | | | | | N/A | | |
| | | | |
2021
£000 |
| |
2020
£000 |
| |
2019
£000 |
| |||||||||
| | Fees1 | | | |
|
1,525
|
| | | | | 1,256 | | | | | | 1,136 | | |
| | Salaries and other emoluments2,5 | | | |
|
3,569
|
| | | | | 2,321 | | | | | | 1,958 | | |
| | Annual incentives3 | | | |
|
694
|
| | | | | 576 | | | | | | 472 | | |
| | Long-term incentives4 | | | |
|
511
|
| | | | | 727 | | | | | | 160 | | |
| |
Year ended 31 Dec
|
| | |
|
6,299
|
| | | | | 4,880 | | | | | | 3,726 | | |
| | | | |
2021
£000 |
| |
2020
£000 |
| |
2019
£000 |
| |||||||||
| | Salaries and other emoluments | | | |
|
1,399
|
| | | | | 1,392 | | | | | | 1,190 | | |
| | Annual incentives1 | | | |
|
558
|
| | | | | 417 | | | | | | 260 | | |
| | Long-term incentives2 | | | |
|
390
|
| | | | | 677 | | | | | | 105 | | |
| |
Year ended 31 Dec
|
| | |
|
2,347
|
| | | | | 2,486 | | | | | | 1,555 | | |
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |||||||||
| | Audit fees payable to PwC | | | |
|
10.4
|
| | | | | 11.3 | | | | | | 10.5 | | |
| | Other audit fees payable | | | |
|
0.4
|
| | | | | 0.4 | | | | | | 0.4 | | |
| |
Year ended 31 Dec
|
| | |
|
10.8
|
| | | | | 11.7 | | | | | | 10.9 | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| | |
2019
£m |
| |||||||||
| | Fees for HSBC Bank plc’s statutory audit1 | | | | |
|
4.8
|
| | | | | | 5.3 | | | | | | | 5.5 | | |
| | Fees for other services provided to the group | | | | |
|
14.3
|
| | | | | | 13.1 | | | | | | | 11.6 | | |
| | – audit of the group’s subsidiaries2 | | | | |
|
5.6
|
| | | | | | 6.0 | | | | | | | 5.0 | | |
| | – audit-related assurance services3 | | | | |
|
5.7
|
| | | | | | 4.2 | | | | | | | 2.7 | | |
| | – other assurance services4 | | | | |
|
3.0
|
| | | | | | 2.9 | | | | | | | 3.9 | | |
| |
Year ended 31 Dec
|
| | | |
|
19.1
|
| | | | | | 18.4 | | | | | | | 17.1 | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| | |
2019
£m |
| |||||||||
| | Current tax | | | | |
|
(187)
|
| | | | | | 195 | | | | | | | (103) | | |
| | – for this year | | | | |
|
(245)
|
| | | | | | 186 | | | | | | | (75) | | |
| | – adjustments in respect of prior years | | | | |
|
58
|
| | | | | | 9 | | | | | | | (28) | | |
| | Deferred tax | | | | |
|
164
|
| | | | | | (331) | | | | | | | 222 | | |
| | – origination and reversal of temporary differences | | | | |
|
248
|
| | | | | | (339) | | | | | | | 48 | | |
| | – effect of changes in tax rates | | | | |
|
(56)
|
| | | | | | (26) | | | | | | | — | | |
| | – adjustments in respect of prior years | | | | |
|
(28)
|
| | | | | | 34 | | | | | | | 174 | | |
| |
Year ended 31 Dec1
|
| | | |
|
(23)
|
| | | | | | (136) | | | | | | | 119 | | |
| | | |
2021
£m |
| |
%
|
| |
2020
£m |
| |
%
|
| |
2019
£m |
| |
%
|
| ||||||||||||||||||
| Profit/(loss) before tax | | | |
|
1,023
|
| | | | | | | | | | | (1,614) | | | | | | | | | | | | (872) | | | | | | | | |
| Tax expense | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Taxation at UK corporation tax rate | | | |
|
194
|
| | | |
|
19.0
|
| | | | | (307) | | | | | | 19.0 | | | | | | (166) | | | | | | 19.0 | | |
| Impact of taxing overseas profits at different rates | | | |
|
7
|
| | | |
|
0.7
|
| | | | | (75) | | | | | | 4.6 | | | | | | 26 | | | | | | (3.0) | | |
| UK banking surcharge | | | |
|
(2)
|
| | | |
|
(0.2)
|
| | | | | (100) | | | | | | 6.2 | | | | | | (34) | | | | | | 3.9 | | |
| Items increasing the tax charge in 2021: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| – impact of temporary differences between French tax returns and IFRS | | | |
|
324
|
| | | |
|
31.7
|
| | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| – bank levy | | | |
|
72
|
| | | |
|
7.0
|
| | | | | 31 | | | | | | (1.9) | | | | | | 17 | | | | | | (1.9) | | |
| – adjustments in respect of prior periods | | | |
|
30
|
| | | |
|
2.9
|
| | | | | 45 | | | | | | (2.8) | | | | | | 146 | | | | | | (16.7) | | |
| – impairment of goodwill | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 219 | | | | | | (25.1) | | |
| Items reducing the tax charge in 2021: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| – tax impact of planned sale of French retail banking business | | | |
|
(324)
|
| | | |
|
(31.7)
|
| | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| – non-taxable income and gains | | | |
|
(92)
|
| | | |
|
(9.0)
|
| | | | | (55) | | | | | | 3.4 | | | | | | (94) | | | | | | 10.8 | | |
| – impact of changes in tax rates | | | |
|
(56)
|
| | | |
|
(5.5)
|
| | | | | (26) | | | | | | 1.6 | | | | | | (16) | | | | | | 1.8 | | |
| – deductions for AT1 coupon payments | | | |
|
(53)
|
| | | |
|
(5.2)
|
| | | | | (51) | | | | | | 3.2 | | | | | | (34) | | | | | | 3.9 | | |
| – movements in unrecognised deferred tax | | | |
|
(47)
|
| | | |
|
(4.6)
|
| | | | | 321 | | | | | | (19.9) | | | | | | 6 | | | | | | (0.7) | | |
| – effect of profits in associates and joint ventures | | | |
|
(43)
|
| | | |
|
(4.2)
|
| | | | | (3) | | | | | | 0.2 | | | | | | 1 | | | | | | (0.1) | | |
| – other permanent differences | | | |
|
(26)
|
| | | |
|
(2.5)
|
| | | | | 24 | | | | | | (1.5) | | | | | | 33 | | | | | | (3.8) | | |
| – local taxes and overseas withholding taxes | | | |
|
(4)
|
| | | |
|
(0.4)
|
| | | | | 49 | | | | | | (3.0) | | | | | | (5) | | | | | | 0.6 | | |
| – other | | | |
|
(3)
|
| | | |
|
(0.3)
|
| | | | | 11 | | | | | | (0.7) | | | | | | 20 | | | | | | (2.3) | | |
|
Year ended 31 Dec
|
| | |
|
(23)
|
| | | |
|
(2.3)
|
| | | | | (136) | | | | | | 8.4 | | | | | | 119 | | | | | | (13.6) | | |
| | | | | |
Retirement
benefits £m |
| | |
Loan impairment
provisions £m |
| | |
Property, plant
and equipment £m |
| | |
FVOCI
investments £m |
| | |
Goodwill and
intangibles £m |
| | |
Relief for tax
losses2 £m |
| | |
Other1
£m |
| | |
Total
£m |
| ||||||||||||||||||||||||
| | Assets | | | | |
|
63
|
| | | | |
|
66
|
| | | | |
|
171
|
| | | | |
|
—
|
| | | | |
|
157
|
| | | | |
|
418
|
| | | | |
|
—
|
| | | | |
|
875
|
| |
| | Liabilities | | | | |
|
—
|
| | | | |
|
(9)
|
| | | | |
|
(6)
|
| | | | |
|
(166)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(117)
|
| | | | |
|
(298)
|
| |
| | At 1 Jan 2021 | | | | | | 63 | | | | | | | 57 | | | | | | | 165 | | | | | | | (166) | | | | | | | 157 | | | | | | | 418 | | | | | | | (117) | | | | | | | 577 | | |
| | Income statement | | | | |
|
28
|
| | | | |
|
(10)
|
| | | | |
|
51
|
| | | | |
|
3
|
| | | | |
|
55
|
| | | | |
|
(37)
|
| | | | |
|
(254)
|
| | | | |
|
(164)
|
| |
| | Other comprehensive income | | | | |
|
(17)
|
| | | | |
|
2
|
| | | | |
|
(1)
|
| | | | |
|
105
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
82
|
| | | | |
|
171
|
| |
| | At 31 Dec 2021 | | | | | | 74 | | | | | | | 49 | | | | | | | 215 | | | | | | | (58) | | | | | | | 212 | | | | | | | 381 | | | | | | | (289) | | | | | | | 584 | | |
| | Assets3 | | | | |
|
74
|
| | | | |
|
53
|
| | | | |
|
215
|
| | | | |
|
—
|
| | | | |
|
212
|
| | | | |
|
381
|
| | | | |
|
—
|
| | | | |
|
935
|
| |
| | Liabilities3 | | | | |
|
—
|
| | | | |
|
(4)
|
| | | | |
|
—
|
| | | | |
|
(58)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(289)
|
| | | | |
|
(351)
|
| |
| | Assets | | | | | | 82 | | | | | | | 41 | | | | | | | 172 | | | | | | | — | | | | | | | 142 | | | | | | | 82 | | | | | | | 2 | | | | | | | 521 | | |
| | Liabilities | | | | | | — | | | | | | | (6) | | | | | | | (6) | | | | | | | (123) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (135) | | |
| | At 1 Jan 2020 | | | | | | 82 | | | | | | | 35 | | | | | | | 166 | | | | | | | (123) | | | | | | | 142 | | | | | | | 82 | | | | | | | 2 | | | | | | | 386 | | |
| | Income statement | | | | | | (37) | | | | | | | 22 | | | | | | | (1) | | | | | | | (3) | | | | | | | 15 | | | | | | | 351 | | | | | | | (16) | | | | | | | 331 | | |
| | Other comprehensive income | | | | | | 18 | | | | | | | — | | | | | | | — | | | | | | | (40) | | | | | | | — | | | | | | | (15) | | | | | | | (103) | | | | | | | (140) | | |
| | At 31 Dec 2020 | | | | | | 63 | | | | | | | 57 | | | | | | | 165 | | | | | | | (166) | | | | | | | 157 | | | | | | | 418 | | | | | | | (117) | | | | | | | 577 | | |
| | Assets3 | | | | | | 63 | | | | | | | 66 | | | | | | | 171 | | | | | | | — | | | | | | | 157 | | | | | | | 418 | | | | | | | — | | | | | | | 875 | | |
| | Liabilities3 | | | | | | — | | | | | | | (9) | | | | | | | (6) | | | | | | | (166) | | | | | | | — | | | | | | | — | | | | | | | (117) | | | | | | | (298) | | |
| | | | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||||||||||||||||||||
| | | | |
£ per share
|
| |
£m
|
| |
£ per share
|
| |
£m
|
| |
£ per share
|
| |
£m
|
| ||||||||||||||||||
| | Dividends paid on ordinary shares | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | In respect of previous year: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – second interim dividend | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 0.51 | | | | | | 406 | | |
| | – first special dividend | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 0.85 | | | | | | 674 | | |
| | In respect of current year: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – first special dividend | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 1.60 | | | | | | 1,277 | | |
| | – second special dividend | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 0.54 | | | | | | 430 | | |
| |
Total
|
| | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 3.50 | | | | | | 2,787 | | |
| | Dividends on preference shares classified as equity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Dividend on HSBC Bank plc non-cumulative third dollar preference shares1 | | | |
|
0.001
|
| | | |
|
—
|
| | | |
|
1.47
|
| | | |
|
51
|
| | | | | 1.47 | | | | | | 51 | | |
| |
Total
|
| | |
|
0.001
|
| | | |
|
—
|
| | | |
|
1.47
|
| | | |
|
51
|
| | | | | 1.47 | | | | | | 51 | | |
| | Total coupons on capital securities classified as equity | | | | | | | | | |
|
194
|
| | | | | | | | | |
|
212
|
| | | | | | | | | | | 147 | | |
| |
Dividends to parent
|
| | | | | | | | |
|
194
|
| | | | | | | | | |
|
263
|
| | | | | | | | | | | 2,985 | | |
| | | | |
First call date
|
| |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |||||||||
| |
Undated subordinated additional tier 1 instruments
|
| | | | | | | | | | | | | | | | | | | | | |
| | – €1,900m undated subordinated resettable additional tier 1 instrument 2015 | | |
Dec 2020
|
| | |
|
84
|
| | | | | 103 | | | | | | 97 | | |
| | – €235m undated subordinated resettable additional tier 1 instrument 2016 | | |
Jan 2022
|
| | |
|
12
|
| | | | | 11 | | | | | | 12 | | |
| | – €300m undated subordinated resettable additional tier 1 instrument 2018 | | |
Mar 2023
|
| | |
|
10
|
| | | | | 10 | | | | | | 10 | | |
| | – £555m undated subordinated resettable additional tier 1 instrument 2018 | | |
Mar 2023
|
| | |
|
28
|
| | | | | 28 | | | | | | 28 | | |
| | – £500m undated subordinated resettable additional tier 1 instrument 2019 | | |
Nov 2024
|
| | |
|
24
|
| | | | | 24 | | | | | | — | | |
| | – €250m undated subordinated resettable additional tier 1 instrument 2019 | | |
Nov 2024
|
| | |
|
7
|
| | | | | 8 | | | | | | — | | |
| | – £431m undated subordinated resettable additional tier 1 instrument 2019 | | |
Dec 2024
|
| | |
|
20
|
| | | | | 20 | | | | | | — | | |
| | – €200m undated subordinated resettable additional tier 1 instrument 2019 | | |
Jan 2025
|
| | |
|
9
|
| | | | | 8 | | | | | | — | | |
| |
Total
|
| | | | | |
|
194
|
| | | | | 212 | | | | | | 147 | | |
| | | | |
2021
|
| |||||||||||||||||||||||||||||||||||||||
| | | | |
MSS
£m |
| |
GB
£m |
| |
GBM
Other £m |
| |
CMB
£m |
| |
WPB
£m |
| |
Corporate
Centre £m |
| |
Total
£m |
| |||||||||||||||||||||
| | Net operating income/(expense) before change in expected credit losses and other credit impairment charges1 | | | | | 2,055 | | | | | | 1,367 | | | | | | 579 | | | | | | 1,095 | | | | | | 1,275 | | | | | | (41) | | | | | | 6,330 | | |
| |
– of which: net interest income/(expense)
|
| | |
|
(232)
|
| | | |
|
568
|
| | | |
|
224
|
| | | |
|
649
|
| | | |
|
567
|
| | | |
|
(22)
|
| | | |
|
1,754
|
| |
| | Change in expected credit losses and other credit impairment charges | | | |
|
1
|
| | | |
|
140
|
| | | |
|
5
|
| | | |
|
7
|
| | | |
|
23
|
| | | |
|
(2)
|
| | | |
|
174
|
| |
| | Net operating income/(expense) | | | | | 2,056 | | | | | | 1,507 | | | | | | 584 | | | | | | 1,102 | | | | | | 1,298 | | | | | | (43) | | | | | | 6,504 | | |
| | Total operating expenses | | | |
|
(2,064)
|
| | | |
|
(918)
|
| | | |
|
(485)
|
| | | |
|
(612)
|
| | | |
|
(975)
|
| | | |
|
(64)
|
| | | |
|
(5,118)
|
| |
| | Operating profit/(loss) | | | | | (8) | | | | | | 589 | | | | | | 99 | | | | | | 490 | | | | | | 323 | | | | | | (107) | | | | | | 1,386 | | |
| | Share of loss in associates and joint ventures | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
191
|
| | | |
|
191
|
| |
| | Adjusted profit/(loss) before tax | | | | | (8) | | | | | | 589 | | | | | | 99 | | | | | | 490 | | | | | | 323 | | | | | | 84 | | | | | | 1,577 | | |
| | | | | | | % | | | | | | % | | | | | | % | | | | | | % | | | | | | % | | | | | | | | | | | | % | | |
| | Adjusted cost efficiency ratio | | | |
|
100.4
|
| | | |
|
67.2
|
| | | |
|
83.9
|
| | | |
|
55.9
|
| | | |
|
76.5
|
| | | | | | | | | |
|
80.9
|
| |
| | | |
2020
|
| |||||||||||||||||||||||||||||||||||||||
|
Net operating income/(expense) before change in expected credit
losses and other credit impairment charges1 |
| |
1,968
|
| |
1,381
|
| |
624
|
| |
1,133
|
| |
1,035
|
| |
(144)
|
| |
5,997
|
| |||||||||||||||||||||
| – of which: net interest income/(expense) | | | | | (96) | | | | | | 651 | | | | | | 46 | | | | | | 686 | | | | | | 664 | | | | | | (53) | | | | | | 1,898 | | |
| Change in expected credit losses and other credit impairment charges | | | | | 1 | | | | | | (448) | | | | | | (4) | | | | | | (322) | | | | | | (39) | | | | | | 4 | | | | | | (808) | | |
| Net operating income/(expense) | | | | | 1,969 | | | | | | 933 | | | | | | 620 | | | | | | 811 | | | | | | 996 | | | | | | (140) | | | | | | 5,189 | | |
| Total operating expenses | | | | | (1,949) | | | | | | (878) | | | | | | (672) | | | | | | (659) | | | | | | (1,128) | | | | | | (86) | | | | | | (5,372) | | |
| Operating profit/(loss) | | | | | 20 | | | | | | 55 | | | | | | (52) | | | | | | 152 | | | | | | (132) | | | | | | (226) | | | | | | (183) | | |
| Share of profit in associates and joint ventures | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (1) | | | | | | (1) | | |
| Adjusted profit/(loss) before tax | | | | | 20 | | | | | | 55 | | | | | | (52) | | | | | | 152 | | | | | | (132) | | | | | | (227) | | | | | | (184) | | |
| | | | | | % | | | | | | % | | | | | | % | | | | | | % | | | | | | % | | | | | | | | | |
%
|
| |||
| Adjusted cost efficiency ratio | | | | | 99.0 | | | | | | 63.6 | | | | | | 107.7 | | | | | | 58.2 | | | | | | 109.0 | | | | | | | | | | | | 89.6 | | |
| | | |
2019
|
| |||||||||||||||||||||||||||||||||||||||
|
Net operating income/(expense) before change in expected credit
losses and other credit impairment charges1 |
| |
1,650
|
| |
1,546
|
| |
577
|
| |
1,212
|
| |
1,357
|
| |
(273)
|
| |
6,069
|
| |||||||||||||||||||||
|
– of which: net interest income/(expense)
|
| | | | 19 | | | | | | 812 | | | | | | (61) | | | | |
|
761
|
| | | |
|
746
|
| | | |
|
(794)
|
| | | |
|
1,483
|
| |
| Change in expected credit losses and other credit impairment charges | | | | | (6) | | | | | | (32) | | | | | | (3) | | | | | | (109) | | | | | | (3) | | | | | | 29 | | | | | | (124) | | |
| Net operating income/(expense) | | | | | 1,644 | | | | | | 1,514 | | | | | | 574 | | | | | | 1,103 | | | | | | 1,354 | | | | | | (244) | | | | | | 5,945 | | |
| Total operating expenses | | | | | (1,949) | | | | | | (898) | | | | | | (684) | | | | | | (646) | | | | | | (1,077) | | | | | | (78) | | | | | | (5,332) | | |
| Operating profit/(loss) | | | | | (305) | | | | | | 616 | | | | | | (110) | | | | | | 457 | | | | | | 277 | | | | | | (322) | | | | | | 613 | | |
| Share of profit in associates and joint ventures | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (10) | | | | | | (10) | | |
| Adjusted profit/(loss) before tax | | | | | (305) | | | | | | 616 | | | | | | (110) | | | | | | 457 | | | | | | 277 | | | | | | (332) | | | | | | 603 | | |
| | | | | | % | | | | | | % | | | | | | % | | | | | | % | | | | | | % | | | | | | | | | |
%
|
| |||
| Adjusted cost efficiency ratio | | | | | 118.1 | | | | | | 58.1 | | | | | | 118.5 | | | | | | 53.3 | | | | | | 79.4 | | | | | | | | | | | | 87.9 | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| | |
2019
£m |
| |||||||||
| |
Reported external net operating income by country1
|
| | | |
|
6,120
|
| | | | | | 5,900 | | | | | | | 6,044 | | |
| | – UK | | | | |
|
2,937
|
| | | | | | 2,914 | | | | | | | 2,987 | | |
| | – France | | | | |
|
1,677
|
| | | | | | 1,528 | | | | | | | 1,653 | | |
| | – Germany | | | | |
|
887
|
| | | | | | 814 | | | | | | | 710 | | |
| | – Other countries | | | | |
|
619
|
| | | | | | 644 | | | | | | | 694 | | |
| | | | |
2021
|
| |
2020
|
| |
2019
|
| |||||||||||||||||||||||||||||||||||||||||||||
| | | | |
Adjusted
£m |
| |
Significant
items £m |
| |
Reported
£m |
| |
Adjusted
£m |
| |
Significant
items £m |
| |
Reported
£m |
| |
Adjusted
£m |
| |
Significant
items £m |
| |
Reported
£m |
| |||||||||||||||||||||||||||
| | Revenue1 | | | |
|
6,330
|
| | | |
|
(210)
|
| | | |
|
6,120
|
| | | | | 5,997 | | | | | | (97) | | | | | | 5,900 | | | | | | 6,069 | | | | | | (25) | | | | | | 6,044 | | |
| | ECL | | | |
|
174
|
| | | |
|
—
|
| | | |
|
174
|
| | | | | (808) | | | | | | — | | | | | | (808) | | | | | | (124) | | | | | | — | | | | | | (124) | | |
| | Operating expenses | | | |
|
(5,118)
|
| | | |
|
(344)
|
| | | |
|
(5,462)
|
| | | | | (5,372) | | | | | | (1,333) | | | | | | (6,705) | | | | | | (5,332) | | | | | | (1,450) | | | | | | (6,782) | | |
| | Share of profit/(loss) in associates and joint ventures | | | |
|
191
|
| | | |
|
—
|
| | | |
|
191
|
| | | | | (1) | | | | | | — | | | | | | (1) | | | | | | (10) | | | | | | — | | | | | | (10) | | |
| |
Profit/(loss) before tax
|
| | |
|
1,577
|
| | | |
|
(554)
|
| | | |
|
1,023
|
| | | | | (184) | | | | | | (1,430) | | | | | | (1,614) | | | | | | 603 | | | | | | (1,475) | | | | | | (872) | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| | |
2019
£m |
| |||||||||
| | Year ended 31 Dec | | | | | | | | | | | | | | | | | | | | | | |
| |
Adjusted profit/(loss) before tax
|
| | | |
|
1,577
|
| | | | | | (184) | | | | | | | 603 | | |
| | Significant items | | | | |
|
(554)
|
| | | | | | (1,430) | | | | | | | (1,475) | | |
| | – fair value movements on financial instruments1 | | | | |
|
(5)
|
| | | | | | (3) | | | | | | | (24) | | |
| | – UK customer redress programmes | | | | | | (1) | | | | | | | | | | | | | | | | |
| | – cost of structural reform | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | (87) | | |
| | – restructuring and other related costs | | | | |
|
(549)
|
| | | | | | (773) | | | | | | | (204) | | |
| | – settlements and provisions in connection with legal and regulatory matters | | | | |
|
—
|
| | | | | | (9) | | | | | | | (7) | | |
| | – impairment of goodwill | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | (1,152) | | |
| | – impairment of other intangible assets | | | | |
|
—
|
| | | | | | (645) | | | | | |
|
—
|
| |
| |
Reported profit/(loss) before tax
|
| | | |
|
1,023
|
| | | | | | (1,614) | | | | | | | (872) | | |
| | | | |
MSS
£m |
| |
GB
£m |
| |
GBM
Other £m |
| |
CMB
£m |
| |
WPB
£m |
| |
Corporate
Centre £m |
| |
Total
£m |
| |||||||||||||||||||||
| | 31 Dec 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Loans and advances to customers | | | |
|
2,016
|
| | | |
|
37,685
|
| | | |
|
197
|
| | | |
|
23,529
|
| | | |
|
27,574
|
| | | |
|
176
|
| | | |
|
91,177
|
| |
| | Customer accounts | | | |
|
34,243
|
| | | |
|
74,179
|
| | | |
|
4,355
|
| | | |
|
50,297
|
| | | |
|
41,939
|
| | | |
|
228
|
| | | |
|
205,241
|
| |
| | 31 Dec 2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Loans and advances to customers | | | | | 3,451 | | | | | | 42,810 | | | | | | 606 | | | | | | 25,809 | | | | | | 28,638 | | | | | | 177 | | | | | | 101,491 | | |
| | Customer accounts | | | | | 23,780 | | | | | | 77,393 | | | | | | 4,173 | | | | | | 48,368 | | | | | | 41,258 | | | | | | 212 | | | | | | 195,184 | | |
| | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Treasury and other eligible bills | | | |
|
2,451
|
| | | | | 3,273 | | |
| | Debt securities | | | |
|
27,004
|
| | | | | 31,399 | | |
| | Equity securities | | | |
|
40,930
|
| | | | | 36,775 | | |
| |
Trading securities
|
| | |
|
70,385
|
| | | | | 71,447 | | |
| | Loans and advances to banks1 | | | |
|
4,142
|
| | | | | 5,058 | | |
| | Loans and advances to customers1 | | | |
|
9,179
|
| | | | | 10,471 | | |
| |
At 31 Dec
|
| | |
|
83,706
|
| | | | | 86,976 | | |
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||||||||||||||||||||||||||
| | | | |
Level 1
£m |
| |
Level 2
£m |
| |
Level 3
£m |
| |
Total
£m |
| |
Level 1
£m |
| |
Level 2
£m |
| |
Level 3
£m |
| |
Total
£m |
| ||||||||||||||||||||||||
| |
Recurring fair value measurements at 31 Dec
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Trading assets | | | |
|
59,813
|
| | | |
|
22,549
|
| | | |
|
1,344
|
| | | |
|
83,706
|
| | | | | 60,890 | | | | | | 24,475 | | | | | | 1,611 | | | | | | 86,976 | | |
| |
Financial assets designated and otherwise
mandatorily measured at fair value through profit or loss |
| | |
|
6,332
|
| | | |
|
9,146
|
| | | |
|
3,171
|
| | | |
|
18,649
|
| | | | | 5,658 | | | | | | 7,095 | | | | | | 3,467 | | | | | | 16,220 | | |
| | Derivatives | | | |
|
1,987
|
| | | |
|
137,418
|
| | | |
|
1,816
|
| | | |
|
141,221
|
| | | | | 1,668 | | | | | | 197,568 | | | | | | 1,974 | | | | | | 201,210 | | |
| | Financial investments | | | |
|
29,669
|
| | | |
|
10,235
|
| | | |
|
1,387
|
| | | |
|
41,291
|
| | | | | 38,347 | | | | | | 11,829 | | | | | | 1,635 | | | | | | 51,811 | | |
| | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Trading liabilities | | | |
|
32,886
|
| | | |
|
12,967
|
| | | |
|
580
|
| | | |
|
46,433
|
| | | | | 29,847 | | | | | | 14,264 | | | | | | 118 | | | | | | 44,229 | | |
| | Financial liabilities designated at fair value | | | |
|
1,020
|
| | | |
|
30,467
|
| | | |
|
2,121
|
| | | |
|
33,608
|
| | | | | 928 | | | | | | 38,714 | | | | | | 1,150 | | | | | | 40,792 | | |
| | Derivatives | | | |
|
1,105
|
| | | |
|
135,809
|
| | | |
|
2,454
|
| | | |
|
139,368
|
| | | | | 1,058 | | | | | | 195,078 | | | | | | 3,096 | | | | | | 199,232 | | |
| | | | |
Assets
|
| |
Liabilities
|
| ||||||||||||||||||||||||||||||||||||
| | | | |
Financial
investments £m |
| |
Trading
assets £m |
| |
Designated and
otherwise mandatorily measured at fair value through profit or loss £m |
| |
Derivatives
£m |
| |
Trading
liabilities £m |
| |
Designated
at fair value £m |
| |
Derivatives
£m |
| |||||||||||||||||||||
| |
Year ended 31 Dec 2021
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Transfers from Level 1 to Level 2 | | | |
|
366
|
| | | |
|
1,731
|
| | | |
|
757
|
| | | |
|
—
|
| | | |
|
27
|
| | | |
|
—
|
| | | |
|
—
|
| |
| | Transfers from Level 2 to Level 1 | | | |
|
244
|
| | | |
|
990
|
| | | |
|
399
|
| | | |
|
—
|
| | | |
|
91
|
| | | |
|
—
|
| | | |
|
—
|
| |
| |
Year ended 31 Dec 2020
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Transfers from Level 1 to Level 2 | | | | | 200 | | | | | | 915 | | | | | | — | | | | | | — | | | | | | 77 | | | | | | 6,013 | | | | | | — | | |
| | Transfers from Level 2 to Level 1 | | | | | 1,557 | | | | | | 1,557 | | | | | | 71 | | | | | | — | | | | | | 304 | | | | | | — | | | | | | — | | |
| | | | | |
2021
|
| | |
20201
|
| ||||||||||||||||||||
| | | | | |
MSS
£m |
| | |
Corporate Centre
£m |
| | |
MSS
£m |
| | |
Corporate Centre
£m |
| ||||||||||||
| | Type of adjustment | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Risk-related | | | | |
|
505
|
| | | | |
|
31
|
| | | | | | 647 | | | | | | | 16 | | |
| | – bid-offer | | | | |
|
190
|
| | | | |
|
—
|
| | | | | | 252 | | | | | | | — | | |
| | – uncertainty | | | | |
|
37
|
| | | | |
|
1
|
| | | | | | 60 | | | | | | | 1 | | |
| | – credit valuation adjustment | | | | |
|
99
|
| | | | |
|
26
|
| | | | | | 211 | | | | | | | 15 | | |
| | – debt valuation adjustment | | | | |
|
(27)
|
| | | | |
|
—
|
| | | | | | (40) | | | | | | | — | | |
| | – funding fair value adjustment | | | | |
|
206
|
| | | | |
|
4
|
| | | | | | 151 | | | | | | | — | | |
| | – other | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 13 | | | | | | | — | | |
| | Model-related | | | | |
|
19
|
| | | | |
|
—
|
| | | | | | 47 | | | | | | | — | | |
| | – model limitation | | | | |
|
19
|
| | | | |
|
—
|
| | | | | | 44 | | | | | | | — | | |
| | – other | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 3 | | | | | | | — | | |
| | Inception profit (Day 1 P&L reserves) | | | | |
|
65
|
| | | | |
|
—
|
| | | | | | 60 | | | | | | | — | | |
| |
At 31 Dec
|
| | | |
|
589
|
| | | | |
|
31
|
| | | | | | 754 | | | | | | | 16 | | |
| | | | |
Assets
|
| |
Liabilities
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| | | | |
Financial
Investments £m |
| |
Held for
trading £m |
| |
Designated and
otherwise mandatorily measured at fair value through profit or loss £m |
| |
Derivatives
£m |
| |
Total
£m |
| |
Held for
trading £m |
| |
Designated
at fair value £m |
| |
Derivatives
£m |
| |
Total
£m |
| |||||||||||||||||||||||||||
| | Private equity including strategic investments | | | |
|
79
|
| | | |
|
1
|
| | | |
|
2,898
|
| | | |
|
—
|
| | | |
|
2,978
|
| | | |
|
7
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
7
|
| |
| | Asset-backed securities | | | |
|
495
|
| | | |
|
97
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
592
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
| | Structured notes | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
2,120
|
| | | |
|
—
|
| | | |
|
2,120
|
| |
| | Derivatives | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
1,816
|
| | | |
|
1,816
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
2,454
|
| | | |
|
2,454
|
| |
| | Other portfolios | | | |
|
813
|
| | | |
|
1,246
|
| | | |
|
273
|
| | | |
|
—
|
| | | |
|
2,332
|
| | | |
|
573
|
| | | |
|
1
|
| | | |
|
—
|
| | | |
|
574
|
| |
| | At 31 Dec 2021 | | | | | 1,387 | | | | | | 1,344 | | | | | | 3,171 | | | | | | 1,816 | | | | | | 7,718 | | | | | | 580 | | | | | | 2,121 | | | | | | 2,454 | | | | | | 5,155 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Private equity including strategic investments | | | | | 75 | | | | | | 3 | | | | | | 3,153 | | | | | | — | | | | | | 3,231 | | | | | | 3 | | | | | | — | | | | | | — | | | | | | 3 | | |
| | Asset-backed securities | | | | | 847 | | | | | | 372 | | | | | | 18 | | | | | | — | | | | | | 1,237 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | Structured notes | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 21 | | | | | | 1,147 | | | | | | — | | | | | | 1,168 | | |
| | Derivatives | | | | | — | | | | | | — | | | | | | — | | | | | | 1,974 | | | | | | 1,974 | | | | | | — | | | | | | — | | | | | | 3,095 | | | | | | 3,095 | | |
| | Other portfolios | | | | | 713 | | | | | | 1,236 | | | | | | 296 | | | | | | — | | | | | | 2,245 | | | | | | 94 | | | | | | 3 | | | | | | 1 | | | | | | 98 | | |
| | At 31 Dec 2020 | | | | | 1,635 | | | | | | 1,611 | | | | | | 3,467 | | | | | | 1,974 | | | | | | 8,687 | | | | | | 118 | | | | | | 1,150 | | | | | | 3,096 | | | | | | 4,364 | | |
| | | | | |
Assets
|
| | |
Liabilities
|
| |||||||||||||||||||||||||||||||||||||||||
| | | | | |
Financial
Investments £m |
| | |
Trading assets
£m |
| | |
Designated and
otherwise mandatorily measured at fair value through profit or loss £m |
| | |
Derivatives
£m |
| | |
Trading
liabilities £m |
| | |
Designated
at fair value £m |
| | |
Derivatives
£m |
| |||||||||||||||||||||
| | At 1 Jan 2021 | | | | | | 1,635 | | | | | | | 1,611 | | | | | | | 3,467 | | | | | | | 1,974 | | | | | | | 118 | | | | | | | 1,150 | | | | | | | 3,096 | | |
| | Total gains/(losses) recognised in profit or loss | | | | |
|
15
|
| | | | |
|
(77)
|
| | | | |
|
148
|
| | | | |
|
1,608
|
| | | | |
|
11
|
| | | | |
|
(316)
|
| | | | |
|
1,362
|
| |
| |
–
net income from financial instruments held for trading or managed on a fair value basis
|
| | | |
|
—
|
| | | | |
|
(77)
|
| | | | |
|
—
|
| | | | |
|
1,608
|
| | | | |
|
11
|
| | | | |
|
—
|
| | | | |
|
1,362
|
| |
| |
–
changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss
|
| | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
148
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(316)
|
| | | | |
|
—
|
| |
| |
–
gains less losses from financial investments at fair value through other comprehensive income
|
| | | |
|
15
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| |
Total gains/(losses) recognised in other comprehensive income (‘OCI’)
|
| | | | | (75) | | | | | | | (4) | | | | | | | (152) | | | | | | | (6) | | | | | | | (1) | | | | | | | (32) | | | | | | | (8) | | |
| |
–
financial investments: fair value gains/(losses)
|
| | | |
|
(27)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| |
–
exchange differences
|
| | | |
|
(48)
|
| | | | |
|
(4)
|
| | | | |
|
(152)
|
| | | | |
|
(6)
|
| | | | |
|
(1)
|
| | | | |
|
(32)
|
| | | | |
|
(8)
|
| |
| | Purchases | | | | |
|
555
|
| | | | |
|
686
|
| | | | |
|
543
|
| | | | |
|
—
|
| | | | |
|
742
|
| | | | |
|
1
|
| | | | |
|
—
|
| |
| | New issuances | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
25
|
| | | | |
|
2,213
|
| | | | |
|
—
|
| |
| | Sales | | | | |
|
(417)
|
| | | | |
|
(209)
|
| | | | |
|
(813)
|
| | | | |
|
—
|
| | | | |
|
(3)
|
| | | | |
|
(20)
|
| | | | |
|
—
|
| |
| | Settlements | | | | |
|
(109)
|
| | | | |
|
(506)
|
| | | | |
|
(5)
|
| | | | |
|
(1,722)
|
| | | | |
|
(504)
|
| | | | |
|
(1,053)
|
| | | | |
|
(2,343)
|
| |
| | Transfers out | | | | |
|
(218)
|
| | | | |
|
(668)
|
| | | | |
|
(41)
|
| | | | |
|
(368)
|
| | | | |
|
(5)
|
| | | | |
|
(137)
|
| | | | |
|
(465)
|
| |
| | Transfers in | | | | |
|
1
|
| | | | |
|
511
|
| | | | |
|
24
|
| | | | |
|
330
|
| | | | |
|
197
|
| | | | |
|
315
|
| | | | |
|
812
|
| |
| | At 31 Dec 2021 | | | | | | 1,387 | | | | | | | 1,344 | | | | | | | 3,171 | | | | | | | 1,816 | | | | | | | 580 | | | | | | | 2,121 | | | | | | | 2,454 | | |
| | Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held at 31 Dec 2021 | | | | |
|
—
|
| | | | |
|
(11)
|
| | | | |
|
51
|
| | | | |
|
846
|
| | | | |
|
—
|
| | | | |
|
102
|
| | | | |
|
(721)
|
| |
| |
–
trading income/(expense) excluding net interest income
|
| | | |
|
—
|
| | | | |
|
(11)
|
| | | | |
|
—
|
| | | | |
|
846
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(721)
|
| |
| |
–
net income/(expense) from other financial instruments designated at fair value
|
| | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
51
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
102
|
| | | | |
|
—
|
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | At 1 Jan 2020 | | | | | | 1,554 | | | | | | | 3,203 | | | | | | | 3,737 | | | | | | | 1,637 | | | | | | | 40 | | | | | | | 943 | | | | | | | 1,681 | | |
| | Total gains/(losses) recognised in profit or loss | | | | | | 14 | | | | | | | 3 | | | | | | | 95 | | | | | | | 1,582 | | | | | | | 237 | | | | | | | 87 | | | | | | | 2,644 | | |
| |
–
net income from financial instruments held for trading or managed on a fair value basis
|
| | | | | — | | | | | | | 3 | | | | | | | — | | | | | | | 1,582 | | | | | | | 237 | | | | | | | — | | | | | | | 2,644 | | |
| |
–
changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss
|
| | | | | — | | | | | | | — | | | | | | | 95 | | | | | | | — | | | | | | | — | | | | | | | 87 | | | | | | | — | | |
| |
–
gains less losses from financial investments at fair value through other comprehensive income
|
| | | | | 14 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | Total gains/(losses) recognised in other comprehensive income (‘OCI’) | | | | | | 21 | | | | | | | 56 | | | | | | | (12) | | | | | | | 33 | | | | | | | 1 | | | | | | | 23 | | | | | | | 7 | | |
| |
–
financial investments: fair value gains/(losses)
|
| | | | | 58 | | | | | | | — | | | | | | | 2 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| |
–
exchange differences
|
| | | | | (37) | | | | | | | 56 | | | | | | | (14) | | | | | | | 33 | | | | | | | 1 | | | | | | | 23 | | | | | | | 7 | | |
| | Purchases | | | | | | 294 | | | | | | | 442 | | | | | | | 1,061 | | | | | | | — | | | | | | | 53 | | | | | | | — | | | | | | | — | | |
| | New issuances | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 5 | | | | | | | 575 | | | | | | | — | | |
| | Sales | | | | | | (525) | | | | | | | (791) | | | | | | | (1,435) | | | | | | | — | | | | | | | (198) | | | | | | | — | | | | | | | — | | |
| | Settlements | | | | | | (116) | | | | | | | (868) | | | | | | | (79) | | | | | | | (1,138) | | | | | | | (20) | | | | | | | (525) | | | | | | | (1,080) | | |
| | Transfers out | | | | | | (61) | | | | | | | (1,336) | | | | | | | (61) | | | | | | | (358) | | | | | | | (7) | | | | | | | (265) | | | | | | | (437) | | |
| | Transfers in | | | | | | 454 | | | | | | | 902 | | | | | | | 161 | | | | | | | 218 | | | | | | | 7 | | | | | | | 312 | | | | | | | 281 | | |
| | At 31 Dec 2020 | | | | | | 1,635 | | | | | | | 1,611 | | | | | | | 3,467 | | | | | | | 1,974 | | | | | | | 118 | | | | | | | 1,150 | | | | | | | 3,096 | | |
| | Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held at 31 Dec 2020 | | | | | | — | | | | | | | (24) | | | | | | | 43 | | | | | | | 505 | | | | | | | (1) | | | | | | | (73) | | | | | | | 1,171 | | |
| |
–
trading income/(expense) excluding net interest income
|
| | | | | — | | | | | | | (24) | | | | | | | — | | | | | | | 505 | | | | | | | (1) | | | | | | | — | | | | | | | 1,171 | | |
| |
–
net income from other financial instruments designated at fair value
|
| | | | | — | | | | | | | — | | | | | | | 43 | | | | | | | — | | | | | | | — | | | | | | | (73) | | | | | | | — | | |
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||||||||||||||||||||||||||
| | | | |
Reflected in
profit or loss |
| |
Reflected in OCI
|
| |
Reflected in
profit or loss |
| |
Reflected in OCI
|
| ||||||||||||||||||||||||||||||||||||
| | | | |
Favourable
changes £m |
| |
Un-
favourable changes £m |
| |
Favourable
changes £m |
| |
Un-
favourable changes £m |
| |
Favourable
changes £m |
| |
Un-
favourable changes £m |
| |
Favourable
changes £m |
| |
Un-
favourable changes £m |
| ||||||||||||||||||||||||
| | Derivatives, trading assets and trading liabilities1 | | | |
|
92
|
| | | |
|
(70)
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 161 | | | | | | (145) | | | | | | — | | | | | | — | | |
| | Designated and otherwise mandatorily measured at fair value through profit or loss | | | |
|
247
|
| | | |
|
(247)
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 226 | | | | | | (226) | | | | | | — | | | | | | — | | |
| | Financial investments | | | |
|
15
|
| | | |
|
(15)
|
| | | |
|
51
|
| | | |
|
(50)
|
| | | | | 26 | | | | | | (26) | | | | | | 49 | | | | | | (49) | | |
| |
Year ended 31 Dec
|
| | |
|
354
|
| | | |
|
(332)
|
| | | |
|
51
|
| | | |
|
(50)
|
| | | | | 413 | | | | | | (397) | | | | | | 49 | | | | | | (49) | | |
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||||||||||||||||||||||||||
| | | | |
Reflected in
profit or loss |
| |
Reflected in OCI
|
| |
Reflected in
profit or loss |
| |
Reflected in OCI
|
| ||||||||||||||||||||||||||||||||||||
| | | | |
Favourable
changes £m |
| |
Un-
favourable changes £m |
| |
Favourable
changes £m |
| |
Un-
favourable changes £m |
| |
Favourable
changes £m |
| |
Un-
favourable changes £m |
| |
Favourable
changes £m |
| |
Un-
favourable changes £m |
| ||||||||||||||||||||||||
| |
Private equity including strategic
investments |
| | |
|
232
|
| | | |
|
(234)
|
| | | |
|
7
|
| | | |
|
(7)
|
| | | | | 193 | | | | | | (195) | | | | | | 7 | | | | | | (7) | | |
| | Asset-backed securities | | | |
|
39
|
| | | |
|
(20)
|
| | | |
|
1
|
| | | |
|
—
|
| | | | | 64 | | | | | | (40) | | | | | | 5 | | | | | | (4) | | |
| | Structured notes | | | |
|
6
|
| | | |
|
(6)
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 23 | | | | | | (23) | | | | |
|
—
|
| | | |
|
—
|
| |
| | Derivatives | | | |
|
29
|
| | | |
|
(34)
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 73 | | | | | | (70) | | | | |
|
—
|
| | | |
|
—
|
| |
| | Other portfolios | | | |
|
48
|
| | | |
|
(38)
|
| | | |
|
43
|
| | | |
|
(43)
|
| | | | | 60 | | | | | | (69) | | | | | | 37 | | | | | | (38) | | |
| |
Year ended 31 Dec
|
| | |
|
354
|
| | | |
|
(332)
|
| | | |
|
51
|
| | | |
|
(50)
|
| | | | | 413 | | | | | | (397) | | | | | | 49 | | | | | | (49) | | |
| | | | | |
Fair value
|
| | | | | | | | | | |
2021
|
| | |
2020
|
| ||||||||||||||||||||||||||||||
| | | | | |
Assets
£m |
| | |
Liabilities
£m |
| | |
Valuation
techniques |
| | |
Key
unobservable inputs |
| | |
Full range of inputs
|
| | |
Full range of inputs
|
| ||||||||||||||||||||||||||
| | | | | |
Lower
|
| | |
Higher
|
| | |
Lower
|
| | |
Higher
|
| ||||||||||||||||||||||||||||||||||
| |
Private equity including strategic
investments |
| | | |
|
2,978
|
| | | | |
|
7
|
| | | |
See below
|
| | |
See below
|
| | | |
|
N/A
|
| | | | |
|
N/A
|
| | | | | | N/A | | | | | | | N/A | | |
| | Asset-backed securities | | | | |
|
592
|
| | | | |
|
—
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – CLO/CDO1 | | | | |
|
14
|
| | | | |
|
—
|
| | | |
Market proxy
|
| | |
Bid quotes
|
| | | |
|
—
|
| | | | |
|
100
|
| | | | | | — | | | | | | | 100 | | |
| | – Other ABSs | | | | |
|
578
|
| | | | |
|
—
|
| | | |
Market proxy
|
| | |
Bid quotes
|
| | | |
|
—
|
| | | | |
|
100
|
| | | | | | — | | | | | | | 100 | | |
| | Structured notes | | | | |
|
—
|
| | | | |
|
2,120
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
– equity-linked notes
|
| | | | | — | | | | | | | 1,856 | | | | |
Model – Option
model |
| | |
Equity
volatility |
| | | | | 6% | | | | | | | 124% | | | | | |
|
0%
|
| | | | |
|
115%
|
| |
| | | | | | | | | | | | | | | | | | | |
|
| | |
Equity correlation
|
| | | |
|
34%
|
| | | | |
|
99%
|
| | | | | | (4)% | | | | | | | 79% | | |
| | – fund-linked notes | | | | |
|
—
|
| | | | |
|
—
|
| | | |
Model – Option
model |
| | |
Fund volatility
|
| | | | | | | | | | | | | | | | | | | 0% | | | | | | | 21% | | |
| | – FX-linked notes | | | | |
|
—
|
| | | | |
|
14
|
| | | |
Model – Option
model |
| | |
FX volatility
|
| | | |
|
3%
|
| | | | |
|
99%
|
| | | | | | 0% | | | | | | | 23% | | |
| | – other | | | | |
|
—
|
| | | | |
|
250
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Derivatives | | | | |
|
1,816
|
| | | | |
|
2,454
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – Interest rate derivatives: | | | | |
|
594
|
| | | | |
|
749
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
securitisation swaps
|
| | | | | 211 | | | | | | | 439 | | | | |
Model – Discounted
cash flow |
| | |
Constant
prepayment rate |
| | | | | 5% | | | | | | | 50% | | | | | |
|
6%
|
| | | | |
|
6%
|
| |
| | long-dated swaptions | | | | |
|
27
|
| | | | |
|
54
|
| | | |
Model – Option
model |
| | |
IR volatility
|
| | | |
|
15%
|
| | | | |
|
35%
|
| | | | | | 6% | | | | | | | 28% | | |
| | other | | | | |
|
356
|
| | | | |
|
256
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – FX derivatives: | | | | |
|
384
|
| | | | |
|
418
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | FX options | | | | |
|
116
|
| | | | |
|
107
|
| | | |
Model – Option
model |
| | |
FX volatility
|
| | | |
|
2%
|
| | | | |
|
99%
|
| | | | | | 3% | | | | | | | 40% | | |
| | other | | | | |
|
268
|
| | | | |
|
311
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | 0% | | | | | | | 70% | | |
| | – Equity derivatives: | | | | |
|
706
|
| | | | |
|
1,140
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | long-dated single stock options | | | | |
|
425
|
| | | | |
|
586
|
| | | |
Model – Option
model |
| | |
Equity volatility
|
| | | |
|
4%
|
| | | | |
|
138%
|
| | | | | | 7% | | | | | | | 70% | | |
| | other2 | | | | |
|
281
|
| | | | |
|
554
|
| | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – Credit derivatives: | | | | |
|
132
|
| | | | |
|
147
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | other | | | | |
|
132
|
| | | | |
|
147
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Other portfolios | | | | |
|
2,332
|
| | | | |
|
574
|
| | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – repurchase agreements | | | | |
|
329
|
| | | | |
|
—
|
| | | |
Model – Discounted
cash flow |
| | |
IR curve
|
| | | |
|
1%
|
| | | | |
|
5%
|
| | | | | | —% | | | | | | | 5% | | |
| | – other3 | | | | |
|
2,003
|
| | | | |
|
574
|
| | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | At 31 Dec | | | | | | 7,718 | | | | | | | 5,155 | | | | |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
Fair value
|
| |||||||||||||||||||||
| | | | |
Carrying amount
£m |
| |
Quoted market
price Level 1 £m |
| |
Observable
inputs Level 2 £m |
| |
Significant unobservable
inputs Level 3 £m |
| |
Total
£m |
| |||||||||||||||
| | At 31 Dec 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Loans and advances to banks | | | |
|
10,784
|
| | | |
|
—
|
| | | |
|
10,786
|
| | | |
|
—
|
| | | |
|
10,786
|
| |
| | Loans and advances to customers | | | |
|
91,177
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
91,276
|
| | | |
|
91,276
|
| |
| | Reverse repurchase agreements – non-trading | | | |
|
54,448
|
| | | |
|
—
|
| | | |
|
54,448
|
| | | |
|
—
|
| | | |
|
54,448
|
| |
| | Financial investments – at amortised cost | | | |
|
10
|
| | | |
|
2
|
| | | |
|
—
|
| | | |
|
8
|
| | | |
|
10
|
| |
| | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Deposits by banks | | | |
|
32,188
|
| | | |
|
—
|
| | | |
|
32,102
|
| | | |
|
—
|
| | | |
|
32,102
|
| |
| | Customer accounts | | | |
|
205,241
|
| | | |
|
—
|
| | | |
|
205,236
|
| | | |
|
—
|
| | | |
|
205,236
|
| |
| | Repurchase agreements – non-trading | | | |
|
27,259
|
| | | |
|
—
|
| | | |
|
27,259
|
| | | |
|
—
|
| | | |
|
27,259
|
| |
| | Debt securities in issue | | | |
|
9,428
|
| | | |
|
—
|
| | | |
|
9,286
|
| | | |
|
144
|
| | | |
|
9,430
|
| |
| | Subordinated liabilities | | | |
|
12,488
|
| | | |
|
—
|
| | | |
|
13,118
|
| | | |
|
—
|
| | | |
|
13,118
|
| |
| | At 31 Dec 2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Loans and advances to banks | | | | | 12,646 | | | | | | — | | | | | | 12,649 | | | | | | — | | | | | | 12,649 | | |
| | Loans and advances to customers | | | | | 101,491 | | | | | | — | | | | | | — | | | | | | 101,584 | | | | | | 101,584 | | |
| | Reverse repurchase agreements – non-trading | | | | | 67,577 | | | | | | — | | | | | | 67,577 | | | | | | — | | | | | | 67,577 | | |
| | Financial investments – at amortised cost | | | | | 15 | | | | | | — | | | | | | 7 | | | | | | 7 | | | | | | 14 | | |
| | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Deposits by banks | | | | | 34,305 | | | | | | — | | | | | | 34,249 | | | | | | — | | | | | | 34,249 | | |
| | Customer accounts | | | | | 195,184 | | | | | | — | | | | | | 195,076 | | | | | | 104 | | | | | | 195,180 | | |
| | Repurchase agreements – non-trading | | | | | 34,903 | | | | | | — | | | | | | 34,903 | | | | | | — | | | | | | 34,903 | | |
| | Debt securities in issue | | | | | 17,371 | | | | | | — | | | | | | 17,094 | | | | | | 273 | | | | | | 17,367 | | |
| | Subordinated liabilities | | | | | 13,764 | | | | | | — | | | | | | 14,638 | | | | | | — | | | | | | 14,638 | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| ||||||
| | Securities | | | | |
|
15,738
|
| | | | | | 14,620 | | |
| | – debt securities | | | | |
|
2,584
|
| | | | | | 2,918 | | |
| | – equity securities | | | | |
|
13,154
|
| | | | | | 11,702 | | |
| | Loans and advances to banks and customers | | | | |
|
2,613
|
| | | | | | 1,285 | | |
| | Other | | | | |
|
298
|
| | | | | | 315 | | |
| |
At 31 Dec
|
| | | |
|
18,649
|
| | | | | | 16,220 | | |
| | | | |
Notional contract amount
|
| |
Fair value – Assets
|
| |
Fair value – Liabilities
|
| |||||||||||||||||||||||||||||||||||||||
| | | | |
Trading
£m |
| |
Hedging
£m |
| |
Trading
£m |
| |
Hedging
£m |
| |
Total
£m |
| |
Trading
£m |
| |
Hedging
£m |
| |
Total
£m |
| ||||||||||||||||||||||||
| | Foreign exchange | | | |
|
4,737,254
|
| | | |
|
4,045
|
| | | |
|
49,775
|
| | | |
|
266
|
| | | |
|
50,041
|
| | | |
|
(48,613)
|
| | | |
|
(67)
|
| | | |
|
(48,680)
|
| |
| | Interest rate | | | |
|
8,727,934
|
| | | |
|
39,553
|
| | | |
|
99,744
|
| | | |
|
144
|
| | | |
|
99,888
|
| | | |
|
(96,297)
|
| | | |
|
(270)
|
| | | |
|
(96,567)
|
| |
| | Equities | | | |
|
498,980
|
| | | |
|
—
|
| | | |
|
9,718
|
| | | |
|
—
|
| | | |
|
9,718
|
| | | |
|
(11,881)
|
| | | |
|
—
|
| | | |
|
(11,881)
|
| |
| | Credit | | | |
|
134,440
|
| | | |
|
—
|
| | | |
|
1,582
|
| | | |
|
—
|
| | | |
|
1,582
|
| | | |
|
(2,159)
|
| | | |
|
—
|
| | | |
|
(2,159)
|
| |
| | Commodity and other | | | |
|
42,677
|
| | | |
|
—
|
| | | |
|
681
|
| | | |
|
—
|
| | | |
|
681
|
| | | |
|
(770)
|
| | | |
|
—
|
| | | |
|
(770)
|
| |
| | Offset (Note 29) | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
(20,689)
|
| | | | | | | | | | | | | | | |
|
20,689
|
| |
| | At 31 Dec 2021 | | | | | 14,141,285 | | | | | | 43,598 | | | | | | 161,500 | | | | | | 410 | | | | | | 141,221 | | | | | | (159,720) | | | | | | (337) | | | | | | (139,368) | | |
| | | | ||||||||||||||||||||||||||||||||||||||||||||||||
| | Foreign exchange | | | | | 4,378,792 | | | | | | 5,297 | | | | | | 60,341 | | | | | | 191 | | | | | | 60,532 | | | | | | (59,990) | | | | | | (41) | | | | | | (60,031) | | |
| | Interest rate | | | | | 8,922,892 | | | | | | 40,258 | | | | | | 155,752 | | | | | | 619 | | | | | | 156,371 | | | | | | (151,623) | | | | | | (488) | | | | | | (152,111) | | |
| | Equities | | | | | 481,638 | | | | | | — | | | | | | 10,857 | | | | | | — | | | | | | 10,857 | | | | | | (12,598) | | | | | | — | | | | | | (12,598) | | |
| | Credit | | | | | 198,306 | | | | | | — | | | | | | 1,874 | | | | | | — | | | | | | 1,874 | | | | | | (2,672) | | | | | | — | | | | | | (2,672) | | |
| | Commodity and other | | | | | 82,130 | | | | | | — | | | | | | 1,572 | | | | | | — | | | | | | 1,572 | | | | | | (1,816) | | | | | | — | | | | | | (1,816) | | |
| | Offset (Note 29) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (29,996) | | | | | | | | | | | | | | | | | | 29,996 | | |
| | At 31 Dec 2020 | | | | | 14,063,758 | | | | | | 45,555 | | | | | | 230,396 | | | | | | 810 | | | | | | 201,210 | | | | | | (228,699) | | | | | | (529) | | | | | | (199,232) | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| ||||||
| | Unamortised balance at 1 Jan | | | | |
|
60
|
| | | | | | 42 | | |
| | Deferral on new transactions | | | | |
|
156
|
| | | | | | 105 | | |
| | Recognised in the income statement during the year: | | | | |
|
(152)
|
| | | | | | (88) | | |
| | – amortisation | | | | |
|
(88)
|
| | | | | | (57) | | |
| | – subsequent to unobservable inputs becoming observable | | | | |
|
(2)
|
| | | | | | (2) | | |
| | – maturity, termination or offsetting derivative | | | | |
|
(60)
|
| | | | | | (28) | | |
| | – risk hedged | | | | |
|
(2)
|
| | | | | | (1) | | |
| | Exchange differences and other | | | | |
|
—
|
| | | | | | 1 | | |
| |
Unamortised balance at 31 Dec1
|
| | | |
|
64
|
| | | | | | 60 | | |
| | | | |
Hedging instrument
|
| |||||||||||||||||||||||||||
| | | | | | | | | | |
Carrying amount
|
| | | | | | | | | | | | | |||||||||
| | | | |
Notional amount1
|
| |
Assets
|
| |
Liabilities
|
| |
Balance sheet
presentation |
| |
Change in
fair value2 |
| |||||||||||||||
| |
Hedged risk
|
| | | | £m | | | | | | £m | | | | | | £m | | | | | | | | | | | | £m | | |
| | Interest rate3 | | | |
|
24,486
|
| | | |
|
139
|
| | | |
|
(270)
|
| | | |
|
Derivatives
|
| | | |
|
159
|
| |
| | At 31 Dec 2021 | | | | | 24,486 | | | | | | 139 | | | | | | (270) | | | | | | | | | | | | 159 | | |
| | Interest rate3 | | | | | 29,737 | | | | | | 617 | | | | | | (488) | | | | | | Derivatives | | | | | | (364) | | |
| | At 31 Dec 2020 | | | | | 29,737 | | | | | | 617 | | | | | | (488) | | | | | | | | | | | | (364) | | |
| | | | |
Hedged item
|
| |
Ineffectiveness
|
| ||||||||||||||||||||||||||||||||||||
| | | | |
Carrying amount
|
| |
Accumulated fair
value hedge adjustments included in carrying amount2 |
| | | | | | | | | | | | | | | | | | | ||||||||||||||||||
| |
Hedged risk
|
| |
Assets
£m |
| |
Liabilities
£m |
| |
Assets
£m |
| |
Liabilities
£m |
| |
Balance sheet presentation
|
| |
Change in fair
value1 £m |
| |
Recognised in
profit and loss £m |
| |
Profit and loss
presentation |
| ||||||||||||||||||
| |
Interest rate3
|
| | | | 14,099 | | | | | | — | | | | | | 167 | | | | | | — | | | |
Financial assets at fair value
through other comprehensive income |
| | | | (278) | | | | | | (9) | | | |
Net income from
financial instruments held for trading or managed on a fair value basis |
|
| | | | | | | 1 | | | | | | — | | | | | | (2) | | | | | | — | | | |
Loans and
advances to banks |
| | | | (2) | | | | | | | | | | | |
| | | | | | | 997 | | | | | | — | | | | | | 7 | | | | | | — | | | |
Loans and advances
to customers |
| | | | (16) | | | | | | | | | | | |
| | | | | | | — | | | | | | 2,844 | | | | | | — | | | | | | 71 | | | |
Debt securities in issue
|
| | | | 24 | | | | | | | | | | | |
| | | | | | | — | | | | | | 5,841 | | | | | | — | | | | | | (77) | | | |
Subordinated liabilities and
deposits by banks4 |
| | | | 104 | | | | | | | | | |
|
|
| | At 31 Dec 2021 | | | | | 15,097 | | | | | | 8,685 | | | | | | 172 | | | | | | (6) | | | |
|
| | | | (168) | | | | | | (9) | | | |
|
|
| | Interest rate3 | | | | | 20,295 | | | | | | — | | | | | | 588 | | | | | | — | | | |
Financial assets at fair
value through other comprehensive income |
| | | | 409 | | | | | | (14) | | | |
Net income from
financial instruments held for trading or managed on a fair value basis |
|
| | | | | | | 4 | | | | | | — | | | | | | 2 | | | | | | — | | | |
Loans and advances
to banks |
| | | | 2 | | | | | | | | | | | |
| | | | | | | 1,327 | | | | | | — | | | | | | 23 | | | | | | — | | | |
Loans and advances
to customers |
| | | | 15 | | | | | | | | | | | |
| | | | | | | — | | | | | | 576 | | | | | | — | | | | | | 108 | | | |
Debt securities in issue
|
| | | | 4 | | | | | | | | | | | |
| | | | | | | — | | | | | | 6,483 | | | | | | — | | | | | | 248 | | | |
Subordinated liabilities and
deposits by banks4 |
| | | | (80) | | | | | | | | | |
|
|
| | At 31 Dec 2020 | | | | | 21,626 | | | | | | 7,059 | | | | | | 613 | | | | | | 356 | | | |
|
| | | | 350 | | | | | | (14) | | | |
|
|
| | | | |
Hedging instrument
|
| |
Hedged item
|
| |
Ineffectiveness
|
| ||||||||||||||||||||||||||||||||||||
| | | | | | | | | | |
Carrying amount
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |||||||||
| |
Hedged risk
|
| |
Notional amount1
£m |
| |
Assets
£m |
| |
Liabilities
£m |
| |
Balance sheet
presentation |
| |
Change in fair
value2 £m |
| |
Change in fair
value3 £m |
| |
Recognised in profit
and loss £m |
| |
Profit and loss
presentation |
| |||||||||||||||||||||
| |
Foreign exchange
|
| |
4,042
|
| |
266
|
| |
(67)
|
| |
Derivatives
|
| |
127
|
| |
127
|
| |
—
|
| |
Net income from
financial instruments held for trading or managed on a fair value basis |
| |||||||||||||||||||||
| | Interest rate | | | |
|
15,067
|
| | | |
|
5
|
| | | |
|
(2)
|
| | | | | | | | | |
|
(178)
|
| | | |
|
(167)
|
| | | |
|
(11)
|
| | | ||
| | At 31 Dec 2021 | | | | | 19,109 | | | | | | 271 | | | | | | (69) | | | | | | | | | | | | (51) | | | | | | (40) | | | | | | (11) | | | |
|
|
| |
Foreign exchange
|
| | | | 5,286 | | | | | | 191 | | | | | | (41) | | | | | | Derivatives | | | | | | (30) | | | | | | (30) | | | | | | — | | | |
Net income from
financial instruments held for trading or managed on a fair value basis |
|
| | Interest rate | | | | | 10,521 | | | | | | 2 | | | | | | — | | | | | | | | | | | | 117 | | | | | | 115 | | | | | | 2 | | | |||
| | At 31 Dec 2020 | | | | | 15,807 | | | | | | 193 | | | | | | (41) | | | | | | | | | | | | 87 | | | | | | 85 | | | | | | 2 | | | |
|
|
| | | | |
Interest rate
£m |
| |
Foreign exchange
£m |
| ||||||
| | Cash flow hedging reserve at 1 Jan 2021 | | | |
|
147
|
| | | |
|
11
|
| |
| | Fair value (losses)/gains | | | |
|
(167)
|
| | | |
|
127
|
| |
| | Fair value (gains) reclassified from cash flow hedge reserve to income statement in respect of: | | | | | | | | | | | | | |
| | – hedged items that have affected profit or loss | | | |
|
(25)
|
| | | |
|
(177)
|
| |
| | Income taxes | | | |
|
77
|
| | | |
|
—
|
| |
| | Cash flow hedging reserve at 31 Dec 2021 | | | | | 32 | | | | | | (39) | | |
| | | | | | | | | | | | | | | |
| | Cash flow hedging reserve at 1 Jan 2020 | | | | | 76 | | | | | | (36) | | |
| | Fair value gains/(losses) | | | | | 115(29) | | | | | | | | |
| |
Fair value (gains)/losses reclassified from cash flow hedge reserve to income statement in respect of:
|
| | | | | | | | | | | | |
| | – hedged items that have affected profit or loss | | | | | (4) | | | | | | 76 | | |
| | Income taxes | | | | | (40) | | | | | | — | | |
| | Cash flow hedging reserve at 31 Dec 2020 | | | | | 147 | | | | | | 11 | | |
| | | | |
Hedging instrument
|
| |||||||||||||||||||||||||||||||||||||||
| | | | |
Impacted by Ibor reform
|
| | | | | | | | | | | | | |||||||||||||||||||||||||||
| | | | |
EUR2
£m |
| |
GBP
£m |
| |
USD
£m |
| |
Other3
£m |
| |
Total
£m |
| |
NOT impacted by
Ibor reform £m |
| |
Notional amount1
£m |
| |||||||||||||||||||||
| | Fair value hedges | | | |
|
6,407
|
| | | |
|
—
|
| | | |
|
336
|
| | | |
|
124
|
| | | |
|
6,867
|
| | | |
|
17,619
|
| | | |
|
24,486
|
| |
| | Cash flow hedges | | | |
|
5,877
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
5,877
|
| | | |
|
9,190
|
| | | |
|
15,067
|
| |
| | At 31 Dec 2021 | | | | | 12,284 | | | | | | — | | | | | | 336 | | | | | | 124 | | | | | | 12,744 | | | | | | 26,809 | | | | | | 39,553 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | £m | | | | | | £m | | | | | | £m | | | | | | £m | | | | | | £m | | | | | | £m | | | | | | £m | | |
| | Fair value hedges | | | | | 12,822 | | | | | | 1,855 | | | | | | 1,908 | | | | | | 60 | | | | | | 16,645 | | | | | | 13,092 | | | | | | 29,737 | | |
| | Cash flow hedges | | | | | 6,111 | | | | | | 1,552 | | | | | | 183 | | | | | | — | | | | | | 7,846 | | | | | | 2,675 | | | | | | 10,521 | | |
| | At 31 Dec 2020 | | | | | 18,933 | | | | | | 3,407 | | | | | | 2,091 | | | | | | 60 | | | | | | 24,491 | | | | | | 15,767 | | | | | | 40,258 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
Financial instruments yet to transition to alternative
benchmarks, by main benchmark |
| |||||||||||||||
| |
At 31 Dec 2021
|
| |
USD Libor
£m |
| |
GBP Libor
£m |
| |
Eonia
£m |
| |
Others1
£m |
| ||||||||||||
| | Non-derivative financial assets2 | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Loans and advances to customers | | | | | 5,999 | | | | | | 2,562 | | | | | | — | | | | | | 26 | | |
| | Financial investments | | | | | 1,171 | | | | | | 140 | | | | | | — | | | | | | — | | |
| | Others | | | | | 693 | | | | | | 499 | | | | | | — | | | | | | — | | |
| | Total non-derivative financial assets | | | | | 7,863 | | | | | | 3,201 | | | | | | — | | | | | | 26 | | |
| | Non-derivative financial liabilities | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Subordinated liabilities | | | | | 1,145 | | | | | | — | | | | | | — | | | | | | — | | |
| | Others | | | | | 479 | | | | | | 181 | | | | | | — | | | | | | — | | |
| | Total non-derivative financial liabilities | | | | | 1,624 | | | | | | 181 | | | | | | — | | | | | | — | | |
| | Derivative notional contract amount | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Foreign exchange | | | | | 8,288 | | | | | | 1,568 | | | | | | — | | | | | | 1,080 | | |
| | Interest rate | | | | | 1,567,577 | | | | | | 215,377 | | | | | | 1,679 | | | | | | 76,059 | | |
| | Others | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | Total derivative notional contract amount | | | | | 1,575,865 | | | | | | 216,945 | | | | | | 1,679 | | | | | | 77,139 | | |
| | At 31 Dec 2020 | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Non-derivative financial assets2 | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Loans and advances to customers | | | | | 7,782 | | | | | | 4,323 | | | | | | 1 | | | | | | 183 | | |
| | Financial investments | | | | | 1,187 | | | | | | 406 | | | | | | — | | | | | | — | | |
| | Others | | | | | 1,043 | | | | | | 1,033 | | | | | | — | | | | | | 1 | | |
| | Ers | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Total non-derivative financial assets | | | | | 10,012 | | | | | | 5,762 | | | | | | 1 | | | | | | 184 | | |
| | Non-derivative financial liabilities | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Subordinated liabilities | | | | | 1,135 | | | | | | 900 | | | | | | — | | | | | | — | | |
| | Others | | | | | 798 | | | | | | 510 | | | | | | 3 | | | | | | 1 | | |
| | Total non-derivative financial liabilities | | | | | 1,933 | | | | | | 1,410 | | | | | | 3 | | | | | | 1 | | |
| | Derivative notional contract amount | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Foreign exchange | | | | | 6,296 | | | | | | 2,768 | | | | | | — | | | | | | 8,148 | | |
| | Interest rate | | | | | 1,694,279 | | | | | | 865,545 | | | | | | 196,515 | | | | | | 126,545 | | |
| | Others | | | | | 7 | | | | | | — | | | | | | — | | | | | | — | | |
| | Total derivative notional contract amount | | | | | 1,700,582 | | | | | | 868,313 | | | | | | 196,515 | | | | | | 134,693 | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| ||||||
| |
Financial investments measured at fair value through other comprehensive income
|
| | | |
|
41,290
|
| | | | | | 51,811 | | |
| | – treasury and other eligible bills | | | | |
|
2,229
|
| | | | | | 3,286 | | |
| | – debt securities | | | | |
|
38,924
|
| | | | | | 48,363 | | |
| | – equity securities | | | | |
|
103
|
| | | | | | 98 | | |
| | – other instruments1 | | | | |
|
34
|
| | | | | | 64 | | |
| |
Debt instruments measured at amortised cost
|
| | | |
|
10
|
| | | | | | 15 | | |
| | – treasury and other eligible bills | | | | |
|
2
|
| | | | | | 5 | | |
| | – debt securities2 | | | | |
|
8
|
| | | | | | 10 | | |
| |
At 31 Dec
|
| | | |
|
41,300
|
| | | | | | 51,826 | | |
| | | | |
Instruments held at year end
|
| |||||||||
| |
Type of equity instruments
|
| |
Fair value
£m |
| |
Dividends recognised
£m |
| ||||||
| | Business facilitation | | | |
|
76
|
| | | |
|
—
|
| |
| | Investments required by central institutions | | | |
|
26
|
| | | |
|
—
|
| |
| | Others | | | |
|
1
|
| | | |
|
—
|
| |
| | At 31 Dec 2021 | | | | | 103 | | | | | | — | | |
| | | | | | | | | | | | | | | |
| | Business facilitation | | | | | 79 | | | | | | 1 | | |
| | Investments required by central institutions | | | | | 18 | | | | | | — | | |
| | Others | | | | | 1 | | | | | | — | | |
| | At 31 Dec 2020 | | | | | 98 | | | | | | 1 | | |
| | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Treasury bills and other eligible securities | | | |
|
990
|
| | | | | 2,382 | | |
| | Loans and advances to customers | | | |
|
18,403
|
| | | | | 20,597 | | |
| | Debt securities | | | |
|
20,247
|
| | | | | 24,069 | | |
| | Equity securities | | | |
|
23,612
|
| | | | | 21,304 | | |
| | Other | | | |
|
30,261
|
| | | | | 39,319 | | |
| |
Assets pledged at 31 Dec
|
| | |
|
93,513
|
| | | | | 107,671 | | |
| | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Trading assets | | | |
|
39,594
|
| | | | | 40,000 | | |
| | Financial investments | | | |
|
1,436
|
| | | | | 3,009 | | |
| |
At 31 Dec
|
| | |
|
41,030
|
| | | | | 43,009 | | |
| | | | |
Carrying amount of:
|
| |||||||||
| | | | |
Transferred assets
£m |
| |
Associated liabilities
£m |
| ||||||
| | At 31 Dec 2021 | | | | | | | | | | | | | |
| | Repurchase agreements | | | |
|
11,710
|
| | | |
|
11,732
|
| |
| | Securities lending agreements | | | |
|
29,321
|
| | | |
|
2,129
|
| |
| | At 31 Dec 2020 | | | | | | | | | | | | | |
| | Repurchase agreements | | | | | 14,232 | | | | | | 14,264 | | |
| | Securities lending agreements | | | | | 28,777 | | | | | | 87 | | |
| | | | |
At 31 Dec 2021
|
| |||||||||
| | | | |
Country of incorporation or
registration |
| |
HSBC Bank plc’s interest in
equity capital |
| |
Share class
|
| |||
| | | | |
|
| |
%
|
| |
|
| |||
| | HSBC Investment Bank Holdings Limited | | |
England and Wales
|
| | |
|
100.00
|
| | |
£1 Ordinary
|
|
| | HSBC Asset Finance (UK) Limited | | |
England and Wales
|
| | |
|
100.00
|
| | |
£1 Ordinary
|
|
| | HSBC Life (UK) Limited | | |
England and Wales
|
| | |
|
100.00
|
| | |
£1 Ordinary
|
|
| |
HSBC Trinkaus & Burkhardt GmbH
(previously HSBC Trinkaus & Burkhardt AG) |
| |
Germany
|
| | |
|
100.00
|
| | |
Stückaktien no par value
|
|
| | HSBC Continental Europe | | |
France
|
| | |
|
99.99
|
| | |
€5 Actions
|
|
| |
HSBC Bank Malta p.l.c
|
| |
Malta
|
| | | | 70.03 | | | |
€0.30 Ordinary
|
|
| | | | |
Conduits
£m |
| |
Securitisations
£m |
| |
HSBC managed
funds1 £m |
| |
Other1
£m |
| |
Total
£m |
| |||||||||||||||
| | At 31 Dec 2021 | | | | | 3,233 | | | | | | 287 | | | | | | 4,653 | | | | | | 568 | | | | | | 8,741 | | |
| | At 31 Dec 2020 | | | | | 5,023 | | | | | | 423 | | | | | | 3,885 | | | | | | 1,079 | | | | | | 10,410 | | |
| | | | | |
Securitisa-tions
|
| | |
HSBC managed
funds1 |
| | |
Non-HSBC
managed funds1 |
| | |
Other
|
| | |
Total
|
| |||||||||||||||
| | Total asset values of the entities (£m) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | 0 – 400 | | | | |
|
2
|
| | | | |
|
157
|
| | | | |
|
1,194
|
| | | | |
|
14
|
| | | | |
|
1,367
|
| |
| | 400 – 1,500 | | | | |
|
—
|
| | | | |
|
81
|
| | | | |
|
774
|
| | | | |
|
—
|
| | | | |
|
855
|
| |
| | 1,500 – 4,000 | | | | |
|
—
|
| | | | |
|
16
|
| | | | |
|
354
|
| | | | |
|
—
|
| | | | |
|
370
|
| |
| | 4,000 – 20,000 | | | | |
|
—
|
| | | | |
|
12
|
| | | | |
|
149
|
| | | | |
|
—
|
| | | | |
|
161
|
| |
| | 20,000+ | | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
9
|
| | | | |
|
—
|
| | | | |
|
11
|
| |
| | Number of entities at 31 Dec 2021 | | | | | | 2 | | | | | | | 268 | | | | | | | 2,480 | | | | | | | 14 | | | | | | | 2,764 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | £m | | | | | | | £m | | | | | | | £m | | | | | | | £m | | | | | | | £m | | |
| | Total assets in relation to the group’s interests in the unconsolidated structured entities | | | | |
|
193
|
| | | | |
|
4,414
|
| | | | |
|
5,225
|
| | | | |
|
631
|
| | | | |
|
10,463
|
| |
| | – trading assets | | | | |
|
—
|
| | | | |
|
1
|
| | | | |
|
1,807
|
| | | | |
|
—
|
| | | | |
|
1,808
|
| |
| | – financial assets designated and otherwise mandatorily measured at fair value | | | | |
|
—
|
| | | | |
|
4,409
|
| | | | |
|
3,273
|
| | | | |
|
—
|
| | | | |
|
7,682
|
| |
| | – loans and advances to customers | | | | |
|
193
|
| | | | |
|
—
|
| | | | |
|
49
|
| | | | |
|
631
|
| | | | |
|
873
|
| |
| | – financial investments | | | | |
|
—
|
| | | | |
|
4
|
| | | | |
|
96
|
| | | | |
|
—
|
| | | | |
|
100
|
| |
| | Total liabilities in relation to the group’s interests in the unconsolidated structured entities | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
—
|
| | | | |
|
2
|
| |
| | Other off-balance sheet commitments | | | | |
|
20
|
| | | | |
|
4
|
| | | | |
|
916
|
| | | | |
|
38
|
| | | | |
|
978
|
| |
| | The group’s maximum exposure at 31 Dec 2021 | | | | | | 213 | | | | | | | 4,418 | | | | | | | 6,139 | | | | | | | 669 | | | | | | | 11,439 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Total asset values of the entities (£m) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | 0 – 400 | | | | | | 5 | | | | | | | 176 | | | | | | | 1,228 | | | | | | | 16 | | | | | | | 1,425 | | |
| | 400 – 1,500 | | | | | | — | | | | | | | 60 | | | | | | | 645 | | | | | | | — | | | | | | | 705 | | |
| | 1,500 – 4,000 | | | | | | — | | | | | | | 28 | | | | | | | 351 | | | | | | | — | | | | | | | 379 | | |
| | 4,000 – 20,000 | | | | | | — | | | | | | | 22 | | | | | | | 271 | | | | | | | — | | | | | | | 293 | | |
| | 20,000+ | | | | | | — | | | | | | | 4 | | | | | | | 39 | | | | | | | — | | | | | | | 43 | | |
| | Number of entities at 31 Dec 2020 | | | | | | 5 | | | | | | | 290 | | | | | | | 2,534 | | | | | | | 16 | | | | | | | 2,845 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | £m | | | | | | | £m | | | | | | | £m | | | | | | | £m | | | | | | | £m | | |
| | Total assets in relation to the group’s interests in the unconsolidated structured entities | | | | | | 686 | | | | | | | 3,884 | | | | | | | 5,985 | | | | | | | 346 | | | | | | | 10,901 | | |
| | – trading assets | | | | | | — | | | | | | | 3 | | | | | | | 2,365 | | | | | | | — | | | | | | | 2,368 | | |
| | – financial assets designated at fair value | | | | | | — | | | | | | | 3,849 | | | | | | | 3,247 | | | | | | | — | | | | | | | 7,096 | | |
| | – loans and advances to customers | | | | | | 686 | | | | | | | — | | | | | | | — | | | | | | | 346 | | | | | | | 1,032 | | |
| | – financial investments | | | | | | — | | | | | | | 32 | | | | | | | 373 | | | | | | | — | | | | | | | 405 | | |
| | Total liabilities in relation to group’s interests in the unconsolidated structured entities | | | | | | — | | | | | | | — | | | | | | | 1 | | | | | | | — | | | | | | | 1 | | |
| | Other off-balance sheet commitments | | | | | | 40 | | | | | | | 1 | | | | | | | 1,450 | | | | | | | — | | | | | | | 1,491 | | |
| | The group’s maximum exposure at 31 Dec 2020 | | | | | | 726 | | | | | | | 3,885 | | | | | | | 7,434 | | | | | | | 346 | | | | | | | 12,391 | | |
| | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Goodwill | | | |
|
—
|
| | | | | — | | |
| | Present value of in-force long-term insurance business | | | |
|
811
|
| | | | | 647 | | |
| | Other intangible assets1 | | | |
|
83
|
| | | | | 119 | | |
| |
At 31 Dec
|
| | |
|
894
|
| | | | | 766 | | |
| | | | |
Impairments on
intangible assets |
| |||
| |
Global business
|
| |
2020
£m |
| |||
| | Wealth and Personal Banking | | | | | 39 | | |
| | Commercial Banking | | | | | 34 | | |
| | Markets and Securities Services | | | | | 1 | | |
| | Global Banking | | | | | — | | |
| | GBM Other | | | | | 461 | | |
| | Corporate Centre | | | | | 267 | | |
| |
Total
|
| | | | 802 | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| ||||||
| |
PVIF at 1 Jan
|
| | | |
|
647
|
| | | | | | 715 | | |
| | Change in PVIF of long-term insurance business | | | | |
|
200
|
| | | | | | (95) | | |
| | – value of new business written during the year | | | | |
|
67
|
| | | | | | 43 | | |
| | – expected return1 | | | | |
|
(70)
|
| | | | | | (74) | | |
| | – assumption changes and experience variances2 | | | | |
|
202
|
| | | | | | (73) | | |
| | – other adjustments | | | | |
|
1
|
| | | | | | 9 | | |
| | Exchange differences | | | | |
|
(36)
|
| | | | | | 27 | | |
| |
PVIF at 31 Dec
|
| | | |
|
811
|
| | | | | | 647 | | |
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||
| | | | |
UK
% |
| |
France1
% |
| |
UK
% |
| |
France1
% |
| ||||||||||||
| | Weighted average risk-free rate | | | |
|
0.95
|
| | | |
|
0.69
|
| | | | | 0.29 | | | | | | 0.34 | | |
| | Weighted average risk discount rate | | | |
|
0.95
|
| | | |
|
1.55
|
| | | | | 0.29 | | | | | | 1.34 | | |
| | Expense inflation | | | |
|
3.80
|
| | | |
|
1.80
|
| | | | | 2.80 | | | | | | 1.60 | | |
| | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Cash collateral and margin receivables | | | |
|
29,947
|
| | | | | 39,702 | | |
| | Settlement accounts | | | |
|
4,960
|
| | | | | 7,138 | | |
| | Bullion | | | |
|
2,253
|
| | | | | 3,597 | | |
| | Prepayments and accrued income | | | |
|
1,365
|
| | | | | 1,308 | | |
| | Property, plant and equipment | | | |
|
846
|
| | | | | 899 | | |
| | Right-of-use assets | | | |
|
251
|
| | | | | 390 | | |
| | Reinsurers’ share of liabilities under insurance contracts (Note 4) | | | |
|
146
|
| | | | | 165 | | |
| | Employee benefit assets (Note 5) | | | |
|
54
|
| | | | | 30 | | |
| | Endorsements and acceptances | | | |
|
196
|
| | | | | 97 | | |
| | Assets held for sale | | | |
|
9
|
| | | | | 90 | | |
| | Other accounts | | | |
|
3,100
|
| | | | | 2,149 | | |
| |
At 31 Dec
|
| | |
|
43,127
|
| | | | | 55,565 | | |
| | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Property, plant and equipment1 | | | |
|
6
|
| | | | | 86 | | |
| | Assets of disposal groups held for sale | | | |
|
3
|
| | | | | 4 | | |
| | Assets classified as held for sale at 31 Dec | | | |
|
9
|
| | | | | 90 | | |
| | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Deposits by banks1 | | | |
|
3,122
|
| | | | | 4,324 | | |
| | Customer accounts1 | | | |
|
6,386
|
| | | | | 7,744 | | |
| | Other debt securities in issue | | | |
|
1,324
|
| | | | | 1,156 | | |
| | Other liabilities – net short positions in securities | | | |
|
35,601
|
| | | | | 31,005 | | |
| |
At 31 Dec
|
| | |
|
46,433
|
| | | | | 44,229 | | |
| | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Deposits by banks and customer accounts | | | |
|
4,302
|
| | | | | 3,273 | | |
| | Liabilities to customers under investment contracts | | | |
|
1,032
|
| | | | | 944 | | |
| | Debt securities in issue | | | |
|
26,049
|
| | | | | 34,228 | | |
| | Subordinated liabilities (Note 27) | | | |
|
2,225
|
| | | | | 2,347 | | |
| |
At 31 Dec
|
| | |
|
33,608
|
| | | | | 40,792 | | |
| | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Cash collateral and margin payables | | | |
|
32,309
|
| | | | | 42,273 | | |
| | Settlement accounts | | | |
|
4,767
|
| | | | | 4,900 | | |
| | Accruals and deferred income | | | |
|
1,507
|
| | | | | 1,566 | | |
| | Amount due to investors in funds consolidated by the group | | | |
|
1,315
|
| | | | | 1,051 | | |
| | Lease liabilities | | | |
|
386
|
| | | | | 558 | | |
| | Employee benefit liabilities (Note 5) | | | |
|
196
|
| | | | | 288 | | |
| | Share-based payment liability to HSBC Holdings | | | |
|
129
|
| | | | | 104 | | |
| | Endorsements and acceptances | | | |
|
189
|
| | | | | 89 | | |
| | Other liabilities | | | |
|
2,658
|
| | | | | 2,566 | | |
| |
At 31 Dec
|
| | |
|
43,456
|
| | | | | 53,395 | | |
| | | | |
Restructuring
costs £m |
| |
Legal proceedings
and regulatory matters £m |
| |
Customer
remediation £m |
| |
Other provisions
£m |
| |
Total
£m |
| |||||||||||||||
| | Provisions (excluding contractual commitments) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | At 1 Jan 2021 | | | |
|
309
|
| | | |
|
237
|
| | | |
|
25
|
| | | |
|
103
|
| | | |
|
674
|
| |
| | Additions | | | |
|
91
|
| | | |
|
32
|
| | | |
|
11
|
| | | |
|
86
|
| | | |
|
220
|
| |
| | Amounts utilized | | | |
|
(170)
|
| | | |
|
(63)
|
| | | |
|
(10)
|
| | | |
|
(32)
|
| | | |
|
(275)
|
| |
| | Unused amounts reversed | | | |
|
(63)
|
| | | |
|
(25)
|
| | | |
|
(6)
|
| | | |
|
(58)
|
| | | |
|
(152)
|
| |
| | Exchange and other movements | | | |
|
(3)
|
| | | |
|
(6)
|
| | | |
|
1
|
| | | |
|
—
|
| | | |
|
(8)
|
| |
| | At 31 Dec 2021 | | | | | 164 | | | | | | 175 | | | | | | 21 | | | | | | 99 | | | | | | 459 | | |
| | Contractual commitments1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | At 1 Jan 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
187
|
| |
| | Net change in expected credit loss provision and other movements | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
(84)
|
| |
| | At 31 Dec 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 103 | | |
| | Total Provisions | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | At 31 Dec 2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 861 | | |
| | At 31 Dec 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 562 | | |
| | Provisions (excluding contractual commitments) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | At 1 Jan 2020 | | | | | 94 | | | | | | 211 | | | | | | 29 | | | | | | 104 | | | | | | 438 | | |
| | Additions | | | | | 315 | | | | | | 68 | | | | | | 5 | | | | | | 66 | | | | | | 454 | | |
| | Amounts utilized | | | | | (80) | | | | | | (51) | | | | | | (4) | | | | | | (39) | | | | | | (174) | | |
| | Unused amounts reversed | | | | | (18) | | | | | | (2) | | | | | | (4) | | | | | | (28) | | | | | | (52) | | |
| | Exchange and other movements | | | | | (2) | | | | | | 11 | | | | | | (1) | | | | | | — | | | | | | 8 | | |
| | At 31 Dec 2020 | | | | | 309 | | | | | | 237 | | | | | | 25 | | | | | | 103 | | | | | | 674 | | |
| | Contractual commitments1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | At 1 Jan 2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 102 | | |
| | Net change in expected credit loss provision and other movements | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 85 | | |
| | At 31 Dec 2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 187 | | |
| | Total provisions | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | At 31 Dec 2019 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 540 | | |
| | At 31 Dec 2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 861 | | |
| | | | | |
2021
£m |
| | |
2020
£m |
| ||||||
| | At amortised cost | | | | |
|
12,488
|
| | | | | | 13,764 | | |
| | – subordinated liabilities | | | | |
|
11,788
|
| | | | | | 13,064 | | |
| | – preferred securities | | | | |
|
700
|
| | | | | | 700 | | |
| | Designated at fair value (Note 24) | | | | |
|
2,225
|
| | | | | | 2,347 | | |
| | – subordinated liabilities | | | | |
|
2,225
|
| | | | | | 2,347 | | |
| | At 31 Dec | | | | | | 14,713 | | | | | |
|
16,111
|
| |
| | | | | | | |
Carrying amount
|
| |||||||||
| | | | | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Capital instruments | | | | | | | | | | | | | | |||
| | Additional tier 1 instruments guaranteed by the bank | | | | | | | | | | | | | | |||
| | £700m | | | 5.844% Non-cumulative Step-up Perpetual Preferred Securities1 | | |
700
|
| | | | 700 | | | |||
| | Tier 2 instruments | | | | | | | | | | | | | | |||
| | $450m | | | Subordinated Floating Rate Notes 20212 | | | |
|
—
|
| | | | | 330 | | |
| | $750m | | | 3.43% Subordinated Loan 2022 | | | |
|
558
|
| | | | | 569 | | |
| | $2,000m | | | 3.5404% Subordinated Loan 20233 | | | |
|
—
|
| | | | | 1,534 | | |
| | £300m | | | 6.5% Subordinated Notes 2023 | | | |
|
300
|
| | | | | 300 | | |
| | €1,500m | | | Floating Rate Subordinated Loan 2023 | | | |
|
1,260
|
| | | | | 1,347 | | |
| | €2,000m | | | 1.125% Subordinated Loan 20243 | | | |
|
—
|
| | | | | 1,856 | | |
| | €1,500m | | | Floating Rate Subordinated Loan 2024 | | | |
|
1,260
|
| | | | | 1,347 | | |
| | €2,000m | | | 1.728% Subordinated Loan 20243 | | | |
|
—
|
| | | | | 1,836 | | |
| | $300m | | | 7.65% Subordinated Notes 2025 | | | |
|
222
|
| | | | | 220 | | |
| | $750m | | | HSBC Bank plc 4.186% Subordinated Loan 2027 | | | |
|
604
|
| | | | | 633 | | |
| | €1,250m | | | 1.4648% Subordinated Loan 20273 | | | |
|
—
|
| | | | | 1,200 | | |
| | €300m | | | Floating Rate Subordinated Loan 2027 | | | |
|
252
|
| | | | | 269 | | |
| | £200m | | | Floating Rate Subordinated Loan 2028 | | | |
|
200
|
| | | | | 200 | | |
| | €300m | | | Floating Rate Subordinated Loan 2028 | | | |
|
252
|
| | | | | 269 | | |
| | €260m | | | Floating Rate Subordinated Loan 2029 | | | |
|
218
|
| | | | | 233 | | |
| | £350m | | | 5.375% Callable Subordinated Step-up Notes 20304 | | | |
|
398
|
| | | | | 427 | | |
| | $2,000m | | | HSBC Bank plc 1.625% Subordinated Loan 20313 | | | |
|
1,457
|
| | | | | — | | |
| | €2,000m | | | HSBC Bank plc 0.375% Subordinated Loan 20313 | | | |
|
1,658
|
| | | | | — | | |
| | €2,000m | | | HSBC Bank plc 0.375% Subordinated Loan 20313 | | | |
|
1,658
|
| | | | | — | | |
| | €1,250m | | | HSBC Bank plc 0.25% Subordinated Loan 20313 | | | |
|
1,036
|
| | | | | — | | |
| | £500m | | | 5.375% Subordinated Notes 2033 | | | |
|
665
|
| | | | | 719 | | |
| | £225m | | | 6.25% Subordinated Notes 2041 | | | |
|
224
|
| | | | | 224 | | |
| | £600m | | | 4.75% Subordinated Notes 2046 | | | |
|
595
|
| | | | | 594 | | |
| | $750m | | | Undated Floating Rate Primary Capital Notes | | | |
|
554
|
| | | | | 549 | | |
| | $500m | | | Undated Floating Rate Primary Capital Notes | | | |
|
369
|
| | | | | 366 | | |
| | $300m | | | Undated Floating Rate Primary Capital Notes (Series 3) | | | |
|
222
|
| | | | | 220 | | |
| | Other tier 2 instruments each less than £100m | | | |
|
51
|
| | | | | 169 | | | |||
| |
At 31 Dec
|
| | |
|
14,713
|
| | | | | 16,111 | | | |||
| | | | |
Due not more than
1 month £m |
| |
Due over 1 month
but not more than 3 months £m |
| |
Due between
3 and 12 months £m |
| |
Due between
1 and 5 years £m |
| |
Due after
5 years £m |
| |
Total
£m |
| ||||||||||||||||||
| | Deposits by banks | | | |
|
16,783
|
| | | |
|
1,555
|
| | | |
|
1,106
|
| | | |
|
12,277
|
| | | |
|
401
|
| | | |
|
32,122
|
| |
| | Customer accounts | | | |
|
196,609
|
| | | |
|
5,599
|
| | | |
|
2,770
|
| | | |
|
199
|
| | | |
|
101
|
| | | |
|
205,278
|
| |
| | Repurchase agreements – non-trading | | | |
|
24,273
|
| | | |
|
1,924
|
| | | |
|
1,061
|
| | | |
|
7
|
| | | |
|
—
|
| | | |
|
27,265
|
| |
| | Trading liabilities | | | |
|
46,433
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
46,433
|
| |
| | Financial liabilities designated at fair value | | | |
|
9,358
|
| | | |
|
2,790
|
| | | |
|
4,310
|
| | | |
|
8,269
|
| | | |
|
11,873
|
| | | |
|
36,600
|
| |
| | Derivatives | | | |
|
139,040
|
| | | |
|
46
|
| | | |
|
104
|
| | | |
|
406
|
| | | |
|
581
|
| | | |
|
140,177
|
| |
| | Debt securities in issue | | | |
|
2,755
|
| | | |
|
2,952
|
| | | |
|
2,145
|
| | | |
|
1,328
|
| | | |
|
335
|
| | | |
|
9,515
|
| |
| | Subordinated liabilities | | | |
|
14
|
| | | |
|
62
|
| | | |
|
123
|
| | | |
|
3,969
|
| | | |
|
10,734
|
| | | |
|
14,902
|
| |
| | Other financial liabilities | | | |
|
40,292
|
| | | |
|
423
|
| | | |
|
442
|
| | | |
|
234
|
| | | |
|
1,417
|
| | | |
|
42,808
|
| |
| | | | | | | 475,557 | | | | | | 15,351 | | | | | | 12,061 | | | | | | 26,689 | | | | | | 25,442 | | | | | | 555,100 | | |
| | Loan and other credit-related commitments | | | |
|
119,476
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
119,476
|
| |
| | Financial guarantees1 | | | |
|
11,054
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
11,054
|
| |
| | At 31 Dec 2021 | | | | | 606,087 | | | | | | 15,351 | | | | | | 12,061 | | | | | | 26,689 | | | | | | 25,442 | | | | | | 685,630 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Deposits by banks | | | | | 20,627 | | | | | | 732 | | | | | | 299 | | | | | | 12,101 | | | | | | 463 | | | | | | 34,222 | | |
| | Customer accounts | | | | | 186,178 | | | | | | 5,769 | | | | | | 2,936 | | | | | | 231 | | | | | | 109 | | | | | | 195,223 | | |
| | Repurchase agreements – non-trading | | | | | 31,635 | | | | | | 1,772 | | | | | | 1,504 | | | | | | 12 | | | | | | — | | | | | | 34,923 | | |
| | Trading liabilities | | | | | 44,229 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 44,229 | | |
| | Financial liabilities designated at fair value | | | | | 9,602 | | | | | | 1,051 | | | | | | 4,989 | | | | | | 12,914 | | | | | | 11,740 | | | | | | 40,296 | | |
| | Derivatives | | | | | 198,758 | | | | | | 54 | | | | | | 125 | | | | | | 483 | | | | | | 408 | | | | | | 199,828 | | |
| | Debt securities in issue | | | | | 1,862 | | | | | | 3,244 | | | | | | 10,554 | | | | | | 1,280 | | | | | | 588 | | | | | | 17,528 | | |
| | Subordinated liabilities | | | | | 94 | | | | | | 397 | | | | | | 231 | | | | | | 9,357 | | | | | | 5,503 | | | | | | 15,582 | | |
| | Other financial liabilities | | | | | 50,107 | | | | | | 349 | | | | | | 444 | | | | | | 384 | | | | | | 1,178 | | | | | | 52,462 | | |
| | | | | | | 543,092 | | | | | | 13,368 | | | | | | 21,082 | | | | | | 36,762 | | | | | | 19,989 | | | | | | 634,293 | | |
| | Loan and other credit-related commitments | | | | | 147,303 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 147,303 | | |
| | Financial guarantees1 | | | | | 3,969 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,969 | | |
| | At 31 Dec 2020 | | | | | 694,364 | | | | | | 13,368 | | | | | | 21,082 | | | | | | 36,762 | | | | | | 19,989 | | | | | | 785,565 | | |
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||||||||||||||
| | | | |
Due within
1 year £m |
| |
Due after
more than 1 year £m |
| |
Total
£m |
| |
Due within
1 year £m |
| |
Due after
more than 1 year £m |
| |
Total
£m |
| ||||||||||||||||||
| | Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
Financial assets designated or otherwise mandatorily
measured at fair value |
| | |
|
3,225
|
| | | |
|
15,424
|
| | | |
|
18,649
|
| | | | | 1,631 | | | | | | 14,589 | | | | | | 16,220 | | |
| | Loans and advances to banks | | | |
|
8,841
|
| | | |
|
1,943
|
| | | |
|
10,784
|
| | | | | 10,186 | | | | | | 2,460 | | | | | | 12,646 | | |
| | Loans and advances to customers | | | |
|
40,837
|
| | | |
|
50,340
|
| | | |
|
91,177
|
| | | | | 47,863 | | | | | | 53,628 | | | | | | 101,491 | | |
| | Reverse repurchase agreement – non-trading | | | |
|
53,079
|
| | | |
|
1,369
|
| | | |
|
54,448
|
| | | | | 65,157 | | | | | | 2,420 | | | | | | 67,577 | | |
| | Financial investments | | | |
|
6,748
|
| | | |
|
34,552
|
| | | |
|
41,300
|
| | | | | 8,984 | | | | | | 42,842 | | | | | | 51,826 | | |
| | Other financial assets | | | |
|
38,851
|
| | | |
|
203
|
| | | |
|
39,054
|
| | | | | 49,744 | | | | | | 274 | | | | | | 50,018 | | |
| |
At 31 Dec
|
| | |
|
151,581
|
| | | |
|
103,831
|
| | | |
|
255,412
|
| | | | | 183,565 | | | | | | 116,213 | | | | | | 299,778 | | |
| | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Deposits by banks | | | |
|
19,439
|
| | | |
|
12,749
|
| | | |
|
32,188
|
| | | | | 21,627 | | | | | | 12,678 | | | | | | 34,305 | | |
| | Customer accounts | | | |
|
204,973
|
| | | |
|
268
|
| | | |
|
205,241
|
| | | | | 194,872 | | | | | | 312 | | | | | | 195,184 | | |
| | Repurchase agreements – non-trading | | | |
|
27,252
|
| | | |
|
7
|
| | | |
|
27,259
|
| | | | | 34,891 | | | | | | 12 | | | | | | 34,903 | | |
| | Financial liabilities designated at fair value | | | |
|
16,329
|
| | | |
|
17,279
|
| | | |
|
33,608
|
| | | | | 17,109 | | | | | | 23,683 | | | | | | 40,792 | | |
| | Debt securities in issue | | | |
|
7,840
|
| | | |
|
1,588
|
| | | |
|
9,428
|
| | | | | 15,620 | | | | | | 1,751 | | | | | | 17,371 | | |
| | Other financial liabilities | | | |
|
41,131
|
| | | |
|
1,754
|
| | | |
|
42,885
|
| | | | | 50,955 | | | | | | 1,704 | | | | | | 52,659 | | |
| | Subordinated liabilities | | | |
|
8
|
| | | |
|
12,480
|
| | | |
|
12,488
|
| | | | | 445 | | | | | | 13,319 | | | | | | 13,764 | | |
| |
At 31 Dec
|
| | |
|
316,972
|
| | | |
|
46,125
|
| | | |
|
363,097
|
| | | | | 335,519 | | | | | | 53,459 | | | | | | 388,978 | | |
| | | | |
Amounts subject to enforceable netting arrangements
|
| | | | | | | | | | | | | |||||||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | |
Amounts not set off in the balance sheet
|
| | | | | | | |
Amounts not
subject to enforceable netting arrangements5 £m |
| | | | | | | ||||||||||||||||||
| | | | |
Gross
amounts £m |
| |
Amounts
offset £m |
| |
Net amounts
in the balance sheet £m |
| |
Financial
instruments £m |
| |
Non-cash
collateral £m |
| |
Cash
collateral £m |
| |
Net
amount £m |
| |
Total
£m |
| ||||||||||||||||||||||||||||||
| | Financial assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Derivatives (Note 14)1 | | | |
|
160,801
|
| | | |
|
(20,689)
|
| | | |
|
140,112
|
| | | |
|
(107,879)
|
| | | |
|
(7,106)
|
| | | |
|
(24,277)
|
| | | |
|
850
|
| | | |
|
1,109
|
| | | |
|
141,221
|
| |
| |
Reverse repos, stock borrowing and
similar agreements classified as: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – trading assets | | | |
|
11,960
|
| | | |
|
(156)
|
| | | |
|
11,804
|
| | | |
|
(265)
|
| | | |
|
(11,539)
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
40
|
| | | |
|
11,844
|
| |
| | – non-trading assets | | | |
|
125,935
|
| | | |
|
(72,788)
|
| | | |
|
53,147
|
| | | |
|
(10,235)
|
| | | |
|
(42,809)
|
| | | |
|
(103)
|
| | | |
|
—
|
| | | |
|
1,301
|
| | | |
|
54,448
|
| |
| | Loans and advances to customers3 | | | |
|
14,741
|
| | | |
|
(6,091)
|
| | | |
|
8,650
|
| | | |
|
(7,053)
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
1,597
|
| | | |
|
5
|
| | | |
|
8,655
|
| |
| | At 31 Dec 2021 | | | | | 313,437 | | | | | | (99,724) | | | | | | 213,713 | | | | | | (125,432) | | | | | | (61,454) | | | | | | (24,380) | | | | | | 2,447 | | | | | | 2,455 | | | | | | 216,168 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Derivatives (Note 14)1 | | | | | 229,891 | | | | | | (29,996) | | | | | | 199,895 | | | | | | (160,907) | | | | | | (8,837) | | | | | | (29,834) | | | | | | 317 | | | | | | 1,315 | | | | | | 201,210 | | |
| |
Reverse repos, stock borrowing and
similar agreements classified as: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – trading assets | | | | | 12,430 | | | | | | (531) | | | | | | 11,899 | | | | | | (519) | | | | | | (11,380) | | | | | | — | | | | | | — | | | | | | 419 | | | | | | 12,318 | | |
| | – non-trading assets | | | | | 128,246 | | | | | | (64,386) | | | | | | 63,860 | | | | | | (10,604) | | | | | | (53,218) | | | | | | (38) | | | | | | — | | | | | | 3,735 | | | | | | 67,595 | | |
| | Loans and advances to customers3 | | | | | 17,312 | | | | | | (6,990) | | | | | | 10,322 | | | | | | (8,713) | | | | | | — | | | | | | — | | | | | | 1,609 | | | | | | 1 | | | | | | 10,323 | | |
| | At 31 Dec 2020 | | | | | 387,879 | | | | | | (101,903) | | | | | | 285,976 | | | | | | (180,743) | | | | | | (73,435) | | | | | | (29,872) | | | | | | 1,926 | | | | | | 5,470 | | | | | | 291,446 | | |
| | | | | | | | | | | | | |||||||||||||||||||||||||||||||||||||||||||||
| | Financial liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Derivatives (Note 14)1 | | | |
|
159,169
|
| | | |
|
(20,689)
|
| | | |
|
138,480
|
| | | |
|
(107,879)
|
| | | |
|
(16,866)
|
| | | |
|
(13,273)
|
| | | |
|
462
|
| | | |
|
888
|
| | | |
|
139,368
|
| |
| | Repos, stock lending and similar agreements classified as: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – trading liabilities | | | |
|
9,444
|
| | | |
|
(156)
|
| | | |
|
9,288
|
| | | |
|
(265)
|
| | | |
|
(9,023)
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
13
|
| | | |
|
9,301
|
| |
| | – non-trading liabilities | | | |
|
100,031
|
| | | |
|
(72,788)
|
| | | |
|
27,243
|
| | | |
|
(10,235)
|
| | | |
|
(16,855)
|
| | | |
|
(153)
|
| | | |
|
—
|
| | | |
|
16
|
| | | |
|
27,259
|
| |
| | Customer accounts4 | | | |
|
21,846
|
| | | |
|
(6,091)
|
| | | |
|
15,755
|
| | | |
|
(7,053)
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
8,702
|
| | | |
|
11
|
| | | |
|
15,766
|
| |
| | At 31 Dec 2021 | | | | | 290,490 | | | | | | (99,724) | | | | | | 190,766 | | | | | | (125,432) | | | | | | (42,744) | | | | | | (13,426) | | | | | | 9,164 | | | | | | 928 | | | | | | 191,694 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Derivatives (Note 14)1 | | | | | 228,372 | | | | | | (29,996) | | | | | | 198,376 | | | | | | (160,907) | | | | | | (14,652) | | | | | | (22,521) | | | | | | 296 | | | | | | 856 | | | | | | 199,232 | | |
| |
Repos, stock lending and similar agreements classified as:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – trading liabilities | | | | | 12,323 | | | | | | (531) | | | | | | 11,792 | | | | | | (519) | | | | | | (11,273) | | | | | | — | | | | | | — | | | | | | 5 | | | | | | 11,797 | | |
| | – non-trading liabilities | | | | | 99,289 | | | | | | (64,386) | | | | | | 34,903 | | | | | | (10,604) | | | | | | (24,143) | | | | | | (156) | | | | | | — | | | | | | — | | | | | | 34,903 | | |
| | Customer accounts4 | | | | | 21,847 | | | | | | (6,990) | | | | | | 14,857 | | | | | | (8,713) | | | | | | — | | | | | | — | | | | | | 6,144 | | | | | | 8 | | | | | | 14,865 | | |
| | At 31 Dec 2020 | | | | | 361,831 | | | | | | (101,903) | | | | | | 259,928 | | | | | | (180,743) | | | | | | (50,068) | | | | | | (22,677) | | | | | | 6,440 | | | | | | 869 | | | | | | 260,797 | | |
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||
| | | | |
Number
|
| |
£m
|
| |
Number
|
| |
£m
|
| ||||||||||||
| |
At 1 Jan
|
| | |
|
796,969,111
|
| | | |
|
797
|
| | | | | 796,969,111 | | | | | | 797 | | |
| |
At 31 Dec
|
| | |
|
796,969,111
|
| | | |
|
797
|
| | | | | 796,969,111 | | | | | | 797 | | |
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||
| | | | |
Number
|
| |
£000
|
| |
Number
|
| |
£000
|
| ||||||||||||
| |
At 1 Jan and 31 Dec
|
| | |
|
35,000,000
|
| | | |
|
172
|
| | | | | 35,000,000 | | | | | | 172 | | |
| | | | | | | |
2021
£m |
| |
2020
£m |
| ||||||
| |
€1,900m
|
| |
Undated Subordinated Resettable Additional Tier 1 instrument issued 2015 (Callable December 2020 onwards)
|
| | |
|
1,388
|
| | | | | 1,388 | | |
| |
€235m
|
| |
Undated Subordinated Resettable Additional Tier 1 instrument issued 2016 (Callable January 2022 onwards)
|
| | |
|
197
|
| | | | | 197 | | |
| |
€300m
|
| |
Undated Subordinated Resettable Additional Tier 1 instrument 2018 (Callable March 2023
onwards) |
| | |
|
263
|
| | | | | 263 | | |
| |
£555m
|
| |
Undated Subordinated Resettable Additional Tier 1 instrument 2018 (Callable March 2023
onwards) |
| | |
|
555
|
| | | | | 555 | | |
| |
£500m
|
| | Undated Subordinated Resettable Additional Tier 1 instrument 2019 (Callable November 2024 onwards) | | | |
|
500
|
| | | | | 500 | | |
| |
€250m
|
| | Undated Subordinated Resettable Additional Tier 1 instrument 2019 (Callable November 2024 onwards) | | | |
|
213
|
| | | | | 213 | | |
| |
£431m
|
| | Undated Subordinated Resettable Additional Tier 1 instrument 2019 (Callable December 2024 onwards) | | | |
|
431
|
| | | | | 431 | | |
| |
€200m
|
| |
Undated Subordinated Resettable Additional Tier 1 instrument 2019 (Callable January 2025
onwards) |
| | |
|
175
|
| | | | | 175 | | |
| |
At 31 Dec
|
| | | | | |
|
3,722
|
| | | | | 3,722 | | |
| | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Guarantees and other contingent liabilities: | | | | | | | | | | | | | |
| | – financial guarantees | | | |
|
11,054
|
| | | | | 3,969 | | |
| | – performance and other guarantees | | | |
|
15,833
|
| | | | | 14,282 | | |
| | – other contingent liabilities | | | |
|
367
|
| | | | | 458 | | |
| |
At 31 Dec
|
| | |
|
27,254
|
| | | | | 18,709 | | |
| | Commitments:1 | | | | | | | | | | | | | |
| | – documentary credits and short-term trade-related transactions | | | |
|
1,928
|
| | | | | 1,366 | | |
| | – forward asset purchases and forward deposits placed | | | |
|
30,005
|
| | | | | 42,793 | | |
| | – standby facilities, credit lines and other commitments to lend | | | |
|
87,543
|
| | | | | 103,144 | | |
| |
At 31 Dec
|
| | |
|
119,476
|
| | | | | 147,303 | | |
| | | | | | | |||||||||||||||||||||
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||
| | | | |
In favour of third
parties £m |
| |
By the group in favour
of other HSBC Group entities £m |
| |
In favour of third
parties £m |
| |
By the group in favour of
other HSBC Group entities £m |
| ||||||||||||
| | Financial guarantees1 | | | |
|
10,635
|
| | | |
|
419
|
| | | | | 3,541 | | | | | | 428 | | |
| | Performance and other guarantees | | | |
|
14,433
|
| | | |
|
1,400
|
| | | | | 13,091 | | | | | | 1,191 | | |
| |
Total
|
| | |
|
25,068
|
| | | |
|
1,819
|
| | | | | 16,632 | | | | | | 1,619 | | |
| | | | | | | |||||||||||||||||||||||||||||||||
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||||||||||||||
| | | | |
Total
future minimum payments £m |
| |
Unearned
finance income £m |
| |
Present
value £m |
| |
Total
future minimum payments £m |
| |
Unearned
finance income £m |
| |
Present
Value £m |
| ||||||||||||||||||
| | Lease receivables: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | No later than one year | | | |
|
409
|
| | | |
|
(20)
|
| | | |
|
389
|
| | | | | 270 | | | | | | (16) | | | | | | 254 | | |
| | One to two years | | | |
|
251
|
| | | |
|
(19)
|
| | | |
|
232
|
| | | | | 253 | | | | | | (17) | | | | | | 236 | | |
| | Two to three years | | | |
|
187
|
| | | |
|
(17)
|
| | | |
|
170
|
| | | | | 424 | | | | | | (15) | | | | | | 409 | | |
| | Three to four years | | | |
|
177
|
| | | |
|
(13)
|
| | | |
|
164
|
| | | | | 305 | | | | | | (15) | | | | | | 290 | | |
| | Four to five years | | | |
|
90
|
| | | |
|
(9)
|
| | | |
|
81
|
| | | | | 152 | | | | | | (9) | | | | | | 143 | | |
| |
Later than one year and no later than five years
|
| | |
|
705
|
| | | |
|
(58)
|
| | | |
|
647
|
| | | | | 1,134 | | | | | | (56) | | | | | | 1,078 | | |
| | Later than five years | | | |
|
556
|
| | | |
|
(33)
|
| | | |
|
523
|
| | | | | 770 | | | | | | (31) | | | | | | 739 | | |
| |
At 31 Dec
|
| | |
|
1,670
|
| | | |
|
(111)
|
| | | |
|
1,559
|
| | | | | 2,174 | | | | | | (103) | | | | | | 2,071 | | |
| | | | |
2021
£000 |
| |
20201
£000 |
| |
20191
£000 |
| |||||||||
| | Short-term employee benefits2,3 | | | |
|
13,678
|
| | | | | 3,865 | | | | | | 3,330 | | |
| | Post-employment benefits4 | | | |
|
46
|
| | | | | 19 | | | | |
|
—
|
| |
| | Other long-term employee benefits | | | |
|
1,378
|
| | | | | 429 | | | | | | 48 | | |
| | Share-based payments | | | |
|
4,331
|
| | | | | 586 | | | | | | 348 | | |
| |
Year ended 31 Dec
|
| | |
|
19,433
|
| | | | | 4,899 | | | | | | 3,726 | | |
| | | | |
2021
|
| |
20203
|
| ||||||||||||||||||
| | | | |
Balance at
31 Dec £m |
| |
Highest amounts
outstanding during year2 £m |
| |
Balance at
31 Dec £m |
| |
Highest amounts
outstanding during year £m |
| ||||||||||||
| | Key Management Personnel1 | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Advances and credits | | | |
|
0.03
|
| | | |
|
0.08
|
| | | | | 0.03 | | | | | | 1.5 | | |
| | Deposits | | | |
|
11
|
| | | |
|
18
|
| | | | | 13 | | | | | | 39 | | |
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||||||||||||||||||||||||||
| | | | |
Due to/from
HSBC Holdings plc |
| |
Due to/from
subsidiaries of HSBC Holdings plc |
| |
Due to/from
HSBC Holdings plc |
| |
Due to/from
subsidiaries of HSBC Holdings plc |
| ||||||||||||||||||||||||||||||||||||
| | | | |
Highest
balance during the year £m |
| |
Balance at
31 Dec £m |
| |
Highest
balance during the year £m |
| |
Balance at
31 Dec £m |
| |
Highest
balance during the year £m |
| |
Balance at
31 Dec £m |
| |
Highest
balance during the year £m |
| |
Balance at
31 Dec £m |
| ||||||||||||||||||||||||
| | Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Trading assets | | | |
|
108
|
| | | |
|
19
|
| | | |
|
4,702
|
| | | |
|
1,360
|
| | | | | 170 | | | | | | 108 | | | | | | 1,664 | | | | | | 1,154 | | |
| | Derivatives | | | |
|
2,002
|
| | | |
|
787
|
| | | |
|
25,566
|
| | | |
|
21,862
|
| | | | | 2,261 | | | | | | 2,002 | | | | | | 33,785 | | | | | | 20,980 | | |
| | Financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | |
|
7
|
| | | |
|
6
|
| | | |
|
29
|
| | | |
|
27
|
| | | | | 7 | | | | | | 7 | | | | | | 29 | | | | | | 28 | | |
| | Loans and advances to banks | | | |
|
—
|
| | | |
|
—
|
| | | |
|
4,890
|
| | | |
|
3,173
|
| | | | | — | | | | | | — | | | | | | 6,222 | | | | | | 4,048 | | |
| | Loans and advances to customers | | | |
|
—
|
| | | |
|
—
|
| | | |
|
490
|
| | | |
|
329
|
| | | | | — | | | | | | — | | | | | | 505 | | | | | | 435 | | |
| | Financial investments | | | |
|
172
|
| | | |
|
154
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 172 | | | | | | 172 | | | | | | — | | | | | | — | | |
| |
Reverse repurchase agreements – non-trading
|
| | |
|
—
|
| | | |
|
—
|
| | | |
|
2,332
|
| | | |
|
1,690
|
| | | | | — | | | | | | — | | | | | | 4,638 | | | | | | 1,137 | | |
| | Prepayments, accrued income and other assets | | | |
|
1,540
|
| | | |
|
1,262
|
| | | |
|
9,853
|
| | | |
|
4,784
|
| | | | | 2,228 | | | | | | 1,431 | | | | | | 10,821 | | | | | | 4,250 | | |
| |
Total related party assets at 31 Dec
|
| | |
|
3,829
|
| | | |
|
2,228
|
| | | |
|
47,862
|
| | | |
|
33,225
|
| | | | | 4,838 | | | | | | 3,720 | | | | | | 57,664 | | | | | | 32,032 | | |
| | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Trading liabilities | | | |
|
158
|
| | | |
|
23
|
| | | |
|
116
|
| | | |
|
82
|
| | | | | 406 | | | | | | 151 | | | | | | 742 | | | | | | 51 | | |
| | Financial liabilities designated at fair value | | | |
|
1,181
|
| | | |
|
1,162
|
| | | |
|
1,201
|
| | | |
|
—
|
| | | | | — | | | | | | — | | | | | | 1,307 | | | | | | 1,201 | | |
| | Deposits by banks | | | |
|
—
|
| | | |
|
—
|
| | | |
|
6,659
|
| | | |
|
2,261
|
| | | | | — | | | | | | — | | | | | | 4,961 | | | | | | 2,534 | | |
| | Customer accounts | | | |
|
2,364
|
| | | |
|
1,875
|
| | | |
|
3,428
|
| | | |
|
3,149
|
| | | | | 4,200 | | | | | | 2,080 | | | | | | 2,565 | | | | | | 2,234 | | |
| | Derivatives | | | |
|
3,443
|
| | | |
|
2,074
|
| | | |
|
26,152
|
| | | |
|
22,133
|
| | | | | 4,649 | | | | | | 3,443 | | | | | | 30,283 | | | | | | 20,878 | | |
| | Subordinated liabilities | | | |
|
9,485
|
| | | |
|
9,251
|
| | | |
|
10,421
|
| | | |
|
—
|
| | | | | — | | | | | | — | | | | | | 10,756 | | | | | | 10,421 | | |
| | Repurchase agreements − non-trading | | | |
|
—
|
| | | |
|
—
|
| | | |
|
6,162
|
| | | |
|
1,841
|
| | | | | — | | | | | | — | | | | | | 8,738 | | | | | | 1,028 | | |
| | Provisions, accruals, deferred income and other liabilities | | | |
|
189
|
| | | |
|
179
|
| | | |
|
8,057
|
| | | |
|
3,826
|
| | | | | 103 | | | | | | 74 | | | | | | 10,719 | | | | | | 3,097 | | |
| |
Total related party liabilities at 31 Dec
|
| | |
|
16,820
|
| | | |
|
14,564
|
| | | |
|
62,196
|
| | | |
|
33,292
|
| | | | | 9,358 | | | | | | 5,748 | | | | | | 70,071 | | | | | | 41,444 | | |
| | Guarantees and commitments | | | |
|
—
|
| | | |
|
—
|
| | | |
|
2,622
|
| | | |
|
2,061
|
| | | | | — | | | | | | — | | | | | | 2,438 | | | | | | 1,762 | | |
| | | | |
Due to/from
HSBC Holdings plc |
| |
Due to/from subsidiaries of
HSBC Holdings plc |
| ||||||||||||||||||||||||||||||
| | | | |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| |
2021
£m |
| |
2020
£m |
| |
2019
£m |
| ||||||||||||||||||
| | Income statement | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Interest income | | | |
|
4
|
| | | | | 5 | | | | | | 9 | | | | |
|
32
|
| | | | | 55 | | | | | | 142 | | |
| | Interest expense1 | | | |
|
50
|
| | | | | (55) | | | | | | 84 | | | | |
|
58
|
| | | | | 256 | | | | | | 329 | | |
| | Fee income | | | |
|
8
|
| | | | | 13 | | | | | | 10 | | | | |
|
61
|
| | | | | 55 | | | | | | 47 | | |
| | Fee expense | | | |
|
—
|
| | | | | — | | | | | | 2 | | | | |
|
357
|
| | | | | 389 | | | | | | 356 | | |
| | Trading income | | | |
|
—
|
| | | | | — | | | | | | — | | | | |
|
2
|
| | | | | 2 | | | | | | 8 | | |
| | Trading expense | | | |
|
—
|
| | | | | — | | | | | | — | | | | |
|
—
|
| | | | | 2 | | | | | | 15 | | |
| | Other operating income | | | |
|
7
|
| | | | | 30 | | | | | | 69 | | | | |
|
236
|
| | | | | 365 | | | | | | 322 | | |
| | General and administrative expenses | | | |
|
143
|
| | | | | 126 | | | | | | 38 | | | | |
|
2,110
|
| | | | | 2,077 | | | | | | 2,207 | | |
| | | | | | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | |
Due to/from
subsidiaries of HSBC Bank plc subsidiaries |
| |
Due to/from
HSBC Holdings plc |
| |
Due to/from
subsidiaries of HSBC Holdings plc |
| |
Due to/from
subsidiaries of HSBC Bank plc subsidiaries |
| |
Due to/from
HSBC Holdings plc |
| |
Due to/from
subsidiaries of HSBC Holdings plc |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | |
Highest
balance during the year £m |
| |
Balance at
31 Dec £m |
| |
Highest
balance during the year £m |
| |
Balance at
31 Dec £m |
| |
Highest
balance during the year £m |
| |
Balance at
31 Dec £m |
| |
Highest
balance during the year £m |
| |
Balance at
31 Dec £m |
| |
Highest
balance during the year £m |
| |
Balance at
31 Dec £m |
| |
Highest
balance during the year £m |
| |
Balance at
31 Dec £m |
| ||||||||||||||||||||||||||||||||||||
| | Assets | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Trading assets | | | |
|
603
|
| | | |
|
264
|
| | | |
|
108
|
| | | |
|
19
|
| | | |
|
4,695
|
| | | |
|
1,360
|
| | | | | 907 | | | | | | 234 | | | | | | 169 | | | | | | 108 | | | | | | 1,664 | | | | | | 1,154 | | |
| | Derivatives | | | |
|
15,309
|
| | | |
|
9,025
|
| | | |
|
2,002
|
| | | |
|
787
|
| | | |
|
22,953
|
| | | |
|
19,755
|
| | | | | 19,139 | | | | | | 15,309 | | | | | | 2,261 | | | | | | 2,002 | | | | | | 31,986 | | | | | | 19,829 | | |
| |
Financial assets designated and
otherwise mandatorily measured at fair value through profit or loss |
| | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | Loans and advances to banks | | | |
|
3,172
|
| | | |
|
2,259
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
3,561
|
| | | |
|
2,100
|
| | | | | 5,263 | | | | | | 2,123 | | | | | | — | | | | | | — | | | | | | 4,794 | | | | | | 3,083 | | |
| | Loans and advances to customers | | | |
|
6,446
|
| | | |
|
3,850
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
416
|
| | | |
|
242
|
| | | | | 8,198 | | | | | | 6,446 | | | | | | — | | | | | | — | | | | | | 395 | | | | | | 322 | | |
| | Financial investments | | | |
|
3,337
|
| | | |
|
3,337
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 2,214 | | | | | | 2,214 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| |
Reverse repurchase agreements – non-
trading |
| | |
|
2,313
|
| | | |
|
2,313
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
2,058
|
| | | |
|
1,428
|
| | | | | 3,070 | | | | | | 965 | | | | | | — | | | | | | — | | | | | | 1,942 | | | | | | 775 | | |
| |
Prepayments, accrued income and other
assets |
| | |
|
5,921
|
| | | |
|
1,685
|
| | | |
|
1,537
|
| | | |
|
1,261
|
| | | |
|
9,327
|
| | | |
|
4,557
|
| | | | | 4,769 | | | | | | 2,986 | | | | | | 2,228 | | | | | | 1,430 | | | | | | 10,063 | | | | | | 4,136 | | |
| |
Investments in subsidiary undertakings
|
| | |
|
6,479
|
| | | |
|
6,479
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| | | | | 6,458 | | | | | | 6,458 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| |
Total related party assets at 31 Dec
|
| | |
|
43,580
|
| | | |
|
29,212
|
| | | |
|
3,647
|
| | | |
|
2,067
|
| | | |
|
43,010
|
| | | |
|
29,442
|
| | | | | 50,018 | | | | | | 36,735 | | | | | | 4,658 | | | | | | 3,540 | | | | | | 50,844 | | | | | | 29,299 | | |
| | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Trading liabilities | | | |
|
112
|
| | | |
|
49
|
| | | |
|
158
|
| | | |
|
21
|
| | | |
|
116
|
| | | |
|
82
|
| | | | | 10 | | | | | | 1 | | | | | | 406 | | | | | | 151 | | | | | | 742 | | | | | | 51 | | |
| | Financial liabilities designated at fair value | | | |
|
—
|
| | | |
|
—
|
| | | |
|
1,181
|
| | | |
|
1,162
|
| | | |
|
1,201
|
| | | |
|
—
|
| | | | | 318 | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,307 | | | | | | 1,201 | | |
| | Deposits by banks | | | |
|
1,808
|
| | | |
|
1,229
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
3,245
|
| | | |
|
965
|
| | | | | 1,956 | | | | | | 1,096 | | | | | | — | | | | | | — | | | | | | 3,089 | | | | | | 1,471 | | |
| | Customer accounts | | | |
|
1,287
|
| | | |
|
696
|
| | | |
|
2,364
|
| | | |
|
1,875
|
| | | |
|
3,321
|
| | | |
|
3,013
|
| | | | | 1,287 | | | | | | 1,287 | | | | | | 4,200 | | | | | | 2,080 | | | | | | 2,509 | | | | | | 2,178 | | |
| | Derivatives | | | |
|
17,378
|
| | | |
|
10,190
|
| | | |
|
3,443
|
| | | |
|
2,074
|
| | | |
|
23,787
|
| | | |
|
20,182
|
| | | | | 18,174 | | | | | | 17,378 | | | | | | 4,649 | | | | | | 3,443 | | | | | | 29,159 | | | | | | 20,161 | | |
| | Subordinated liabilities | | | |
|
700
|
| | | |
|
700
|
| | | |
|
9,262
|
| | | |
|
9,033
|
| | | |
|
10,187
|
| | | |
|
—
|
| | | | | 700 | | | | | | 700 | | | | | | — | | | | | | — | | | | | | 10,519 | | | | | | 10,187 | | |
| | Repurchase agreements – non-trading | | | |
|
988
|
| | | |
|
431
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
5,670
|
| | | |
|
1,645
|
| | | | | 2,349 | | | | | | 988 | | | | | | — | | | | | | — | | | | | | 8,468 | | | | | | 1,028 | | |
| | Provisions, accruals, deferred income and other liabilities | | | |
|
6,166
|
| | | |
|
1,127
|
| | | |
|
174
|
| | | |
|
166
|
| | | |
|
6,423
|
| | | |
|
3,302
|
| | | | | 7,716 | | | | | | 1,563 | | | | | | 63 | | | | | | 45 | | | | | | 9,578 | | | | | | 2,510 | | |
| |
Total related party liabilities at 31 Dec
|
| | |
|
28,439
|
| | | |
|
14,422
|
| | | |
|
16,582
|
| | | |
|
14,331
|
| | | |
|
53,950
|
| | | |
|
29,189
|
| | | | | 32,510 | | | | | | 23,013 | | | | | | 9,318 | | | | | | 5,719 | | | | | | 65,371 | | | | | | 38,787 | | |
| | Guarantees and commitments | | | |
|
5,338
|
| | | |
|
2,676
|
| | | |
|
—
|
| | | |
|
—
|
| | | |
|
1,686
|
| | | |
|
1,130
|
| | | | | 11,011 | | | | | | 4,974 | | | | | | — | | | | | | — | | | | | | 1,427 | | | | | | 893 | | |
| | | | | |
31 Dec 2021
|
| | |
31 Dec 2020
|
| ||||||||||||||||||||
| | | | | |
Gross
carrying/nominal amount £m |
| | |
Allowance
for ECL1 £m |
| | |
Gross
carrying/nominal amount £m |
| | |
Allowance
for ECL1 £m |
| ||||||||||||
| | Loans and advances to customers at amortised cost | | | | |
|
92,331
|
| | | | |
|
(1,154)
|
| | | | | | 102,960 | | | | | | | (1,469) | | |
| | – personal | | | | |
|
25,394
|
| | | | |
|
(163)
|
| | | | | | 26,499 | | | | | | | (208) | | |
| | – corporate and commercial | | | | |
|
56,087
|
| | | | |
|
(964)
|
| | | | | | 62,987 | | | | | | | (1,168) | | |
| | – non-bank financial institutions | | | | |
|
10,850
|
| | | | |
|
(27)
|
| | | | | | 13,474 | | | | | | | (93) | | |
| | Loans and advances to banks at amortised cost | | | | |
|
10,789
|
| | | | |
|
(5)
|
| | | | | | 12,662 | | | | | | | (16) | | |
| | Other financial assets measured at amortised cost | | | | |
|
202,137
|
| | | | |
|
(9)
|
| | | | | | 202,763 | | | | | | | (12) | | |
| | – cash and balances at central banks | | | | |
|
108,482
|
| | | | |
|
—
|
| | | | | | 85,093 | | | | | | | (1) | | |
| | – items in the course of collection from other banks | | | | |
|
346
|
| | | | |
|
—
|
| | | | | | 243 | | | | | | | — | | |
| | – reverse repurchase agreements - non trading | | | | |
|
54,448
|
| | | | |
|
—
|
| | | | | | 67,577 | | | | | | | — | | |
| | – financial investments | | | | |
|
10
|
| | | | |
|
—
|
| | | | | | 15 | | | | | | | — | | |
| | – prepayments, accrued income and other assets2 | | | | |
|
38,851
|
| | | | |
|
(9)
|
| | | | | | 49,835 | | | | | | | (11) | | |
| |
Total gross carrying amount on balance sheet
|
| | | |
|
305,257
|
| | | | |
|
(1,168)
|
| | | | | | 318,385 | | | | | | | (1,497) | | |
| | Loans and other credit related commitments | | | | |
|
115,695
|
| | | | |
|
(55)
|
| | | | | | 143,036 | | | | | | | (112) | | |
| | – personal | | | | |
|
2,269
|
| | | | |
|
(1)
|
| | | | | | 2,211 | | | | | | | (1) | | |
| | – corporate and commercial | | | | |
|
63,352
|
| | | | |
|
(48)
|
| | | | | | 75,863 | | | | | | | (89) | | |
| | – financial | | | | |
|
50,074
|
| | | | |
|
(6)
|
| | | | | | 64,962 | | | | | | | (22) | | |
| | Financial guarantees3 | | | | |
|
11,054
|
| | | | |
|
(17)
|
| | | | | | 3,969 | | | | | | | (23) | | |
| | – personal | | | | |
|
26
|
| | | | |
|
—
|
| | | | | | 32 | | | | | | | — | | |
| | – corporate and commercial | | | | |
|
9,894
|
| | | | |
|
(16)
|
| | | | | | 2,735 | | | | | | | (19) | | |
| | – financial | | | | |
|
1,134
|
| | | | |
|
(1)
|
| | | | | | 1,202 | | | | | | | (4) | | |
| |
Total nominal amount off balance sheet4
|
| | | |
|
126,749
|
| | | | |
|
(72)
|
| | | | | | 147,005 | | | | | | | (135) | | |
| | | | | | |
|
432,006
|
| | | | |
|
(1,240)
|
| | | | | | 465,390 | | | | | | | (1,632) | | |
| | | | |
Fair value
£m |
| |
Memorandum
allowance for ECL5 £m |
| |
Fair value
£m |
| |
Memorandum
allowance for ECL5 £m |
| | | | ||||||||||||
| |
Debt instruments measured at fair value through other
comprehensive income (‘FVOCI’) |
| | |
|
41,188
|
| | | |
|
(19)
|
| | | | | 51,713 | | | | | | (22) | | | | | |
| | | | |||||||||||||||||||||||||||
| | | | | |
Gross carrying/nominal amount2
|
| | | | | | | | | |
Allowance for ECL
|
| | | | | | | | | |
ECL coverage %
|
| | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | |
Stage 1
£m |
| | |
Stage 2
£m |
| | |
Stage 3
£m |
| | |
POCI3
£m |
| | |
Total
£m |
| | |
Stage 1
£m |
| | |
Stage 2
£m |
| | |
Stage 3
£m |
| | |
POCI3
£m |
| | |
Total
£m |
| | |
Stage 1
% |
| | |
Stage 2
% |
| | |
Stage 3
% |
| | |
POCI3
% |
| | |
Total
% |
| |||||||||||||||||||||||||||||||||||||||||||||
| | Loans and advances to customers at amortised cost | | | | |
|
80,730
|
| | | | |
|
9,121
|
| | | | |
|
2,478
|
| | | | |
|
2
|
| | | | |
|
92,331
|
| | | | |
|
(86)
|
| | | | |
|
(158)
|
| | | | |
|
(908)
|
| | | | |
|
(2)
|
| | | | |
|
(1,154)
|
| | | | |
|
0.1
|
| | | | |
|
1.7
|
| | | | |
|
36.6
|
| | | | |
|
100.0
|
| | | | |
|
1.2
|
| |
| | – personal | | | | |
|
24,255
|
| | | | |
|
686
|
| | | | |
|
453
|
| | | | |
|
—
|
| | | | |
|
25,394
|
| | | | |
|
(22)
|
| | | | |
|
(16)
|
| | | | |
|
(125)
|
| | | | |
|
—
|
| | | | |
|
(163)
|
| | | | |
|
0.1
|
| | | | |
|
2.3
|
| | | | |
|
27.6
|
| | | | |
|
—
|
| | | | |
|
0.6
|
| |
| | – corporate and commercial | | | | |
|
46,237
|
| | | | |
|
8,066
|
| | | | |
|
1,782
|
| | | | |
|
2
|
| | | | |
|
56,087
|
| | | | |
|
(58)
|
| | | | |
|
(137)
|
| | | | |
|
(767)
|
| | | | |
|
(2)
|
| | | | |
|
(964)
|
| | | | |
|
0.1
|
| | | | |
|
1.7
|
| | | | |
|
43.0
|
| | | | |
|
100.0
|
| | | | |
|
1.7
|
| |
| | – non-bank financial institutions | | | | |
|
10,238
|
| | | | |
|
369
|
| | | | |
|
243
|
| | | | |
|
—
|
| | | | |
|
10,850
|
| | | | |
|
(6)
|
| | | | |
|
(5)
|
| | | | |
|
(16)
|
| | | | |
|
—
|
| | | | |
|
(27)
|
| | | | |
|
0.1
|
| | | | |
|
1.4
|
| | | | |
|
6.6
|
| | | | |
|
—
|
| | | | |
|
0.2
|
| |
| |
Loans and advances to banks
at amortised cost |
| | | |
|
10,750
|
| | | | |
|
39
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
10,789
|
| | | | |
|
(4)
|
| | | | |
|
(1)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(5)
|
| | | | |
|
—
|
| | | | |
|
2.6
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| |
Other financial assets measured at amortised cost
|
| | | |
|
202,048
|
| | | | |
|
47
|
| | | | |
|
42
|
| | | | |
|
—
|
| | | | |
|
202,137
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(9)
|
| | | | |
|
—
|
| | | | |
|
(9)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
21.4
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| |
Loan and other credit-related
commitments |
| | | |
|
107,922
|
| | | | |
|
7,571
|
| | | | |
|
202
|
| | | | |
|
—
|
| | | | |
|
115,695
|
| | | | |
|
(25)
|
| | | | |
|
(22)
|
| | | | |
|
(8)
|
| | | | |
|
—
|
| | | | |
|
(55)
|
| | | | |
|
—
|
| | | | |
|
0.3
|
| | | | |
|
4.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – personal | | | | |
|
2,152
|
| | | | |
|
114
|
| | | | |
|
3
|
| | | | |
|
—
|
| | | | |
|
2,269
|
| | | | |
|
(1)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(1)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – corporate and commercial | | | | |
|
56,325
|
| | | | |
|
6,829
|
| | | | |
|
198
|
| | | | |
|
—
|
| | | | |
|
63,352
|
| | | | |
|
(20)
|
| | | | |
|
(20)
|
| | | | |
|
(8)
|
| | | | |
|
—
|
| | | | |
|
(48)
|
| | | | |
|
—
|
| | | | |
|
0.3
|
| | | | |
|
4.0
|
| | | | |
|
—
|
| | | | |
|
0.1
|
| |
| | – financial | | | | |
|
49,445
|
| | | | |
|
628
|
| | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
50,074
|
| | | | |
|
(4)
|
| | | | |
|
(2)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(6)
|
| | | | |
|
—
|
| | | | |
|
0.3
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Financial guarantees1 | | | | |
|
10,215
|
| | | | |
|
740
|
| | | | |
|
99
|
| | | | |
|
—
|
| | | | |
|
11,054
|
| | | | |
|
(3)
|
| | | | |
|
(7)
|
| | | | |
|
(7)
|
| | | | |
|
—
|
| | | | |
|
(17)
|
| | | | |
|
—
|
| | | | |
|
0.9
|
| | | | |
|
7.1
|
| | | | |
|
—
|
| | | | |
|
0.2
|
| |
| | – personal | | | | |
|
23
|
| | | | |
|
2
|
| | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
26
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – corporate and commercial | | | | |
|
9,257
|
| | | | |
|
540
|
| | | | |
|
97
|
| | | | |
|
—
|
| | | | |
|
9,894
|
| | | | |
|
(2)
|
| | | | |
|
(7)
|
| | | | |
|
(7)
|
| | | | |
|
—
|
| | | | |
|
(16)
|
| | | | |
|
—
|
| | | | |
|
1.3
|
| | | | |
|
7.2
|
| | | | |
|
—
|
| | | | |
|
0.2
|
| |
| | – financial | | | | |
|
935
|
| | | | |
|
198
|
| | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
1,134
|
| | | | |
|
(1)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(1)
|
| | | | |
|
0.1
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
0.1
|
| |
| | At 31 Dec 2021 | | | | | | 411,665 | | | | | | | 17,518 | | | | | | | 2,821 | | | | | | | 2 | | | | | | | 432,006 | | | | | | | (118) | | | | | | | (188) | | | | | | | (932) | | | | | | | (2) | | | | | | | (1,240) | | | | | | | — | | | | | | | 1.1 | | | | | | | 33.0 | | | | | | | 100.0 | | | | | | | 0.3 | | |
| | | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | |
Gross carrying amount
|
| | |
Allowance for ECL
|
| | |
ECL coverage %
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | |
Of which:
|
| | |
Of which:
|
| | | | | | | | | |
Of which:
|
| | |
Of which:
|
| | | | | | | | | |
Of which:
|
| | |
Of which:
|
| ||||||||||||||||||
| | | | | |
Stage 2
£m |
| | |
1 to 29 DPD1,2
£m |
| | |
30 and >
DPD1,2 £m |
| | |
Stage 2
£m |
| | |
1 to 29 DPD1,2
£m |
| | |
30 and >
DPD1,2 £m |
| | |
Stage 2
% |
| | |
1 to 29 DPD1,2
% |
| | |
30 and >
DPD1,2 % |
| |||||||||||||||||||||||||||
| |
Loans and advances to customers at amortised cost:
|
| | |
9,121
|
| | |
56
|
| | |
237
|
| | |
(158)
|
| | |
(1)
|
| | |
(1)
|
| | |
1.7
|
| | |
1.8
|
| | |
0.4
|
| |||||||||||||||||||||||||||
| | – personal | | | | |
|
686
|
| | | | |
|
49
|
| | | | |
|
29
|
| | | | |
|
(16)
|
| | | | |
|
(1)
|
| | | | |
|
(1)
|
| | | | |
|
2.3
|
| | | | |
|
2.0
|
| | | | |
|
3.4
|
| |
| | – corporate and commercial | | | | |
|
8,066
|
| | | | |
|
7
|
| | | | |
|
199
|
| | | | |
|
(137)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
1.7
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – non-bank financial institutions | | | | |
|
369
|
| | | | |
|
—
|
| | | | |
|
9
|
| | | | |
|
(5)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
1.4
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Loans and advances to banks at amortised cost | | | | |
|
39
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(1)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2.6
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Other financial assets measured at amortised cost | | | | |
|
47
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | | | | |
Gross carrying/nominal amount2
|
| | |
Allowance for ECL
|
| | |
ECL coverage %
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | |
Stage 1
£m |
| | |
Stage 2
£m |
| | |
Stage 3
£m |
| | |
POCI3
£m |
| | |
Total
£m |
| | |
Stage 1
£m |
| | |
Stage 2
£m |
| | |
Stage 3
£m |
| | |
POCI3
£m |
| | |
Total
£m |
| | |
Stage 1
% |
| | |
Stage 2
% |
| | |
Stage 3
% |
| | |
POCI3
% |
| | |
Total
% |
| |||||||||||||||||||||||||||||||||||||||||||||
| | Loans and advances to customers at amortised cost | | | | | | 83,179 | | | | | | | 16,774 | | | | | | | 2,966 | | | | | | | 41 | | | | | | | 102,960 | | | | | | | (129) | | | | | | | (297) | | | | | | | (1,031) | | | | | | | (12) | | | | | | | (1,469) | | | | | | | 0.2 | | | | | | | 1.8 | | | | | | | 34.8 | | | | | | | 29.3 | | | | | | | 1.4 | | |
| | – personal | | | | | | 24,991 | | | | | | | 974 | | | | | | | 534 | | | | | | | — | | | | | | | 26,499 | | | | | | | (18) | | | | | | | (37) | | | | | | | (153) | | | | | | | — | | | | | | | (208) | | | | | | | 0.1 | | | | | | | 3.8 | | | | | | | 28.7 | | | | | | | — | | | | | | | 0.8 | | |
| | – corporate and commercial | | | | | | 46,773 | | | | | | | 14,052 | | | | | | | 2,121 | | | | | | | 41 | | | | | | | 62,987 | | | | | | | (100) | | | | | | | (225) | | | | | | | (831) | | | | | | | (12) | | | | | | | (1,168) | | | | | | | 0.2 | | | | | | | 1.6 | | | | | | | 39.2 | | | | | | | 29.3 | | | | | | | 1.9 | | |
| | – non-bank financial institutions | | | | | | 11,415 | | | | | | | 1,748 | | | | | | | 311 | | | | | | | — | | | | | | | 13,474 | | | | | | | (11) | | | | | | | (35) | | | | | | | (47) | | | | | | | — | | | | | | | (93) | | | | | | | 0.1 | | | | | | | 2.0 | | | | | | | 15.1 | | | | | | | — | | | | | | | 0.7 | | |
| |
Loans and advances to banks
at amortised cost |
| | | | | 12,533 | | | | | | | 129 | | | | | | | — | | | | | | | — | | | | | | | 12,662 | | | | | | | (13) | | | | | | | (3) | | | | | | | — | | | | | | | — | | | | | | | (16) | | | | | | | 0.1 | | | | | | | 2.3 | | | | | | | — | | | | | | | — | | | | | | | 0.1 | | |
| | Other financial assets measured at amortised cost | | | | | | 202,659 | | | | | | | 65 | | | | | | | 39 | | | | | | | — | | | | | | | 202,763 | | | | | | | (2) | | | | | | | — | | | | | | | (10) | | | | | | | — | | | | | | | (12) | | | | | | | — | | | | | | | — | | | | | | | 25.6 | | | | | | | — | | | | | | | — | | |
| |
Loan and other credit-related
commitments |
| | | | | 128,956 | | | | | | | 13,814 | | | | | | | 266 | | | | | | | — | | | | | | | 143,036 | | | | | | | (34) | | | | | | | (68) | | | | | | | (10) | | | | | | | — | | | | | | | (112) | | | | | | | — | | | | | | | 0.5 | | | | | | | 3.8 | | | | | | | — | | | | | | | 0.1 | | |
| | – personal | | | | | | 1,991 | | | | | | | 217 | | | | | | | 3 | | | | | | | — | | | | | | | 2,211 | | | | | | | — | | | | | | | (1) | | | | | | | — | | | | | | | — | | | | | | | (1) | | | | | | | — | | | | | | | 0.5 | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | – corporate and commercial | | | | | | 65,199 | | | | | | | 10,404 | | | | | | | 260 | | | | | | | — | | | | | | | 75,863 | | | | | | | (29) | | | | | | | (51) | | | | | | | (9) | | | | | | | — | | | | | | | (89) | | | | | | | — | | | | | | | 0.5 | | | | | | | 3.5 | | | | | | | — | | | | | | | 0.1 | | |
| | – financial | | | | | | 61,766 | | | | | | | 3,193 | | | | | | | 3 | | | | | | | — | | | | | | | 64,962 | | | | | | | (5) | | | | | | | (16) | | | | | | | (1) | | | | | | | — | | | | | | | (22) | | | | | | | — | | | | | | | 0.5 | | | | | | | 33.3 | | | | | | | — | | | | | | | — | | |
| | Financial guarantees1 | | | | | | 2,839 | | | | | | | 1,008 | | | | | | | 121 | | | | | | | 1 | | | | | | | 3,969 | | | | | | | (4) | | | | | | | (10) | | | | | | | (9) | | | | | | | — | | | | | | | (23) | | | | | | | 0.1 | | | | | | | 1.0 | | | | | | | 7.4 | | | | | | | — | | | | | | | 0.6 | | |
| | – personal | | | | | | 26 | | | | | | | 5 | | | | | | | 1 | | | | | | | — | | | | | | | 32 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | – corporate and commercial | | | | | | 1,878 | | | | | | | 737 | | | | | | | 119 | | | | | | | 1 | | | | | | | 2,735 | | | | | | | (3) | | | | | | | (7) | | | | | | | (9) | | | | | | | — | | | | | | | (19) | | | | | | | 0.2 | | | | | | | 0.9 | | | | | | | 7.6 | | | | | | | — | | | | | | | 0.7 | | |
| | – financial | | | | | | 935 | | | | | | | 266 | | | | | | | 1 | | | | | | | — | | | | | | | 1,202 | | | | | | | (1) | | | | | | | (3) | | | | | | | — | | | | | | | — | | | | | | | (4) | | | | | | | 0.1 | | | | | | | 1.1 | | | | | | | — | | | | | | | — | | | | | | | 0.3 | | |
| | At 31 Dec 2020 | | | | | | 430,166 | | | | | | | 31,790 | | | | | | | 3,392 | | | | | | | 42 | | | | | | | 465,390 | | | | | | | (182) | | | | | | | (378) | | | | | | | (1,060) | | | | | | | (12) | | | | | | | (1,632) | | | | | | | — | | | | | | | 1.2 | | | | | | | 31.3 | | | | | | | 28.6 | | | | | | | 0.4 | | |
| | | | | |
Gross carrying amount
|
| | |
Allowance for ECL
|
| | |
ECL coverage %
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | |
Stage 2
£m |
| | |
Of which:
1 to 29 DPD1,2 £m |
| | |
Of which:
30 and > DPD1,2 £m |
| | |
Stage 2
£m |
| | |
Of which:
1 to 29 DPD1,2 £m |
| | |
Of which:
30 and > DPD1,2 £m |
| | |
Stage 2
% |
| | |
Of which:
1 to 29 DPD1,2 % |
| | |
Of which:
30 and > DPD1,2 % |
| |||||||||||||||||||||||||||
| | Loans and advances to customers at amortised cost | | | | | | 16,774 | | | | | |
|
64
|
| | | | |
|
50
|
| | | | | | (297) | | | | | |
|
(3)
|
| | | | |
|
(2)
|
| | | | | | 1.8 | | | | | |
|
4.7
|
| | | | |
|
4.0
|
| |
| | – personal | | | | | | 974 | | | | | |
|
54
|
| | | | |
|
39
|
| | | | | | (37) | | | | | |
|
(2)
|
| | | | |
|
(2)
|
| | | | | | 3.8 | | | | | |
|
3.7
|
| | | | |
|
5.1
|
| |
| | – corporate and commercial | | | | | | 14,052 | | | | | |
|
9
|
| | | | |
|
11
|
| | | | | | (225) | | | | | |
|
(1)
|
| | | | |
|
—
|
| | | | | | 1.6 | | | | | |
|
11.1
|
| | | | |
|
—
|
| |
| | – non-bank financial institutions | | | | | | 1,748 | | | | | |
|
1
|
| | | | |
|
—
|
| | | | | | (35) | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 2.0 | | | | | |
|
—
|
| | | | |
|
—
|
| |
| | Loans and advances to banks at amortised cost | | | | | | 129 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | (3) | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | 2.3 | | | | | |
|
—
|
| | | | |
|
—
|
| |
| | Other financial assets measured at amortised cost | | | | | | 65 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | — | | | | | |
|
—
|
| | | | |
|
—
|
| | | | | | — | | | | | |
|
—
|
| | | | |
|
—
|
| |
| |
‘Maximum exposure to credit risk’ table
|
|
| |
The following table presents our maximum exposure before taking account of any collateral held or other credit enhancements (unless such enhancements meet accounting offsetting requirements). The table excludes financial instruments whose carrying amount best represents the net exposure to credit risk and it excludes equity securities as they are not subject to credit risk. For the financial assets recognised on the balance sheet, the maximum exposure to credit risk equals their carrying amount; for financial guarantees and other guarantees granted, it is the maximum amount that the group would have to pay if the guarantees were called upon. For loan commitments and other credit-related commitments, it is generally the full amount of the committed facilities.
|
|
| |
The offset in the table relates to amounts where there is a legally enforceable right of offset in the event of counterparty default and where, as a result, there is a net exposure for credit risk purposes. However, as there is no intention to settle these balances on a net basis under normal circumstances, they do not qualify for net presentation for accounting purposes. No offset has been applied to off-balance sheet collateral. In the case of derivatives the offset column also includes collateral received in cash and other financial assets.
|
|
| | | | | |
2021
|
| | |
2020
|
| | | ||||||||||||||||||||||||||||||||||||
| | | | | |
Maximum
exposure £m |
| | |
Offset
£m |
| | |
Net
£m |
| | |
Maximum
exposure £m |
| | |
Offset
£m |
| | |
Net
£m |
| | | | | ||||||||||||||||||
| |
Loans and advances to customers held at amortised cost
|
| | | |
|
91,177
|
| | | | |
|
(7,057)
|
| | | | |
|
84,120
|
| | | | | | 101,491 | | | | | | | (8,717) | | | | | | | 92,774 | | | | | | |
| | – personal | | | | |
|
25,231
|
| | | | |
|
—
|
| | | | |
|
25,231
|
| | | | | | 26,291 | | | | | | | (3) | | | | | | | 26,288 | | | | | | |
| | – corporate and commercial | | | | |
|
55,123
|
| | | | |
|
(6,228)
|
| | | | |
|
48,895
|
| | | | | | 61,819 | | | | | | | (7,662) | | | | | | | 54,157 | | | | | | |
| | – non-bank financial institutions | | | | |
|
10,823
|
| | | | |
|
(829)
|
| | | | |
|
9,994
|
| | | | | | 13,381 | | | | | | | (1,052) | | | | | | | 12,329 | | | | | | |
| |
Loans and advances to banks at amortised cost
|
| | | |
|
10,784
|
| | | | |
|
(88)
|
| | | | |
|
10,696
|
| | | | | | 12,646 | | | | | | | (137) | | | | | | | 12,509 | | | | | | |
| |
Other financial assets held at amortised cost
|
| | | |
|
202,455
|
| | | | |
|
(10,239)
|
| | | | |
|
192,216
|
| | | | | | 203,084 | | | | | | | (10,604) | | | | | | | 192,480 | | | | | | |
| | – cash and balances at central banks | | | | |
|
108,482
|
| | | | |
|
—
|
| | | | |
|
108,482
|
| | | | | | 85,092 | | | | | | | — | | | | | | | 85,092 | | | | | | |
| | – items in the course of collection from other banks | | | | |
|
346
|
| | | | |
|
—
|
| | | | |
|
346
|
| | | | | | 243 | | | | | | | — | | | | | | | 243 | | | | | | |
| | – reverse repurchase agreements – non trading | | | | |
|
54,448
|
| | | | |
|
(10,239)
|
| | | | |
|
44,209
|
| | | | | | 67,577 | | | | | | | (10,604) | | | | | | | 56,973 | | | | | | |
| | – financial investments | | | | |
|
10
|
| | | | |
|
—
|
| | | | |
|
10
|
| | | | | | 15 | | | | | | | — | | | | | | | 15 | | | | | | |
| | – prepayments, accrued income and other assets | | | | |
|
39,169
|
| | | | |
|
—
|
| | | | |
|
39,169
|
| | | | | | 50,157 | | | | | | | — | | | | | | | 50,157 | | | | | | |
| |
Derivatives
|
| | | |
|
141,221
|
| | | | |
|
(139,668)
|
| | | | |
|
1,553
|
| | | | | | 201,210 | | | | | | | (200,137) | | | | | | | 1,073 | | | | | | |
| |
Total on balance sheet exposure to credit risk
|
| | | |
|
445,637
|
| | | | |
|
(157,052)
|
| | | | |
|
288,585
|
| | | | | | 518,431 | | | | | | | (219,595) | | | | | | | 298,836 | | | | | | |
| | Total off-balance sheet | | | | |
|
146,261
|
| | | | |
|
—
|
| | | | |
|
146,261
|
| | | | | | 165,368 | | | | | | | — | | | | | | | 165,368 | | | | | | |
| | – financial and other guarantees1 | | | | |
|
26,840
|
| | | | |
|
—
|
| | | | |
|
26,840
|
| | | | | | 18,177 | | | | | | | — | | | | | | | 18,177 | | | | | | |
| | – loan and other credit-related commitments | | | | |
|
119,421
|
| | | | |
|
—
|
| | | | |
|
119,421
|
| | | | | | 147,191 | | | | | | | — | | | | | | | 147,191 | | | | | | |
| |
At 31 Dec
|
| | | |
|
591,898
|
| | | | |
|
(157,052)
|
| | | | |
|
434,846
|
| | | | | | 683,799 | | | | | | | (219,595) | | | | | | | 464,204 | | | | | ||
| | | | |
UK
|
| |
France
|
| ||||||
| | | | |
%
|
| |
%
|
| ||||||
| | GDP growth rate | | | | | | | | | | | | | |
| | 2022: Annual average growth rate | | | |
|
5.0
|
| | | |
|
3.9
|
| |
| | 2023: Annual average growth rate | | | |
|
2.1
|
| | | |
|
2.1
|
| |
| | 2024: Annual average growth rate | | | |
|
1.9
|
| | | |
|
1.6
|
| |
| | 5-year average | | | |
|
2.5
|
| | | |
|
2.1
|
| |
| | Unemployment rate | | | | | | | | | | | | | |
| | 2022: Annual average rate | | | |
|
4.5
|
| | | |
|
8.0
|
| |
| | 2023: Annual average rate | | | |
|
4.3
|
| | | |
|
7.7
|
| |
| | 2024: Annual average rate | | | |
|
4.2
|
| | | |
|
7.6
|
| |
| | 5-year average | | | |
|
4.3
|
| | | |
|
7.7
|
| |
| | House price growth | | | | | | | | | | | | | |
| | 2022: Annual average growth rate | | | |
|
5.5
|
| | | |
|
4.9
|
| |
| | 2023: Annual average growth rate | | | |
|
3.3
|
| | | |
|
4.6
|
| |
| | 2024: Annual average growth rate | | | |
|
3.3
|
| | | |
|
4.0
|
| |
| | 5-year average | | | |
|
3.5
|
| | | |
|
3.9
|
| |
| | Short-term interest rate | | | | | | | | | | | | | |
| | 2022: Annual average rate | | | |
|
1.0
|
| | | |
|
(0.5)
|
| |
| | 2023: Annual average rate | | | |
|
1.3
|
| | | |
|
(0.3)
|
| |
| | 2024: Annual average rate | | | |
|
1.2
|
| | | |
|
(0.1)
|
| |
| | 5-year average | | | |
|
1.2
|
| | | |
|
(0.2)
|
| |
| | Probability | | | | | 60 | | | | | | 60 | | |
| | | | |
UK
% |
| |
France
% |
| ||||||||||||||||||
| | GDP growth rate | | | |
|
9.9
|
| | | |
|
(1Q22)
|
| | | |
|
7.0
|
| | | |
|
(2Q22)
|
| |
| | Unemployment rate | | | |
|
3.0
|
| | | |
|
(4Q23)
|
| | | |
|
6.6
|
| | | |
|
(4Q23)
|
| |
| | House price growth | | | |
|
7.4
|
| | | |
|
(2Q23)
|
| | | |
|
6.8
|
| | | |
|
(2Q22)
|
| |
| | Short-term interest rate | | | |
|
0.7
|
| | | |
|
(1Q22)
|
| | | |
|
(0.5)
|
| | | |
|
(1Q22)
|
| |
| | Probability | | | | | | | | | | | 10 | | | | | | | | | | | | 10 | | |
| | | | |
UK
% |
| |
France
% |
| ||||||||||||||||||
| | GDP growth rate | | | |
|
(0.5)
|
| | | |
|
(3Q23)
|
| | | |
|
0.5
|
| | | |
|
(4Q23)
|
| |
| | Unemployment rate | | | |
|
5.6
|
| | | |
|
(4Q22)
|
| | | |
|
9.1
|
| | | |
|
(3Q22)
|
| |
| | House price growth | | | |
|
(4.2)
|
| | | |
|
(1Q23)
|
| | | |
|
2.0
|
| | | |
|
(4Q22)
|
| |
| | Short-term interest rate | | | |
|
0.2
|
| | | |
|
(4Q23)
|
| | | |
|
(0.5)
|
| | | |
|
(1Q22)
|
| |
| | Probability | | | | | | | | | | | 15 | | | | | | | | | | | | 15 | | |
| | | | |
UK
% |
| |
France
% |
| ||||||||||||||||||
| | GDP growth rate | | | |
|
(4.6)
|
| | | |
|
(4Q22)
|
| | | |
|
(4.6)
|
| | | |
|
(4Q22)
|
| |
| | Unemployment rate | | | |
|
7.5
|
| | | |
|
(2Q23)
|
| | | |
|
10.0
|
| | | |
|
(4Q23)
|
| |
| | House price growth | | | |
|
(14.2)
|
| | | |
|
(2Q23)
|
| | | |
|
(6.0)
|
| | | |
|
(2Q23)
|
| |
| | Short-term interest rate | | | |
|
1.6
|
| | | |
|
(2Q22)
|
| | | |
|
0.4
|
| | | |
|
(2Q22)
|
| |
| | Probability | | | | | | | | | | | 15 | | | | | | | | | | | | 15 | | |
| | | | |
Retail
£m |
| |
Wholesale
£m |
| |
Total
£m |
| |||||||||
| | Low-risk counterparties (banks, sovereigns and government entities) | | | |
|
—
|
| | | |
|
(4)
|
| | | |
|
(4)
|
| |
| | Corporate lending adjustments | | | |
|
—
|
| | | |
|
31
|
| | | |
|
31
|
| |
| | Retail lending probability of default adjustments | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
| | Retail model default timing adjustments | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
| | Macroeconomic-related adjustments | | | |
|
17
|
| | | |
|
—
|
| | | |
|
17
|
| |
| | Pandemic-related economic recovery adjustments | | | |
|
3
|
| | | |
|
—
|
| | | |
|
3
|
| |
| | Other retail lending adjustments | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
| | Total | | | | | 20 | | | | | | 27 | | | | | | 47 | | |
| | | | |
Retail
£m |
| |
Wholesale
£m |
| |
Total
£m |
| |||||||||
| | Low-risk counterparties (banks, sovereigns and government entities) | | | |
|
(5)
|
| | | |
|
8
|
| | | |
|
3
|
| |
| | Corporate lending adjustments | | | |
|
—
|
| | | |
|
56
|
| | | |
|
56
|
| |
| | Retail lending probability of default adjustments | | | |
|
(10)
|
| | | |
|
—
|
| | | |
|
(10)
|
| |
| | Retail model default timing adjustments | | | |
|
3
|
| | | |
|
—
|
| | | |
|
3
|
| |
| | Macroeconomic-related adjustments | | | |
|
11
|
| | | |
|
—
|
| | | |
|
11
|
| |
| | Pandemic-related economic recovery adjustments | | | |
|
—
|
| | | |
|
—
|
| | | |
|
—
|
| |
| | Other retail lending adjustments | | | |
|
4
|
| | | |
|
—
|
| | | |
|
4
|
| |
| | Total | | | | | 3 | | | | | | 64 | | | | | | 67 | | |
| | | | |
UK
£m |
| |
France
£m |
| ||||||
| |
ECL of loans and advances to customers at
31 December 2021 |
| | | | | | | | | | | | |
| | Reported ECL | | | |
|
104
|
| | | |
|
98
|
| |
| | Consensus scenarios | | | | | | | | | | | | | |
| | Central scenario | | | |
|
90
|
| | | |
|
89
|
| |
| | Upside scenario | | | |
|
71
|
| | | |
|
78
|
| |
| | Downside scenario | | | |
|
109
|
| | | |
|
120
|
| |
| | Downside 2 scenario | | | |
|
189
|
| | | |
|
138
|
| |
| | Gross carrying amount2 | | | |
|
142,450
|
| | | |
|
120,955
|
| |
| |
ECL of loans and advances to customers at
31 December 2020 |
| | | | | | | | | | | | |
| | Reported ECL | | | | | 317 | | | | | | 88 | | |
| | Consensus scenarios | | | | | | | | | | | | | |
| | Central scenario | | | | | 219 | | | | | | 82 | | |
| | Upside scenario | | | | | 156 | | | | | | 73 | | |
| | Downside scenario | | | | | 339 | | | | | | 98 | | |
| | Additional Downside scenario | | | | | 657 | | | | | | 178 | | |
| | Gross carrying amount2 | | | | | 137,825 | | | | | | 123,444 | | |
| | | | |
UK
£m |
| |
France
£m |
| ||||||
| | ECL of loans and advances to customers at 31 December 2021 | | | | | | | | | | | | | |
| | Reported ECL | | | |
|
5
|
| | | |
|
91
|
| |
| | Consensus scenarios | | | | | | | | | | | | | |
| | Central scenario | | | |
|
4
|
| | | |
|
91
|
| |
| | Upside scenario | | | |
|
4
|
| | | |
|
91
|
| |
| | Downside scenario | | | |
|
5
|
| | | |
|
92
|
| |
| | Downside 2 scenario | | | |
|
10
|
| | | |
|
93
|
| |
| | Gross carrying amount | | | |
|
2,007
|
| | | |
|
18,295
|
| |
| | | | |
UK
|
| |
France
|
| ||||||
| | ECL of loans and advances to customers at 31 December 2020 | | | | | | | | | | | | | |
| | Reported ECL | | | | | 12 | | | | | | 114 | | |
| | Consensus scenarios | | | | | | | | | | | | | |
| | Central scenario | | | | | 11 | | | | | | 113 | | |
| | Upside scenario | | | | | 8 | | | | | | 111 | | |
| | Downside scenario | | | | | 14 | | | | | | 115 | | |
| | Additional Downside scenario | | | | | 17 | | | | | | 118 | | |
| | Gross carrying amount | | | | | 1,980 | | | | | | 19,254 | | |
| | | | | |
Non credit – impaired
|
| | |
Credit – impaired
|
| | | | | | | | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | |
Stage 1
|
| | |
Stage 2
|
| | |
Stage 3
|
| | |
POCI
|
| | |
Total
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | |
Gross
carrying/ nominal amount £m |
| | |
Allowance
for ECL £m |
| | |
Gross
carrying/ nominal amount £m |
| | |
Allowance
for ECL £m |
| | |
Gross
carrying/ nominal amount £m |
| | |
Allowance
for ECL £m |
| | |
Gross
carrying/ nominal amount £m |
| | |
Allowance
for ECL £m |
| | |
Gross
carrying/ nominal amount £m |
| | |
Allowance
for ECL £m |
| ||||||||||||||||||||||||||||||
| | At 1 Jan 2021 | | | | | | 184,715 | | | | | | | (180) | | | | | | | 31,726 | | | | | | | (378) | | | | | | | 3,352 | | | | | | | (1,050) | | | | | | | 40 | | | | | | | (12) | | | | | | | 219,833 | | | | | | | (1,620) | | |
| | Transfers of financial instruments | | | | |
|
5,245
|
| | | | |
|
(66)
|
| | | | |
|
(5,617)
|
| | | | |
|
90
|
| | | | |
|
372
|
| | | | |
|
(24)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – Transfers from stage 1 to stage 2 | | | | |
|
(8,431)
|
| | | | |
|
14
|
| | | | |
|
8,431
|
| | | | |
|
(14)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – Transfers from stage 2 to stage 1 | | | | |
|
13,714
|
| | | | |
|
(78)
|
| | | | |
|
(13,714)
|
| | | | |
|
78
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – Transfers to stage 3 | | | | |
|
(93)
|
| | | | |
|
—
|
| | | | |
|
(401)
|
| | | | |
|
28
|
| | | | |
|
494
|
| | | | |
|
(28)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – Transfers from stage 3 | | | | |
|
55
|
| | | | |
|
(2)
|
| | | | |
|
67
|
| | | | |
|
(2)
|
| | | | |
|
(122)
|
| | | | |
|
4
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Net remeasurement of ECL arising from transfer of stage | | | | |
|
—
|
| | | | |
|
43
|
| | | | |
|
—
|
| | | | |
|
(22)
|
| | | | |
|
—
|
| | | | |
|
(5)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
16
|
| |
| | New financial assets originated or purchased | | | | |
|
72,348
|
| | | | |
|
(55)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
72,348
|
| | | | |
|
(55)
|
| |
| | Asset derecognised (including final repayments) | | | | |
|
(57,098)
|
| | | | |
|
6
|
| | | | |
|
(3,481)
|
| | | | |
|
32
|
| | | | |
|
(454)
|
| | | | |
|
95
|
| | | | |
|
(3)
|
| | | | |
|
2
|
| | | | |
|
(61,036)
|
| | | | |
|
135
|
| |
| | Changes to risk parameters – further lending/repayments | | | | |
|
(16,766)
|
| | | | |
|
76
|
| | | | |
|
(3,927)
|
| | | | |
|
62
|
| | | | |
|
(213)
|
| | | | |
|
40
|
| | | | |
|
(29)
|
| | | | |
|
2
|
| | | | |
|
(20,935)
|
| | | | |
|
180
|
| |
| | Changes to risk parameters – credit quality | | | | |
|
—
|
| | | | |
|
54
|
| | | | |
|
—
|
| | | | |
|
7
|
| | | | |
|
—
|
| | | | |
|
(176)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(115)
|
| |
| | Changes to model used for ECL calculation | | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
—
|
| | | | |
|
9
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
11
|
| |
| | Assets written off | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(152)
|
| | | | |
|
152
|
| | | | |
|
(5)
|
| | | | |
|
5
|
| | | | |
|
(157)
|
| | | | |
|
157
|
| |
| | Credit related modifications that resulted in derecognition | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Foreign exchange | | | | |
|
(7,512)
|
| | | | |
|
2
|
| | | | |
|
(1,060)
|
| | | | |
|
10
|
| | | | |
|
(126)
|
| | | | |
|
46
|
| | | | |
|
(1)
|
| | | | |
|
1
|
| | | | |
|
(8,699)
|
| | | | |
|
59
|
| |
| | Others2 | | | | |
|
(1,320)
|
| | | | |
|
—
|
| | | | |
|
(170)
|
| | | | |
|
2
|
| | | | |
|
—
|
| | | | |
|
(1)
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
(1,490)
|
| | | | |
|
1
|
| |
| | At 31 Dec 2021 | | | | | | 179,612 | | | | | | | (118) | | | | | | | 17,471 | | | | | | | (188) | | | | | | | 2,779 | | | | | | | (923) | | | | | | | 2 | | | | | | | (2) | | | | | | | 199,864 | | | | | | | (1,231) | | |
| |
ECL income statement release/(charge)
for the period |
| | | | | | | | | | |
|
126
|
| | | | | | | | | | | |
|
88
|
| | | | | | | | | | | |
|
(46)
|
| | | | | | | | | | | |
|
4
|
| | | | | | | | | | | |
|
172
|
| |
| | Recoveries | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
3
|
| |
| | Others | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
(23)
|
| |
| |
Total ECL income statement release for
the period |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 152 | | |
| | | | |
At 31 Dec 2021
|
| |
12 months ended 31 Dec 2021
|
| ||||||||||||
| | | | |
Gross carrying/
nominal amount £m |
| |
Allowance
for ECL £m |
| |
ECL release/(charge)
£m |
| |||||||||
| | As above | | | | | 199,864 | | | | | | (1,231) | | | | | | 152 | | |
| | Other financial assets measured at amortised cost | | | |
|
202,137
|
| | | |
|
(9)
|
| | | |
|
(1)
|
| |
| | Non-trading reverse purchase agreement commitments | | | |
|
30,005
|
| | | |
|
—
|
| | | |
|
—
|
| |
| | Performance and other guarantees not considered for IFRS 9 | | | | | | | | | | | | | | | |
|
18
|
| |
| | Summary of financial instruments to which the impairment requirements in IFRS 9 are applied/Summary consolidated income statement | | | | | 432,006 | | | | | | (1,240) | | | | | | 169 | | |
| | Debt instruments measured at FVOCI | | | |
|
41,188
|
| | | |
|
(19)
|
| | | |
|
5
|
| |
| | Total allowance for ECL/total income statement ECL release for the period | | | | | n/a | | | | | | (1,259) | | | | | | 174 | | |
| | | | | |
Non credit – impaired
|
| | |
Credit – impaired
|
| | | | | | | | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | |
Stage 1
|
| | |
Stage 2
|
| | |
Stage 3
|
| | |
POCI
|
| | |
Total
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | |
Gross
carrying/ nominal amount £m |
| | |
Allowance
for ECL £m |
| | |
Gross
carrying/ nominal amount £m |
| | |
Allowance
for ECL £m |
| | |
Gross
carrying/ nominal amount £m |
| | |
Allowance
for ECL £m |
| | |
Gross
carrying/ nominal amount £m |
| | |
Allowance
for ECL £m |
| | |
Gross
carrying/ nominal amount £m |
| | |
Allowance
for ECL £m |
| ||||||||||||||||||||||||||||||
| | At 1 Jan 2020 | | | | | | 195,249 | | | | | | | (132) | | | | | | | 11,103 | | | | | | | (143) | | | | | | | 2,235 | | | | | | | (796) | | | | | | | 78 | | | | | | | (33) | | | | | | | 208,665 | | | | | | | (1,104) | | |
| | Transfers of financial instruments: | | | | | | (19,123) | | | | | | | (62) | | | | | | | 16,792 | | | | | | | 93 | | | | | | | 2,331 | | | | | | | (31) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | – Transfers from stage 1 to stage 2 | | | | | | (31,600) | | | | | | | 54 | | | | | | | 31,600 | | | | | | | (54) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | – Transfers from stage 2 to stage 1 | | | | | | 12,821 | | | | | | | (121) | | | | | | | (12,821) | | | | | | | 121 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | – Transfers to stage 3 | | | | | | (351) | | | | | | | 7 | | | | | | | (2,147) | | | | | | | 32 | | | | | | | 2,498 | | | | | | | (39) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | – Transfers from stage 3 | | | | | | 7 | | | | | | | (2) | | | | | | | 160 | | | | | | | (6) | | | | | | | (167) | | | | | | | 8 | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| |
Net remeasurement of ECL arising
from transfer of stage |
| | | | | — | | | | | | | 60 | | | | | | | — | | | | | | | (67) | | | | | | | — | | | | | | | (2) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (9) | | |
| | New financial assets originated or purchased | | | | | | 95,477 | | | | | | | (62) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 10 | | | | | | | (1) | | | | | | | 95,487 | | | | | | | (63) | | |
| | Asset derecognised (including final repayments) | | | | | | (72,860) | | | | | | | 6 | | | | | | | (2,553) | | | | | | | 21 | | | | | | | (998) | | | | | | | 139 | | | | | | | (16) | | | | | | | 1 | | | | | | | (76,427) | | | | | | | 167 | | |
| | Changes to risk parameters – further lending/repayments | | | | | | (21,912) | | | | | | | 48 | | | | | | | 5,666 | | | | | | | 6 | | | | | | | (41) | | | | | | | 101 | | | | | | | (11) | | | | | | | (2) | | | | | | | (16,298) | | | | | | | 153 | | |
| |
Changes to risk parameters – credit
quality |
| | | | | — | | | | | | | (53) | | | | | | | — | | | | | | | (248) | | | | | | | — | | | | | | | (687) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (988) | | |
| | Changes to model used for ECL calculation | | | | | | — | | | | | | | 10 | | | | | | | — | | | | | | | (36) | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (26) | | |
| | Assets written off | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (252) | | | | | | | 252 | | | | | | | (23) | | | | | | | 23 | | | | | | | (275) | | | | | | | 275 | | |
| | Credit related modifications that resulted in derecognition | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | (18) | | | | | | | 5 | | | | | | | — | | | | | | | — | | | | | | | (18) | | | | | | | 5 | | |
| | Foreign exchange | | | | | | 6,058 | | | | | | | 5 | | | | | | | 498 | | | | | | | (3) | | | | | | | 95 | | | | | | | (33) | | | | | | | 2 | | | | | | | — | | | | | | | 6,653 | | | | | | | (31) | | |
| | Others2 | | | | | | 1,826 | | | | | | | — | | | | | | | 220 | | | | | | | (1) | | | | | | | — | | | | | | | 2 | | | | | | | — | | | | | | | — | | | | | | | 2,046 | | | | | | | 1 | | |
| | At 31 Dec 2020 | | | | | | 184,715 | | | | | | | (180) | | | | | | | 31,726 | | | | | | | (378) | | | | | | | 3,352 | | | | | | | (1,050) | | | | | | | 40 | | | | | | | (12) | | | | | | | 219,833 | | | | | | | (1,620) | | |
| | ECL income statement charge for the period | | | | | | | | | | | | | 9 | | | | | | | | | | | | | | (324) | | | | | | | | | | | | | | (449) | | | | | | | | | | | | | | (2) | | | | | | | | | | | | | | (766) | | |
| | Recoveries | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2 | | |
| | Others | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (17) | | |
| |
Total ECL income statement charge
for the period |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (781) | | |
| | | | | | | |||||||||||||||
| | | | |
At 31 Dec 2020
|
| |
12 months ended 31 Dec 2020
|
| ||||||||||||
| | | | |
Gross carrying/
nominal amount £m |
| |
Allowance
for ECL £m |
| |
ECL charge
£m |
| |||||||||
| | As above | | | | | 219,833 | | | | | | (1,620) | | | | | | (781) | | |
| | Other financial assets measured at amortised cost | | | | | 202,763 | | | | | | (12) | | | | | | (2) | | |
| | Non-trading reverse purchase agreement commitments | | | | | 42,794 | | | | | | — | | | | | | — | | |
| | Performance and other guarantees not considered for IFRS 9 | | | | | | | | | | | | | | | | | (17) | | |
| |
Summary of financial instruments to which the
impairment requirements in IFRS 9 are applied/Summary consolidated income statement |
| | | | 465,390 | | | | | | (1,632) | | | | | | (800) | | |
| | Debt instruments measured at FVOCI | | | | | 51,713 | | | | | | (22) | | | | | | (8) | | |
| | Total allowance for ECL/total income statement ECL charge for the period | | | | | n/a | | | | | | (1,654) | | | | | | (808) | | |
| | | | | |
Gross carrying/notional amount
|
| | | | | | | | | | | | | | | ||||||||||||||||||||||||||||||||||||||
| | | | | |
Strong
£m |
| | |
Good
£m |
| | |
Satisfactory
£m |
| | |
Sub-
standard £m |
| | |
Credit
impaired £m |
| | |
Total
£m |
| | |
Allowance
for ECL £m |
| | |
Net
£m |
| ||||||||||||||||||||||||
| | In-scope for IFRS 9 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| |
Loans and advances to customers held at
amortised cost |
| | | |
|
41,339
|
| | | | |
|
20,531
|
| | | | |
|
23,469
|
| | | | |
|
4,512
|
| | | | |
|
2,480
|
| | | | |
|
92,331
|
| | | | |
|
(1,154)
|
| | | | |
|
91,177
|
| |
| | – personal | | | | |
|
18,956
|
| | | | |
|
4,136
|
| | | | |
|
1,793
|
| | | | |
|
56
|
| | | | |
|
453
|
| | | | |
|
25,394
|
| | | | |
|
(163)
|
| | | | |
|
25,231
|
| |
| | – corporate and commercial | | | | |
|
16,533
|
| | | | |
|
13,867
|
| | | | |
|
19,597
|
| | | | |
|
4,305
|
| | | | |
|
1,785
|
| | | | |
|
56,087
|
| | | | |
|
(964)
|
| | | | |
|
55,123
|
| |
| | – non-bank financial institutions | | | | |
|
5,850
|
| | | | |
|
2,528
|
| | | | |
|
2,079
|
| | | | |
|
151
|
| | | | |
|
242
|
| | | | |
|
10,850
|
| | | | |
|
(27)
|
| | | | |
|
10,823
|
| |
| | Loans and advances to banks held at amortised cost | | | | |
|
8,649
|
| | | | |
|
320
|
| | | | |
|
1,815
|
| | | | |
|
5
|
| | | | |
|
—
|
| | | | |
|
10,789
|
| | | | |
|
(5)
|
| | | | |
|
10,784
|
| |
| | Cash and balances at central banks | | | | |
|
108,133
|
| | | | |
|
198
|
| | | | |
|
151
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
108,482
|
| | | | |
|
—
|
| | | | |
|
108,482
|
| |
| | Items in the course of collection from other banks | | | | |
|
343
|
| | | | |
|
—
|
| | | | |
|
3
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
346
|
| | | | |
|
—
|
| | | | |
|
346
|
| |
| | Reverse repurchase agreements – non-trading | | | | |
|
47,071
|
| | | | |
|
6,355
|
| | | | |
|
1,022
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
54,448
|
| | | | |
|
—
|
| | | | |
|
54,448
|
| |
| | Financial investments | | | | |
|
2
|
| | | | |
|
—
|
| | | | |
|
8
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
10
|
| | | | |
|
—
|
| | | | |
|
10
|
| |
| |
Prepayments, accrued income and other
assets |
| | | |
|
36,558
|
| | | | |
|
666
|
| | | | |
|
1,574
|
| | | | |
|
11
|
| | | | |
|
42
|
| | | | |
|
38,851
|
| | | | |
|
(9)
|
| | | | |
|
38,842
|
| |
| | – endorsements and acceptances | | | | |
|
105
|
| | | | |
|
61
|
| | | | |
|
23
|
| | | | |
|
—
|
| | | | |
|
7
|
| | | | |
|
196
|
| | | | |
|
—
|
| | | | |
|
196
|
| |
| | – accrued income and other | | | | |
|
36,453
|
| | | | |
|
605
|
| | | | |
|
1,551
|
| | | | |
|
11
|
| | | | |
|
35
|
| | | | |
|
38,655
|
| | | | |
|
(9)
|
| | | | |
|
38,646
|
| |
| |
Debt instruments measured at fair value
through other comprehensive income1 |
| | | |
|
36,410
|
| | | | |
|
1,899
|
| | | | |
|
1,406
|
| | | | |
|
118
|
| | | | |
|
—
|
| | | | |
|
39,833
|
| | | | |
|
(19)
|
| | | | |
|
39,814
|
| |
| | Out-of-scope for IFRS 9 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Trading assets | | | | |
|
28,110
|
| | | | |
|
5,331
|
| | | | |
|
8,985
|
| | | | |
|
350
|
| | | | |
|
—
|
| | | | |
|
42,776
|
| | | | |
|
—
|
| | | | |
|
42,776
|
| |
| | Other financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | |
|
2,246
|
| | | | |
|
304
|
| | | | |
|
2,644
|
| | | | |
|
3
|
| | | | |
|
—
|
| | | | |
|
5,197
|
| | | | |
|
—
|
| | | | |
|
5,197
|
| |
| | Derivatives | | | | |
|
111,471
|
| | | | |
|
25,487
|
| | | | |
|
4,054
|
| | | | |
|
207
|
| | | | |
|
2
|
| | | | |
|
141,221
|
| | | | |
|
—
|
| | | | |
|
141,221
|
| |
| | Total gross carrying amount on balance sheet | | | | | | 420,332 | | | | | | | 61,091 | | | | | | | 45,131 | | | | | | | 5,206 | | | | | | | 2,524 | | | | | | | 534,284 | | | | | | | (1,187) | | | | | | | 533,097 | | |
| | Percentage of total credit quality | | | | | | 78.7% | | | | | | | 11.4% | | | | | | | 8.4% | | | | | | | 1.0% | | | | | | | 0.5% | | | | | | | 100.0% | | | | | | | | | | | | | | | | |
| | Loans and other credit-related commitments | | | | |
|
71,741
|
| | | | |
|
21,860
|
| | | | |
|
20,018
|
| | | | |
|
1,874
|
| | | | |
|
202
|
| | | | |
|
115,695
|
| | | | |
|
(55)
|
| | | | |
|
115,640
|
| |
| | Financial guarantees | | | | |
|
8,412
|
| | | | |
|
1,088
|
| | | | |
|
1,245
|
| | | | |
|
210
|
| | | | |
|
99
|
| | | | |
|
11,054
|
| | | | |
|
(17)
|
| | | | |
|
11,037
|
| |
| | In-scope: Irrevocable loan commitments and financial guarantees | | | | | | 80,153 | | | | | | | 22,948 | | | | | | | 21,263 | | | | | | | 2,084 | | | | | | | 301 | | | | | | | 126,749 | | | | | | | (72) | | | | | | | 126,677 | | |
| | Loans and other credit-related commitments | | | | |
|
2,134
|
| | | | |
|
1,114
|
| | | | |
|
432
|
| | | | |
|
94
|
| | | | |
|
7
|
| | | | |
|
3,781
|
| | | | |
|
—
|
| | | | |
|
3,781
|
| |
| | Performance and other guarantees | | | | |
|
7,738
|
| | | | |
|
4,359
|
| | | | |
|
3,130
|
| | | | |
|
490
|
| | | | |
|
116
|
| | | | |
|
15,833
|
| | | | |
|
(31)
|
| | | | |
|
15,802
|
| |
| | Out-of-scope: Revocable loan commitments and non-financial guarantees | | | | | | 9,872 | | | | | | | 5,473 | | | | | | | 3,562 | | | | | | | 584 | | | | | | | 123 | | | | | | | 19,614 | | | | | | | (31) | | | | | | | 19,583 | | |
| | | | | |
Gross carrying/notional amount
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | |
Strong
£m |
| | |
Good
£m |
| | |
Satisfactory
£m |
| | |
Sub-standard
£m |
| | |
Credit
impaired £m |
| | |
Total
£m |
| | |
Allowance
for ECL £m |
| | |
Net
£m |
| ||||||||||||||||||||||||
| | In-scope for IFRS 9 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Loans and advances to customers held at amortised cost | | | | | | 43,077 | | | | | | | 24,780 | | | | | | | 26,477 | | | | | | | 5,619 | | | | | | | 3,007 | | | | | | | 102,960 | | | | | | | (1,469) | | | | | | | 101,491 | | |
| | – personal | | | | | | 19,232 | | | | | | | 4,341 | | | | | | | 2,251 | | | | | | | 141 | | | | | | | 534 | | | | | | | 26,499 | | | | | | | (208) | | | | | | | 26,291 | | |
| | – corporate and commercial | | | | | | 16,340 | | | | | | | 17,132 | | | | | | | 22,330 | | | | | | | 5,023 | | | | | | | 2,162 | | | | | | | 62,987 | | | | | | | (1,168) | | | | | | | 61,819 | | |
| | – non-bank financial institutions | | | | | | 7,505 | | | | | | | 3,307 | | | | | | | 1,896 | | | | | | | 455 | | | | | | | 311 | | | | | | | 13,474 | | | | | | | (93) | | | | | | | 13,381 | | |
| | Loans and advances to banks held at amortised cost | | | | | | 10,518 | | | | | | | 721 | | | | | | | 1,412 | | | | | | | 11 | | | | | | | — | | | | | | | 12,662 | | | | | | | (16) | | | | | | | 12,646 | | |
| | Cash and balances at central banks | | | | | | 84,964 | | | | | | | — | | | | | | | 129 | | | | | | | — | | | | | | | — | | | | | | | 85,093 | | | | | | | (1) | | | | | | | 85,092 | | |
| | Items in the course of collection from other banks | | | | | | 240 | | | | | | | — | | | | | | | 3 | | | | | | | — | | | | | | | — | | | | | | | 243 | | | | | | | — | | | | | | | 243 | | |
| | Reverse repurchase agreements – non-trading | | | | | | 57,282 | | | | | | | 8,370 | | | | | | | 1,920 | | | | | | | 5 | | | | | | | — | | | | | | | 67,577 | | | | | | | — | | | | | | | 67,577 | | |
| | Financial investments | | | | | | 2 | | | | | | | — | | | | | | | 13 | | | | | | | — | | | | | | | — | | | | | | | 15 | | | | | | | — | | | | | | | 15 | | |
| | Prepayments, accrued income and other assets | | | | | | 47,928 | | | | | | | 566 | | | | | | | 1,285 | | | | | | | 17 | | | | | | | 39 | | | | | | | 49,835 | | | | | | | (11) | | | | | | | 49,824 | | |
| | – endorsements and acceptances | | | | | | 62 | | | | | | | 2 | | | | | | | 31 | | | | | | | 2 | | | | | | | 2 | | | | | | | 99 | | | | | | | (1) | | | | | | | 98 | | |
| | – accrued income and other | | | | | | 47,866 | | | | | | | 564 | | | | | | | 1,254 | | | | | | | 15 | | | | | | | 37 | | | | | | | 49,736 | | | | | | | (10) | | | | | | | 49,726 | | |
| | Debt instruments measured at fair value through other comprehensive income1 | | | | | | 46,029 | | | | | | | 2,487 | | | | | | | 405 | | | | | | | 153 | | | | | | | — | | | | | | | 49,074 | | | | | | | (22) | | | | | | | 49,052 | | |
| | Out-of-scope for IFRS 9 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Trading assets | | | | | | 34,302 | | | | | | | 5,996 | | | | | | | 9,493 | | | | | | | 410 | | | | | | | — | | | | | | | 50,201 | | | | | | | — | | | | | | | 50,201 | | |
| | Other financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | 2,460 | | | | | | | 1,152 | | | | | | | 587 | | | | | | | 4 | | | | | | | — | | | | | | | 4,203 | | | | | | | — | | | | | | | 4,203 | | |
| | Derivatives | | | | | | 165,868 | | | | | | | 30,113 | | | | | | | 4,299 | | | | | | | 890 | | | | | | | 40 | | | | | | | 201,210 | | | | | | | — | | | | | | | 201,210 | | |
| | Total gross carrying amount on balance sheet | | | | | | 492,670 | | | | | | | 74,185 | | | | | | | 46,023 | | | | | | | 7,109 | | | | | | | 3,086 | | | | | | | 623,073 | | | | | | | (1,519) | | | | | | | 621,554 | | |
| | Percentage of total credit quality | | | | | | 79% | | | | | | | 12% | | | | | | | 8% | | | | | | | 1% | | | | | | | — | | | | | | | 100% | | | | | | | | | | | | | | | | |
| | Loans and other credit-related commitments | | | | | | 97,281 | | | | | | | 26,361 | | | | | | | 17,081 | | | | | | | 2,047 | | | | | | | 266 | | | | | | | 143,036 | | | | | | | (112) | | | | | | | 142,924 | | |
| | Financial guarantees | | | | | | 1,340 | | | | | | | 1,153 | | | | | | | 1,020 | | | | | | | 334 | | | | | | | 122 | | | | | | | 3,969 | | | | | | | (23) | | | | | | | 3,946 | | |
| | In-scope: Irrevocable loan commitments and financial guarantees | | | | | | 98,621 | | | | | | | 27,514 | | | | | | | 18,101 | | | | | | | 2,381 | | | | | | | 388 | | | | | | | 147,005 | | | | | | | (135) | | | | | | | 146,870 | | |
| | Loans and other credit-related commitments | | | | | | 2,525 | | | | | | | 986 | | | | | | | 578 | | | | | | | 177 | | | | | | | 1 | | | | | | | 4,267 | | | | | | | — | | | | | | | 4,267 | | |
| | Performance and other guarantees | | | | | | 6,728 | | | | | | | 3,808 | | | | | | | 3,145 | | | | | | | 422 | | | | | | | 179 | | | | | | | 14,282 | | | | | | | (51) | | | | | | | 14,231 | | |
| | Out-of-scope: Revocable loan commitments and non-financial guarantees | | | | | | 9,253 | | | | | | | 4,794 | | | | | | | 3,723 | | | | | | | 599 | | | | | | | 180 | | | | | | | 18,549 | | | | | | | (51) | | | | | | | 18,498 | | |
| | | | | |
Gross carrying/notional amount
|
| | | | | | | | | | | | | | | ||||||||||||||||||||||||||||||||||||||
| | | | | |
Strong
£m |
| | |
Good
£m |
| | |
Satisfactory
£m |
| | |
Sub-standard
£m |
| | |
Credit
impaired £m |
| | |
Total
£m |
| | |
Allowance
for ECL £m |
| | |
Net
£m |
| ||||||||||||||||||||||||
| | Loans and advances to customers at amortised cost | | | | | | 41,339 | | | | | | | 20,531 | | | | | | | 23,469 | | | | | | | 4,512 | | | | | | | 2,480 | | | | | | | 92,331 | | | | | | | (1,154) | | | | | | | 91,177 | | |
| | – stage 1 | | | | |
|
40,831
|
| | | | |
|
19,376
|
| | | | |
|
19,077
|
| | | | |
|
1,446
|
| | | | |
|
—
|
| | | | |
|
80,730
|
| | | | |
|
(86)
|
| | | | |
|
80,644
|
| |
| | – stage 2 | | | | |
|
508
|
| | | | |
|
1,155
|
| | | | |
|
4,392
|
| | | | |
|
3,066
|
| | | | |
|
—
|
| | | | |
|
9,121
|
| | | | |
|
(158)
|
| | | | |
|
8,963
|
| |
| | – stage 3 | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2,478
|
| | | | |
|
2,478
|
| | | | |
|
(908)
|
| | | | |
|
1,570
|
| |
| | – POCI | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
2
|
| | | | |
|
(2)
|
| | | | |
|
—
|
| |
| | Loans and advances to banks at amortised cost | | | | | | 8,649 | | | | | | | 320 | | | | | | | 1,815 | | | | | | | 5 | | | | | | | — | | | | | | | 10,789 | | | | | | | (5) | | | | | | | 10,784 | | |
| | – stage 1 | | | | |
|
8,620
|
| | | | |
|
311
|
| | | | |
|
1,814
|
| | | | |
|
5
|
| | | | |
|
—
|
| | | | |
|
10,750
|
| | | | |
|
(4)
|
| | | | |
|
10,746
|
| |
| | – stage 2 | | | | |
|
29
|
| | | | |
|
9
|
| | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
39
|
| | | | |
|
(1)
|
| | | | |
|
38
|
| |
| | – stage 3 | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – POCI | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Other financial assets measured at amortised cost | | | | | | 192,107 | | | | | | | 7,219 | | | | | | | 2,758 | | | | | | | 11 | | | | | | | 42 | | | | | | | 202,137 | | | | | | | (9) | | | | | | | 202,128 | | |
| | – stage 1 | | | | |
|
192,105
|
| | | | |
|
7,214
|
| | | | |
|
2,727
|
| | | | |
|
2
|
| | | | |
|
—
|
| | | | |
|
202,048
|
| | | | |
|
—
|
| | | | |
|
202,048
|
| |
| | – stage 2 | | | | |
|
2
|
| | | | |
|
5
|
| | | | |
|
31
|
| | | | |
|
9
|
| | | | |
|
—
|
| | | | |
|
47
|
| | | | |
|
—
|
| | | | |
|
47
|
| |
| | – stage 3 | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
42
|
| | | | |
|
42
|
| | | | |
|
(9)
|
| | | | |
|
33
|
| |
| | – POCI | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Loans and other credit-related commitments | | | | | | 71,741 | | | | | | | 21,860 | | | | | | | 20,018 | | | | | | | 1,874 | | | | | | | 202 | | | | | | | 115,695 | | | | | | | (55) | | | | | | | 115,640 | | |
| | – stage 1 | | | | |
|
71,074
|
| | | | |
|
19,960
|
| | | | |
|
16,337
|
| | | | |
|
551
|
| | | | |
|
—
|
| | | | |
|
107,922
|
| | | | |
|
(25)
|
| | | | |
|
107,897
|
| |
| | – stage 2 | | | | |
|
667
|
| | | | |
|
1,900
|
| | | | |
|
3,681
|
| | | | |
|
1,323
|
| | | | |
|
—
|
| | | | |
|
7,571
|
| | | | |
|
(22)
|
| | | | |
|
7,549
|
| |
| | – stage 3 | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
202
|
| | | | |
|
202
|
| | | | |
|
(8)
|
| | | | |
|
194
|
| |
| | – POCI | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Financial guarantees | | | | | | 8,412 | | | | | | | 1,088 | | | | | | | 1,245 | | | | | | | 210 | | | | | | | 99 | | | | | | | 11,054 | | | | | | | (17) | | | | | | | 11,037 | | |
| | – stage 1 | | | | |
|
8,340
|
| | | | |
|
951
|
| | | | |
|
849
|
| | | | |
|
75
|
| | | | |
|
—
|
| | | | |
|
10,215
|
| | | | |
|
(3)
|
| | | | |
|
10,212
|
| |
| | – stage 2 | | | | |
|
72
|
| | | | |
|
137
|
| | | | |
|
396
|
| | | | |
|
135
|
| | | | |
|
—
|
| | | | |
|
740
|
| | | | |
|
(7)
|
| | | | |
|
733
|
| |
| | – stage 3 | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
99
|
| | | | |
|
99
|
| | | | |
|
(7)
|
| | | | |
|
92
|
| |
| | – POCI | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | At 31 Dec 2021 | | | | | | 322,248 | | | | | | | 51,018 | | | | | | | 49,305 | | | | | | | 6,612 | | | | | | | 2,823 | | | | | | | 432,006 | | | | | | | (1,240) | | | | | | | 430,766 | | |
| | Debt instruments at FVOCI1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – stage 1 | | | | |
|
36,005
|
| | | | |
|
1,825
|
| | | | |
|
1,292
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
39,122
|
| | | | |
|
(10)
|
| | | | |
|
39,112
|
| |
| | – stage 2 | | | | |
|
405
|
| | | | |
|
74
|
| | | | |
|
114
|
| | | | |
|
118
|
| | | | |
|
—
|
| | | | |
|
711
|
| | | | |
|
(9)
|
| | | | |
|
702
|
| |
| | – stage 3 | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – POCI | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | At 31 Dec 2021 | | | | | | 36,410 | | | | | | | 1,899 | | | | | | | 1,406 | | | | | | | 118 | | | | | | | — | | | | | | | 39,833 | | | | | | | (19) | | | | | | | 39,814 | | |
| | | | | |
Gross carrying/notional amount
|
| | | | | | | | | | | | | | | ||||||||||||||||||||||||||||||||||||||
| | | | | |
Strong
£m |
| | |
Good
£m |
| | |
Satisfactory
£m |
| | |
Sub-standard
£m |
| | |
Credit
impaired £m |
| | |
Total
£m |
| | |
Allowance
for ECL £m |
| | |
Net
£m |
| ||||||||||||||||||||||||
| | Loans and advances to customers at amortised cost | | | | | | 43,077 | | | | | | | 24,780 | | | | | | | 26,477 | | | | | | | 5,619 | | | | | | | 3,007 | | | | | | | 102,960 | | | | | | | (1,469) | | | | | | | 101,491 | | |
| | – stage 1 | | | | | | 42,579 | | | | | | | 21,351 | | | | | | | 17,556 | | | | | | | 1,693 | | | | | | | — | | | | | | | 83,179 | | | | | | | (129) | | | | | | | 83,050 | | |
| | – stage 2 | | | | | | 498 | | | | | | | 3,429 | | | | | | | 8,921 | | | | | | | 3,926 | | | | | | | — | | | | | | | 16,774 | | | | | | | (297) | | | | | | | 16,477 | | |
| | – stage 3 | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 2,966 | | | | | | | 2,966 | | | | | | | (1,031) | | | | | | | 1,935 | | |
| | – POCI | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 41 | | | | | | | 41 | | | | | | | (12) | | | | | | | 29 | | |
| | Loans and advances to banks at amortised cost | | | | | | 10,518 | | | | | | | 721 | | | | | | | 1,412 | | | | | | | 11 | | | | | | | — | | | | | | | 12,662 | | | | | | | (16) | | | | | | | 12,646 | | |
| | – stage 1 | | | | | | 10,479 | | | | | | | 674 | | | | | | | 1,372 | | | | | | | 8 | | | | | | | — | | | | | | | 12,533 | | | | | | | (13) | | | | | | | 12,520 | | |
| | – stage 2 | | | | | | 39 | | | | | | | 47 | | | | | | | 40 | | | | | | | 3 | | | | | | | — | | | | | | | 129 | | | | | | | (3) | | | | | | | 126 | | |
| | – stage 3 | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | – POCI | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | Other financial assets measured at amortised cost | | | | | | 190,416 | | | | | | | 8,936 | | | | | | | 3,350 | | | | | | | 22 | | | | | | | 39 | | | | | | | 202,763 | | | | | | | (12) | | | | | | | 202,751 | | |
| | – stage 1 | | | | | | 190,407 | | | | | | | 8,924 | | | | | | | 3,321 | | | | | | | 7 | | | | | | | — | | | | | | | 202,659 | | | | | | | (2) | | | | | | | 202,657 | | |
| | – stage 2 | | | | | | 9 | | | | | | | 12 | | | | | | | 29 | | | | | | | 15 | | | | | | | — | | | | | | | 65 | | | | | | | — | | | | | | | 65 | | |
| | – stage 3 | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 39 | | | | | | | 39 | | | | | | | (10) | | | | | | | 29 | | |
| | – POCI | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | Loans and other credit-related commitments | | | | | | 97,281 | | | | | | | 26,361 | | | | | | | 17,081 | | | | | | | 2,047 | | | | | | | 266 | | | | | | | 143,036 | | | | | | | (112) | | | | | | | 142,924 | | |
| | – stage 1 | | | | | | 95,270 | | | | | | | 21,398 | | | | | | | 11,758 | | | | | | | 530 | | | | | | | — | | | | | | | 128,956 | | | | | | | (34) | | | | | | | 128,922 | | |
| | – stage 2 | | | | | | 2,011 | | | | | | | 4,963 | | | | | | | 5,323 | | | | | | | 1,517 | | | | | | | — | | | | | | | 13,814 | | | | | | | (68) | | | | | | | 13,746 | | |
| | – stage 3 | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 266 | | | | | | | 266 | | | | | | | (10) | | | | | | | 256 | | |
| | – POCI | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | Financial guarantees | | | | | | 1,340 | | | | | | | 1,153 | | | | | | | 1,020 | | | | | | | 334 | | | | | | | 122 | | | | | | | 3,969 | | | | | | | (23) | | | | | | | 3,946 | | |
| | – stage 1 | | | | | | 1,337 | | | | | | | 883 | | | | | | | 496 | | | | | | | 123 | | | | | | | — | | | | | | | 2,839 | | | | | | | (4) | | | | | | | 2,835 | | |
| | – stage 2 | | | | | | 3 | | | | | | | 270 | | | | | | | 524 | | | | | | | 211 | | | | | | | — | | | | | | | 1,008 | | | | | | | (10) | | | | | | | 998 | | |
| | – stage 3 | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 121 | | | | | | | 121 | | | | | | | (9) | | | | | | | 112 | | |
| | – POCI | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 1 | | | | | | | 1 | | | | | | | — | | | | | | | 1 | | |
| | At 31 Dec 2020 | | | | | | 342,632 | | | | | | | 61,951 | | | | | | | 49,340 | | | | | | | 8,033 | | | | | | | 3,434 | | | | | | | 465,390 | | | | | | | (1,632) | | | | | | | 463,758 | | |
| | Debt instruments at FVOCI1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – stage 1 | | | | | | 45,958 | | | | | | | 2,424 | | | | | | | 233 | | | | | | | — | | | | | | | — | | | | | | | 48,615 | | | | | | | (12) | | | | | | | 48,603 | | |
| | – stage 2 | | | | | | 71 | | | | | | | 63 | | | | | | | 172 | | | | | | | 153 | | | | | | | — | | | | | | | 459 | | | | | | | (10) | | | | | | | 449 | | |
| | – stage 3 | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | – POCI | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | — | | |
| | At 31 Dec 2020 | | | | | | 46,029 | | | | | | | 2,487 | | | | | | | 405 | | | | | | | 153 | | | | | | | — | | | | | | | 49,074 | | | | | | | (22) | | | | | | | 49,052 | | |
| | | | | |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | |
Of which:
|
| ||||||||||||||||||||||||||||||||||||||
| | | | | |
Total
|
| | |
UK
|
| | |
France
|
| | |
Germany
|
| ||||||||||||||||||||||||||||||||||||||||
| | | | | |
Gross
carrying/nominal amount £m |
| | |
ECL coverage
% |
| | |
Gross
carrying/nominal amount £m |
| | |
ECL coverage
% |
| | |
Gross
carrying/nominal amount £m |
| | |
ECL coverage
% |
| | |
Gross
carrying/nominal amount £m |
| | |
ECL coverage
% |
| ||||||||||||||||||||||||
| | Stage 1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Not collateralised | | | | |
|
109,435
|
| | | | |
|
0.1
|
| | | | |
|
40,298
|
| | | | |
|
0.1
|
| | | | |
|
52,583
|
| | | | |
|
—
|
| | | | |
|
11,479
|
| | | | |
|
—
|
| |
| | Fully collateralised | | | | |
|
10,399
|
| | | | |
|
0.1
|
| | | | |
|
6,133
|
| | | | |
|
0.1
|
| | | | |
|
2,221
|
| | | | |
|
0.1
|
| | | | |
|
708
|
| | | | |
|
—
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | |
|
2,450
|
| | | | |
|
0.2
|
| | | | |
|
1,649
|
| | | | |
|
0.1
|
| | | | |
|
587
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 51% to 75% | | | | |
|
3,543
|
| | | | |
|
0.1
|
| | | | |
|
2,124
|
| | | | |
|
—
|
| | | | |
|
989
|
| | | | |
|
0.1
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 76% to 90% | | | | |
|
801
|
| | | | |
|
0.1
|
| | | | |
|
446
|
| | | | |
|
—
|
| | | | |
|
349
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | |
|
3,605
|
| | | | |
|
—
|
| | | | |
|
1,914
|
| | | | |
|
—
|
| | | | |
|
296
|
| | | | |
|
—
|
| | | | |
|
708
|
| | | | |
|
—
|
| |
| | Partially collateralised (A): | | | | |
|
3,424
|
| | | | |
|
0.1
|
| | | | |
|
85
|
| | | | |
|
—
|
| | | | |
|
3,248
|
| | | | |
|
0.1
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| |
– collateral value on A
|
| | | |
|
2,661
|
| | | | | | | | | | | |
|
51
|
| | | | | | | | | | | |
|
2,555
|
| | | | | | | | | | | |
|
—
|
| | | | | | | | |
| |
Total stage 1
|
| | | |
|
123,258
|
| | | | |
|
0.1
|
| | | | |
|
46,516
|
| | | | |
|
0.1
|
| | | | |
|
58,052
|
| | | | |
|
—
|
| | | | |
|
12,187
|
| | | | |
|
—
|
| |
| | Stage 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Not collateralised | | | | |
|
11,024
|
| | | | |
|
0.9
|
| | | | |
|
4,365
|
| | | | |
|
0.9
|
| | | | |
|
1,890
|
| | | | |
|
1.5
|
| | | | |
|
3,942
|
| | | | |
|
0.6
|
| |
| | Fully collateralised | | | | |
|
1,675
|
| | | | |
|
1.1
|
| | | | |
|
608
|
| | | | |
|
0.8
|
| | | | |
|
639
|
| | | | |
|
1.1
|
| | | | |
|
243
|
| | | | |
|
0.4
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | |
|
689
|
| | | | |
|
1.7
|
| | | | |
|
217
|
| | | | |
|
1.4
|
| | | | |
|
350
|
| | | | |
|
1.1
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 51% to 75% | | | | |
|
253
|
| | | | |
|
0.8
|
| | | | |
|
217
|
| | | | |
|
0.9
|
| | | | |
|
34
|
| | | | |
|
2.9
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 76% to 90% | | | | |
|
271
|
| | | | |
|
0.4
|
| | | | |
|
165
|
| | | | |
|
—
|
| | | | |
|
106
|
| | | | |
|
0.9
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | |
|
462
|
| | | | |
|
0.9
|
| | | | |
|
9
|
| | | | |
|
—
|
| | | | |
|
149
|
| | | | |
|
1.3
|
| | | | |
|
243
|
| | | | |
|
0.4
|
| |
| | Partially collateralised (B): | | | | |
|
1,573
|
| | | | |
|
0.9
|
| | | | |
|
4
|
| | | | |
|
—
|
| | | | |
|
1,567
|
| | | | |
|
0.9
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| |
– collateral value on B
|
| | | |
|
1,408
|
| | | | | | | | | | | |
|
3
|
| | | | | | | | | | | |
|
1,404
|
| | | | | | | | | | | |
|
—
|
| | | | | | | | |
| |
Total stage 2
|
| | | |
|
14,272
|
| | | | |
|
0.9
|
| | | | |
|
4,977
|
| | | | |
|
0.9
|
| | | | |
|
4,096
|
| | | | |
|
1.2
|
| | | | |
|
4,185
|
| | | | |
|
0.5
|
| |
| | Stage 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Not collateralised | | | | |
|
1,598
|
| | | | |
|
37.2
|
| | | | |
|
669
|
| | | | |
|
25.1
|
| | | | |
|
378
|
| | | | |
|
86.0
|
| | | | |
|
393
|
| | | | |
|
17.8
|
| |
| | Fully collateralised | | | | |
|
148
|
| | | | |
|
16.2
|
| | | | |
|
77
|
| | | | |
|
7.8
|
| | | | |
|
10
|
| | | | |
|
50.0
|
| | | | |
|
24
|
| | | | |
|
16.7
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | |
|
76
|
| | | | |
|
18.4
|
| | | | |
|
41
|
| | | | |
|
7.3
|
| | | | |
|
6
|
| | | | |
|
50.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 51% to 75% | | | | |
|
22
|
| | | | |
|
13.6
|
| | | | |
|
19
|
| | | | |
|
10.5
|
| | | | |
|
2
|
| | | | |
|
50.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 76% to 90% | | | | |
|
18
|
| | | | |
|
5.6
|
| | | | |
|
17
|
| | | | |
|
—
|
| | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | |
|
32
|
| | | | |
|
15.6
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
1
|
| | | | |
|
100.0
|
| | | | |
|
24
|
| | | | |
|
16.7
|
| |
| | Partially collateralised (C): | | | | |
|
216
|
| | | | |
|
27.3
|
| | | | |
|
35
|
| | | | |
|
17.1
|
| | | | |
|
165
|
| | | | |
|
27.3
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| |
– collateral value on C
|
| | | |
|
152
|
| | | | | | | | | | | |
|
22
|
| | | | | | | | | | | |
|
123
|
| | | | | | | | | | | |
|
—
|
| | | | | | | | |
| |
Total stage 3
|
| | | |
|
1,962
|
| | | | |
|
34.6
|
| | | | |
|
781
|
| | | | |
|
23.0
|
| | | | |
|
553
|
| | | | |
|
67.8
|
| | | | |
|
417
|
| | | | |
|
17.7
|
| |
| | POCI | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Not collateralised | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Fully collateralised | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 51% to 75% | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 76% to 90% | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Partially collateralised (D): | | | | |
|
2
|
| | | | |
|
100.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
100.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| |
– collateral value on D
|
| | | |
|
2
|
| | | | | | | | | | | |
|
—
|
| | | | | | | | | | | |
|
2
|
| | | | | | | | | | | |
|
—
|
| | | | | | | | |
| |
Total POCI
|
| | | |
|
2
|
| | | | |
|
100.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
100.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| |
At 31 Dec 2021
|
| | | |
|
139,494
|
| | | | |
|
0.6
|
| | | | |
|
52,274
|
| | | | |
|
0.5
|
| | | | |
|
62,703
|
| | | | |
|
0.7
|
| | | | |
|
16,789
|
| | | | |
|
0.6
|
| |
| | | | | |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | |
Of which:
|
| ||||||||||||||||||||||||||||||||||||||
| | | | | |
Total
|
| | |
UK
|
| | |
France
|
| | |
Germany
|
| ||||||||||||||||||||||||||||||||||||||||
| | | | | |
Gross
carrying/nominal amount £m |
| | |
ECL coverage
% |
| | |
Gross
carrying/nominal amount £m |
| | |
ECL coverage
% |
| | |
Gross
carrying/nominal amount £m |
| | |
ECL coverage
% |
| | |
Gross
carrying/nominal amount £m |
| | |
ECL coverage
% |
| ||||||||||||||||||||||||
| | Stage 1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Not collateralised | | | | | | 117,820 | | | | | | | 0.1 | | | | | |
|
49,970
|
| | | | |
|
0.1
|
| | | | |
|
47,647
|
| | | | |
|
—
|
| | | | |
|
13,685
|
| | | | |
|
—
|
| |
| | Fully collateralised | | | | | | 12,232 | | | | | | | 0.1 | | | | | |
|
8,241
|
| | | | |
|
0.2
|
| | | | |
|
2,163
|
| | | | |
|
—
|
| | | | |
|
638
|
| | | | |
|
—
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | | | 1,886 | | | | | | | 0.3 | | | | | |
|
1,019
|
| | | | |
|
0.3
|
| | | | |
|
543
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 51% to 75% | | | | | | 4,403 | | | | | | | 0.2 | | | | | |
|
3,489
|
| | | | |
|
0.2
|
| | | | |
|
901
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 76% to 90% | | | | | | 751 | | | | | | | 0.1 | | | | | |
|
267
|
| | | | |
|
0.4
|
| | | | |
|
360
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | | | 5,192 | | | | | | | — | | | | | |
|
3,466
|
| | | | |
|
—
|
| | | | |
|
359
|
| | | | |
|
—
|
| | | | |
|
638
|
| | | | |
|
—
|
| |
| |
Partially collateralised (A):
|
| | | | | 3,476 | | | | | | | 0.1 | | | | | |
|
59
|
| | | | |
|
—
|
| | | | |
|
3,167
|
| | | | |
|
0.1
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – collateral value on A | | | | | | 2,855 | | | | | | | | | | | | | | 32 | | | | | | | | | | | | | | 2,621 | | | | | | | | | | | | | | — | | | | | | | | | |
| | Total stage 1 | | | | | | 133,528 | | | | | | | 0.1 | | | | | |
|
58,270
|
| | | | |
|
0.1
|
| | | | |
|
52,977
|
| | | | |
|
—
|
| | | | |
|
14,323
|
| | | | |
|
—
|
| |
| | Stage 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Not collateralised | | | | | | 23,132 | | | | | | | 1.0 | | | | | |
|
12,398
|
| | | | |
|
1.2
|
| | | | |
|
2,447
|
| | | | |
|
1.1
|
| | | | |
|
6,220
|
| | | | |
|
0.4
|
| |
| | Fully collateralised | | | | | | 1,838 | | | | | | | 1.2 | | | | | |
|
630
|
| | | | |
|
1.0
|
| | | | |
|
649
|
| | | | |
|
1.1
|
| | | | |
|
290
|
| | | | |
|
0.3
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | | | 824 | | | | | | | 1.5 | | | | | |
|
326
|
| | | | |
|
1.2
|
| | | | |
|
348
|
| | | | |
|
0.6
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 51% to 75% | | | | | | 334 | | | | | | | 1.2 | | | | | |
|
269
|
| | | | |
|
0.4
|
| | | | |
|
45
|
| | | | |
|
2.2
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 76% to 90% | | | | | | 47 | | | | | | | 2.1 | | | | | |
|
26
|
| | | | |
|
3.8
|
| | | | |
|
17
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | | | 633 | | | | | | | 0.8 | | | | | |
|
9
|
| | | | |
|
—
|
| | | | |
|
239
|
| | | | |
|
1.3
|
| | | | |
|
290
|
| | | | |
|
0.3
|
| |
| | Partially collateralised (B): | | | | | | 2,629 | | | | | | | 0.7 | | | | | |
|
87
|
| | | | |
|
2.3
|
| | | | |
|
2,528
|
| | | | |
|
0.6
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – collateral value on B | | | | | | 2,223 | | | | | | | | | | | | | | 14 | | | | | | | | | | | | | | 2,200 | | | | | | | | | | | | | | — | | | | | | | | | |
| | Total stage 2 | | | | | | 27,599 | | | | | | | 1.0 | | | | | |
|
13,115
|
| | | | |
|
1.2
|
| | | | |
|
5,624
|
| | | | |
|
0.9
|
| | | | |
|
6,510
|
| | | | |
|
0.4
|
| |
| | Stage 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Not collateralised | | | | | | 1,803 | | | | | | | 36.3 | | | | | |
|
740
|
| | | | |
|
29.7
|
| | | | |
|
529
|
| | | | |
|
63.9
|
| | | | |
|
441
|
| | | | |
|
15.2
|
| |
| | Fully collateralised | | | | | | 210 | | | | | | | 9.5 | | | | | |
|
152
|
| | | | |
|
1.3
|
| | | | |
|
12
|
| | | | |
|
66.7
|
| | | | |
|
21
|
| | | | |
|
14.3
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | | | 25 | | | | | | | 28.0 | | | | | |
|
2
|
| | | | |
|
—
|
| | | | |
|
7
|
| | | | |
|
57.1
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 51% to 75% | | | | | | 27 | | | | | | | 29.6 | | | | | |
|
17
|
| | | | |
|
5.9
|
| | | | |
|
3
|
| | | | |
|
66.7
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 76% to 90% | | | | | | 120 | | | | | | | 0.8 | | | | | |
|
118
|
| | | | |
|
0.8
|
| | | | |
|
1
|
| | | | |
|
100.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | | | 38 | | | | | | | 10.5 | | | | | |
|
15
|
| | | | |
|
—
|
| | | | |
|
1
|
| | | | |
|
100.0
|
| | | | |
|
21
|
| | | | |
|
14.3
|
| |
| |
Partially collateralised (C):
|
| | | | | 275 | | | | | | | 24.0 | | | | | |
|
71
|
| | | | |
|
11.3
|
| | | | |
|
191
|
| | | | |
|
26.2
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – collateral value on C | | | | | | 182 | | | | | | | | | | | | | | 40 | | | | | | | | | | | | | | 136 | | | | | | | | | | | | | | — | | | | | | | | | |
| | Total stage 3 | | | | | | 2,288 | | | | | | | 32.4 | | | | | |
|
963
|
| | | | |
|
23.9
|
| | | | |
|
732
|
| | | | |
|
54.1
|
| | | | |
|
462
|
| | | | |
|
15.2
|
| |
| | POCI | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Not collateralised | | | | | | 37 | | | | | | | 27.0 | | | | | |
|
2
|
| | | | |
|
100.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | Fully collateralised | | | | | | — | | | | | | | — | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | | | — | | | | | | | — | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 51% to 75% | | | | | | — | | | | | | | — | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 76% to 90% | | | | | | — | | | | | | | — | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | | | — | | | | | | | — | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| |
Partially collateralised (D):
|
| | | | | 3 | | | | | | | 100.0 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
3
|
| | | | |
|
100.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – collateral value on D | | | | | | 3 | | | | | | | | | | | | | | — | | | | | | | | | | | | | | 3 | | | | | | | | | | | | | | — | | | | | | | | | |
| | Total POCI | | | | | | 40 | | | | | | | 32.5 | | | | | |
|
2
|
| | | | |
|
100.0
|
| | | | |
|
3
|
| | | | |
|
100.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | At 31 Dec 2020 | | | | | | 163,455 | | | | | | | 0.7 | | | | | |
|
72,350
|
| | | | |
|
0.7
|
| | | | |
|
59,336
|
| | | | |
|
0.8
|
| | | | |
|
21,295
|
| | | | |
|
0.5
|
| |
| | | | | |
|
| ||||||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | |
Of which:
|
| ||||||||||||||||||||||||
| | | | | |
Total
|
| | |
UK
|
| | |
France
|
| ||||||||||||||||||||||||||||||
| | | | | |
Gross
exposure £m |
| | |
ECL coverage
% |
| | |
Gross
exposure £m |
| | |
ECL coverage
% |
| | |
Gross
exposure £m |
| | |
ECL coverage
% |
| ||||||||||||||||||
| | Stage 1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fully collateralised | | | | |
|
6,915
|
| | | | |
|
0.2
|
| | | | |
|
2,789
|
| | | | |
|
—
|
| | | | |
|
2,088
|
| | | | |
|
—
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | |
|
3,400
|
| | | | |
|
0.1
|
| | | | |
|
1,308
|
| | | | |
|
—
|
| | | | |
|
1,110
|
| | | | |
|
0.1
|
| |
| | – 51% to 60% | | | | |
|
1,274
|
| | | | |
|
0.2
|
| | | | |
|
540
|
| | | | |
|
—
|
| | | | |
|
431
|
| | | | |
|
—
|
| |
| | – 61% to 70% | | | | |
|
1,074
|
| | | | |
|
0.2
|
| | | | |
|
452
|
| | | | |
|
—
|
| | | | |
|
296
|
| | | | |
|
—
|
| |
| | – 71% to 80% | | | | |
|
776
|
| | | | |
|
0.3
|
| | | | |
|
358
|
| | | | |
|
—
|
| | | | |
|
177
|
| | | | |
|
—
|
| |
| | – 81% to 90% | | | | |
|
345
|
| | | | |
|
0.3
|
| | | | |
|
113
|
| | | | |
|
—
|
| | | | |
|
48
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | |
|
46
|
| | | | |
|
—
|
| | | | |
|
18
|
| | | | |
|
—
|
| | | | |
|
26
|
| | | | |
|
—
|
| |
| | Partially collateralised (A): | | | | |
|
90
|
| | | | |
|
—
|
| | | | |
|
11
|
| | | | |
|
—
|
| | | | |
|
50
|
| | | | |
|
—
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – 101% to 110% | | | | |
|
18
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
—
|
| | | | |
|
12
|
| | | | |
|
—
|
| |
| | – 111% to 120% | | | | |
|
9
|
| | | | |
|
—
|
| | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
5
|
| | | | |
|
—
|
| |
| | – greater than 120% | | | | |
|
63
|
| | | | |
|
—
|
| | | | |
|
8
|
| | | | |
|
—
|
| | | | |
|
33
|
| | | | |
|
—
|
| |
| |
– collateral value on A
|
| | | |
|
63
|
| | | | | | | | | | | |
|
4
|
| | | | | | | | | | | |
|
50
|
| | | | | | | | |
| |
Total
|
| | | |
|
7,005
|
| | | | |
|
0.2
|
| | | | |
|
2,800
|
| | | | |
|
—
|
| | | | |
|
2,138
|
| | | | |
|
—
|
| |
| | Stage 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fully collateralised | | | | |
|
169
|
| | | | |
|
3.0
|
| | | | |
|
46
|
| | | | |
|
—
|
| | | | |
|
83
|
| | | | |
|
1.2
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | |
|
91
|
| | | | |
|
2.2
|
| | | | |
|
18
|
| | | | |
|
—
|
| | | | |
|
48
|
| | | | |
|
2.1
|
| |
| | – 51% to 60% | | | | |
|
25
|
| | | | |
|
4.0
|
| | | | |
|
6
|
| | | | |
|
—
|
| | | | |
|
13
|
| | | | |
|
—
|
| |
| | – 61% to 70% | | | | |
|
34
|
| | | | |
|
2.9
|
| | | | |
|
17
|
| | | | |
|
—
|
| | | | |
|
12
|
| | | | |
|
—
|
| |
| | – 71% to 80% | | | | |
|
15
|
| | | | |
|
6.7
|
| | | | |
|
5
|
| | | | |
|
—
|
| | | | |
|
7
|
| | | | |
|
—
|
| |
| | – 81% to 90% | | | | |
|
3
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
1
|
| | | | |
|
—
|
| |
| | Partially collateralised (B): | | | | |
|
5
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | | | — | | | | | |
|
2
|
| | | | |
|
—
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – 101% to 110% | | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – 111% to 120% | | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – greater than 120% | | | | |
|
3
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
—
|
| |
| |
– collateral value on B
|
| | | |
|
4
|
| | | | | | | | | | | |
|
—
|
| | | | | | | | | | | |
|
3
|
| | | | | | | | |
| |
Total
|
| | | |
|
174
|
| | | | |
|
2.9
|
| | | | |
|
46
|
| | | | |
|
—
|
| | | | |
|
85
|
| | | | |
|
1.2
|
| |
| | Stage 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fully collateralised | | | | |
|
204
|
| | | | |
|
24.5
|
| | | | |
|
9
|
| | | | |
|
11.1
|
| | | | |
|
62
|
| | | | |
|
21.0
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | |
|
94
|
| | | | |
|
12.8
|
| | | | |
|
6
|
| | | | |
|
16.7
|
| | | | |
|
24
|
| | | | |
|
20.8
|
| |
| | – 51% to 60% | | | | |
|
31
|
| | | | |
|
19.4
|
| | | | |
|
3
|
| | | | |
|
—
|
| | | | |
|
8
|
| | | | |
|
25.0
|
| |
| | – 61% to 70% | | | | |
|
34
|
| | | | |
|
23.5
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
19
|
| | | | |
|
10.5
|
| |
| | – 71% to 80% | | | | |
|
13
|
| | | | |
|
38.5
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
3
|
| | | | |
|
33.3
|
| |
| | – 81% to 90% | | | | |
|
14
|
| | | | |
|
42.9
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
4
|
| | | | |
|
25.0
|
| |
| | – 91% to 100% | | | | |
|
18
|
| | | | |
|
72.2
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
4
|
| | | | |
|
50.0
|
| |
| | Partially collateralised (C): | | | | |
|
30
|
| | | | |
|
53.3
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
24
|
| | | | |
|
58.3
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – 101% to 110% | | | | |
|
2
|
| | | | |
|
50.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
50.0
|
| |
| | – 111% to 120% | | | | |
|
2
|
| | | | |
|
50.0
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
50.0
|
| |
| | – greater than 120% | | | | |
|
26
|
| | | | |
|
53.8
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
20
|
| | | | |
|
60.0
|
| |
| |
– collateral value on C
|
| | | |
|
6
|
| | | | | | | | | | | |
|
—
|
| | | | | | | | | | | |
|
6
|
| | | | | | | | |
| |
Total
|
| | | |
|
234
|
| | | | |
|
28.2
|
| | | | |
|
9
|
| | | | |
|
11.1
|
| | | | |
|
86
|
| | | | |
|
31.4
|
| |
| |
At 31 Dec 2021
|
| | | |
|
7,413
|
| | | | |
|
1.1
|
| | | | |
|
2,855
|
| | | | |
|
—
|
| | | | |
|
2,309
|
| | | | |
|
1.3
|
| |
| | | | | |
|
| ||||||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | |
Of which:
|
| ||||||||||||||||||||||||
| | | | | |
Total
|
| | |
UK
|
| | |
France
|
| ||||||||||||||||||||||||||||||
| | | | | |
Gross
exposure £m |
| | |
ECL coverage
% |
| | |
Gross
exposure £m |
| | |
ECL coverage
% |
| | |
Gross
exposure £m |
| | |
ECL coverage
% |
| ||||||||||||||||||
| | Stage 1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fully collateralised | | | | | | 7,308 | | | | | | | 0.1 | | | | | |
|
2,751
|
| | | | |
|
—
|
| | | | |
|
2,364
|
| | | | |
|
—
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | | | 3,110 | | | | | | | 0.1 | | | | | |
|
1,018
|
| | | | |
|
—
|
| | | | |
|
1,147
|
| | | | |
|
—
|
| |
| | – 51% to 60% | | | | | | 1,074 | | | | | | | 0.1 | | | | | |
|
293
|
| | | | |
|
—
|
| | | | |
|
513
|
| | | | |
|
—
|
| |
| | – 61% to 70% | | | | | | 991 | | | | | | | 0.1 | | | | | |
|
316
|
| | | | |
|
—
|
| | | | |
|
378
|
| | | | |
|
—
|
| |
| | – 71% to 80% | | | | | | 789 | | | | | | | 0.3 | | | | | |
|
214
|
| | | | |
|
—
|
| | | | |
|
225
|
| | | | |
|
—
|
| |
| | – 81% to 90% | | | | | | 505 | | | | | | | 0.4 | | | | | |
|
109
|
| | | | |
|
—
|
| | | | |
|
70
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | | | 839 | | | | | | | 0.1 | | | | | |
|
801
|
| | | | |
|
—
|
| | | | |
|
31
|
| | | | |
|
—
|
| |
| | Partially collateralised (A): | | | | | | 90 | | | | | | | — | | | | | |
|
9
|
| | | | |
|
—
|
| | | | |
|
63
|
| | | | |
|
—
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – 101% to 110% | | | | | | 21 | | | | | | | — | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
13
|
| | | | |
|
—
|
| |
| | – 111% to 120% | | | | | | 14 | | | | | | | — | | | | | |
|
2
|
| | | | |
|
—
|
| | | | |
|
10
|
| | | | |
|
—
|
| |
| | – greater than 120% | | | | | | 55 | | | | | | | — | | | | | |
|
7
|
| | | | |
|
—
|
| | | | |
|
40
|
| | | | |
|
—
|
| |
| | – collateral value on A | | | | | | 81 | | | | | | | | | | | | | | 5 | | | | | | | | | | | | | | 63 | | | | | | | | | |
| | Total | | | | | | 7,398 | | | | | | | 0.1 | | | | | |
|
2,760
|
| | | | |
|
—
|
| | | | |
|
2,427
|
| | | | |
|
—
|
| |
| | Stage 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fully collateralised | | | | | | 202 | | | | | | | 4.0 | | | | | |
|
34
|
| | | | |
|
2.9
|
| | | | |
|
116
|
| | | | |
|
0.9
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | | | 114 | | | | | | | 1.8 | | | | | |
|
17
|
| | | | |
|
—
|
| | | | |
|
64
|
| | | | |
|
1.6
|
| |
| | – 51% to 60% | | | | | | 31 | | | | | | | 3.2 | | | | | |
|
4
|
| | | | |
|
—
|
| | | | |
|
21
|
| | | | |
|
—
|
| |
| | – 61% to 70% | | | | | | 22 | | | | | | | 4.5 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
17
|
| | | | |
|
—
|
| |
| | – 71% to 80% | | | | | | 15 | | | | | | | 13.3 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
10
|
| | | | |
|
—
|
| |
| | – 81% to 90% | | | | | | 6 | | | | | | | 16.7 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
3
|
| | | | |
|
—
|
| |
| | – 91% to 100% | | | | | | 14 | | | | | | | 7.1 | | | | | |
|
13
|
| | | | |
|
7.7
|
| | | | |
|
1
|
| | | | |
|
—
|
| |
| | Partially collateralised (B): | | | | | | 10 | | | | | | | 20.0 | | | | | |
|
—
|
| | | | | | — | | | | | |
|
5
|
| | | | |
|
—
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – 101% to 110% | | | | | | 4 | | | | | | | 25.0 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
—
|
| |
| | – 111% to 120% | | | | | | 2 | | | | | | | 50.0 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| |
| | – greater than 120% | | | | | | 4 | | | | | | | — | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
3
|
| | | | |
|
—
|
| |
| | – collateral value on B | | | | | | 10 | | | | | | | | | | | | | | — | | | | | | | | | | | | | | 5 | | | | | | | | | |
| | Total | | | | | | 212 | | | | | | | 4.7 | | | | | |
|
34
|
| | | | |
|
2.9
|
| | | | |
|
121
|
| | | | |
|
0.8
|
| |
| | Stage 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fully collateralised | | | | | | 200 | | | | | | | 22.0 | | | | | |
|
12
|
| | | | |
|
8.3
|
| | | | |
|
69
|
| | | | |
|
23.2
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – less than 50% | | | | | | 95 | | | | | | | 13.7 | | | | | |
|
8
|
| | | | |
|
12.5
|
| | | | |
|
30
|
| | | | |
|
23.3
|
| |
| | – 51% to 60% | | | | | | 34 | | | | | | | 23.5 | | | | | |
|
3
|
| | | | |
|
—
|
| | | | |
|
10
|
| | | | |
|
30.0
|
| |
| | – 61% to 70% | | | | | | 34 | | | | | | | 26.5 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
16
|
| | | | |
|
12.5
|
| |
| | – 71% to 80% | | | | | | 23 | | | | | | | 34.8 | | | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
7
|
| | | | |
|
28.6
|
| |
| | – 81% to 90% | | | | | | 9 | | | | | | | 44.4 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2
|
| | | | |
|
50.0
|
| |
| | – 91% to 100% | | | | | | 5 | | | | | | | 40.0 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
4
|
| | | | |
|
25.0
|
| |
| | Partially collateralised (C): | | | | | | 65 | | | | | | | 50.8 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
36
|
| | | | |
|
38.9
|
| |
| | LTV ratio: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | – 101% to 110% | | | | | | 10 | | | | | | | 60.0 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
3
|
| | | | |
|
33.3
|
| |
| | – 111% to 120% | | | | | | 8 | | | | | | | 62.5 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
1
|
| | | | |
|
—
|
| |
| | – greater than 120% | | | | | | 47 | | | | | | | 46.8 | | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
32
|
| | | | |
|
40.6
|
| |
| | – collateral value on C | | | | | | 35 | | | | | | | | | | | | | | — | | | | | | | | | | | | | | 17 | | | | | | | | | |
| | Total | | | | | | 265 | | | | | | | 29.1 | | | | | |
|
12
|
| | | | |
|
8.3
|
| | | | |
|
105
|
| | | | |
|
28.6
|
| |
| | At 31 Dec 2020 | | | | | | 7,875 | | | | | | | 1.2 | | | | | |
|
2,806
|
| | | | |
|
0.1
|
| | | | |
|
2,653
|
| | | | |
|
1.2
|
| |
| | | | | |
With DPF
£m |
| | |
Unit- linked
£m |
| | |
Other
contracts1 £m |
| | |
Shareholder
assets and liabilities £m |
| | |
Total
£m |
| |||||||||||||||
| | Financial assets | | | | |
|
19,384
|
| | | | |
|
2,924
|
| | | | |
|
254
|
| | | | |
|
2,704
|
| | | | |
|
25,266
|
| |
| | – financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | |
|
9,876
|
| | | | |
|
2,859
|
| | | | |
|
89
|
| | | | |
|
1,236
|
| | | | |
|
14,060
|
| |
| | – derivatives | | | | |
|
47
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
1
|
| | | | |
|
48
|
| |
| | – financial investments – at amortised cost | | | | |
|
815
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
42
|
| | | | |
|
857
|
| |
| | – financial investments – at fair value through other comprehensive income | | | | |
|
7,490
|
| | | | |
|
—
|
| | | | |
|
104
|
| | | | |
|
1,327
|
| | | | |
|
8,921
|
| |
| | – other financial assets2 | | | | |
|
1,156
|
| | | | |
|
65
|
| | | | |
|
61
|
| | | | |
|
98
|
| | | | |
|
1,380
|
| |
| | Reinsurance assets | | | | |
|
—
|
| | | | |
|
53
|
| | | | |
|
104
|
| | | | |
|
—
|
| | | | |
|
157
|
| |
| | PVIF3 | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
811
|
| | | | |
|
811
|
| |
| | Other assets and investment properties | | | | |
|
748
|
| | | | |
|
1
|
| | | | |
|
—
|
| | | | |
|
59
|
| | | | |
|
808
|
| |
| | Total assets at 31 Dec 2021 | | | | | | 20,132 | | | | | | | 2,978 | | | | | | | 358 | | | | | | | 3,574 | | | | | | | 27,042 | | |
| | Liabilities under investment contracts designated at fair value | | | | |
|
—
|
| | | | |
|
1,031
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
1,031
|
| |
| | Liabilities under insurance contracts | | | | |
|
19,998
|
| | | | |
|
1,938
|
| | | | |
|
328
|
| | | | |
|
—
|
| | | | |
|
22,264
|
| |
| | Deferred tax4 | | | | |
|
133
|
| | | | |
|
6
|
| | | | |
|
—
|
| | | | |
|
46
|
| | | | |
|
185
|
| |
| | Other liabilities | | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
—
|
| | | | |
|
2,003
|
| | | | |
|
2,003
|
| |
| | Total liabilities at 31 Dec 2021 | | | | | | 20,131 | | | | | | | 2,975 | | | | | | | 328 | | | | | | | 2,049 | | | | | | | 25,483 | | |
| | Total equity at 31 Dec 2021 | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 1,559 | | | | | | | 1,559 | | |
| | Total liabilities and equity at 31 Dec 2021 | | | | | | 20,131 | | | | | | | 2,975 | | | | | | | 328 | | | | | | | 3,608 | | | | | | | 27,042 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Financial assets | | | | | | 20,261 | | | | | | | 2,412 | | | | | | | 249 | | | | | | | 2,490 | | | | | | | 25,412 | | |
| | – financial assets designated and otherwise mandatorily measured at fair value through profit or loss | | | | | | 9,148 | | | | | | | 2,352 | | | | | | | 92 | | | | | | | 991 | | | | | | | 12,583 | | |
| | – derivatives | | | | | | 76 | | | | | | | — | | | | | | | — | | | | | | | 2 | | | | | | | 78 | | |
| | – financial investments – at amortised cost | | | | | | 372 | | | | | | | 1 | | | | | | | — | | | | | | | 17 | | | | | | | 390 | | |
| | – financial investments – at fair value through other comprehensive income | | | | | | 8,724 | | | | | | | — | | | | | | | 112 | | | | | | | 1,341 | | | | | | | 10,177 | | |
| | – other financial assets2 | | | | | | 1,941 | | | | | | | 59 | | | | | | | 45 | | | | | | | 139 | | | | | | | 2,184 | | |
| | Reinsurance assets | | | | | | — | | | | | | | 47 | | | | | | | 134 | | | | | | | — | | | | | | | 181 | | |
| | PVIF3 | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 647 | | | | | | | 647 | | |
| | Other assets and investment properties | | | | | | 809 | | | | | | | 1 | | | | | | | — | | | | | | | 60 | | | | | | | 870 | | |
| | Total assets at 31 Dec 2020 | | | | | | 21,070 | | | | | | | 2,460 | | | | | | | 383 | | | | | | | 3,197 | | | | | | | 27,110 | | |
| | Liabilities under investment contracts designated at fair value | | | | | | — | | | | | | | 944 | | | | | | | — | | | | | | | — | | | | | | | 944 | | |
| | Liabilities under insurance contracts | | | | | | 20,962 | | | | | | | 1,512 | | | | | | | 342 | | | | | | | — | | | | | | | 22,816 | | |
| | Deferred tax4 | | | | | | 107 | | | | | | | 3 | | | | | | | — | | | | | | | 39 | | | | | | | 149 | | |
| | Other liabilities | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 1,776 | | | | | | | 1,776 | | |
| | Total liabilities at 31 Dec 2020 | | | | | | 21,069 | | | | | | | 2,459 | | | | | | | 342 | | | | | | | 1,815 | | | | | | | 25,685 | | |
| | Total equity at 31 Dec 2020 | | | | | | — | | | | | | | — | | | | | | | — | | | | | | | 1,425 | | | | | | | 1,425 | | |
| | Total liabilities and equity at 31 Dec 2020 | | | | | | 21,069 | | | | | | | 2,459 | | | | | | | 342 | | | | | | | 3,240 | | | | | | | 27,110 | | |
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||||||||||||||
| | | | |
Investment
returns implied by guarantee % |
| |
Long-term
investment returns on relevant portfolios % |
| |
Cost of
guarantees £m |
| |
Investment
returns implied by guarantee % |
| |
Long-term
investment returns on relevant portfolios % |
| |
Cost of
guarantees £m |
| ||||||||||||||||||
| | Capital | | | |
|
—
|
| | | |
|
0.8-2.0
|
| | | |
|
127
|
| | | | | — | | | | | | 0.7 – 2.0 | | | | | | 162 | | |
| | Nominal annual return | | | |
|
2.6
|
| | | |
|
2.2
|
| | | |
|
92
|
| | | | | 2.6 | | | | | | 2.0 | | | | | | 96 | | |
| | Nominal annual return | | | |
|
4.5
|
| | | |
|
2.2
|
| | | |
|
80
|
| | | | | 4.5 | | | | | | 2.0 | | | | | | 89 | | |
| |
At 31 Dec
|
| | | | | | | | | | | | | | |
|
299
|
| | | | | | | | | | | | | | | | | 347 | | |
| | | | |
2021
|
| |
2020
|
| ||||||||||||||||||
| | | | |
Effect on
profit after tax £m |
| |
Effect on
total equity £m |
| |
Effect on profit
after tax £m |
| |
Effect on
total equity £m |
| ||||||||||||
| | +100 basis point parallel shift in yield curves | | | |
|
119
|
| | | |
|
96
|
| | | | | 110 | | | | | | 89 | | |
| | -100 basis point parallel shift in yield curves | | | |
|
(229)
|
| | | |
|
(203)
|
| | | | | (203) | | | | | | (179) | | |
| | 10% increase in equity prices | | | |
|
46
|
| | | |
|
46
|
| | | | | 39 | | | | | | 39 | | |
| | 10% decrease in equity prices | | | |
|
(49)
|
| | | |
|
(49)
|
| | | | | (42) | | | | | | (42) | | |
| | | | |
Expected cash flows (undiscounted)
|
| |||||||||||||||||||||||||||
| | | | |
Within 1 year
£m |
| |
1-5 years
£m |
| |
5-15 years
£m |
| |
Over 15 years
£m |
| |
Total
£m |
| |||||||||||||||
| | Unit-linked | | | |
|
230
|
| | | |
|
565
|
| | | |
|
927
|
| | | |
|
926
|
| | | |
|
2,648
|
| |
| | With DPF and Other contracts | | | |
|
1,341
|
| | | |
|
5,102
|
| | | |
|
7,318
|
| | | |
|
6,415
|
| | | |
|
20,176
|
| |
| | At 31 Dec 2021 | | | | | 1,571 | | | | | | 5,667 | | | | | | 8,245 | | | | | | 7,341 | | | | | | 22,824 | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Unit-linked | | | | | 222 | | | | | | 539 | | | | | | 790 | | | | | | 672 | | | | | | 2,223 | | |
| | With DPF and Other contracts | | | | | 1,565 | | | | | | 5,765 | | | | | | 7,735 | | | | | | 6,077 | | | | | | 21,142 | | |
| | At 31 Dec 2020 | | | | | 1,787 | | | | | | 6,304 | | | | | | 8,525 | | | | | | 6,749 | | | | | | 23,365 | | |
| | | | |
2021
£m |
| |
2020
£m |
| ||||||
| | Effect on profit after tax and total equity at 31 Dec | | | | | | | | | | | | | |
| | 10% increase in mortality and/or morbidity rates | | | |
|
(20)
|
| | | | | (15) | | |
| | 10% decrease in mortality and/or morbidity rates | | | |
|
19
|
| | | | | 15 | | |
| | 10% increase in lapse rates | | | |
|
(19)
|
| | | | | (19) | | |
| | 10% decrease in lapse rates | | | |
|
20
|
| | | | | 21 | | |
| | 10% increase in expense rates | | | |
|
(40)
|
| | | | | (46) | | |
| | 10% decrease in expense rates | | | |
|
40
|
| | | | | 43 | | |
| | | | |
Foreign
exchange (‘FX’) and commodity £m |
| |
Interest
rate (‘IR’) £m |
| |
Equity (‘EQ’)
£m |
| |
Credit
Spread (‘CS’) £m |
| |
Portfolio
Diversification1 £m |
| |
Total2
£m |
| ||||||||||||||||||
| | Balance at 31 Dec 2021 | | | |
|
4.5
|
| | | |
|
10.0
|
| | | |
|
10.5
|
| | | |
|
14.9
|
| | | |
|
(20.9)
|
| | | |
|
19.0
|
| |
| | Average | | | |
|
7.1
|
| | | |
|
12.8
|
| | | |
|
10.2
|
| | | |
|
12.6
|
| | | |
|
(20.4)
|
| | | |
|
22.3
|
| |
| | Maximum | | | |
|
19.3
|
| | | |
|
26.7
|
| | | |
|
14.9
|
| | | |
|
16.7
|
| | | |
|
—
|
| | | |
|
31.9
|
| |
| | Minimum | | | |
|
3.7
|
| | | |
|
9.3
|
| | | |
|
6.3
|
| | | |
|
9.2
|
| | | |
|
—
|
| | | |
|
17.3
|
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Balance at 31 Dec 2020 | | | | | 7.6 | | | | | | 11.0 | | | | | | 13.9 | | | | | | 14.1 | | | | | | (19.2) | | | | | | 27.5 | | |
| | Average | | | | | 6.5 | | | | | | 13.5 | | | | | | 18.7 | | | | | | 14.1 | | | | | | (20.8) | | | | | | 32.1 | | |
| | Maximum | | | | | 14.2 | | | | | | 21.2 | | | | | | 33.2 | | | | | | 29.2 | | | | | | — | | | | | | 47.7 | | |
| | Minimum | | | | | 2.0 | | | | | | 9.2 | | | | | | 8.1 | | | | | | 9.6 | | | | | | — | | | | | | 20.9 | | |
| | | |
Interest
rate (‘IR’) £m |
| |
Credit
spread (‘CS’) £m |
| |
Portfolio
diversification1 £m |
| |
Total2
£m |
| ||||||||||||
| Balance at Balance at 31 Dec 2021 | | | | | 28.7 | | | | | | 9.0 | | | | | | (8.4) | | | | | | 29.4 | | |
| Average | | | |
|
26.6
|
| | | |
|
10.0
|
| | | |
|
(5.6)
|
| | | |
|
31.0
|
| |
| Maximum | | | |
|
34.6
|
| | | |
|
12.7
|
| | | |
|
—
|
| | | |
|
37.8
|
| |
| Minimum | | | |
|
18.0
|
| | | |
|
7.2
|
| | | |
|
—
|
| | | |
|
22.5
|
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| Balance at 31 Dec 2020 | | | | | 25.1 | | | | | | 11.6 | | | | | | (3.4) | | | | | | 33.3 | | |
| Average | | | | | 21.9 | | | | | | 12.3 | | | | | | (6.3) | | | | | | 27.9 | | |
| Maximum | | | | | 28.8 | | | | | | 16.6 | | | | | | — | | | | | | 35.0 | | |
| Minimum | | | | | 14.3 | | | | | | 5.5 | | | | | | — | | | | | | 15.0 | | |
| | | | |
At
|
| | | | | | | |||
| |
Ref*
|
| |
31 Dec
2021 £m |
| |
31 Dec
2020 £m |
| ||||||
| |
Common equity tier 1 (‘CET1’) capital: instruments and reserves
|
| | | | | | | | | | | | |
| |
1
Capital instruments and the related share premium accounts
|
| | |
|
797
|
| | | | | 797 | | |
| |
– ordinary shares
|
| | |
|
797
|
| | | | | 797 | | |
| | 2 Retained earnings1 | | | |
|
15,511
|
| | | | | 17,229 | | |
| | 3 Accumulated other comprehensive income (and other reserves) | | | |
|
1,975
|
| | | | | 2,888 | | |
| | 5 Minority interests (amount allowed in consolidated CET1) | | | |
|
57
|
| | | | | 66 | | |
| | 5a Independently reviewed interim net profits net of any foreseeable charge or dividend2 | | | |
|
625
|
| | | | | (1,755) | | |
| | 6 Common equity tier 1 capital before regulatory adjustments | | | |
|
18,965
|
| | | | | 19,225 | | |
| | 28 Total regulatory adjustments to common equity tier 11 | | | |
|
(958)
|
| | | | | (1,183) | | |
| | 29 Common equity tier 1 capital | | | |
|
18,007
|
| | | | | 18,042 | | |
| | 36 Additional tier 1 capital before regulatory adjustments | | | |
|
3,906
|
| | | | | 4,167 | | |
| | 43 Total regulatory adjustments to additional tier 1 capital | | | |
|
(44)
|
| | | | | (44) | | |
| | 44 Additional tier 1 capital | | | |
|
3,862
|
| | | | | 4,123 | | |
| | 45 Tier 1 capital | | | |
|
21,869
|
| | | | | 22,165 | | |
| | 51 Tier 2 capital before regulatory adjustments | | | |
|
11,591
|
| | | | | 11,724 | | |
| | 57 Total regulatory adjustments to tier 2 capital | | | |
|
(424)
|
| | | | | (451) | | |
| | 58 Tier 2 capital | | | |
|
11,167
|
| | | | | 11,273 | | |
| | 59 Total capital | | | |
|
33,036
|
| | | | | 33,438 | | |
| |
Subsidiaries
|
| |
% of share class held by
immediate parent company (or by HSBC Bank plc where this varies) |
| |
Footnotes
|
| ||||||||||||
| | Assetfinance December (H) Limited | | | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| | Assetfinance December (P) Limited | | | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | Assetfinance December (R) Limited | | | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| | Assetfinance June (A) Limited | | | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| | Assetfinance Limited | | | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| | Assetfinance March (B) Limited | | | | | 100.00 | | | | | | | | | | |
|
16
|
| |
| | Assetfinance March (F) Limited | | | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| |
Assetfinance September (F) Limited
|
| | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| |
Banco Nominees (Guernsey)
Limited |
| | | | 100.00 | | | | | | | | | | |
|
17
|
| |
| |
Banco Nominees 2 (Guernsey) Limited
|
| | | | 100.00 | | | | | | | | | | |
|
17
|
| |
| | Beau Soleil Limited Partnership | | | | | n/a | | | | | | | | | | |
|
0,18
|
| |
| |
BentallGreenOak China Real
Estate |
| | | | n/a | | | | | | | | | | |
|
0,19
|
| |
| | Billingsgate Nominees Limited (In Liquidation) | | | | | 100.00 | | | | | | | | | | |
|
2,20
|
| |
| | Canada Crescent Nominees (UK) Limited | | | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | CCF & Partners Asset Management Limited | | | | | 100.00 | | | | | | (99.99) | | | | |
|
15
|
| |
| | CCF Holding (LIBAN) S.A.L. (In Liquidation) | | | | | 74.99 | | | | | | | | | | |
|
21
|
| |
| |
Charterhouse Administrators
(D.T.) Limited |
| | | | 100.00 | | | | | | (99.99) | | | | |
|
15
|
| |
| |
Charterhouse Management Services Limited
|
| | | | 100.00 | | | | | | (99.99) | | | | |
|
15
|
| |
| |
Charterhouse Pensions Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | COIF Nominees Limited | | | | | n/a | | | | | | | | | | |
|
0,2,15
|
| |
| |
Corsair IV Financial Services
Capital Partners - B L.P |
| | | | n/a | | | | | | | | | | | | 0,22 | | |
| | Dem 9 | | | | | 100.00 | | | | | | (99.99) | | | | |
|
4,23
|
| |
| | Dempar 1 | | | | | 100.00 | | | | | | (99.99) | | | | |
|
4,23
|
| |
| | Eton Corporate Services Limited | | | | | 100.00 | | | | | | | | | | |
|
17
|
| |
| | Flandres Contentieux S.A. | | | | | 100.00 | | | | | | (99.99) | | | | |
|
23
|
| |
| | Foncière Elysées | | | | | 100.00 | | | | | | (99.99) | | | | |
|
23
|
| |
| |
Subsidiaries
|
| |
% of share class held by
immediate parent company (or by HSBC Bank plc where this varies) |
| |
Footnotes
|
| ||||||||||||
| |
Griffin International Limited
|
| | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| | Grundstuecksgesellschaft Trinkausstrasse Kommanditgesellschaft | | | | | n/a | | | | | | | | | | |
|
0,24
|
| |
| | HSBC (BGF) Investments Limited | | | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | HSBC Asset Finance (UK) Limited | | | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| |
HSBC Asset Finance M.O.G.
Holdings (UK) Limited |
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| |
HSBC Assurances Vie (France)
|
| | | | 100.00 | | | | | | (99.99) | | | | |
|
25
|
| |
| |
HSBC Bank (General Partner) Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,26
|
| |
| | HSBC Bank (RR) (Limited Liability Company) | | | | | n/a | | | | | | | | | | |
|
0,7,27
|
| |
| | HSBC Bank Armenia cjsc | | | | | 100.00 | | | | | | | | | | |
|
28
|
| |
| |
HSBC Bank Capital Funding
(Sterling 1) LP |
| | | | n/a | | | | | | | | | | |
|
0,26
|
| |
| |
HSBC Bank Capital Funding
(Sterling 2) LP |
| | | | n/a | | | | | | | | | | |
|
0,26
|
| |
| | HSBC Bank Malta p.l.c. | | | | | 70.03 | | | | | | | | | | |
|
29
|
| |
| |
HSBC City Funding Holdings
|
| | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| | HSBC Client Holdings Nominee (UK) Limited | | | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | HSBC Client Nominee (Jersey) Limited | | | | | 100.00 | | | | | | | | | | |
|
2,30
|
| |
| | HSBC Continental Europe | | | | | 99.99 | | | | | | | | | | |
|
23
|
| |
| | HSBC Corporate Trustee Company (UK) Limited | | | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | HSBC Custody Services (Guernsey) Limited | | | | | 100.00 | | | | | | | | | | |
|
17
|
| |
| | HSBC Epargne Entreprise (France) | | | | | 100.00 | | | | | | (99.99) | | | | |
|
25
|
| |
| |
HSBC Equity (UK) Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | HSBC Europe B.V. | | | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| | HSBC Factoring (France) | | | | | 100.00 | | | | | | (99.99) | | | | |
|
23
|
| |
| |
HSBC Germany Holdings GmbH
|
| | | | 100.00 | | | | | | | | | | |
|
2,24
|
| |
| |
HSBC Global Asset
Management (Deutschland) GmbH |
| | | | 100.00 | | | | | | | | | | |
|
24
|
| |
| | HSBC Global Asset Management (France) | | | | | 100.00 | | | | | | (99.99) | | | | |
|
25
|
| |
| |
Subsidiaries
|
| |
% of share class held by
immediate parent company (or by HSBC Bank plc where this varies) |
| |
Footnotes
|
| ||||||||||||
| |
HSBC Global Asset
Management (International) Limited (In Liquidation) |
| | | | 100.00 | | | | | | | | | | |
|
2,31
|
| |
| |
HSBC Global Asset Management (Malta) Limited
|
| | | | 100.00 | | | | | | (70.03) | | | | |
|
32
|
| |
| | HSBC Global Asset Management (Oesterreich) GmbH (In Liquidation) | | | | | 100.00 | | | | | | | | | | |
|
6,33
|
| |
| |
HSBC Global Asset Management (Switzerland) AG
|
| | | | 100.00 | | | | | | (99.99) | | | | |
|
4,34
|
| |
| |
HSBC Global Custody Nominee (UK) Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | HSBC Global Custody Proprietary Nominee (UK) Limited | | | | | 100.00 | | | | | | | | | | |
|
1,2,15
|
| |
| | HSBC Global Shared Services (India) Private Limited (In Liquidation) | | | | | 99.99 | | | | | | | | | | |
|
1,35
|
| |
| |
HSBC Infrastructure Limited
|
| | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| |
HSBC INKA Investment-AG
TGV |
| | | | 100.00 | | | | | | | | | | |
|
8,24
|
| |
| |
HSBC Insurance Services Holdings Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| |
HSBC Investment Bank Holdings Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| |
HSBC Issuer Services Common Depositary
|
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | HSBC Issuer Services Depositary Nominee (UK) Limited | | | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | HSBC Leasing (France) | | | | | 100.00 | | | | | | (99.99) | | | | |
|
23
|
| |
| | HSBC Life (UK) Limited | | | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | HSBC Life Assurance (Malta) Limited | | | | | 100.00 | | | | | | (70.03) | | | | |
|
32
|
| |
| |
HSBC LU Nominees Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| |
HSBC Marking Name Nominee (UK) Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | HSBC Middle East Leasing Partnership | | | | | n/a | | | | | | | | | | |
|
0,36
|
| |
| | HSBC Operational Services GmbH | | | | | 80.00 | | | | | | | | | | |
|
24
|
| |
| | HSBC Overseas Nominee (UK) Limited | | | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | HSBC PB Corporate Services 1 Limited | | | | | 100.00 | | | | | | | | | | |
|
37
|
| |
| | HSBC Pension Trust (Ireland) DAC | | | | | 100.00 | | | | | | | | | | |
|
2,38
|
| |
| | HSBC PI Holdings (Mauritius) Limited | | | | | 100.00 | | | | | | | | | | |
|
39
|
| |
| |
HSBC Preferential LP (UK)
|
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| |
Subsidiaries
|
| |
% of share class held by
immediate parent company (or by HSBC Bank plc where this varies) |
| |
Footnotes
|
| ||||||||||||
| | HSBC Private Banking Nominee 3 (Jersey) | | | | | 100.00 | | | | | | | | | | |
|
40
|
| |
| | HSBC Private Equity Investments (UK) Limited | | | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| | HSBC Private Markets Management SARL | | | | | 100.00 | | | | | | | | | | |
|
41
|
| |
| | HSBC Property Funds (Holding) Limited | | | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| |
HSBC Real Estate Leasing (France)
|
| | | | 100.00 | | | | | | (99.99) | | | | |
|
23
|
| |
| | HSBC REIM (France) | | | | | 100.00 | | | | | | (99.99) | | | | |
|
25
|
| |
| | HSBC Securities (Egypt) S.A.E. (In Liquidation) | | | | | 100.00 | | | | | | (0.8) | | | | |
|
42
|
| |
| |
HSBC Securities (South Africa) (Pty) Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,43
|
| |
| |
HSBC Securities Services (Guernsey) Limited
|
| | | | 100.00 | | | | | | (99.99) | | | | |
|
17
|
| |
| |
HSBC Securities Services (Ireland) DAC
|
| | | | 100.00 | | | | | | | | | | |
|
38
|
| |
| | HSBC Securities Services (Luxembourg) S.A. | | | | | 100.00 | | | | | | | | | | |
|
2,44
|
| |
| | HSBC Securities Services Holdings (Ireland) DAC | | | | | 100.00 | | | | | | | | | | |
|
38
|
| |
| | HSBC Service Company Germany GmbH | | | | | 100.00 | | | | | | | | | | |
|
24
|
| |
| | HSBC Services (France) | | | | | 100.00 | | | | | | (99.99) | | | | |
|
23
|
| |
| | HSBC SFH (France) | | | | | 100.00 | | | | | | (99.99) | | | | |
|
4,25
|
| |
| | HSBC SFT (C.I.) Limited | | | | | 100.00 | | | | | | | | | | |
|
2,17
|
| |
| |
HSBC Specialist Investments
Limited |
| | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| |
HSBC Transaction Services GmbH
|
| | | | 100.00 | | | | | | | | | | |
|
6,24
|
| |
| |
HSBC Trinkaus & Burkhardt
(International) |
| | | | 100.00 | | | | | | | | | | |
|
44
|
| |
| |
HSBC Trinkaus & Burkhardt
GmbH |
| | | | 100.00 | | | | | | | | | | |
|
24
|
| |
| |
HSBC Trinkaus & Burkhardt
Gesellschaft fur Bankbeteiligungen mbH |
| | | | 100.00 | | | | | | | | | | |
|
24
|
| |
| |
HSBC Trinkaus Europa Immobilien-Fonds Nr. 5 GmbH
|
| | | | 100.00 | | | | | | | | | | |
|
24
|
| |
| |
HSBC Trinkaus Family Office GmbH
|
| | | | 100.00 | | | | | | | | | | |
|
6,24
|
| |
| | HSBC Trinkaus Real Estate GmbH | | | | | 100.00 | | | | | | | | | | |
|
6,24
|
| |
| |
HSBC Trustee (C.I.) Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,40
|
| |
| |
HSBC Trustee (Guernsey) Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,17
|
| |
| | HSIL Investments Limited | | | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| |
Subsidiaries
|
| |
% of share class held by
immediate parent company (or by HSBC Bank plc where this varies) |
| |
Footnotes
|
| ||||||||||||
| | INKA Internationale Kapitalanlagegesellschaft mbH | | | | | 100.00 | | | | | | | | | | |
|
24
|
| |
| |
James Capel & Co. Limited (In Liquidation)
|
| | | | 100.00 | | | | | | | | | | |
|
2,45
|
| |
| |
James Capel (Nominees) Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| |
James Capel (Taiwan) Nominees Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| | Keyser Ullmann Limited | | | | | 100.00 | | | | | | (99.99) | | | | |
|
15
|
| |
| | Midcorp Limited | | | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| |
Prudential Client HSBC GIS
Nominee (UK) Limited |
| | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| |
Republic Nominees Limited
|
| | | | 100.00 | | | | | | | | | | |
|
2,17
|
| |
| |
RLUKREF Nominees (UK)
One Limited |
| | | | 100.00 | | | | | | | | | | |
|
1,2,15
|
| |
| |
RLUKREF Nominees (UK)
Two Limited |
| | | | 100.00 | | | | | | | | | | |
|
1,2,15
|
| |
| |
S.A.P.C. - Ufipro Recouvrement
|
| | | | 99.99 | | | | | | | | | | |
|
23
|
| |
| | Saf Baiyun | | | | | 100.00 | | | | | | (99.99) | | | | |
|
4,23
|
| |
| | Saf Guangzhou | | | | | 100.00 | | | | | | (99.99) | | | | |
|
4,23
|
| |
| |
SCI HSBC Assurances Immo
|
| | | | 100.00 | | | | | | (99.99) | | | | |
|
25
|
| |
| | SFM | | | | | 100.00 | | | | | | (99.99) | | | | |
|
23
|
| |
| | SFSS Nominees (Pty) Limited | | | | | 100.00 | | | | | | | | | | |
|
43
|
| |
| | SNC Dorique | | | | | 99.99 | | | | | | | | | | |
|
1,5,46
|
| |
| |
SNC Les Oliviers D’Antibes
|
| | | | 60.00 | | | | | | (59.99) | | | | |
|
25
|
| |
| | SNCB/M6 - 2008 A | | | | | 100.00 | | | | | | (99.99) | | | | |
|
23
|
| |
| | SNCB/M6-2007 A | | | | | 100.00 | | | | | | (99.99) | | | | |
|
4,23
|
| |
| | SNCB/M6-2007 B | | | | | 100.00 | | | | | | (99.99) | | | | |
|
4,23
|
| |
| | Société Française et Suisse | | | | | 100.00 | | | | | | (99.99) | | | | |
|
23
|
| |
| | Somers Dublin DAC | | | | | 100.00 | | | | | | (99.99) | | | | |
|
38
|
| |
| | Sopingest | | | | | 100.00 | | | | | | (99.99) | | | | |
|
23
|
| |
| | South Yorkshire Light Rail Limited | | | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| | Swan National Limited | | | | | 100.00 | | | | | | | | | | |
|
15
|
| |
| | The Venture Catalysts Limited | | | | | 100.00 | | | | | | | | | | |
|
2,15
|
| |
| |
Trinkaus Australien Immobilien Fonds Nr. 1 Brisbane GmbH & Co. KG
|
| | | | 100.00 | | | | | | | | | | |
|
24
|
| |
| | Trinkaus Australien Immobilien-Fonds Nr. 1 Treuhand-GmbH | | | | | 100.00 | | | | | | | | | | |
|
6,24
|
| |
| |
Trinkaus Europa Immobilien-
Fonds Nr.3 Objekt Utrecht Verwaltungs-GmbH |
| | | | 100.00 | | | | | | | | | | |
|
24
|
| |
| |
Trinkaus Immobilien-Fonds
Geschaeftsfuehrungs-GmbH |
| | | | 100.00 | | | | | | | | | | |
|
6,24
|
| |
| |
Trinkaus Immobilien-Fonds
Verwaltungs-GmbH |
| | | | 100.00 | | | | | | | | | | |
|
6,24
|
| |
| | Trinkaus Private Equity Management GmbH | | | | | 100.00 | | | | | | | | | | |
|
24
|
| |
| | Trinkaus Private Equity Verwaltungs GmbH | | | | | 100.00 | | | | | | | | | | |
|
6,24
|
| |
| | Valeurs Mobilières Elysées | | | | | 100.00 | | | | | | (99.99) | | | | |
|
23
|
| |
|
Joint Ventures
|
| |
% of share class held by
immediate parent company (or by HSBC Bank plc where this varies) |
| |
Footnotes
|
| |||||||||
| HCM Holdings Limited (In Liquidation) | | | | | 50.99 | | | | | | | |
|
20
|
| |
| The London Silver Market Fixing Limited | | | | | n/a | | | | | | | |
|
0,1,2,47
|
| |
|
Associates
|
| |
% of share class held by
immediate parent company (or by HSBC Bank plc where this varies) |
| |
Footnotes
|
| |||||||||
| BGF Group PLC | | | | | 24.62 | | | | | | | | | 48 | | |
| Bud Financial Limited | | | | | 10.89 | | | | | | | | | 1,3,49 | | |
|
CFAC Payment Scheme Limited (In Liquidation)
|
| | | | 33.33 | | | | | | | | | 2,3,50 | | |
| Contour Pte Ltd | | | | | 11.76 | | | | | | | | | 51 | | |
|
Divido Financial Services Limited
|
| | | | 5.60 | | | | | | | | | 52 | | |
| Episode Six Limited | | | | | 8.09 | | | | | | | | | 53 | | |
| Euro Secured Notes Issuer | | | | | 16.66 | | | | | | | | | 54 | | |
| LiquidityMatch LLC | | | | | n/a | | | | | | | | | 0,55 | | |
| London Precious Metals Clearing Limited | | | | | 25.00 | | | | | | | | | 2,56 | | |
| Quantexa Ltd | | | | | 10.10 | | | | | | | | | 57 | | |
|
Services Epargne Enterprise
|
| | | | 14.18 | | | | | | | | | 58 | | |
| Simon Group LLC | | | | | n/a | | | | | | | | | 0,12 | | |
| sino AG | | | | | 24.94 | | | | | | | | | 11 | | |
| Threadneedle Software Holdings Limited | | | | | 6.60 | | | | | | | | | 13 | | |
|
Trade Information Network
Limited |
| | | | 16.66 | | | | | | | | | 10 | | |
|
Trinkaus Europa Immobilien-
Fonds Nr. 7 |
| | | | n/a | | | | | | | | | 0,24 | | |
| Vizolution Limited | | | | | 17.95 | | | | | | | | | 1,9 | | |
| We Trade Innovation Designated Activity | | | | | 9.88 | | | | | | | | | 1,14 | | |
| |
0
|
| |
Where an entity is governed by voting rights, HSBC consolidates when it holds - directly or indirectly - the necessary voting rights to pass resolutions by the governing body. In all other cases, the assessment of control is more complex and requires judgement of other factors, including having exposure to variability of returns, power to direct relevant activities, and whether power is held as an agent or principal. HSBC’s consolidation policy is described in Note 1.2(a).
|
|
| |
1
|
| |
Management has determined that these undertakings are excluded from consolidation in the Group accounts as these entities do not meet the definition of subsidiaries in accordance with IFRSs. HSBC’s consolidation policy is described in Note 1.2(a).
|
|
| |
2
|
| | Directly held by HSBC Bank plc | |
| |
3
|
| | Preference Shares | |
| |
4
|
| | Actions | |
| |
5
|
| | Parts | |
| |
6
|
| | GmbH Anteil | |
| |
7
|
| | Russian Limited Liability Company Shares | |
| |
8
|
| | Stückaktien | |
| |
9
|
| |
Office Block A, Bay Studios Business Park, Fabian Way, Swansea, Wales, United Kingdom, SA1 8QB
|
|
| | 10 | | | 3 More London Riverside, London, United Kingdom, SE1 2AQ | |
| | 11 | | | Ernst-Schneider-Platz 1, Duesseldorf, Germany, 40212 | |
| | 12 | | |
125 W 25th St. New York, New York, United States of America, 10001
|
|
| | 13 | | | 34 Copse Wood Way, Northwood, Middlesex, United Kingdom, HA6 2UA | |
| | 14 | | | 10 Earlsfort Terrace, Dublin, Ireland, D02 T380 | |
| | 15 | | |
8 Canada Square , London, United Kingdom, E14 5HQ
|
|
| | 16 | | |
5 Donegal Square South, Northern Ireland, Belfast, United Kingdom, BT1 5JP
|
|
| | 17 | | |
Arnold House, St Julians Avenue, St Peter Port, Guernsey, GY1 3NF
|
|
| | 18 | | |
HSBC Main Building, 1 Queen’s Road Central, Hong Kong
|
|
| | 19 | | |
Oak House, Hirzel Street, St Peter Port, Guernsey, GY1 2NP
|
|
| | 20 | | |
156 Great Charles Street, Queensway, Birmingham, West Midlands, United Kingdom, B3 3HN
|
|
| | 21 | | |
Solidere - Rue Saad Zaghloul Immeuble - 170 Marfaa, P.O. Box 17 5476 Mar Michael, Beyrouth, Lebanon, 11042040
|
|
| | 22 | | | c/o Walkers Corporate Services Limited, Walker House, 87 Mary Street, George Town, Grand Cayman, Cayman Islands, KY1-9005 | |
| | 23 | | | 38 avenue Kléber, Paris, France, 75116 | |
| | 24 | | | Hansaallee 3, Düsseldorf, Germany, 40549 | |
| | 25 | | | Immeuble Cœur Défense, 110 esplanade du Général de Gaulle, Courbevoie, France, 92400 | |
| | 26 | | | HSBC House Esplanade, St. Helier, Jersey, JE4 8UB | |
| | 27 | | | 2 Paveletskaya Square Building 2, Moscow, Russian Federation, 115054 | |
| | 28 | | | 66 Teryan Street, Yerevan, Armenia, 0009 | |
| | 29 | | | 116 Archbishop Street, Valletta, Malta | |
| | 30 | | | HSBC House Esplanade, St. Helier, Jersey, JE1 1HS | |
| | 31 | | | HSBC House Esplanade, St. Helier, Jersey, JE4 8WP | |
| | 32 | | | 80 Mill Street, Qormi, Malta, QRM 3101 | |
| | 33 | | | Herrengasse 1-3, Wien, Austria, 1010 | |
| | 34 | | | 26 Gartenstrasse, Zurich, Switzerland, 8002 | |
| | 35 | | | 52/60 M G Road Fort, Mumbai, India, 400 001 | |
| | 36 | | |
Unit 101 Level 1, Gate Village Building No. 8 Dubai International Financial Centre (DIFC), Dubai, United Arab Emirates, P.O. Box 506553
|
|
| | 37 | | | HSBC House Esplanade, St. Helier, Jersey, JE1 1GT | |
| | 38 | | | 1 Grand Canal Square, Grand Canal Harbour, Dublin 2, Ireland, D02 P820 | |
| | 39 | | | 6th floor HSBC Centre 18, Cybercity, Ebene, Mauritius, 72201 | |
| | 40 | | | HSBC House Esplanade, St Helier, Jersey, JE1 1GT | |
| | 41 | | | 5 rue Heienhaff, Senningerberg, Luxembourg, 1736 | |
| | 42 | | | 306 Corniche El Nil, Maadi, Egypt, 11728 | |
| | 43 | | |
1 Mutual Place, 107 Rivonia Road, Sandton, Gauteng, South Africa, 2196
|
|
| | 44 | | | 16 Boulevard d’Avranches, Luxembourg, L-1160 | |
| | 45 | | |
Teneo Restructuring Limited, 156 Great Charles Street, Queensway, West Midlands, Birmingham, United Kingdom, B3 3HN
|
|
| | 46 | | | 43 rue de Paris, Saint Denis, France, 97400 | |
| | 47 | | |
c/o Hackwood Secretaries Limited One Silk Street, London, United Kingdom, EC2Y 8HQ
|
|
| | 48 | | | 13-15 York Buildings, London, United Kingdom, WC2N 6JU | |
| | 49 | | | Ground Floor, 25b Vyner Street, London, United Kingdom, E2 9DG | |
| | 50 | | | 65 Gresham Street 6th Floor, London, United Kingdom, EC2V 7NQ | |
| | 51 | | | 50 Raffles Place, #32-01 Singapore Land Tower, Singapore, 048623 | |
| | 52 | | | Office 7, 35-37 Ludgate Hill, London, United Kingdom, EC4M 7JN | |
| | 53 | | | 9/F Amtel Bldg, 148 des Voeux Rd Central, Central, Hong Kong | |
| | 54 | | | 3 avenue de l’Opera, Paris, France, 75001 | |
| | 55 | | | 100 Town Square Place, Suite 201 | Jersey City, NJ, United States of America, 07310 | |
| | 56 | | | 1-2 Royal Exchange Buildings Royal Exchange, London, United Kingdom, EC3V 3LF | |
| | 57 | | |
75 Park Lane, Croydon, Surrey, United Kingdom, CR9 1XS
|
|
| | 58 | | | 32 rue du Champ de Tir, Nantes, France, 44300 | |